<SEC-DOCUMENT>0001144204-19-025292.txt : 20190510
<SEC-HEADER>0001144204-19-025292.hdr.sgml : 20190510
<ACCEPTANCE-DATETIME>20190510163338
ACCESSION NUMBER:		0001144204-19-025292
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20190509
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190510
DATE AS OF CHANGE:		20190510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Armata Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37544
		FILM NUMBER:		19815479

	BUSINESS ADDRESS:	
		STREET 1:		3579 VALLEY CENTRE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		804-827-2524

	MAIL ADDRESS:	
		STREET 1:		3579 VALLEY CENTRE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AmpliPhi Biosciences Corp
		DATE OF NAME CHANGE:	20130222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv521048_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B>&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND
EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C.
20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section&nbsp;13
or 15(d) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Securities Exchange
Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date of Report
(Date of earliest event reported): May 9, 2019 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File
Number: 001-37544 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Armata
Pharmaceuticals, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Exact name of
registrant as specified in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>91-1549568</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
    or other jurisdiction of incorporation)</B></FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
    Employer Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>4503 Glencoe Avenue
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Marina del Rey,
California 90292</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal
executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(310) 655-2928</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Registrant&rsquo;s
telephone number)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AmpliPhi Biosciences
Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Former name or
former address, if changed since last report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
                                         communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
                                         material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
                                         communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
                                         communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company </FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="width: 1%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock</B></FONT></TD>
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARMP</B></FONT></TD>
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NYSE
    American</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 1.01</B></TD><TD><B>Entry into a Material Definitive Agreement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure relating to the Registration Rights Agreement
set forth in Item 3.02 below is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 2.01</B></TD><TD><B>Completion of Acquisition or Disposition of Assets.
                                         </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As previously disclosed, on January 3, 2019, Armata Pharmaceuticals,
Inc. (f/k/a AmpliPhi Biosciences Corporation) (&ldquo;<I>Armata</I>&rdquo;) entered into an Agreement and Plan of Merger and Reorganization
(as amended on March 25, 2019, the &ldquo;<I>Merger Agreement</I>&rdquo;) with C3J Therapeutics, Inc., a Washington corporation
(&ldquo;<I>C3J</I>&rdquo;), a clinical-stage biotechnology company focused on the development and commercialization of novel targeted
antimicrobials, and Ceres Merger Sub, Inc., a Washington corporation and wholly owned subsidiary of Armata (&ldquo;<I>Merger Sub</I>&rdquo;).
Upon the terms and subject to the satisfaction of the conditions described in the Merger Agreement, including approval of the
transaction by Armata&rsquo;s shareholders and C3J&rsquo;s shareholders, Merger Sub would be merged with and into C3J (the&nbsp;&ldquo;<I>Merger</I>&rdquo;),
with C3J surviving the Merger as a wholly-owned subsidiary of Armata. The Merger is intended to qualify as a tax-free reorganization
for U.S. federal income tax purposes. Concurrently with the execution of the Merger Agreement, certain officers, directors and
shareholders of Armata and C3J entered into lock-up agreements (the &ldquo;<I>Lock-Up Agreements</I>&rdquo;), pursuant to which
they accepted certain restrictions on transfers of the shares of Armata for the 180-day period following the effective time of
the Merger (the &ldquo;<I>Effective Time</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 9, 2019, the Merger was completed following a Special
Meeting of Armata&rsquo;s shareholders (as defined and described in Item 5.07 below). Pursuant to Articles of Merger (the &ldquo;<I>Articles
of Merger</I>&rdquo;), filed by Armata, which became effective at 8:05 a.m. PT on May 9, 2019, C3J was merged with and into Merger
Sub. As a result of the Merger, C3J became a wholly-owned subsidiary of Armata. At the Effective Time, each share of C3J common
stock outstanding was converted into the right to receive 0.04932975 shares of Armata common stock (after giving effect to the
Reverse Split, as defined below, the &ldquo;<I>Merger Consideration</I>&rdquo;). Accordingly, Armata issued 5,578,166 shares of
common stock as of the Effective Time in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended, and the related
instructions related thereto) (the &ldquo;<I>Securities Act</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger was treated as a reverse merger under the acquisition
method of accounting in accordance with accounting principles generally accepted in the United States. For accounting purposes,
C3J is considered to have acquired Armata.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immediately prior to the consummation of the Merger, Armata
filed Articles of Amendment (the &ldquo;<I>Amendment</I>&rdquo;) to its Amended and Restated Articles of Incorporation to effectuate
a 1-for-14 reverse split of its issued and outstanding shares of common stock (the &ldquo;<I>Reverse Split</I>&rdquo;) and to
change its name to &ldquo;Armata Pharmaceuticals, Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immediately following the consummation of the Merger, Armata
completed the Financing (as defined and described in Item 3.02 below). The disclosures set forth in Item 3.02 below are incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Armata common stock began trading on the NYSE American
(the &ldquo;<I>NYSE</I>&rdquo;) under the symbol &ldquo;ARMP&rdquo; and with the new CUSIP number 04216R 102 when the NYSE market
opened on May 10, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the consummation of the transactions described above,
as of the close of business on May 9, 2019, there were 9,960,078 shares of Armata common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the Merger, the headquarters of Armata are located
in Marina del Rey (C3J&rsquo;s former headquarters).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description does not constitute a complete summary
of the terms of the Amendment or the Articles of Merger, and is qualified in its entirety by reference to the full text of the
Amendment and the Articles of Merger, copies of which are filed as Exhibit 3.1 and 3.2 to this report, respectively, and incorporated
by reference herein. In addition, the description of the Merger Agreement is qualified in its entirety by reference to the Agreement
and Plan of Merger and Reorganization, included as Exhibit 2.1 to the Current Report on Form 8-K filed by Armata on January 4,
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On  May 9, 2019, Armata issued a press release
relating to, among other things, certain of the matters set forth in this report. A copy of the press release is attached as Exhibit
99.1 hereto and is incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 3.01</B></TD><TD><B>Notice of Delisting or Failure to Satisfy a Continued
                                         Listing Rule or Standard; Transfer of Listing.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to the consummation of the Merger, shares of Armata common
stock were listed on the NYSE under the symbol &ldquo;APHB.&rdquo; In connection with the Merger, Armata submitted an initial
listing application with NYSE to seek listing of the combined company&rsquo;s common stock on the NYSE upon the consummation of
the Merger, and such request was granted on May 6, 2019, subject to compliance with all applicable listing standards at the time
of commencement of trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The NYSE&rsquo;s listing standards require an issuer seeking
to qualify for listing to have, among other things, a $3.00 per share minimum bid price. Therefore, Armata completed the Reverse
Split, which became effective at 8:00 a.m. PT on May 9, 2019, immediately prior to the consummation of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As disclosed in Item 5.07 below, at the Special Meeting, prior
to completing the Reverse Split, Armata&rsquo;s shareholders approved a proposal authorizing Armata&rsquo;s board of directors
to effect a reverse stock split by a ratio in the range between 1-for-3 to 1-for-20, inclusive. The final ratio of 1-for-14 was
determined by Armata&rsquo;s board of directors following the Special Meeting on May 8, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: White">As a result of the Reverse
Split, each fourteen pre-split shares of Armata common stock outstanding were automatically combined into one new share of Armata
common stock without any action on the part of the shareholders. The number of outstanding shares of Armata common stock was reduced
from approximately 33.5 million to approximately 2.4 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: White">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares of Armata common stock began trading on a split-adjusted
basis, symbol &ldquo;ARMP&rdquo; and with the new CUSIP number 04216R 102 when the NYSE market opened on May 10, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Reverse Split did not change the number of authorized shares
of Armata common stock or preferred stock, or the par value of Armata common stock or preferred stock. No fractional shares were
issued in connection with the Reverse Split. Shareholders who would have otherwise been entitled to receive a fractional share
will instead receive a cash payment based on the closing price of Armata&rsquo;s common stock on May 8, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 3.02</B></TD><TD><B>Unregistered Sales of Equity Securities.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Merger Consideration</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure relating to the Merger Consideration set forth
in Item 2.01 above is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Financing Transaction</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As previously disclosed, on February 5, 2019, Armata and C3J
entered into a share purchase agreement (the &ldquo;<I>Share Purchase Agreement</I>&rdquo;) with certain shareholders of C3J (the
&ldquo;<I>Investors</I>&rdquo;), pursuant to which Armata agreed to sell, and the Investors agreed to buy, in a private placement,
shares of Armata common stock (the &ldquo;<I>Financing Shares</I>&rdquo;) immediately following the Effective Time of the Merger,
having an aggregate purchase price of&thinsp; $10.0 million (the&nbsp;&ldquo;<I>Financing</I>&rdquo;). An aggregate of 1,991,269
shares of Armata common stock was issued to the Investors in the Financing at a price of approximately $5.02192 per share. The
Financing Shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act,
and such shares bear appropriate restrictive legends. In addition, the Financing Shares are subject to the provisions of the Lock-Up
Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immediately following the closing of the Merger and the Financing,
the former C3J security holders (including the Investors) own approximately 76% of the aggregate number of shares of Armata common
stock (of which approximately 20% is comprised of the shares issued in the Financing to the Investors) and the security holders
of Armata as of immediately prior to the Merger own approximately 24% of the aggregate number of shares of Armata common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Financing, Armata and the Investors
entered into a registration rights agreement (the&nbsp;&ldquo;<I>Registration Rights Agreement</I>&rdquo;), dated May 9, 2019,
pursuant to which Armata will agree to cause the Shares to be registered for resale under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description does not constitute a complete summary
of the terms of the Registration Rights Agreement and is qualified in its entirety by reference to the full text of the Registration
Rights Agreement, a copy of which is filed as Exhibit 10.1 to this report and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 3.03</B></TD><TD><B>Material Modification to Rights of Security Holders.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosures set forth in Items 2.01 and 3.02 above and
in Items 5.01, 5.03, and 5.07 below, are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of May 9, 2019, Armata adopted a new form of stock certificate
representing its common stock on and after the Effective Time to reflect the name change, the Reverse Split, and updated signatories.
The form of stock certificate is attached hereto as Exhibit 4.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 4.01</B></TD><TD><B>Changes in Registrant&rsquo;s Certifying Accountant.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure set forth in Item 2.01 above is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dismissal of PwC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PricewaterhouseCoopers LLP (&ldquo;<I>PwC</I>&rdquo;) was previously
engaged as the independent registered public accounting firm for C3J. On January 28, 2019, the Audit Committee of C3J&rsquo;s
board of directors (the &ldquo;<I>C3J Audit Committee</I>&rdquo;) dismissed PwC as C3J&rsquo;s independent registered public accounting
firm, effective immediately (the &ldquo;<I>January Termination</I>&rdquo;), and engaged Ernst &amp; Young LLP (&ldquo;<I>EY</I>&rdquo;)
as discussed below to serve in such capacity instead. EY has served as Armata&rsquo;s independent registered public accounting
firm since 2015, and will serve as the independent registered public accounting firm for the combined company following the consummation
of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In anticipation of the Merger, however, the C3J Audit Committee
engaged PwC to audit C3J&rsquo;s consolidated financial statements for the fiscal year ended December 31, 2017 in accordance with
the standards of the Public Company Accounting Oversight Board (United States) (the &ldquo;<I>PCAOB standards audit</I>&rdquo;).
PwC had previously audited those financial statements in accordance with auditing standards generally accepted in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 18, 2019, the C3J Audit Committee determined to
terminate PwC&rsquo;s engagement with respect to the PCAOB standards audit of C3J&rsquo;s December 31, 2017 consolidated financial
statements, and PwC was notified of such determination on February 18, 2019 (such termination, the &ldquo;<I>February Termination</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PwC&rsquo;s PCAOB standards audit of C3J&rsquo;s December 31,
2017 consolidated financial statements was in process but not yet complete at the time of the February Termination. Accordingly,
PwC did not complete the PCAOB standards audit of C3J&rsquo;s 2017 consolidated financial statements, and PwC did not issue an
audit report under PCAOB standards with respect to those financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The reports of PwC on C3J&rsquo;s consolidated financial statements
for the years ended December&nbsp;31, 2017 and 2016 (which were issued under auditing standards generally accepted in the United
States but were never filed with the U.S. Securities and Exchange Commission (the &ldquo;<I>Commission</I>&rdquo;) because C3J
was not subject to such reporting requirements) did not contain an adverse opinion or disclaimer of opinion, nor were they qualified
or modified as to uncertainty, audit scope, or accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s fiscal years ended December 31, 2018 and
2017 and the subsequent interim period through dates of the January Termination and the February Termination, respectively, there
were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K under the Securities Act (&ldquo;<I>Regulation S-K</I>&rdquo;))
between C3J and PwC on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or
procedures, which disagreements, if not resolved to PwC&rsquo;s satisfaction, would have caused PwC to make reference to the subject
matter of the disagreement in their reports on C3J&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s fiscal years ended December 31, 2018 and
2017 and the subsequent interim period through dates of the January Termination and the February Termination, respectively, there
were no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K), except that PwC reported to C3J and the C3J Audit
Committee that it believed a material weakness in internal control over financial reporting existed related to the lack of segregation
of duties, particularly as it relates to the processing of journal entries (such matter as reported by PwC to C3J and the C3J
Audit Committee being hereinafter referred to as the &ldquo;<I>Matter</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata has provided PwC with a copy of the disclosures it is
making in this report and requested that PwC furnish a letter addressed to the Commission stating whether or not it agrees with
the statements made herein. A copy of the letter, dated May 10, 2019, is filed as Exhibit 16.1 to this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Engagement of EY</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described above, effective January 29, 2019, C3J retained
EY as its registered public accounting firm, and effective February 21, 2019, C3J retained EY to conduct the PCAOB standards audit
of C3J&rsquo;s December 31, 2017 consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s two most recent fiscal years and the subsequent
interim period preceding the engagement of EY, neither C3J nor anyone on its behalf consulted with EY with respect to: (i) the
application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that
might be rendered on C3J&rsquo;s consolidated financial statements, and no written report or oral advice of EY was provided to
C3J that was an important factor considered by C3J in reaching a decision as to the accounting, auditing, or financial reporting
issue; or (ii) any matter that was either the subject of a &ldquo;disagreement&rdquo; (as defined in Item 304(a)(1)(iv) of Regulation
S-K), or any &ldquo;reportable event&rdquo; (as defined in Item 304(a)(1)(v) of Regulation S-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.01</B></TD><TD><B>Changes in Control of Registrant.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosures contained in Items 2.01, 3.02, 3.03 above,
and Item 5.07 below, are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immediately upon consummation of the Merger, the C3J shareholders
prior to the Merger hold a majority of the voting interest of the combined company. In addition, the seven-member board of directors
of the combined company include five of the individuals that served as members of the C3J board of directors immediately prior
to the consummation of the Merger, and therefore, such members possess majority control of the board of directors of the combined
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.02</B></TD><TD><B>Departure of Directors or Certain Officers; Election
                                         of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
                                         </B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Appointment and Departure of Certain Directors and Officers</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Merger Agreement, the officers of Armata include:
(i) Todd R. Patrick, who served as chief executive officer of C3J before the Effective Time, and became chief executive officer
of Armata upon the Effective Time; (ii)&nbsp;Brian Varnum, Ph.D., who served as chief development officer of C3J before the Effective
Time, and became the president and chief development officer of Armata upon the Effective Time; (iii) Steve R. Martin, who served
as Armata&rsquo;s chief financial officer prior to the Effective Time, and retained his position as chief financial officer of
Armata upon the Effective Time, and (iv) Duane Morris, who served as the vice president, operations of C3J prior to the Effective
Time, and became the vice president, operations of Armata upon the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the Effective Time, Paul C. Grint, M.D. resigned from
his position as chief executive officer of Armata. In connection with his resignation, Dr. Grint became entitled to receive the
severance and change of control payments described in his offer letter agreement with Armata, dated June 1, 2017. For additional
information regarding these payments, please refer to &ldquo;Interests of the AmpliPhi Directors and Executive Officers in the
Merger&mdash;Directors and Executive Officers Following the Merger&rdquo; beginning on page 83 of the Definitive Proxy Statement
on Schedule 14A, initially filed by Armata with the Commission on April 4, 2019 and as amended and supplemented on April 15, 2019
and May 1, 2019 (the &ldquo;<I>Proxy Statement</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While Dr. Grint resigned as an officer of Armata, he is continuing
as a consultant in a transitional role for a period of six months. As consideration for his consulting services, Armata will grant
him, subject to approval by Armata&rsquo;s board of directors, an option under the 2016 Plan (as defined below) to purchase 1,786
shares of the Company&rsquo;s common stock at an exercise price equal to the fair market value of the share of the Company&rsquo;s
common stock on the date of grant. Subject to certain terms and conditions, the option will vest at the end of the six-month consulting
period and will remain exercisable for a period of one year after the termination of such six-month consulting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, each of Louis Drapeau, Dr. Grint, Wendy S. Johnson
and Vijay Samant resigned from Armata&rsquo;s board of directors upon the Effective Time, and the designees of C3J pursuant to
the Merger Agreement, Richard Bastiani, Ph.D., Richard Bear, H. Stewart Parker, Todd R. Patrick and Joseph M. Patti, Ph.D. were
appointed to fill the vacancies created by the resignations of the former Armata directors listed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jeremy Curnock Cook and Michael S. Perry, D.V.M, Ph.D. each
served as directors of Armata prior to the Merger and continue to serve as directors of Armata following the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Patrick is subject to an Employment Agreement, dated October
1, 2018, between Mr. Patrick and C3J Therapeutics, Inc., as amended on January 3, 2019 (the &ldquo;<I>Employment Agreement</I>&rdquo;).
The Employment Agreement provides for an initial term of three years. Mr. Patrick will be paid an annual base salary as may be
established from time to time by the board of directors, and an annual cash bonus, in accordance with a milestone based structure
established by the board of directors, enabling him to earn between 50% and 100% of the amount of his base salary as a bonus.
He will also be eligible for all fringe benefit plans available to other full-time employees. If Mr. Patrick is terminated without
Cause (as defined in the 2016 Plan ) or resigns for Good Reason (as defined in the Employment Agreement), then he will be entitled
to a severance payment equal to his base salary plus 50% bonus (the bonus to be paid whether earned or unearned) for the then
remaining term of the contract, or through September 30, 2021, such payment to be lengthened to a minimum of one year or twelve
(12) months of base salary and bonus, if his termination occurs during any month during the 2021 calendar year. The foregoing
description does not constitute a complete summary of the terms of the Employment Agreement and is qualified in its entirety by
reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.2 and Exhibit 10.3 (collectively)
to this report and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other than as set forth above, there is no arrangement or understanding
between any of Mr. Patrick, Dr. Varnum, Mr.&nbsp;Martin, or Mr. Morris and any other person pursuant to which he was selected
as an officer of Armata, and there are no family relationships between any of Mr. Patrick, Dr. Varnum, Mr. Martin, or Mr. Morris
and any of Armata&rsquo;s directors or executive officers. There are no transactions to which Armata is a party and in which any
of Mr. Patrick, Dr. Varnum, Mr. Martin, or Mr. Morris has a direct or indirect material interest that would be required to be
disclosed under Item 404(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with their appointment, each director will receive
a standard director appointment letter (the &ldquo;<I>Director Letter</I>&rdquo;), setting forth, among other things, such director&rsquo;s
duties as a member of the board of directors of Armata and compensation arrangements. A form of Director Letter is attached hereto
as Exhibit 10.4 and is incorporated herein by reference. In addition, Armata intends to enter into an indemnity agreement with
each director and executive officer, a form of which was filed by Armata with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information regarding the new directors and executive officers
of Armata was previously disclosed in the Proxy Statement, under the heading &ldquo;Directors and Officers of AmpliPhi Following
the Merger.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>EIP Amendment</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure set forth in Item 5.07 relating to the EIP Amendment
(as defined below) is incorporated by reference herein. The EIP Amendment is described in greater detail in the Proxy Statement
under the caption &ldquo;Matters Being Submitted to a Vote of AmpliPhi Shareholders &mdash; Proposal No. 4 &mdash;Approval of
the amendment to the AmpliPhi 2016 Equity Incentive Plan to increase the shares authorized for issuance under the plan by 13,822,963&rdquo;,
which disclosure is incorporated herein by reference. After giving effect to the Reverse Split, the number of shares authorized
for issuance under the plan was increased by 987,354. The description of the 2016 Plan contained in the Proxy Statement is qualified
in its entirety by reference to the full text of the 2016 Plan, which is attached as Appendix E thereto and is incorporated therein
by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.03</B></TD><TD><B>Amendments to Articles of Incorporation or Bylaws;
                                         Change in Fiscal Year.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure set forth in Items 2.01, 3.01, and 5.01 above,
and Item 5.07 below, are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.07</B></TD><TD><B>Submission of Matters to a Vote of Security Holders</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosures set forth in Items 2.01, 3.01, 3.02, 3.03,
5.01, and 5.03 above are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 8, 2019, a Special Meeting (the &ldquo;<I>Special Meeting</I>&rdquo;)
of Armata&rsquo;s common shareholders was held. At the close of business on the record date, Armata had 32,774,690 shares of common
stock outstanding (pre-Reverse Split) and entitled to vote. A summary of the matters voted upon by the Armata shareholders is
set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A total of 19,177,595 shares of Armata common stock were present
at the meeting in person or by proxy, which represents approximately 58.5% of the shares of Armata common stock outstanding on
the record date for the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following actions occurred at the Special Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD>The Merger was approved;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD>The Financing was approved;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD>The Amendment and the Reverse Split were approved; &#8203;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD>An amendment to Armata&rsquo;s 2016 Equity Incentive Plan (the
                                         &ldquo;<I>2016 Plan</I>&rdquo;) to increase the shares authorized for issuance thereunder
                                         by 13,822,963 shares (without giving effect to the Reverse Split) (the&nbsp;&ldquo;<I>EIP
                                         Amendment</I>&rdquo;) was approved; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.</TD><TD>Authorization of the adjournment of the Special Meeting, if
                                         necessary, in order to solicit additional proxies if there are not sufficient votes to
                                         approve Proposal Nos. 1 through 4.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8203;The votes were as follows (which votes are presented
on a pre-Reverse Split basis):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 1 &mdash; Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">18,110,167 shares voted for, 700,640 shares voted against,
376,788 shares abstained from voting, and there were no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 2 &mdash; Financing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">17,551,913 shares voted for, 1,231,225 shares voted against,
394,457 shares abstained from voting, and there were no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 3 &mdash; Reverse Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,663,951 shares voted for, 2,336,145 shares voted against,
177,499 shares abstained from voting, and there were no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 4 &mdash; EIP Amendment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">14,187,863 shares voted for, 4,549,588 shares voted against,
440,144 shares abstained from voting, and there were no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 5 &mdash; Adjournment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,032,308 shares voted for, 2,529,322 shares voted against,
615,965 shares abstained from voting, and there were no broker non-votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements
of Businesses Acquired.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial statements and information required by this Item
9.01(a) will be filed by amendment to this report not later than 71 calendar days after the date on which this report is required
to be filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro Forma Financial
Information</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial statements and information required by this Item
9.01(b) will be filed by amendment to this report not later than 71 calendar days after the date on which this report is required
to be filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid">Exhibit
                                         Number</P>

</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid">Description</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 27pt; width: 8%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 85%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;3.1</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Articles
    of Amendment to Amended and Restated Articles of Incorporation, dated as of May 9, 2019.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;3.2</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Articles
    of Merger, dated as of May 9, 2019. </FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;4.1</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
    of the Armata Pharmaceuticals, Inc. Common Stock Certificate.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Registration
    Rights Agreement, dated as of May 9, 2019, by and among Armata Pharmaceuticals, Inc. and the Investors.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.2</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employment
    Agreement, dated October 1, 2018, between C3J Therapeutics, Inc. and Todd R. Patrick.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex10-3.htm" STYLE="-sec-extract: exhibit">10.3</A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated as of January 16, 2019,&nbsp;&nbsp;between C3J Therapeutics, Inc. and Todd R. Patrick.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.4</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
    of Director Appointment Letter.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex16-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">16.1</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex16-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Letter
    from PricewaterhouseCoopers LLP to the U.S. Securities and Exchange Commission, dated May 10, 2019.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"><A HREF="tv521048_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">99.1</FONT></A></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv521048_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif">Press
    release, dated May 9, 2019.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: May 10, 2019</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Armata Pharmaceuticals, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Todd R.
    Patrick</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Todd R. Patrick</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tv521048_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 65%; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: center; font-size: 10pt; font-weight: bold">FILED</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt; font-weight: bold">Secretary of State <BR>
State of Washington <BR>
Date Filed: 05/09/2019 <BR>
Effective Date: 05/09/2019 <BR>
UBI No: 601 166 399</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: normal; color: black"><B>ARTICLES
OF AMENDMENT </B></FONT><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: normal; color: black"><B>AMENDED
AND </B></FONT><B>RESTATED <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: normal; color: black">ARTICLES
</FONT>OF <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: normal; color: black">INCORPORATION</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-style: normal; font-variant: normal"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>AMPLIPHI
BIOSCIENCES CORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>(a
Washington corporation)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="background-color: white">Pursuant
to the provisions of the Washington Business Corporation Act (the &ldquo;WBCA&rdquo;), RCW 23B.10.020 and RCW 23B.10.060, the undersigned
corporation hereby submits these Articles of Amendment for filing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="font-variant: small-caps; background-color: white"><B>First:
</B></FONT><FONT STYLE="background-color: white">The name of the corporation is AmpliPhi
Biosciences Corporation (the &ldquo;Corporation&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="font-variant: small-caps; background-color: white"><B>Second:
</B></FONT><FONT STYLE="background-color: white">This amendment to the Corporation&rsquo;s Amended and Restated Articles of Incorporation
(&ldquo;Amended Articles&rdquo;) was adopted by the Board of Directors of the Corporation (the &ldquo;Board&rdquo;) on May 8,
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; background-color: white"><B>Third:
</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Effective as of 8:00 a.m., Pacific
time, on May 9, 2019 (the &ldquo;Effective Time&rdquo;), Section </FONT>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">1
of Article 4 of the Amended Articles be, and it hereby is, amended and restated in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><FONT STYLE="font-style: normal; font-variant: normal"><B>&ldquo;4.1
Authorized Capital.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The
total authorized stock of this corporation shall consist of 217,000,000 shares of Common Stock, par value $0.01 per share, and
10,000,000 shares of Preferred Stock, par value $0.</FONT>01 <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">per
share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; background-color: transparent"><FONT STYLE="background-color: white">Effective
as of the Effective Time, each fourteen (14) shares of the Corporation&rsquo;s Common Stock, par value $0.01 per share, issued
and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the Corporation
or the respective holders thereof, be combined into one (1) share of Common Stock without increasing or decreasing the par value
of each share of Common Stock (the &ldquo;Reverse Split&rdquo;); <I>provided, however,</I> no fractional shares of Common Stock
shall be issued as a result of the Reverse Split and, in lieu thereof, upon receipt after the Effective Time by the exchange agent
selected by the Corporation of a properly completed and duly executed transmittal letter and, where shares are held in certificated
form, the surrender of the stock certificate(s) formerly representing shares of pre-Reverse Split Common Stock, any shareholder
who would otherwise be entitled to a fractional share of post-Reverse Split Common Stock as a result of the Reverse Split, following
the Effective Time (after taking into account all fractional shares of post-Reverse Split Common Stock otherwise issuable to such
shareholder), shall be entitled to receive a cash payment (without interest) equal to the fractional share of post-Reverse Split
Common Stock to which such shareholder would otherwise be entitled multiplied by the average of the closing sales prices of a share
of the Corporation&rsquo;s Common Stock (as adjusted to give effect to the Reverse Split) on the NYSE American during regular trading
hours for the five (5) consecutive trading days immediately preceding the date these Articles of Amendment are filed with the Secretary
of State of the State of Washington. Each stock certificate that, immediately prior to the Effective Time, represented shares of
pre-Reverse Split Common Stock shall, from and after the Effective Time, automatically and without any action on the part of the
Corporation or the respective holders thereof, represent that number of whole shares of post-Reverse Split Common Stock into which
the shares of pre-Reverse Split Common Stock represented by such certificate shall have been combined (as well as the right to
receive cash in lieu of any fractional shares of post-Reverse Split Common Stock as set forth above; provided, however, that each
holder of record of a certificate that represented shares of pre-Reverse Split Common Stock shall receive, upon surrender of such
certificate, a new certificate representing the number of whole shares of post-Reverse Split Common Stock into which the shares
of pre-Reverse Split Common Stock represented by such certificate shall have been combined pursuant to the Reverse Split, as well
as any cash in lieu of fractional shares of post-Reverse Split Common Stock to which such holder may be entitled as set forth above.
The Reverse Split shall be effected on a record holder-by-record holder basis, such that any fractional shares of post-Reverse
Split Common Stock resulting from the Reverse Split and held by a single record holder shall be aggregated.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="font-variant: small-caps; background-color: white"><B>Fourth:
</B></FONT><FONT STYLE="background-color: white">The only sentence contained in Article <FONT STYLE="font-variant: small-caps">1
</FONT>of the Amended Articles is amended to read in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="background-color: white">&ldquo;The
name of this corporation shall be Armata Pharmaceuticals, Inc.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: transparent"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps; background-color: white"><B>Fifth:
</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Thereafter, pursuant to a resolution
by the Board, the amendment contained in these Articles of Amendment that required approval of the Corporation&rsquo;s shareholders
was submitted to the shareholders of the Corporation for their approval at a special meeting of the Corporation&rsquo;s shareholders
that was duly called and held, upon notice, at which meeting the necessary number of shares as required </FONT>by <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">statute
were voted in favor of such amendment. Accordingly, said amendment was duly adopted in accordance with the provisions of RCW 23B.10.030
and RCW 23B.10.040.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-weight: normal; font-variant: normal">[<I>Signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-variant: normal"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: transparent"><FONT STYLE="background-color: white"><B>IN
WITNESS WHEREOF</B>, AmpliPhi Biosciences Corporation has caused these Articles of Amendment to be executed by its duly authorized
officer on May 9, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: transparent">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">AMPLIPHI BIOSCIENCES CORPORATION </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Paul C. Grint, M.D.</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Name: Paul C. Grint, M.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>[Washington
Secretary of State name change form to be attached]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="tv521048_ex3-1img01.jpg" ALT=""></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B><U>Office
        of the Secretary of State </U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>Corporations
        &amp; Charities Division</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-variant: normal; color: black">(360)
        725 - 0377 | </FONT><FONT STYLE="color: windowtext">www.sos.wa.gov/corps</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">801
        Capitol Way S, Olympia,  WA 98504-0234</FONT></P></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left; vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This Box for Office Use Only<FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">Amendment
Fee $30</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Amendment
Fee with Expedited Service $80</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>ARTICLES
OF AMENDMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>PROFIT
CORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-style: normal; font-variant: normal"><B><U>RCW
23B.10</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Please
provide UBI # <U>601 166 399&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-variant: small-caps; background-color: white"><B>NAME
OF PROFIT CORPORATION:</B> </FONT><FONT STYLE="font-weight: normal; font-variant: normal">(as currently recorded with the Office
of the Secretary of State) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Ampliphi
Biosciences Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal"><B>BUSINESS
TYPE:</B> <FONT STYLE="font-weight: normal">Are you changing your business type? </FONT></FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Yes
</FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&thorn;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No
(if no, continue to next section)</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">If
yes, select the change being made:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">WA PROFESSIONAL
SERVICE CORPORATION&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-variant: normal; color: black">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">WA PUBLIC
UTILITY CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">WA SOCIAL
PURPOSE CORPORATION</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal"><B>ENTITY
NAME CHANGE:</B> <FONT STYLE="font-weight: normal">Are you changing your business name? </FONT></FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Yes
</FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No&nbsp;&nbsp;
If no, continue to Jurisdiction</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">If
yes, do you already have an entity name reserved? </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Yes </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">If
Yes, provide the Name Reservation Number and Name&nbsp;&nbsp; If No, provide only the name</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Reservation
Number: <U>1277541.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Name:
<U>Armata Pharmaceuticals, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal"><B>CORPORATE
SHARES:</B> <FONT STYLE="font-weight: normal">Are you changing your business&rsquo;s authorized shares? </FONT></FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;Yes
</FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No&nbsp;&nbsp;
If no, continue to next section</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">New
number of authorized shares: ________________ Class of shares: </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Common
Stock </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Preferred
Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Did
your share information change? (check one) </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Yes </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No&nbsp;&nbsp; If No,
continue to next section </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">If
Yes, implementation plan for change: (attach additional pages if needed)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Has your registered agent changed? </B><FONT STYLE="font-family: Wingdings; font-style: normal; font-variant: normal">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal"><B>YES </B></FONT><FONT STYLE="font-family: Wingdings; font-style: normal; font-variant: normal">x
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal"><B>NO &nbsp;&nbsp;If
Yes, please be sure to complete page 2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-variant: normal">&nbsp;</FONT>



<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Articles
of Amendment -  Profit </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Pg
1 | Revised 7.2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>NEW REGISTERED
AGENT:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Is
the Registered Agent a Commercial Registered Agent? </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Yes </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">No</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>If Yes</B><FONT STYLE="font-weight: normal">,
provide the name of the Commercial Registered Agent: _______________________________</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">A
Commercial Registered Agent is an entity or individual that is registered with the Office of the Secretary of </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">State
to receive legal documents on behalf of a corporation. A Commercial Registered Agent has the entities/individual&rsquo;s address
on record with the office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>A Registered
Agent consent is still required for a Commercial Registered Agent located below.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>If No</B><FONT STYLE="font-weight: normal">,
please continue below</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>Please
complete <U>ONE</U> type of Registered Agent below, be sure to include the name below the checked box. Then continue to provide
the required street address. Mailing address if needed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 30%; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt; font-weight: normal; font-style: normal">&uml;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Individual</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt; font-weight: normal; font-style: normal">&uml;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Entity</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt; font-weight: normal; font-style: normal">&uml;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Office or Position</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First and last name
    of a Non-commercial Registered Agent. (Any person not registered as a Commercial Registered Agent.)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of a Non-commercial
    Registered Agent. (Any business not registered as a Commercial Registered Agent.)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List the Office or
    Position serves as agent. (Only if using the specific office or position as the registered agent, no matter who holds the
    position like: Secretary, Member or Treasurer.)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Phone:
    </FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Email:</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid; width: 40%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; background-color: white"><B>Registered
    Agent Street Address (required) <BR>
(Must be a physical address No PO Box or PMB)</B></FONT></TD>
    <TD STYLE="width: 51%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; background-color: white"><B>Registered
    Agent Mailing Address (optional) <BR>
<FONT STYLE="font-family: Wingdings; font-size: 10pt; font-weight: normal; font-style: normal">&uml;
    </FONT> Check if mailing address is the same as street address</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Country: <U>United
    States</U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State: <U>Washington</U> </B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Country: <U>United
    States</U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State: <U>Washington</U> </B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; background-color: white">Address
    : _____________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; background-color: white">Address
    : _____________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">________________________________</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt; font-weight: normal; font-style: normal">________________________________</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; background-color: white">Zip:
    __________ City: __________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; background-color: white">Zip:
    __________ City: __________________</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>CONSENT
TO SERVE AS REGISTERED AGENT - REQUIRED FOR ALL TYPES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">1
hereby consent to serve as Registered Agent in the State of Washington for the named entity. I understand it will be my responsibility
to accept service of process, notices, and demands on behalf of the entity; to forward mail to the entity; and to immediately notify
the Office of the Secretary of State if I resign or change the Registered Office Address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid"></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Signature
of Registered Agent</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Printed Name/Title</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Date</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Articles
of Amendment - Profit </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Pg
</FONT><FONT STYLE="font-style: normal; background-color: white">2 |</FONT> <FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Revised
7.2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent"><FONT STYLE="font-style: normal; font-variant: normal"><B>DURATION:
</B></FONT>R<FONT STYLE="font-weight: normal">equired only if changed <FONT STYLE="font-style: normal">&nbsp;&nbsp;Please check
<FONT STYLE="font-variant: normal"><U>ONE </U>of </FONT><FONT STYLE="background-color: white">the following</FONT></FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">This Company
shall have a perpetual duration </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">This Company
shall have a duration of _____________ years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">This
Company shall expire </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black; background-color: white">on
__________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>ADOPTION
OF ARTICLES OF AMENDMENT:</B> <FONT STYLE="font-weight: normal">This Amendment was duly adopted by the following method </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">By a sufficient
vote of shareholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">By the
board of directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal; color: black">By
the incorporators prior to the issuance of shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>EFFECTIVE
DATE:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-variant: normal">x
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal">Date of filing </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-variant: normal">&uml;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal">Specify </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">a
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-variant: normal">Date ________________
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">cannot be more than 90 days following
received date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>DATE
OF ADOPTION:</B> <FONT STYLE="font-weight: normal">When was this Amendment adopted?</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">&uml;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Date of
filing </FONT><FONT STYLE="font-family: Wingdings; font-weight: normal; font-style: normal; font-variant: normal">x</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; font-variant: normal">Specify
a date: 05/08/2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-variant: normal"><B>RETURN ADDRESS FOR THIS FILING:
</B></FONT><B><FONT STYLE="background-color: white"><I>(Optional)</I></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">This
address will be sent document(s) regarding this specific filing in addition to document(s) being sent to the Registered Agent's street/mailing
address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Attention to:</FONT></TD>
    <TD STYLE="width: 60%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Steven V. Masillo</FONT></TD>
    <TD STYLE="width: 25%; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">steve.masillo@thompsonhine.com</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">335 Madison Ave</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">City</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">New York  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State NY &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zip 10017</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>AUTHORIZED
PERSON:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>This
record is hereby executed under penalties of perjury, and is, to the best of my knowledge, true and correct.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    <FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Steven V. Masillo</FONT></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Steven
    V. Masillo</FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5/9/19</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>Signature
    of Authorized Person</B></FONT></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>Printed
    Name/Title</B></FONT></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>Date</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Articles
of Amendment - Profit </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal; font-style: normal; font-variant: normal">Pg
3 | Revised 7.2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 7</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245074 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $80.00</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-style: normal; font-variant: normal"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><IMG SRC="tv521048_ex3-1img02.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: right">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Washington Secretary of State</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Corporations and Charities Division</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">801 Capitol Way South</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">PO Box 40234</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Olympia, WA 98504-0234</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(360) 725-0377</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>corps@sos.wa.gov</U></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">05/09/2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ARMATA PHARMACEUTICALS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">NATIONAL REGISTERED AGENTS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">711 CAPITOL WAY S STE 204</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">OLYMPIA WA 98501</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>UBI Number: 601 166 399</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Business Name: ARMATA PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear NATIONAL REGISTERED AGENTS, INC.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Thank you for your recent submission. This letter is to confirm
that the following documents have been received and successfully filed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ARTICLES OF AMENDMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">You can view and download your filed document(s) for no charge
at our website, <U>www.sos.wa.gov/ccfs</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If you haven&rsquo;t already, please sign up for a user account
on our website, <U>www.sos.wa.gov/ccfs</U>, to file online, conduct searches, and receive status updates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Please contact our office at <U>corps@sos.wa.gov</U> or (360) 725-0377
if you have any questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Corporations and Charities Division</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Office of the Secretary of State</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>www.sos.wa.gov/corps</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>tv521048_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: transparent"><IMG SRC="tv521048_ex3-2img01.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: transparent">CERTIFICATE
OF MERGER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent"><B>I,
KIM WYMAN</B>, Secretary of State of the State of Washington and custodian of its seal, hereby certify that documents meeting statutory
requirements have been filed and processed with the Secretary of State merging the below listed &ldquo;Merging Entity/Entities&rdquo;
into:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 50%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 50%; font-weight: bold">C3J THERAPEUTICS, INC</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">WA PROFIT CORPORATION</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">UBI: 603 589 506 </TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Effective Date: 05/09/2019 </TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Filing Date: 05/09/2019</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 20%; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">Merging Entities:</FONT></TD>
    <TD STYLE="width: 80%; text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">604 381 158</FONT></TD>
    <TD STYLE="text-align: left; text-indent: 0in">CERES MERGER SUB, INC., WA PROFIT CORPORATION</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left; text-indent: 0in; background-color: white"><IMG SRC="tv521048_ex3-2img02.jpg" ALT=""></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent"><FONT STYLE="background-color: white">Given
        under my hand and the Seal of the State of Washington at Olympia, the State Capital</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent"><FONT STYLE="background-color: white"><U>/s/
        Kim Wyman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent"><FONT STYLE="background-color: white">Kim
        Wyman, Secretary of State</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent"><FONT STYLE="background-color: white">Date
        Issued: 05/09/2019</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%; text-align: right; text-indent: 0in; background-color: white; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 30%">
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">FILED</P>
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">Secretary
        of State</P>
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">State
        of Washington</P>
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">Date
        Filed: 05/09/2019</P>
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">Effective
        Date: 05/09/2019</P>
        <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">UBI
        No:         603 589 506</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent"><B>ARTICLES
OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">CERES
MERGER SUB, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">a
Washington corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">WITH
AND INTO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">C3J
THERAPEUTICS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">a
Washington Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.25in; background-color: transparent">Pursuant
to RCW 23B.11.050 of the Washington Business Corporation Act (the <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">&ldquo;<U>WBCA</U>&rdquo;</FONT>),
these Articles of Merger are filed for the purpose of effecting the merger (the <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">&ldquo;<U>Merger</U></FONT>&rdquo;)
of Ceres Merger Sub, Inc., a Washington corporation ( &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Merge</U></FONT><U>r
Sub</U>&rdquo;), with and into C3J Therapeutics, Inc., a Washington corporation (<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">&ldquo;<U>C3J</U>&rdquo;)</FONT>.
C3J will be the surviving corporation in the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: transparent"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: left">The Agreement and Plan of Merger and Reorganization
                                         is set forth on the attached Exhibit A (the &ldquo;<U>Plan of <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Merger</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif">&rdquo;</FONT>)
                                         and made part of these Articles of Merger.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: -0.25in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: transparent"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: left">The Plan of Merger <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">was </FONT>duly
                                                           approved by the sole shareholder <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">of </FONT>Merger
                                                           Sub pursuant to RCW 23B.11.030 of the WBCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: -0.25in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: transparent"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: left">The Plan of Merger was duly approved by the shareholders of C3J pursuant to RCW 23B.11.030 and 23B.07.040
of the WBCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left; text-indent: -0.25in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: transparent"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: left">The Merger shall become effective at 8:05 a.m. Pacific Time <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">on
</FONT>May 9, 2019.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">[<I>Signature
Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 3</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245047 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $90.00</P></TD></TR></TABLE>&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">IN
WITNESS WHEREOF, the undersigned have caused these Articles of Merger to be executed as of the NINTH day of MAY, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>CERES MERGER SUB, INC.</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">a Washington corporation</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 50%; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in; padding-bottom: 1pt">By:</TD>
    <TD STYLE="text-align: left; text-indent: 0in; border-bottom: Black 1pt solid">/s/ Steve Martin</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">Name: Steve Martin</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">Title: Director</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>C3J THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">a Washington corporation</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">By:</TD>
    <TD STYLE="text-align: left; text-indent: 0in; border-bottom: Black 1pt solid">/s/ Todd Patrick</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">Name: Todd Patrick</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">Title: Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent">[<I>Signature
Page to the Articles of Merger</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 3</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245047 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $90.00</P></TD></TR></TABLE>&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0in; background-color: transparent"><FONT STYLE="background-color: white"><U>Exhibit
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in; background-color: transparent"><B>AGREEMENT
AND PLAN OF MERGER AND REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in; background-color: transparent">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 40%">&nbsp;</TD><TD STYLE="width: 20%; text-align: center; vertical-align: bottom">Page: <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 3</TD><TD STYLE="width: 40%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Work Order #: 2019050900245047 - 1</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Received Date: 05/09/2019</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Amount Received: $90.00</P></TD></TR></TABLE>&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B><BR>
<B>AND REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">among:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMPLIPHI BIOSCIENCES CORPORATION</B>,<BR>
a Washington corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERES MERGER SUB, INC.</B>,<BR>
a Washington corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>C3J THERAPEUTICS, INC.</B>,<BR>
a Washington corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of January 3, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: none; text-align: right; padding-bottom: 0; padding-top: 0"><B>Page</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 1.</B></TD>
    <TD STYLE="width: 81%; padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>DESCRIPTION OF TRANSACTION</B></TD>
    <TD STYLE="width: 6%; padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>The Merger</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Effects of the Merger</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Closing; Effective Time</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>2</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Articles of Incorporation and Bylaws; Directors and Officers</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>3</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Conversion of Shares</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>3</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Closing of the Company&rsquo;s Transfer Books</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>5</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Surrender of Certificates</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>5</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Dissenting Shares</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>7</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>1.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Further Action</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>7</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 2.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>7</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Due Organization; Subsidiaries</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>7</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Organizational Documents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>8</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Authority; Binding Nature of Agreement</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>8</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Vote Required</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>8</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Non-Contravention; Consents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>8</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Capitalization</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>10</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Financial Statements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>11</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Absence of Changes</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>12</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Absence of Undisclosed Liabilities</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>12</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.10</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Title to Assets</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>12</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.11</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Real Property; Leasehold</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>12</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.12</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Intellectual Property</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>13</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.13</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Agreements, Contracts and Commitments</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>14</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.14</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Compliance; Permits; Restrictions</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>16</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.15</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Legal Proceedings; Orders</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>18</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.16</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Tax Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>18</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.17</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Employee and Labor Matters; Benefit Plans</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>20</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.18</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Environmental Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>23</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.19</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Insurance</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>23</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.20</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Financial Advisors</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.21</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Transactions with Affiliates</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.22</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Anti-Bribery</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>2.23</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Disclaimer of Other Representations and Warranties</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 3.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>24</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Due Organization; Subsidiaries</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>25</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Organizational Documents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>25</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Authority; Binding Nature of Agreement</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>25</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Vote Required</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>26</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Non-Contravention; Consents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>26</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center">(continued)</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>Page</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap; width: 13%"><B>3.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; width: 81%"><B>Capitalization</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right; width: 6%"><B>27</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>SEC Filings; Financial Statements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>28</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Absence of Changes</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Absence of Undisclosed Liabilities</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.10</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Title to Assets</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.11</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Real Property; Leasehold</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>30</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.12</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Intellectual Property</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>31</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.13</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Agreements, Contracts and Commitments</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>32</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.14</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Compliance; Permits</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>34</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.15</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Legal Proceedings; Orders</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>35</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.16</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Tax Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>36</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.17</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Employee and Labor Matters; Benefit Plans</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>37</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.18</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Environmental Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>40</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.19</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Transactions with Affiliates</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.20</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Insurance</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.21</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Financial Advisors</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.22</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Anti-Bribery</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.23</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Valid Issuance</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.24</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Opinion of Financial Advisor</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>41</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>3.25</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Disclaimer of Other Representations or Warranties</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>42</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 4.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>CERTAIN COVENANTS OF THE PARTIES</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>42</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Operation of Parent&rsquo;s Business</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>42</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Operation of the Company&rsquo;s Business</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>44</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Access and Investigation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>45</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Parent Non-Solicitation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>46</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Non-Solicitation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>47</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>4.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Notification of Certain Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>48</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 5.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>ADDITIONAL AGREEMENTS OF THE PARTIES</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>48</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Proxy Statement</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>48</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Stockholder Written Consent</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>49</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Parent Stockholders&rsquo; Meeting</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>51</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Regulatory Approvals</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>53</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Options and Company RSAs</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>53</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Employee Benefits</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>54</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Indemnification of Officers and Directors</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>55</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Additional Agreements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>56</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Disclosure</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>56</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.10</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Listing</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>57</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.11</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Tax Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>57</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.12</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Legends</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>57</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.13</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Directors and Officers</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>57</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.14</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Termination of Certain Agreements and Rights</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>58</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center">(continued)</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>Page</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap; width: 13%"><B>5.15</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; width: 81%"><B>Section 16 Matters</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right; width: 6%"><B>58</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.16</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Cooperation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>58</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.17</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Certificates</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>58</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.18</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Financial Statements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.19</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Takeover Statutes</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.20</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Stockholder Litigation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>5.21</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Lock-Up</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 6.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>6.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Restraints</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>59</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>6.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Stockholder Approval</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>6.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Legal Proceedings</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>6.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Listing</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 7.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Accuracy of Representations</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Performance of Covenants</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Documents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>60</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>FIRPTA Certificate</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Company Material Adverse Effect</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Termination of Investor Agreements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Lock-Up Agreements</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Accredited Investors</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Stock Purchase Agreement</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.10</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Stockholder Written Consent</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.11</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Company Cash</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>7.12</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Dissenting Shares</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>61</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 8.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>8.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Accuracy of Representations</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>8.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Performance of Covenants</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>8.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Documents</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>8.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Parent Material Adverse Effect</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>8.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Parent Cash</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>62</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 9.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>TERMINATION</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>63</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>9.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Termination</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>63</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>9.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Effect of Termination</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>64</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>9.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Expenses; Termination Fees</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>64</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0; text-indent: 0in; text-transform: uppercase; white-space: nowrap"><B>Section 10.</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; padding-bottom: 0; padding-top: 0"><B>MISCELLANEOUS PROVISIONS</B></TD>
    <TD STYLE="padding-right: 0; text-indent: 0in; text-transform: uppercase; text-align: right; padding-bottom: 0; padding-top: 0"><B>66</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.1</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Non-Survival of Representations and Warranties</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>66</B></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.75pt; text-align: center">(continued)</P>



<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>Page</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap; width: 13%"><B>10.2</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; width: 81%"><B>Amendment</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right; width: 6%"><B>66</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.3</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Waiver</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>66</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.4</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Entire Agreement; Counterparts; Exchanges by Electronic Transmission</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>67</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.5</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Applicable Law; Jurisdiction</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>67</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.6</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Attorneys&rsquo; Fees</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>67</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.7</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Assignability</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>67</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.8</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Notices</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>67</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.9</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Cooperation</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>68</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.10</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Severability</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>68</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.11</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Other Remedies; Specific Performance</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>68</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.12</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>No Third Party Beneficiaries</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>69</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 10pt 0 0.375in; text-indent: 0in; white-space: nowrap"><B>10.13</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in"><B>Construction</B></TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-bottom: 0; text-indent: 0in; text-align: right"><B>69</B></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibits:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 19%; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit A</P></TD>
    <TD STYLE="vertical-align: bottom; width: 81%; padding-right: 0; padding-left: 0; text-align: justify">Definitions</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit B-1</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Company Stockholder Support Agreement</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit B-2</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Parent Stockholder Support Agreement</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit C-1</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Company Lock-Up Agreement</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit C-2</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Parent Lock-Up Agreement</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit D</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Stock Purchase Agreement</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit E</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Post-Closing Directors and Officers</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit F</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Parent EIP Amendment</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit G</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parent Warrants</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">Exhibit H</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">Form of Company Stockholder Written Consent</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: justify">Exhibit I</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: justify">Form of Investor Questionnaire</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->viii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>THIS AGREEMENT AND
PLAN OF MERGER AND REORGANIZATION</B> (this &ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of January 3, 2019,
by and among <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>AmpliPhi Biosciences Corporation</B></FONT>,
a Washington corporation (&ldquo;<B><I>Parent</I></B>&rdquo;), <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Ceres
Merger Sub, Inc.</B></FONT>, a Washington corporation and wholly owned subsidiary of Parent (&ldquo;<B><I>Merger Sub</I></B>&rdquo;),
and <FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>C3J Therapeutics, Inc.</B></FONT>, a
Washington corporation (the &ldquo;<B><I>Company</I></B>&rdquo;). Certain capitalized terms used in this Agreement are defined
in <B>Exhibit A</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and the Company intend to effect a merger of Merger Sub with and into the Company (the &ldquo;<B><I>Merger</I></B>&rdquo;)
in accordance with this Agreement and the Washington Business Corporation Act (as amended, the &ldquo;<B><I>WBCA</I></B>&rdquo;).
Upon consummation of the Merger, Merger Sub will cease to exist and the Company will become a wholly owned subsidiary of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Parties intend that the Merger qualify as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the
Code and the Treasury Regulations promulgated thereunder, and by executing this Agreement, the Parties intend to adopt a plan of
reorganization within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Parent Board has (a) determined that the Contemplated Transactions are fair to, advisable and in the best interests
of Parent and its stockholders; (b) authorized, approved and declared advisable this Agreement and the Contemplated Transactions,
including the issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement;
and (c) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders
of Parent vote to approve the Parent Stockholder Matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Merger Sub Board has (i) determined that the Contemplated Transactions are fair to, advisable, and in the best interests
of Merger Sub and its sole stockholder, (ii) approved and declared advisable this Agreement and the Contemplated Transactions and
(iii) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of
Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company Board has (i) determined that the Contemplated Transactions are fair to, advisable and in the best interests
of the Company and its stockholders, (ii) approved and declared advisable this Agreement and the Contemplated Transactions and
(iii) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders
of the Company vote to approve the Company Stockholder Matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">F.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Concurrently with the execution and delivery of this Agreement and as a condition and inducement to Parent&rsquo;s willingness
to enter into this Agreement, the officers, directors and stockholders of the Company listed on Section A of the Company Disclosure
Schedule (solely in their capacity as stockholders of the Company) (the &ldquo;<B><I>Company Signatories</I></B>&rdquo;) are executing
(a) support agreements in favor of Parent in substantially the form attached hereto as <B>Exhibit B-1</B> (the &ldquo;<B><I>Company
Stockholder Support Agreement</I></B>&rdquo;), pursuant to which such Persons have, subject to the terms and conditions set forth
therein, agreed to vote all of their shares of Company Common Stock in favor of the Company Stockholder Matters and against any
competing proposals, and (b) lock-up agreements in substantially the form attached hereto as <B>Exhibit C-1</B> (the &ldquo;<B><I>Company
Lock-Up Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">G.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Concurrently with the execution and delivery of this Agreement and as a condition and inducement to the Company&rsquo;s
willingness to enter into this Agreement, the officers and directors of Parent listed on Section A of the Parent Disclosure Schedule
(solely in their capacity as stockholders of Parent) (the &ldquo;<B><I>Parent Signatories</I></B>&rdquo;) are executing (a) support
agreements in favor of the Company in substantially the form attached hereto as <B>Exhibit B-2</B> (the &ldquo;<B><I>Parent Stockholder
Support Agreement</I></B>&rdquo;), pursuant to which such Persons have, subject to the terms and conditions set forth therein,
agreed to vote all of their shares of Parent Common Stock in favor of the Parent Stockholder Matters and against any competing
proposals and (b) lock-up agreements in substantially the form attached hereto as <B>Exhibit C-2 </B>(the &ldquo;<B><I>Parent Lock-Up
Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">H.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>It is expected that within five Business Days after the execution and delivery of this Agreement, (a) each of the Company
Signatories that are stockholders in the Company will execute an investor questionnaire in substantially the form attached hereto
as <B>Exhibit I</B> (the &ldquo;<B><I>Investor Questionnaire</I></B>&rdquo;), provided that no more than 10 such Persons do not
represent that they are &ldquo;accredited investors&rdquo; as defined in Regulation D under the Securities Act (&ldquo;<B><I>Regulation
D</I></B>&rdquo;), and (b) no less than 66 2/3% of the stockholders of the Company will execute and deliver an action by written
consent in substantially the form attached hereto as <B>Exhibit H</B> (each, a &ldquo;<B><I>Company Stockholder Written Consent</I></B>&rdquo;
and collectively, the &ldquo;<B><I>Company Stockholder Written Consents</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Immediately prior to the execution and delivery of this Agreement, certain investors have executed an equity commitment
letter<B>,</B> among Parent and the Persons named therein (representing an aggregate commitment of $10,000,000) and after the execution
and delivery of this Agreement but prior to the filing of the Definitive Proxy Statement on Schedule 14A (representing an aggregate
commitment of $10,000,000), those certain investors shall have executed a Stock Purchase Agreement, substantially in the form attached
hereto as <B>Exhibit D</B> (or in such other form as may be agreed to by Parent and the Company), among Parent, the Company and
the Persons named therein, pursuant to which such Persons will have agreed to purchase the number of shares of Parent Common Stock
set forth therein immediately following the Closing in connection with the Parent Post-Closing Financing (the &ldquo;<B><I>Stock
Purchase Agreement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Parties, intending
to be legally bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">DESCRIPTION
OF TRANSACTION</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Merger</U></B>. Upon the terms and subject to the conditions set forth in this Agreement, at the Effective Time,
Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease. The Company will continue
as the surviving corporation in the Merger (the &ldquo;<B><I>Surviving Corporation</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effects of the Merger</U></B>. The Merger shall have the effects set forth in this Agreement, the Articles of Merger
and in the applicable provisions of the WBCA. As a result of the Merger, the Company will become a wholly owned subsidiary of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing; Effective Time</U></B>. Unless this Agreement is earlier terminated pursuant to the provisions of <U>Section&nbsp;9.1</U>,
and subject to the satisfaction or waiver of the conditions set forth in <U>Section 6</U>, <U>7</U> and <U>8</U>, the consummation
of the Merger (the &ldquo;<B><I>Closing</I></B>&rdquo;) shall take place remotely as promptly as practicable (but in no event later
than the second Business Day following the satisfaction or waiver of the last to be satisfied or waived of the conditions set forth
in <U>Section 6</U>, <U>7</U> and <U>8</U>, other than those conditions that by their nature are to be satisfied at the Closing,
but subject to the satisfaction or waiver of each of such conditions), or at such other time, date and place as Parent and the
Company may mutually agree in writing. The date on which the Closing actually takes place is referred to as the &ldquo;<B><I>Closing
Date</I></B>.&rdquo; At the Closing, the Parties shall cause the Merger to be consummated by executing and filing with the Secretary
of State of the State of Washington articles of merger with respect to the Merger, satisfying the applicable requirements of the
WBCA and in a form reasonably acceptable to Parent and the Company (the &ldquo;<B><I>Articles of Merger</I></B>&rdquo;). The Merger
shall become effective at the time of the filing of the Articles of Merger with the Secretary of State of the State of Washington
or at such later time as may be specified in the Articles of Merger with the consent of Parent and the Company (the time as of
which the Merger becomes effective being referred to as the &ldquo;<B><I>Effective Time</I></B>&rdquo;). This Agreement together
with the Articles of Merger but excluding the other Exhibits and schedules to this Agreement shall be deemed the &ldquo;plan of
merger&rdquo; under Chapter 11 of the WBCA and shall be filed with the Articles of Merger pursuant to Section 23B.11.050(1) of
the WBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Articles of Incorporation and Bylaws; Directors and Officers</U></B>. At the Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the articles of incorporation of the Surviving Corporation shall be amended and restated in its entirety to read identically
to the articles of incorporation of Merger Sub as in effect immediately prior to the Effective Time, until thereafter amended as
provided by the WBCA and such articles of incorporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the articles of incorporation of Parent shall be identical to the articles of incorporation of Parent immediately prior
to the Effective Time, until thereafter amended as provided by WBCA and such articles of incorporation; <I>provided</I>, <I>however</I>,
that at the Effective Time, Parent shall file one or more amendments to its articles of incorporation to the extent approved by
the holders of Parent Common Stock, to (i) change the name of Parent to a name to be determined in good faith by the Parties, (ii)
as contemplated by <U>Section 5.3(a)(i)</U>, effect the NYSE Reverse Split, and (iii) make such other changes as are mutually agreeable
to Parent and the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the bylaws of the Surviving Corporation shall be amended and restated in their entirety to read identically to the bylaws
of Merger Sub as in effect immediately prior to the Effective Time, until thereafter amended as provided by the WBCA and such bylaws;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the directors and officers of Parent, each to hold office in accordance with the articles of incorporation and bylaws
of Parent, shall be as set forth in <U>Section&nbsp;5.13</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the directors and officers of the Surviving Corporation, each to hold office in accordance with the articles of incorporation
and bylaws of the Surviving Corporation, shall be the directors and officers of Parent as set forth in <U>Section 5.13</U>, after
giving effect to the provisions of <U>Section 5.13</U>, or such other persons as shall be mutually agreed upon by Parent and the
Company and in accordance with the articles of incorporation and the bylaws of the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conversion of Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the
Company or any stockholder of the Company or Parent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>any shares of Company Common Stock held as treasury stock or held or owned by the Company, Merger Sub, or any Subsidiary
of the Company immediately prior to the Effective Time shall be canceled and retired and shall cease to exist, and no consideration
shall be delivered in exchange therefor; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>subject to <U>Section&nbsp;1.5(c)</U>, each share of Company Common Stock outstanding immediately prior to the Effective
Time (excluding shares to be canceled pursuant to <U>Section&nbsp;1.5(a)(i)</U> and excluding Dissenting Shares) shall be automatically
converted solely into the right to receive a number of shares of Parent Common Stock equal to the Exchange Ratio (the &ldquo;<B><I>Merger
Consideration</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If any shares of Company Common Stock outstanding immediately prior to the Effective Time are unvested or are subject
to a repurchase option or a risk of forfeiture under any applicable restricted stock purchase agreement or other similar agreement
with the Company, then the shares of Parent Common Stock issued in exchange for such shares of Company Common Stock will to the
same extent be unvested and subject to the same repurchase option or risk of forfeiture, and such shares of Parent Common Stock
shall accordingly be marked with appropriate legends. The Company shall take all actions that may be necessary to ensure that,
from and after the Effective Time, Parent is entitled to exercise any such repurchase option or other right set forth in any such
restricted stock purchase agreement or other agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No fractional shares of Parent Common Stock shall be issued in connection with the Merger, and no certificates or scrip
for any such fractional shares shall be issued. Any holder of Company Common Stock who would otherwise be entitled to receive a
fraction of a share of Parent Common Stock (after aggregating all fractional shares of Parent Common Stock issuable to such holder)
shall, in lieu of such fraction of a share and upon surrender by such holder of a letter of transmittal in accordance with <U>Section&nbsp;1.7</U>
and any accompanying documents as required therein, be paid in cash the dollar amount (rounded to the nearest whole cent), without
interest, determined by multiplying such fraction by the Parent Closing Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All Company Options outstanding immediately prior to the Effective Time under the 2016 Company Plan and 2006 Company
Plan shall be treated in accordance with <U>Section&nbsp;5.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All Company RSAs outstanding immediately prior to the Effective Time shall be assumed by Parent and converted to restricted
stock awards to purchase Parent Common Stock in accordance with <U>Section 5.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each share of common stock, $0.0001 par value per share, of Merger Sub issued and outstanding immediately prior to the
Effective Time shall be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock,
$0.0001 par value per share, of the Surviving Corporation. Each stock certificate of Merger Sub evidencing ownership of any such
shares shall, as of the Effective Time, evidence ownership of such shares of common stock of the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If, between the date of this Agreement and the Effective Time, the outstanding shares of Company Common Stock or Parent
Common Stock shall have been changed into, or exchanged for, a different number of shares or a different class, by reason of any
stock dividend, subdivision, reclassification, recapitalization, split (including the NYSE Reverse Split to the extent any such
split has not previously been taken into account in calculating the Exchange Ratio), combination or exchange of shares or other
like change, the Exchange Ratio shall be equitably adjusted to reflect such change to the extent necessary to provide the holders
of Company Common Stock, Parent Common Stock and Company RSAs with the same economic effect as contemplated by this Agreement prior
to such stock dividend, subdivision, reclassification, recapitalization, split (including the NYSE Reverse Split to the extent
any such split has not previously been taken into account in calculating the Exchange Ratio), combination or exchange of shares
or other like change; <I>provided, however</I>, that nothing herein will be construed to permit the Company or Parent to take any
action with respect to Company Common Stock or Parent Common Stock, respectively, that is prohibited or not expressly permitted
by the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing of the Company&rsquo;s Transfer Books</U></B>. At the Effective Time: (a) all shares of Company Common Stock
outstanding immediately prior to the Effective Time shall be treated in accordance with <U>Section&nbsp;1.5(a)</U>, and all holders
of certificates representing shares of Company Common Stock that were outstanding immediately prior to the Effective Time shall
cease to have any rights as stockholders of the Company; and (b) the stock transfer books of the Company shall be closed with respect
to all shares of Company Common Stock outstanding immediately prior to the Effective Time. No further transfer of any such shares
of Company Common Stock shall be made on such stock transfer books after the Effective Time. If, after the Effective Time, a valid
certificate previously representing any shares of Company Common Stock outstanding immediately prior to the Effective Time (a &ldquo;<B><I>Company
Stock Certificate</I></B>&rdquo;) is presented to the Exchange Agent or to the Surviving Corporation, such Company Stock Certificate
shall be canceled and shall be exchanged as provided in <U>Sections&nbsp;1.5</U> and 1.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Surrender of Certificates</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>On or prior to the Closing Date, Parent and the Company shall agree upon and select a reputable bank, transfer agent
or trust company to act as exchange agent in the Merger (the &ldquo;<B><I>Exchange Agent</I></B>&rdquo;). At the Effective Time,
Parent shall deposit with the Exchange Agent: (i) certificates or evidence of book-entry shares representing the Parent Common
Stock issuable pursuant to <U>Section&nbsp;1.5(a)</U> and (ii) cash sufficient to make payments in lieu of fractional shares in
accordance with <U>Section&nbsp;1.5(c)</U>. The Parent Common Stock and cash amounts so deposited with the Exchange Agent, together
with any dividends or distributions received by the Exchange Agent with respect to such shares, are referred to collectively as
the &ldquo;<B><I>Exchange Fund</I></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Promptly after the Effective Time, the Parties shall cause the Exchange Agent to mail to the Persons who were record
holders of shares of Company Common Stock that were converted into the right to receive the Merger Consideration: (i) a letter
of transmittal in customary form; and (ii) instructions for effecting the surrender of Company Stock Certificates in exchange for
shares of Parent Common Stock. Upon surrender of a Company Stock Certificate to the Exchange Agent for exchange, together with
a duly executed letter of transmittal and such other documents as may be reasonably required by the Exchange Agent or Parent: (A)
the holder of such Company Stock Certificate shall be entitled to receive in exchange therefor a certificate or certificates or
book-entry shares representing the Merger Consideration (in a number of whole shares of Parent Common Stock) that such holder has
the right to receive pursuant to the provisions of <U>Section&nbsp;1.5(a)</U> (and cash in lieu of any fractional share of Parent
Common Stock pursuant to the provisions of <U>Section&nbsp;1.5(c)</U>); and (B) the Company Stock Certificate so surrendered shall
be canceled. Until surrendered as contemplated by this <U>Section&nbsp;1.7(b)</U>, each Company Stock Certificate shall be deemed,
from and after the Effective Time, to represent only the right to receive a certificate or certificates or book-entry shares of
Parent Common Stock representing the Merger Consideration (and cash in lieu of any fractional share of Parent Common Stock). If
any Company Stock Certificate shall have been lost, stolen or destroyed, Parent may, in its discretion and as a condition precedent
to the delivery of any shares of Parent Common Stock, require the owner of such lost, stolen or destroyed Company Stock Certificate
to provide an applicable affidavit with respect to such Company Stock Certificate. In the event of a transfer of ownership of a
Company Stock Certificate that is not registered in the transfer records of the Company, payment of the Merger Consideration may
be made to a Person other than the Person in whose name such Company Stock Certificate so surrendered is registered if such Company
Stock Certificate shall be properly endorsed or otherwise be in proper form for transfer and the Person requesting such payment
shall pay any transfer or other Taxes required by reason of the transfer or establish to the reasonable satisfaction of Parent
that such Taxes have been paid or are not applicable. The Merger Consideration and any dividends or other distributions as are
payable pursuant to this <U>Section 1.7(b)</U> shall be deemed to have been in full satisfaction of all rights pertaining to Company
Common Stock formerly represented by such Company Stock Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No dividends or other distributions declared or made with respect to Parent Common Stock with a record date on or after
the Effective Time shall be paid to the holder of any unsurrendered Company Stock Certificate with respect to the shares of Parent
Common Stock that such holder has the right to receive in the Merger until such holder surrenders such Company Stock Certificate
or provides an affidavit of loss or destruction in lieu thereof in accordance with this <U>Section&nbsp;1.7</U> (at which time
(or, if later, on the applicable payment date) such holder shall be entitled, subject to the effect of applicable abandoned property,
escheat or similar Laws, to receive all such dividends and distributions, without interest).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Any portion of the Exchange Fund that remains undistributed to holders of Company Stock Certificates as of the date
that is one year after the Closing Date shall be delivered to Parent upon demand, and any holders of Company Stock Certificates
who have not theretofore surrendered their Company Stock Certificates in accordance with this <U>Section&nbsp;1.7</U> shall thereafter
look only to Parent for satisfaction of their claims for Parent Common Stock, cash in lieu of fractional shares of Parent Common
Stock and any dividends or distributions with respect to shares of Parent Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of the Exchange Agent, Parent and the Surviving Corporation shall be entitled to deduct and withhold from any consideration
deliverable pursuant to this Agreement to any holder of any Company Stock Certificate such amounts as are required to be deducted
or withheld from such consideration under the Code or under any other applicable Law. To the extent such amounts are so deducted
or withheld, and remitted to the appropriate taxing authority, such amounts shall be treated for all purposes under this Agreement
as having been paid to the Person to whom such amounts would otherwise have been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No Party to this Agreement shall be liable to any holder of any Company Stock Certificate or to any other Person with
respect to any shares of Parent Common Stock (or dividends or distributions with respect thereto) or for any cash amounts delivered
to any public official pursuant to any applicable abandoned property Law, escheat Law or similar Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All shares of Parent Common Stock issued pursuant to this Agreement shall bear a legend (and Parent will make a notation
on its transfer books to such effect) prominently stamped or printed thereon or the substance of which will otherwise be reflected
on the books and records of the transfer agent for Parent Common Stock with respect to book-entry shares, in each case reading
substantially as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&ldquo;THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO RESALE IN CONNECTION WITH A DISTRIBUTION AND MAY NOT BE SOLD OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND APPLICABLE STATE SECURITIES LAWS, OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Dissenting Shares</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Notwithstanding anything in this Agreement to the contrary, any shares of Company Common Stock that are issued and outstanding
immediately prior to the Effective Time and held by a stockholder who has neither voted in favor of the Merger nor consented thereto
in writing and who has properly exercised such stockholder&rsquo;s appraisal rights in compliance with the provisions of Chapter
23B.13 of the WBCA (the &ldquo;<B><I>Dissenting Shares</I></B>&rdquo;) shall not be converted into or be exchangeable for the right
to receive the Merger Consideration, unless and until such stockholder shall have failed to perfect, or shall have effectively
withdrawn or lost such stockholder&rsquo;s right to appraisal under the WBCA. By virtue of the Merger, all Dissenting Shares shall
be cancelled and shall cease to exist and the holders of such Dissenting Shares shall thereafter be entitled only to such rights
with respect to such Dissenting Shares as are provided under Chapter 23B.13 of the WBCA; <I>provided</I>, <I>however</I>, that
notwithstanding the foregoing, all Dissenting Shares held by a stockholder who shall have failed to perfect or shall have effectively
withdrawn or lost such right to appraisal shall thereupon be converted into and become exchangeable only for the right to receive,
as of the Effective Time, the Merger Consideration for each share of Company Common Stock held by such stockholder without any
interest thereon, subject, in the case of Company Common Stock formerly evidenced by Company Stock Certificate(s), to the surrender
of such Company Stock Certificate(s) in the manner set forth in this <U>Section 1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company shall give Parent prompt notice of any demands for appraisal of any shares of Company Common Stock, withdrawals
of such demands and any other instruments served pursuant to the WBCA and received by the Company relating to rights to be paid
the &ldquo;fair value&rdquo; of Dissenting Shares, as provided in the WBCA, and Parent and Merger Sub shall have the right to direct
all negotiations and proceedings with respect to any such demands; <I>provided</I>, that the Company shall have the right to participate
in any such negotiations and proceedings. The Company shall not, except with the prior written consent of Parent, voluntarily make
any payment with respect to any demands for appraisals, offer to settle or settle any such demands or approve any withdrawal of
any such demands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Further Action</U></B>. If, at any time after the Effective Time, any further action is determined by the Surviving Corporation
to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right,
title and possession of and to all rights and property of the Company, then the officers and directors of the Surviving Corporation
shall be fully authorized, and shall use their and its commercially reasonable efforts (in the name of the Company, in the name
of Merger Sub, in the name of the Surviving Corporation and otherwise) to take such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">REPRESENTATIONS
AND WARRANTIES OF THE COMPANY</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to <U>Section&nbsp;10.13(h)</U>,
except as set forth in the written disclosure schedule delivered by the Company to Parent (the &ldquo;<B><I>Company Disclosure
Schedule</I></B>&rdquo;), the Company represents and warrants to Parent and Merger Sub as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Due Organization; Subsidiaries</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company is a corporation or other legal entity duly incorporated, validly existing and in good standing under the
Laws of Washington and has all necessary corporate power and authority: (i) to conduct its business in the manner in which its
business is currently being conducted; (ii) to own or lease and use its property and assets in the manner in which its property
and assets are currently owned or leased and used; and (iii) to perform its obligations under all Contracts by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company is qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under
the Laws of all jurisdictions where the nature of its business requires such qualification other than in jurisdictions where the
failure to be so qualified individually or in the aggregate would not reasonably be expected to have a Company Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company has no Subsidiaries, except for the Entities identified in <U>Section&nbsp;2.1(c)</U> of the Company Disclosure
Schedule; and neither the Company nor any of the Entities identified in <U>Section&nbsp;2.1(c)</U> of the Company Disclosure Schedule
owns any capital stock of, or any equity, ownership or profit sharing interest of any nature in, or controls directly or indirectly,
any other Entity other than the Entities identified in <U>Section&nbsp;2.1(c)</U> of the Company Disclosure Schedule. Each of the
Company&rsquo;s Subsidiaries is a corporation or other legal entity duly organized, validly existing and, if applicable, in good
standing under the Laws of the jurisdiction of its organization and has all necessary corporate or other power and authority to
conduct its business in the manner in which its business is currently being conducted and to own or lease and use its property
and assets in the manner in which its property and assets are currently owned or leased and used, except where the failure to have
such power or authority would not reasonably be expected to have a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company or its Subsidiary is or has otherwise been, directly or indirectly, a party to, member of or participant
in any partnership, joint venture or similar business entity. Neither the Company nor its Subsidiary has agreed or is obligated
to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital contribution
to any other Entity. Neither the Company nor its Subsidiary has, at any time, been a general partner of, or has otherwise been
liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organizational Documents</U></B>. The Company has made available to Parent accurate and complete copies of the Organizational
Documents of the Company and its Subsidiary in effect as of the date of this Agreement. Neither the Company nor its Subsidiary
is in material breach or violation of its respective Organizational Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authority; Binding Nature of Agreement</U>. </B> The Company has all necessary corporate power and authority to enter
into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Company Board has
(i) determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders,
(ii) authorized, approved and declared advisable this Agreement and the Contemplated Transactions and (iii) determined to recommend,
upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt this
Agreement and thereby approve the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement has
been duly executed and delivered by the Company and assuming the due authorization, execution and delivery by Parent and Merger
Sub, constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its
terms, subject to the Enforceability Exceptions. Prior to the execution of the Company Stockholder Support Agreements, the Company
Board approved the Company Stockholder Support Agreements and the transactions contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vote Required</U>. </B> The affirmative vote (or written consent) of holders of a majority of the shares of Company Common
Stock outstanding on the record date for the Company Stockholder Written Consent and entitled to vote thereon (the &ldquo;<B><I>Required
Company Stockholder Vote</I></B>&rdquo;), is the only vote (or written consent) of the holders of any Company Common Stock necessary
to adopt and approve this Agreement and approve the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Contravention; Consents</U>. </B> Subject to obtaining the Required Company Stockholder Vote and the filing of the
Articles of Merger required by the WBCA, neither (x) the execution, delivery or performance of this Agreement by the Company, nor
(y) the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation of any of the provisions of the Company&rsquo;s Organizational Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation of, or give any Governmental Body or, to the Knowledge of the Company,
any other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any
Law or any order, writ, injunction, judgment or decree to which the Company or its Subsidiary, or any of the assets owned or used
by the Company or its Subsidiary, is subject, except as would not reasonably be expected to be material to the Company or its business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>to the Knowledge of the Company, contravene, conflict with or result in a violation of any of the terms or requirements
of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization
that is held by the Company or its Subsidiary, except as would not reasonably be expected to be material to the Company or its
business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any
Company Material Contract, or give any Person the right to: (i) declare a default or exercise any remedy under any Company Material
Contract; (ii) any material payment, rebate, chargeback, penalty or change in delivery schedule under any Company Material Contract;
(iii) accelerate the maturity or performance of any Company Material Contract; or (iv) cancel, terminate or modify any term of
any Company Material Contract, except in the case of any non-material breach, default, penalty or modification; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>result in the imposition or creation of any Encumbrance upon or with respect to any material asset owned or used by
the Company or its Subsidiary (except for Permitted Encumbrances).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for (i) any Consent set forth on
<U>Section&nbsp;2.5</U> of the Company Disclosure Schedule under any Company Contract, (ii) the Required Company Stockholder Vote,
(iii) the filing of the Articles of Merger with the Secretary of State of the State of Washington pursuant to the WBCA, and (iv)
such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable
federal and state securities Laws, neither the Company nor its Subsidiary is or will be required to make any filing with or give
any notice to, or to obtain any Consent from, any Person in connection with (x) the execution, delivery or performance of this
Agreement, or (y) the consummation of the Contemplated Transactions, which if individually or in the aggregate were not given or
obtained, would reasonably be expected to prevent or materially delay the ability of the Company to consummate the Contemplated
Transactions. The Company Board has taken and will take all actions necessary to ensure that the restrictions applicable to business
combinations contained in Chapter 23B.19 of the WBCA are, and will be, inapplicable to the execution, delivery and performance
of this Agreement, the Company Stockholder Support Agreements, the Company Lock-Up Agreements and to the consummation of the Contemplated
Transactions. No other state Takeover Statute or similar Law applies or purports to apply to the Merger, this Agreement, the Company
Stockholder Support Agreements, the Company Lock-Up Agreements or any of the other Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Capitalization</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The authorized Company Common Stock as of the date of this Agreement consists of (i) 150,000,000 shares of Company Common
Stock, no par value per share, of which 102,770,818 shares have been issued and are outstanding as of the date of this Agreement.
The Company does not hold any shares of its capital stock in its treasury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All of the outstanding shares of Company Common Stock have been duly authorized and validly issued, and are fully paid
and nonassessable. Except as set forth in the Investor Agreements, none of the outstanding shares of Company Common Stock is entitled
or subject to any preemptive right, right of participation, right of maintenance or any similar right or any right of first refusal
in favor of the Company. Except as contemplated herein and in the Investor Agreements, there is no Company Contract relating to
the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting
any option or similar right with respect to), any shares of Company Common Stock. The Company is not under any obligation, nor
is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding
shares of Company Common Stock or other securities. <U>Section 2.6(b)</U> of the Company Disclosure Schedule accurately and completely
lists all repurchase rights held by the Company with respect to shares of Company Common Stock (including shares issued pursuant
to the exercise of stock options) and specifies which of those repurchase rights are currently exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except for the Amended and Restated 2006 Stock Option Plan (the &ldquo;<B><I>2006 Company Plan</I></B>&rdquo;) and the
2016 Stock Plan (the &ldquo;<B><I>2016 Company Plan</I></B>&rdquo;), the Company does not have any stock option plan or any other
plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement,
the Company has reserved 2,806,192 shares of Company Common Stock for issuance under the 2006 Company Plan, of which 2,756,675
shares have been issued, are currently outstanding, and fully vested, 0 shares have been issued and are underlying outstanding
and unvested Company RSAs, 0 shares have been reserved for issuance upon exercise of Company Options previously granted and currently
outstanding under the 2006 Company Plan, and 0 shares of Company Common Stock remain available for future issuance pursuant to
the 2006 Company Plan. As of the date of this Agreement, the Company has reserved 13,972,109 shares of Company Common Stock for
issuance under the 2016 Company Plan, of which 0 shares have been issued, are currently outstanding and fully vested, 8,450,712
shares have been issued and are underlying and unvested Company RSAs, 10,000 shares have been reserved for issuance upon exercise
of Company Options previously granted and currently outstanding under the 2016 Company Plan, and 5,511,397 shares of Company Common
Stock remain available for future issuance pursuant to the 2016 Company Plan. <U>Section&nbsp;2.6(c)</U> of the Company Disclosure
Schedule sets forth the following information with respect to each Company Option outstanding as of the date of this Agreement:
(i) the name of the optionee; (ii) the number of shares of Company Common Stock subject to such Company Option at the time of grant;
(iii) the number of shares of Company Common Stock subject to such Company Option as of the date of this Agreement; (iv) the exercise
price of such Company Option; (v) the date on which such Company Option was granted; (vi) the applicable vesting schedule, including
the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions; (vii) the date on which
such Company Option expires; and (viii) whether such Company Option is intended to constitute an &ldquo;incentive stock option&rdquo;
(as defined in the Code) or a non-qualified stock option. <U>Section&nbsp;2.6(c)</U> of the Company Disclosure Schedule sets forth
the following information with respect to each Company RSA outstanding as of the date of this Agreement: (i) the name of the holder;
(ii) the number of shares of Company Common Stock subject to such RSA at the time of grant; (iii) the number of shares of Company
Common Stock subject to such RSA as of the date of this Agreement; (iv) the date on which such RSA was granted; and (v) the applicable
vesting schedule, including the number of vested and unvested shares as of the date of this Agreement and any acceleration provisions.
The Company has made available to Parent an accurate and complete copy of the 2006 Company Plan, the 2016 Company Plan and all
stock option agreements evidencing outstanding options granted thereunder. No vesting of Company Options or Company RSAs will accelerate
in connection with the closing of the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except for the Company Options and the Company RSAs set forth on <U>Section 2.6(c)</U> of the Company Disclosure Schedule,
there is no: (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any
shares of the capital stock or other securities of the Company or its Subsidiary; (ii) outstanding security, instrument or obligation
that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of the Company or
its Subsidiary; or (iii) condition or circumstance that is reasonably likely to give rise to or provide a basis for the assertion
of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock or other
securities of the Company or its Subsidiary. There are no outstanding or authorized stock appreciation, phantom stock, profit participation
or other similar rights with respect to the Company or its Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All outstanding shares of Company Common Stock, Company Options, Company RSAs and other securities of the Company have
been issued and granted in material compliance with (i) all applicable securities Laws and other applicable Law, and (ii) all requirements
set forth in applicable Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Concurrently with the execution hereof, the Company has provided to Parent true and complete copies of (i) the Company&rsquo;s
audited consolidated balance sheets at December 31, 2017, 2016 and 2015, together with related audited consolidated statements
of income, stockholders&rsquo; equity and cash flows, and notes thereto, of the Company for the fiscal years then ended and (ii)
the Company Unaudited Interim Balance Sheet, together with the unaudited consolidated statements of income, stockholders&rsquo;
equity and cash flows of the Company for the period reflected in the Company Unaudited Interim Balance Sheet (collectively, the
 &ldquo;<B><I>Company Financials</I></B>&rdquo;). The Company Financials were prepared in accordance with GAAP (except as may be
indicated in the notes to such financial statements and except that the unaudited financial statements may not contain footnotes
and are subject to normal and recurring year-end adjustments, none of which are material) and fairly present, in all material respects,
the financial position and operating results of the Company and its consolidated Subsidiary as of the dates and for the periods
indicated therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of the Company and its Subsidiary maintains accurate books and records reflecting their assets and liabilities
and maintains a system of internal accounting controls designed to provide reasonable assurance that: (i) transactions are executed
in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as reasonably necessary
to permit preparation of the financial statements of the Company and its Subsidiary and to maintain accountability of the Company&rsquo;s
and its Subsidiary&rsquo;s assets; (iii) access to the Company&rsquo;s and its Subsidiary&rsquo;s assets is permitted only in accordance
with management&rsquo;s general or specific authorization; (iv) the recorded accountability for the Company&rsquo;s and its Subsidiary&rsquo;s
assets is compared with the existing assets at regular intervals and appropriate action is taken with respect to any differences;
and (v) accounts, notes and other receivables and inventory are recorded accurately, and proper and adequate procedures are implemented
to effect the collection thereof on a current and timely basis. Each of the Company and its Subsidiary maintains internal control
over financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;2.7(c)</U> of the Company Disclosure Schedule lists, and the Company has delivered to Parent accurate
and complete copies of the documentation creating or governing, all securitization transactions and &ldquo;off-balance sheet arrangements&rdquo;
(as defined in Item 303(c) of Regulation S-K under the Exchange Act) effected by the Company or its Subsidiary since January 1,
2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Since January 1, 2016, there have been no formal internal investigations regarding financial reporting or accounting
policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial
officer or general counsel of the Company, the Company Board or any committee thereof. Since January 1, 2016, neither the Company
nor its independent auditors have identified (i) any significant deficiency or material weakness in the design or operation of
the system of internal accounting controls utilized by the Company and its Subsidiary, (ii) any fraud, whether or not material,
that involves the Company, any of its Subsidiaries, the Company&rsquo;s management or other employees who have a role in the preparation
of financial statements or the internal accounting controls utilized by the Company and its Subsidiary or (iii) any claim or allegation
regarding any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Changes</U></B>. Except as set forth on <U>Section&nbsp;2.8</U> of the Company Disclosure Schedule, between
the date of the Company Unaudited Interim Balance Sheet and the date of this Agreement, the Company has conducted its business
in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations
and transactions related thereto and to the other Contemplated Transactions) and there has not been any (a) Company Material Adverse
Effect or (b) action, event or occurrence that would have required the consent of Parent pursuant to <U>Section&nbsp;4.2(b)</U>
had such action, event or occurrence taken place after the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Undisclosed Liabilities</U></B>. As of the date hereof, neither the Company nor its Subsidiary has any Liability
of a type required to be recorded or reflected on a balance sheet or disclosed in the footnotes thereto under GAAP, except for:
(a) Liabilities disclosed, reflected or reserved against in the Company Unaudited Interim Balance Sheet; (b) Liabilities that have
been incurred by the Company or its Subsidiaries since the date of the Company Unaudited Interim Balance Sheet in the Ordinary
Course of Business; (c) Liabilities for performance of obligations of the Company under Company Contracts; (d) Liabilities incurred
in connection with the Contemplated Transactions; (e) Liabilities which would not, individually or in the aggregate, reasonably
be expected to have a Company Material Adverse Effect; and (f) Liabilities described in <U>Section&nbsp;2.9</U> of the Company
Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Title to Assets</U></B>. Each of the Company and its Subsidiary owns, and has good and valid title to, or, in the case
of leased properties and assets, valid leasehold interests in, all material tangible properties or assets and equipment used or
held for use in its business or operations or purported to be owned by it, including: (a) all tangible assets reflected on the
Company Unaudited Interim Balance Sheet (other than assets disposed of in the Ordinary Course of Business since the date of the
Company Unaudited Interim Balance Sheet); and (b) all other tangible assets reflected in the books and records of the Company or
its Subsidiary as being owned by the Company or such Subsidiary. All of such assets are owned or, in the case of leased assets,
leased by the Company or any of its Subsidiary free and clear of any Encumbrances, other than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Real Property; Leasehold</U></B>. Neither the Company nor its Subsidiary owns or has ever owned any real property. The
Company has made available to Parent (a) an accurate and complete list of all real properties with respect to which the Company
or its Subsidiary directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession
of or leased by the Company or any of its Subsidiaries, and (b) copies of all leases under which any such real property is possessed
(the &ldquo;<B><I>Company Real Estate Leases</I></B>&rdquo;), each of which is in full force and effect, with no existing material
default thereunder. The Company&rsquo;s use and operation of each such leased property conforms to all applicable Laws in all material
respects, and the Company has exclusive possession of each such leased property and has not granted any occupancy rights to tenants
or licensees with respect to such leased property. In addition, each such leased property is free and clear of all Encumbrances
other than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Intellectual Property</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 2.12(a)</U> of the Company Disclosure Schedule identifies (i)&nbsp;the name of the applicant/registrant,
(ii)&nbsp;the jurisdiction of application/registration, (iii)&nbsp;the application or registration number and (iv) any other co-owners,
for each item of material Registered IP owned in whole or in part by the Company or its Subsidiary. To the Knowledge of the Company,
each of the patents and patent applications included in the material Registered IP properly identifies by name each and every inventor
of the inventions claimed therein as determined in accordance with applicable Laws. As of the date of this Agreement, no interference,
opposition, reissue, reexamination or other proceeding of any nature (other than initial examination proceedings) is pending or,
to the Knowledge of the Company, threatened in writing, in which the scope, validity, enforceability or ownership of any Registered
IP listed on <U>Section 2.12(a)</U> of the Company Disclosure Schedule is being or has been contested or challenged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company or its Subsidiary owns all right, title and interest in and to all material Company IP (other than as disclosed
on <U>Section 2.12(a)</U> of the Company Disclosure Schedule), free and clear of all Encumbrances other than Permitted Encumbrances,
and has the right, pursuant to enforceable agreements to use all other material Intellectual Property Rights used by the Company
or its Subsidiary in its business as currently conducted. Each Company Associate involved in the creation or development of any
Company IP, pursuant to such Company Associate&rsquo;s activities on behalf of the Company or its Subsidiary, has signed a written
agreement containing an assignment of Intellectual Property Rights to the Company or its Subsidiary and confidentiality provisions
protecting the Company IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>To the Knowledge of the Company, no funding, facilities or personnel of any Governmental Body or any university, college,
research institute or other educational institution is being used to create Company IP, except for Company IP licensed from the
Regents of the University of California under that certain agreement listed on <U>Section 2.12(c)</U> of the Company Disclosure
Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 2.12(d)</U> of the Company Disclosure Schedule sets forth each Contract pursuant to which the Company (i)
is granted a license under any material Intellectual Property Right owned by any third party that is used by the Company or its
Subsidiary in its business as currently conducted (each a &ldquo;<B><I>Company In-bound License</I></B>&rdquo;) or (ii) grants
to any third party a license under any material Company IP or material Intellectual Property Right licensed to the Company or its
Subsidiary under a Company In-bound License (each a &ldquo;<B><I>Company Out-bound License</I></B>&rdquo;) (<I>provided</I>, that,
Company In-bound Licenses shall not include material transfer agreements, clinical trial agreements, non-disclosure agreements,
commercially available Software-as-a-Service offerings, or off-the-shelf software licenses entered into in the Ordinary Course
of Business; and Company Out-bound Licenses shall not include limited, non-exclusive licenses granted under material transfer agreements,
clinical trial agreements, non-disclosure agreements, or non-exclusive outbound licenses entered into in the Ordinary Course of
Business).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>To the Knowledge of the Company: (i)&nbsp;the operation of the businesses of the Company and its Subsidiary as currently
conducted does not infringe any valid and enforceable Registered IP or misappropriate or otherwise violate any other Intellectual
Property Right owned by any other Person; and (ii)&nbsp;no other Person is infringing, misappropriating or otherwise violating
any Company IP or any Intellectual Property Rights exclusively licensed to the Company or its Subsidiary. As of the date of this
Agreement, no Legal Proceeding is pending (or, to the Knowledge of the Company, is threatened in writing) (A)&nbsp;against the
Company or its Subsidiary alleging that the operation of the business of the Company or its Subsidiary infringes or constitutes
the misappropriation or other violation of any Intellectual Property Rights of another Person or (B)&nbsp;by the Company or its
Subsidiary alleging that another Person has infringed, misappropriated or otherwise violated any of the Company IP or any Intellectual
Property Rights exclusively licensed to the Company or its Subsidiary. Since January 1, 2016, neither the Company nor its Subsidiary
has received any written notice or other written communication alleging that the operation of the business of the Company or its
Subsidiary infringes or constitutes the misappropriation or other violation of any Intellectual Property Right of another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company and its Subsidiary have taken reasonable security and other measures, including measures against unauthorized
disclosure, to protect the secrecy, confidentiality, and value of its trade secrets and other technical information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>None of the Company IP or, to the Knowledge of the Company, any material Intellectual Property Rights exclusively licensed
to the Company or its Subsidiary is subject to any pending or outstanding injunction, directive, order, judgment or other disposition
of dispute that adversely and materially restricts the use, transfer, registration or licensing by the Company or its Subsidiary
of any such Company IP or material Intellectual Property Rights exclusively licensed to the Company or its Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company and its Subsidiary maintain commercially reasonable policies regarding data security, privacy, transfer,
and use of personally identifiable information and sensitive business information (collectively, &ldquo;<B><I>Sensitive Data</I></B>&rdquo;)
that support compliance by the Company and its Subsidiary with all applicable Laws. The Company and the operation of the Company&rsquo;s
business are in substantial compliance with all such policies and other Laws pertaining to data privacy and data security of any
Sensitive Data except as would not reasonably be expected to, individually or in the aggregate, have a Company Material Adverse
Effect. To the Knowledge of the Company, since January 1, 2016, there have been (i) no material losses or thefts of data or security
breaches relating to Sensitive Data used in the business of the Company or its Subsidiary, (ii) no violations of any security policy
of the Company or its Subsidiary regarding any such Sensitive Data, (iii) no unauthorized access or unauthorized use of any Sensitive
Data used in the business of the Company or its Subsidiary and (iv) no unintended or improper disclosure of any personally identifiable
information in the possession, custody or control of the Company or its Subsidiary or a contractor or agent acting on behalf of
the Company or its Subsidiary, in each case of (i) through (iv), except as would not reasonably be expected to, individually or
in the aggregate, have a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agreements, Contracts and Commitments</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;2.13(a)</U> of the Company Disclosure Schedule lists the following Company Contracts in effect as of
the date of this Agreement other than any Company Benefit Plans (each, a &ldquo;<B><I>Company Material Contract</I></B>&rdquo;
and collectively, the &ldquo;<B><I>Company Material Contracts</I></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course
of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract containing (A) any covenant limiting the freedom of the Company, its Subsidiary or the Surviving
Corporation to engage in any line of business or compete with any Person, (B) any most-favored pricing arrangement, (C) any exclusivity
provision, or (D) any non-solicitation provision applicable to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess
of $150,000 pursuant to its express terms and not cancelable without penalty;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract relating to the disposition or acquisition of material assets or any ownership interest in any
Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements
or other agreements or instruments relating to the borrowing of money or extension of credit or creating any material Encumbrances
with respect to any assets of the Company or any of its Subsidiaries or any loans or debt obligations with officers or directors
of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract requiring payment by or to the Company after the date of this Agreement in excess of $150,000
pursuant to its express terms relating to: (A) any distribution agreement (identifying any that contain exclusivity provisions);
(B) any agreement involving provision of services or products with respect to any pre-clinical or clinical development activities
of the Company; (C) any dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or other agreement
currently in force under which the Company has continuing obligations to develop or market any product, technology or service,
or any agreement pursuant to which the Company has continuing obligations to develop any Intellectual Property Rights that will
not be owned, in whole or in part, by the Company; or (D) any Contract to license any third party to manufacture or produce any
product, service or technology of the Company or any Contract to sell, distribute or commercialize any products or service of the
Company, in each case, except for Company Contracts entered into in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract with any Person, including any financial advisor, broker, finder, investment banker or other Person,
providing advisory services to the Company in connection with the Contemplated Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Real Estate Lease;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract with any Governmental Body;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Out-bound License and Company In-bound License;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Company Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of the
Company or its Subsidiary; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>any other Company Contract that is not terminable (with no penalty or payment) by the Company or its Subsidiary without
more than 30 days&rsquo; prior written notice, and (A) which involves payment or receipt by the Company or its Subsidiary after
the date of this Agreement under any such agreement, Contract or commitment of more than $150,000 in the aggregate, or obligations
after the date of this Agreement in excess of $150,000 in the aggregate, or (B) that is material to the business or operations
of the Company and its Subsidiary, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company has made available to Parent accurate and complete copies of all Company Material Contracts, including all
amendments thereto. Except as set forth in <U>Section&nbsp;2.13(b)</U> of the Company Disclosure Schedule, there are no Company
Material Contracts that are not in written form. Neither the Company nor its Subsidiary has, nor to the Knowledge of the Company,
as of the date of this Agreement has any other party to a Company Material Contract, breached, violated or defaulted under, or
received written notice that it breached, violated or defaulted under, any of the terms or conditions of any Company Material Contract
in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other
party to seek damages that would reasonably be expected to be material to the Company or its business. As to the Company and its
Subsidiary, as of the date of this Agreement, each Company Material Contract is valid, binding, enforceable and in full force and
effect, subject to the Enforceability Exceptions. The Company is not currently renegotiating, and no Person has a right pursuant
to the terms of any Company Material Contract to change, any material amount paid or payable to the Company under any Company Material
Contract or any other material term or provision of any Company Material Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance; Permits; Restrictions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company and its Subsidiary are, and since January 1, 2016 have been, in compliance in all material respects with
all applicable Laws, including the Federal Food, Drug, and Cosmetic Act (&ldquo;<B><I>FDCA</I></B>&rdquo;), the Food and Drug Administration
(&ldquo;<B><I>FDA</I></B>&rdquo;) regulations adopted thereunder, the Public Health Service Act and any other similar Law administered
or promulgated by the FDA or other comparable Governmental Body responsible for regulation of the development, clinical testing,
manufacturing, sale, marketing, distribution and importation or exportation of drug and biopharmaceutical products (each, a &ldquo;<B><I>Drug
Regulatory Agency</I></B>&rdquo;), except for any noncompliance, either individually or in the aggregate, which would not be material
to the Company. No investigation, claim, suit, proceeding, inspection, audit or other action by any Governmental Body is pending
or, to the Knowledge of the Company, threatened in writing against the Company or its Subsidiary. There is no agreement, judgment,
injunction, order or decree binding upon the Company or its Subsidiary that (i) has or would reasonably be expected to have the
effect of prohibiting or materially impairing any business practice of the Company and its Subsidiary, taken as a whole, any acquisition
of material property by the Company or its Subsidiary or the conduct of business by the Company or its Subsidiary, taken as a whole,
as currently conducted, (ii) is reasonably likely to have a material adverse effect on the Company&rsquo;s ability to comply with
or perform any covenant or obligation under this Agreement, or (iii) is reasonably likely to have the effect of preventing, delaying,
making illegal or otherwise interfering with the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of the Company and its Subsidiary hold all required Governmental Authorizations that are material to the operation
of the business of the Company and its Subsidiary, as the case may be, as currently conducted (the &ldquo;<B><I>Company Permits</I></B>&rdquo;).
<U>Section&nbsp;2.14(b)</U> of the Company Disclosure Schedule identifies each Company Permit. Each of the Company and its Subsidiary
is in material compliance with the terms of the Company Permits. No Legal Proceeding is pending or, to the Knowledge of the Company,
threatened in writing, which seeks to revoke, limit, suspend, or materially modify any Company Permit. The rights and benefits
of each Company Permit will be available to the Surviving Corporation or its Subsidiaries, as applicable, immediately after the
Effective Time on terms substantially identical to those enjoyed by the Company and its Subsidiary as of the date of this Agreement
and immediately prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no proceedings pending or, to the Knowledge of the Company, threatened in writing with respect to an alleged
material violation by the Company or its Subsidiary of the FDCA, FDA regulations adopted thereunder, the Public Health Service
Act or any other similar Law administered or promulgated by any Drug Regulatory Agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, the Company or
its Subsidiary, or in which the Company or its Subsidiary or their respective current products or product candidates have participated,
were and, if still pending, are being conducted in all material respects in accordance with standard medical and scientific research
procedures and in compliance in all material respects with the applicable regulations of any applicable Drug Regulatory Agency
and other applicable Law, including 21 C.F.R. Parts 50, 54, 56, 58, 210, 211 and 312. No preclinical or clinical trial conducted
by or on behalf of the Company or its Subsidiary has been terminated or suspended prior to completion for safety or non-compliance
reasons. Since January 1, 2016, neither the Company nor its Subsidiary has received any notices, correspondence, or other communications
from any Drug Regulatory Agency requiring, or to the Knowledge of the Company threatening to initiate, the termination or suspension
of any clinical studies conducted by or on behalf of, or sponsored by, the Company or its Subsidiary or in which the Company or
its Subsidiary or their respective current products or product candidates have participated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary is the subject of any pending or, to the Knowledge of the Company, threatened
investigation in respect of its business or products by the FDA pursuant to its &ldquo;Fraud, Untrue Statements of Material Facts,
Bribery, and Illegal Gratuities&rdquo; Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto.
To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has committed any acts, made any statement, or
failed to make any statement, in each case in respect of its business or products that would violate the FDA&rsquo;s &ldquo;Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&rdquo; Final Policy, and any amendments thereto. None of the
Company, its Subsidiary or any of their respective officers, employees or agents has been convicted of any crime or engaged in
any conduct that would reasonably be expected to result in a debarment or exclusion (i) under 21 U.S.C. Section 335a or (ii) any
similar applicable Law. To the Knowledge of the Company, no debarment or exclusionary claims, actions, proceedings or investigations
in respect of their business or products are pending or threatened in writing against the Company, or its Subsidiary or any of
their respective officers, employees or agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company and its Subsidiary have complied with all applicable Laws relating to patient, medical or individual health
information, including the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations promulgated
thereunder, all as amended from time to time (collectively &ldquo;<B><I>HIPAA</I></B>&rdquo;), including the standards for the
privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the standards for the
protection of Electronic Protected Health Information set forth at 45 C.F.R. Part 160 and 45 C.F.R. Part 164, Subpart A and Subpart
C, the standards for transactions and code sets used in electronic transactions at 45 C.F.R. Part 160, Subpart A and Part 162,
and the standards for Breach Notification for Unsecured Protected Health Information at 45 C.F.R. Part 164, Subpart D, all as amended
from time to time.&nbsp; The Company and its Subsidiary have entered into, where required, and are in compliance in all material
respects with the terms of all Business Associate (as defined in HIPAA) agreements to which the Company is a party or otherwise
bound.&nbsp; The Company and its Subsidiary have created and maintained written policies and procedures to protect the privacy
of all protected health information, provide training to all employees and agents as required under HIPAA, and have implemented
security procedures, including physical, technical and administrative safeguards, intended to protect all personal information
and Protected Health Information stored or transmitted in electronic form. Neither the Company nor its Subsidiary have received
written notice from the Office for Civil Rights for the U.S. Department of Health and Human Services or any other Governmental
Body of any allegation regarding its failure to comply with HIPAA or any other state law or regulation applicable to the protection
of individually identifiable health information or personally identifiable information.&nbsp; No successful Security Incident,
Breach of Unsecured Protected Health Information or breach of personally identifiable information under applicable state or federal
Laws have occurred with respect to information maintained or transmitted to the Company, its Subsidiary, or an agent or third party
subject to a Business Associate Agreement with the Company or a Subsidiary of the Company.&nbsp; The Company is currently submitting,
receiving and handling or is capable of submitting receiving and handling transactions in accordance with the Standard Transaction
Rule.&nbsp; All capitalized terms in this <U>Section&nbsp;2.14(f)</U> not otherwise defined in this Agreement shall have the meanings
set forth under HIPAA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Proceedings; Orders</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As of the date of this Agreement, there is no pending Legal Proceeding and, to the Knowledge of the Company, no Person
has threatened in writing to commence any Legal Proceeding: (i) that involves (A) the Company, (B) the Company&rsquo;s Subsidiary,
(C) any Company Associate (in his or her capacity as such) or (D) any of the material assets owned or used by the Company or its
Subsidiary; or (ii) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering
with, the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth in <U>Section&nbsp;2.15(b)</U> of the Company Disclosure Schedule, since January 1, 2016, no Legal
Proceeding has been pending against the Company that resulted in material Liability to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is no order, writ, injunction, judgment or decree to which the Company or its Subsidiary, or any of the material
assets owned or used by the Company or its Subsidiary, is subject. To the Knowledge of the Company, no executive officer of the
Company or its Subsidiary is subject to any order, writ, injunction, judgment or decree that prohibits such officer from engaging
in or continuing any conduct, activity or practice relating to the business of the Company or to any material assets owned or used
by the Company or its Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company and its Subsidiary have timely filed all income Tax Returns and other material Tax Returns that they were
required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been prepared
in compliance with all applicable Law. No claim has ever been made by any Governmental Body in any jurisdiction where the Company
or its Subsidiary does not file a particular Tax Return or pay a particular Tax that the Company is subject to taxation by that
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All income and other material Taxes due and owing by the Company or its Subsidiary on or before the date hereof (whether
or not shown on any Tax Return) have been fully paid. The unpaid Taxes of the Company and its Subsidiary did not, as of the date
of the Company Unaudited Interim Balance Sheet, materially exceed the reserve for Tax Liability (excluding any reserve for deferred
Taxes established to reflect timing differences between book and Tax items) set forth on the Company Unaudited Interim Balance
Sheet. Since the date of the Company Unaudited Interim Balance Sheet, neither the Company nor its Subsidiary has incurred any material
Liability for Taxes outside the Ordinary Course of Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All Taxes that the Company or its Subsidiary are or were required by Law to withhold or collect have been duly and timely
withheld or collected in all material respects on behalf of its respective employees, independent contractors, stockholders, or
other third parties and, have been timely paid to the proper Governmental Body or other Person or properly set aside in accounts
for this purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no Encumbrances for material Taxes (other than Taxes not yet due and payable) upon any of the assets of the
Company or its Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No deficiencies for income or other material Taxes with respect to the Company or its Subsidiary have been claimed,
proposed or assessed by any Governmental Body in writing. There are no pending or ongoing, and to the Knowledge of the Company,
threatened audits, assessments or other actions for or relating to any Liability in respect of a material amount of Taxes of the
Company or its Subsidiary. Neither the Company nor its Subsidiary (or any of their predecessors) has waived any statute of limitations
in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material
Tax assessment or deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary has been a United States real property holding corporation within the meaning
of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity
agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of
Business the principal subject matter of which is not Taxes or an agreement or arrangement between or among the Company and its
Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary will be required to include any material item of income in, or exclude any material
item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any:
(i) change in method of accounting for Tax purposes; (ii) use of an improper method of accounting for a Tax period ending on or
prior to the Closing Date; (iii) &ldquo;closing agreement&rdquo; as described in Section 7121 of the Code (or any similar provision
of state, local or foreign Law) executed on or prior to the Closing Date; (iv) intercompany transaction or excess loss account
described in Treasury Regulations under Section 1502 of the Code (or any similar provision of state, local or foreign Law); (v)
installment sale or open transaction disposition made on or prior to the Closing Date; (vi) prepaid amount received or deferred
revenue accrued on or prior to the Closing Date; (vii) application of Sections 951, 951A or 965 of the Code to any income received
or accrued on or prior to the Closing Date by any Subsidiary owned by the Company prior to the Effective Time; or (viii) election
under Section 108(i) of the Code (or any similar provision of state, local or foreign Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary has ever been a member of a consolidated, combined or unitary Tax group (other
than such a group the common parent of which is the Company). Neither the Company nor its Subsidiary has any Liability for any
material Taxes of any Person (other than the Company and its Subsidiary) under Treasury Regulations Section 1.1502-6 (or any similar
provision of state, local, or foreign Law), or as a transferee or successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary has distributed stock of another Person, or has had its stock distributed by
another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code or
Section 361 of the Code (or any similar provisions of state, local or foreign Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary (i) is a &ldquo;controlled foreign corporation&rdquo; as defined in Section 957
of the Code, (ii) is a &ldquo;passive foreign investment company&rdquo; within the meaning of Section 1297 of the Code, or (iii)
has ever had a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place
of business in a jurisdiction outside of the country in which it is incorporated or organized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary has participated in or been a party to a transaction that, as of the date of
this Agreement, constitutes a &ldquo;listed transaction&rdquo; that is required to be reported to the IRS pursuant to Section 6011
of the Code and applicable Treasury Regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary has taken any action or knows of any fact that would reasonably be expected to
prevent the Merger from qualifying for the Intended Tax Treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For purposes of this
<U>Section&nbsp;2.16</U>, each reference to the Company or its Subsidiary shall be deemed to include any Person that was liquidated
into, merged with, or is otherwise a predecessor to, the Company or its Subsidiary (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employee and Labor Matters; Benefit Plans</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;2.17(a)</U> of the Company Disclosure Schedule is a list of all material Company Benefit Plans, including,
without limitation, each Company Benefit Plan that provides for retirement, change in control, stay or retention, deferred compensation,
incentive compensation, severance or retiree medical or life insurance benefits. &ldquo;<B><I>Company Benefit Plan</I></B>&rdquo;
means each (i) &ldquo;employee benefit plan&rdquo; as defined in Section 3(3) of ERISA and (ii) other pension, retirement, deferred
compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based, phantom equity, employment (other than
at-will employment offer letters on the Company&rsquo;s standard form and other than individual Company Options, Company RSAs or
other compensatory equity award agreements made pursuant to the Company&rsquo;s standard forms, in which case only representative
standard forms of such agreements shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability,
group insurance, paid-time off, holiday, welfare and fringe benefit plan, program, agreement, Contract, or arrangement (whether
written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated), in
any case, maintained, contributed to, or required to be contributed to, by the Company, its Subsidiary or any of the Company ERISA
Affiliates for the benefit of any current or former employee, director, officer or independent contractor of the Company or its
Subsidiary or under which the Company or its Subsidiary has any actual or contingent Liability (including, without limitation,
as to the result of it being treated as a single employer under Code Section 414 with any other person).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As applicable with respect to each material Company Benefit Plan, the Company has made available to Parent, true and
complete copies of (i) each material Company Benefit Plan, including all amendments thereto, and in the case of an unwritten material
Company Benefit Plan, a written description thereof, (ii) all current trust documents, investment management Contracts, custodial
agreements, administrative services agreements and insurance and annuity contracts relating thereto, (iii) the current summary
plan description and each summary of material modifications thereto, (iv) the most recently filed annual reports with any Governmental
Body (<I>e.g.</I>, Form 5500 and all schedules thereto), (v) the most recent IRS determination, opinion or advisory letter, (vi)
the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee
reports, (vii) all records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations,
 &ldquo;prohibited transactions&rdquo; within the meaning of Section 406 of ERISA or Section 4975 of the Code, (viii) all policies
and procedures established to comply with the privacy and security rules of HIPAA and (ix) any written reports constituting a valuation
of the Company&rsquo;s capital stock for purposes of Sections 409A or 422 of the Code, whether prepared internally by the Company
or by an outside, third-party valuation firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each Company Benefit Plan has been maintained, operated and administered in compliance in all material respects with
its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company Benefit Plans which are &ldquo;employee pension benefit plans&rdquo; within the meaning of Section 3(2)
of ERISA and which are intended to meet the qualification requirements of Section 401(a) of the Code have received determination
or opinion letters from the IRS on which they may currently rely to the effect that such plans are qualified under Section 401(a)
of the Code and the related trusts are exempt from federal income Taxes under Section 501(a) of the Code, respectively, and to
the Knowledge of the Company, nothing has occurred that would reasonably be expected to materially adversely affect the qualification
of such Company Benefit Plan or the tax exempt status of the related trust.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company, any of its Subsidiaries nor any Company ERISA Affiliate maintains, contributes to, is required
to contribute to, or has any actual or contingent Liability with respect to, (i) any &ldquo;employee pension benefit plan&rdquo;
(within the meaning of Section 3(2) of ERISA) that is subject to Title IV or Section 302 of ERISA or Section 412 of the Code, (ii)
any &ldquo;multiemployer plan&rdquo; (within the meaning of Section 3(37) of ERISA), (iii) any &ldquo;multiple employer plan&rdquo;
(within the meaning of Section 413 of the Code) or (iv) any &ldquo;multiple employer welfare arrangement&rdquo; (within the meaning
of Section 3(40) of ERISA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no pending audits or investigations by any Governmental Body involving any Company Benefit Plan, and no pending
or, to the Knowledge of the Company, threatened claims (except for individual claims for benefits payable in the normal operation
of the Company Benefit Plans), suits or proceedings involving any Company Benefit Plan, any fiduciary thereof or service provider
thereto, in any case except as would not be reasonably expected to result in material Liability to the Company or its Subsidiary.
All contributions and premium payments required to have been made under any of the Company Benefit Plans or by applicable Law (without
regard to any waivers granted under Section 412 of the Code), have been timely made and neither the Company nor any Company ERISA
Affiliate has any Liability for any unpaid contributions with respect to any Company Benefit Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company, any of its Subsidiaries or Company ERISA Affiliates, nor to the Knowledge of the Company, any fiduciary,
trustee or administrator of any Company Benefit Plan, has engaged in, or in connection with the transactions contemplated by this
Agreement will engage in, any transaction with respect to any Company Benefit Plan which would subject any such Company Benefit
Plan, the Company, any of its Subsidiaries or Company ERISA Affiliates or Parent to a material Tax, material penalty or material
Liability for a &ldquo;prohibited transaction&rdquo; under Section 406 of ERISA or Section 4975 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No Company Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination
of service or retirement other than coverage mandated by Law and neither the Company or Company ERISA Affiliates has made a written
or oral representation promising the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the execution of, nor the performance of the transactions contemplated by, this Agreement will either alone
or in connection with any other event(s) (i)&nbsp;result in any payment becoming due to any current or former employee, director,
officer, or independent contractor of the Company or its Subsidiary, (ii) increase any amount of compensation or benefits otherwise
payable under any Company Benefit Plan, (iii) result in the acceleration of the time of payment, funding or vesting of any benefits
under any Company Benefit Plan, (iv) require any contribution or payment to fund any obligation under any Company Benefit Plan
or (v)&nbsp;limit the right to merge, amend or terminate any Company Benefit Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the execution of, nor the consummation of the transactions contemplated by this Agreement (either alone or when
combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the
receipt or retention by any person who is a &ldquo;disqualified individual&rdquo; (within the meaning of Code Section 280G) with
respect to the Company and its Subsidiary of any payment or benefit that is or could be characterized as a &ldquo;parachute payment&rdquo;
(within the meaning of Code Section 280G), determined without regard to the application of Code Section 280G(b)(5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The exercise price of each Company Option is not, never has been and can never be less than the fair market value of
one share of Company Common Stock as of the grant date of such Company Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 2.17(l)</U> of the Company Disclosure Schedule lists each Company Benefit Plan that provides for deferred
compensation that constitutes a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined in Section 409A(d)(1) of the
Code and the regulations promulgated thereunder). Each Company Benefit Plan providing for deferred compensation that constitutes
a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined in Section 409A(d)(1) of the Code and the Treasury Regulations)
is, and has been, established, administered and maintained in compliance with the requirements of Section 409A of the Code and
the regulations promulgated thereunder in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No current or former employee, officer, director or independent contractor of the Company or its Subsidiary has any
 &ldquo;gross up&rdquo; agreements or other assurance of reimbursement for any Taxes imposed under Code Section 409A or Code Section
4999.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the Company nor its Subsidiary is a party to, bound by, or has a duty to bargain under, any collective bargaining
agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there
is no labor union, labor organization, or similar Person representing or, to the Knowledge of the Company, purporting to represent
or seeking to represent any employees of the Company or its Subsidiary, including through the filing of a petition for representation
election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of the Company and its Subsidiary is, and since January 1, 2016 has been, in material compliance with all applicable
Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification,
discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration,
employee safety and health, wages (including overtime wages), unemployment and workers&rsquo; compensation, leaves of absence,
and hours of work. Except as would not be reasonably likely to result in a material Liability to the Company or its Subsidiary,
with respect to employees of the Company and its Subsidiary, the Company and its Subsidiary, since January 1, 2016: (i) has withheld
and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other
payments, benefits, or compensation to employees, (ii) is not liable for any arrears of wages (including overtime wages), severance
pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any
trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation
benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in
the Ordinary Course of Business). There are no actions, suits, claims, charges, lawsuits, investigations, audits or administrative
matters pending or, to the Knowledge of the Company, threatened in writing against the Company or its Subsidiary relating to any
employee, applicant for employment, consultant, employment agreement or Company Benefit Plan (other than routine claims for benefits).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as would not be reasonably likely to result in a material Liability to the Company or its Subsidiary, with respect
to each individual who currently renders services to the Company or its Subsidiary, the Company or its Subsidiary, as applicable,
has accurately classified each such individual as an employee, independent contractor, or otherwise under all applicable Laws and,
for each individual classified as an employee, the Company or its Subsidiary, as applicable, has accurately classified him or her
as overtime eligible or overtime ineligible under all applicable Laws. Neither the Company nor its Subsidiary has any material
Liability with respect to any misclassification of: (a) any Person as an independent contractor rather than as an employee, (b)
any employee leased from another employer, or (c) any employee currently or formerly classified as exempt from overtime wages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is not and has not been in the past three years, nor is there or has there been in the past three years any threat
of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute,
or, to the Knowledge of the Company, any union organizing activity, against the Company or its Subsidiary. No event has occurred,
and no condition or circumstance exists, that might directly or indirectly be likely to give rise to or provide a basis for the
commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar
activity or dispute, or, to the Knowledge of the Company, any union organizing activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is no Legal Proceeding, claim, unfair labor practice charge or complaint, labor dispute or grievance pending or,
to the Knowledge of the Company, threatened against Company or its Subsidiary relating to labor, employment, employment practices,
or terms and conditions of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As of the date hereof, no Key Employee has submitted his or her resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Matters</U>. </B> The Company and its Subsidiary are in compliance, and since January 1, 2016 have complied
with, all applicable Environmental Laws, which compliance includes the possession by the Company and its Subsidiary of all permits
and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions
thereof, except for any failure to be in such compliance that, either individually or in the aggregate, would not reasonably be
expected to have a Company Material Adverse Effect. Neither the Company nor its Subsidiary has received since January 1, 2016 (or
prior to that time, which is pending and unresolved), any written notice or other communication (in writing or otherwise), whether
from a Governmental Body or other Person, that alleges that the Company or its Subsidiary is not in compliance with or has Liability
pursuant to any Environmental Law and, to the Knowledge of the Company, there are no circumstances that would reasonably be expected
to prevent or interfere with the Company&rsquo;s or its Subsidiary&rsquo;s compliance in any material respects with any Environmental
Law, except where such failure to comply would not reasonably be expected to have a Company Material Adverse Effect. No current
or (during the time a prior property was leased or controlled by the Company or its Subsidiary) prior property leased or controlled
by the Company or its Subsidiary has had a release of or exposure to Hazardous Materials in material violation of or as would reasonably
be expected to result in any material Liability of the Company or its Subsidiary pursuant to Environmental Law. No Consent of or
registration or filing with any Governmental Body is required by Environmental Laws in connection with the execution and delivery
of this Agreement or the consummation of the Contemplated Transactions. Prior to the date hereof, the Company or its Subsidiary
has provided or otherwise made available to Parent true and correct copies of all material environmental reports, assessments,
studies and audits in the possession or control of the Company or its Subsidiary with respect to any property leased or controlled
by the Company or its Subsidiary or any business operated by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance</U></B>. The Company has delivered or made available to Parent accurate and complete copies of all material
insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and
operations of the Company and its Subsidiary. Each of such insurance policies is in full force and effect and the Company and its
Subsidiary are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications
from insurance carriers, since January 1, 2016, neither the Company nor its Subsidiary has received any notice or other communication
regarding any actual or possible: (i) cancellation or invalidation of any insurance policy; or (ii) refusal or denial of any coverage,
reservation of rights or rejection of any material claim under any insurance policy. The Company and its Subsidiary have provided
timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against the Company
or its Subsidiary for which the Company or its Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage
or a reservation of rights with respect to any such Legal Proceeding, or the Company, informed the Company or its Subsidiary of
its intent to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Financial Advisors</U></B>. Except as set forth on <U>Section&nbsp;2.20</U> of the Company Disclosure Schedule, no
broker, finder or investment banker is entitled to any brokerage fee, finder&rsquo;s fee, opinion fee, success fee, transaction
fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of
the Company or its Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transactions with Affiliates</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;2.21(a)</U> of the Company Disclosure Schedule describes all material transactions or relationships,
since January 1, 2016, between, on one hand, the Company or its Subsidiary and, on the other hand, any (i) executive officer or
director of the Company or, to the Knowledge of the Company, its Subsidiary or any of such executive officer&rsquo;s or director&rsquo;s
immediate family members, (ii) owner of more than 5% of the voting power of the outstanding Company Common Stock or (iii) to the
Knowledge of the Company, any &ldquo;related person&rdquo; (within the meaning of Item 404 of Regulation S-K under the Securities
Act) of any such officer, director or owner (other than the Company or its Subsidiary) in the case of each of (i), (ii) or (iii)
that is of the type that would be required to be disclosed under Item 404 of Regulation S-K under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;2.21(b)</U> of the Company Disclosure Schedule lists each stockholders agreement, voting agreement,
registration rights agreement, co-sale agreement or other similar Contract between the Company and any holders of Company Common
Stock, including any such Contract granting any Person investor rights, rights of first refusal, rights of first offer, registration
rights, director designation rights or similar rights (collectively, the &ldquo;<B><I>Investor Agreements</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Anti-Bribery</U></B>. None of the Company or its Subsidiary or any of their respective directors, officers, employees
or, to the Company&rsquo;s Knowledge, agents or any other Person acting on their behalf has directly or indirectly made any bribes,
rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form
of cash, gifts, or otherwise, or taken any other action, in violation of the Foreign Corrupt Practices Act of 1977, the UK Bribery
Act of 2010 or any other anti-bribery or anti-corruption Law (collectively, the &ldquo;<B><I>Anti-Bribery Laws</I></B>&rdquo;).
Neither the Company nor its Subsidiary is or has been the subject of any investigation or inquiry by any Governmental Body with
respect to potential violations of Anti-Bribery Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclaimer of Other Representations and Warranties</U></B>. Except as expressly set forth in this <U>Section 2</U>, the
Company makes no representation or warranty, express or implied, at law or in equity, including with respect to it or any of its
assets, liabilities or operations, and any such other representations and warranties are hereby expressly disclaimed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to <U>Section&nbsp;10.13(h)</U>,
except (a) as set forth in the written disclosure schedule delivered by Parent to the Company (the &ldquo;<B><I>Parent Disclosure
Schedule</I></B>&rdquo;) or (b) as disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof and publicly
available on the SEC&rsquo;s Electronic Data Gathering Analysis and Retrieval system (but (i) without giving effect to any amendment
thereof filed with, or furnished to the SEC on or after the date hereof and (ii) excluding any disclosures contained under the
heading &ldquo;Risk Factors&rdquo; and any disclosure of risks included in any &ldquo;forward-looking statements&rdquo; disclaimer
or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature),
Parent and Merger Sub represent and warrant to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Due Organization; Subsidiaries</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of Parent and Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws
of the jurisdiction of its incorporation, and has all necessary corporate power and authority to conduct its business in the manner
in which its business is currently being conducted and to own or lease and use its property and assets in the manner in which its
property and assets are currently owned or leased and used, except where the failure to have such power or authority would not
reasonably be expected to prevent or materially delay the ability of Parent and Merger Sub to consummate the Contemplated Transactions.
Since the date of its incorporation, Merger Sub has not engaged in any activities other than activities incident to its formation
or in connection with or as contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent is qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the
Laws of all jurisdictions where the nature of its business requires such licensing or qualification other than in jurisdictions
where the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a Parent Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of Parent&rsquo;s Subsidiaries is a corporation or other legal entity duly organized, validly existing and, if
applicable, in good standing under the Laws of the jurisdiction of its organization and has all necessary corporate or other power
and authority to conduct its business in the manner in which its business is currently being conducted and to own or lease and
use its property and assets in the manner in which its property and assets are currently owned or leased and used, except where
the failure to have such power or authority would not be reasonably expected to have a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries is or has otherwise been, directly or indirectly, a party to, member of or
participant in any partnership, joint venture or similar business entity. Neither Parent nor any of its Subsidiaries has agreed
or is obligated to make, or is bound by any Contract under which it may become obligated to make, any future investment in or capital
contribution to any other Entity. Neither Parent nor any of its Subsidiaries has, at any time, been a general partner of, or has
otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organizational Documents</U>. </B> Parent has made available to the Company accurate and complete copies of Parent&rsquo;s
and its Subsidiaries&rsquo; Organizational Documents in effect as of the date of this Agreement. Neither Parent nor any of its
Subsidiaries is in material breach or violation of its respective Organizational Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authority; Binding Nature of Agreement</U></B>. Each of Parent and Merger Sub has all necessary corporate power and authority
to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Parent Board
has: (a) determined that the Contemplated Transactions are fair to, advisable and in the best interests of Parent and its stockholders;
(b) authorized, approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares
of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement and the treatment of the Company
Options pursuant to this Agreement; and (c) determined to recommend, upon the terms and subject to the conditions set forth in
this Agreement, that the stockholders of Parent vote to approve this Agreement and the Contemplated Transactions, including the
issuance of shares of Parent Common Stock to the stockholders of the Company pursuant to the terms of this Agreement. The Merger
Sub Board (by unanimous written consent) has: (x) determined that the Contemplated Transactions are fair to, advisable, and in
the best interests of Merger Sub and its sole stockholder; (y) deemed advisable and approved this Agreement and the Contemplated
Transactions; and (z) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the
stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions. This Agreement has been
duly executed and delivered by Parent and Merger Sub and, assuming the due authorization, execution and delivery by the Company,
constitutes the legal, valid and binding obligation of Parent and Merger Sub, enforceable against each of Parent and Merger Sub
in accordance with its terms, subject to the Enforceability Exceptions. Prior to the execution of the Parent Stockholder Support
Agreements, the Parent Board approved the Parent Stockholder Support Agreements and the transactions contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vote Required</U></B>. (A) The affirmative vote of the holders of a majority of outstanding shares of Parent&rsquo;s
Common Stock is the only vote of the holders of any class or series of Parent Common Stock necessary to approve the proposals in
clauses 5.3(a)(i) and 5.3(a)(ii), and (B) the affirmative vote of the holders of a majority of shares of Parent&rsquo;s Common
Stock cast on the proposals in clauses 5.3(a)(iii) and 5.3(a)(iv), is the only vote of the holders of any class or series of Parent
Common Stock necessary to approve the proposals in clauses 5.3(a)(iii) and 5.3(a)(iv). The required votes specified in this paragraph
with respect to the matters specified in clauses 5.3(a)(i)-(iii) shall be referred to herein as the &ldquo;<B><I>Required Parent
Stockholder Votes</I></B><I>,</I>&rdquo; and the votes specified in this paragraph with respect to the matters specified in clauses
5.3(a)(iv) shall be referred to herein as the &ldquo;<B><I>Other Parent Stockholder Votes</I></B><I>,</I>&rdquo; and the Required
Parent Stockholder Votes and the Other Parent Stockholder Votes shall be collectively referred to herein as the &ldquo;<B><I>Parent
Stockholder Votes</I>.</B>&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Contravention; Consents</U></B>. Subject to obtaining the Parent Stockholder Vote and the filing of the Articles
of Merger required by the WBCA, neither (x) the execution, delivery or performance of this Agreement by Parent or Merger Sub, nor
(y) the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of Parent
or Merger Sub;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation of, or give any Governmental Body, or to the Knowledge of Parent,
any other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any
Law or any order, writ, injunction, judgment or decree to which Parent or its Subsidiaries, or any of the assets owned or used
by Parent or its Subsidiaries, is subject, except as would not reasonably be expected to be material to Parent or its business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>to the Knowledge of Parent, contravene, conflict with or result in a violation of any of the terms or requirements of,
or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization
that is held by Parent or its Subsidiaries, except as would not reasonably be expected to be material to Parent or its business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any
Parent Material Contract, or give any Person the right to: (i) declare a default or exercise any remedy under any Parent Material
Contract; (ii) any material payment, rebate, chargeback, penalty or change in delivery schedule under any Parent Material Contract;
(iii) accelerate the maturity or performance of any Parent Material Contract; or (iv) cancel, terminate or modify any term of any
Parent Material Contract, except in the case of any non-material breach, default, penalty or modification; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>result in the imposition or creation of any Encumbrance upon or with respect to any material asset owned or used by
Parent or its Subsidiaries (except for Permitted Encumbrances).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for (i) any Consent set forth on
<U>Section&nbsp;3.5</U> of the Parent Disclosure Schedule under any Parent Contract, (ii) the Parent Stockholder Vote, (iii) the
filing of the Articles of Merger with the Secretary of State of the State of Washington pursuant to the WBCA, and (iv) such consents,
waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal
and state securities Laws, Parent is not and will not be required to make any filing with or give any notice to, or to obtain any
Consent from, any Person in connection with (x) the execution, delivery or performance of this Agreement, or (y) the consummation
of the Contemplated Transactions, which if individually or in the aggregate were not given or obtained, would reasonably be expected
to prevent or materially delay the ability of Parent and Merger Sub to consummate the Contemplated Transactions. The Parent Board
and the Merger Sub Board have taken and will take all actions necessary to ensure that the restrictions applicable to business
combinations contained in Chapter 23B.19 of the WBCA are, and will be, inapplicable to the execution, delivery and performance
of this Agreement and to the consummation of the Contemplated Transactions. No other state Takeover Statute or similar Law applies
or purports to apply to the Merger, this Agreement or any of the other Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Capitalization</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The authorized capital stock of Parent as of the date of this Agreement consists of (i) 217,000,000 shares of Parent
Common Stock, par value $0.01 per share, of which 32,294,008 shares have been issued and are outstanding as of the close of business
on the Reference Date and (ii) 10,000,000 shares of preferred stock of Parent, par value $0.01 per share, of which no shares have
been issued and are outstanding as of the date of this Agreement. Parent does not hold any shares of its capital stock in its treasury.
As of the close of business on the Reference Date, there are outstanding Parent Warrants to purchase 26,969,827 shares of Parent
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All of the outstanding shares of Parent Common Stock have been duly authorized and validly issued, and are fully paid
and nonassessable. None of the outstanding shares of Parent Common Stock is entitled or subject to any preemptive right, right
of participation, right of maintenance or any similar right and none of the outstanding shares of Parent Common Stock is subject
to any right of first refusal in favor of Parent. Except as contemplated herein, there is no Parent Contract relating to the voting
or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option
or similar right with respect to), any shares of Parent Common Stock. Parent is not under any obligation, nor is it bound by any
Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Parent
Common Stock or other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except for the Parent Stock Plans and the ESPP, and except as set forth on <U>Section&nbsp;3.6(c)</U> of the Parent
Disclosure Schedule, Parent does not have any stock option plan or any other plan, program, agreement or arrangement providing
for any equity-based compensation for any Person. As of the close of business on the Reference Date, 1,150,164 shares have been
reserved for issuance upon exercise of Parent Options granted under the Parent Stock Plans that are outstanding as of the date
of this Agreement and 446,127 shares remain available for future issuance pursuant to the Parent Stock Plans. No vesting of Parent
Options will accelerate in connection with the closing of the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except for the Parent Warrants, Parent Stock Plans and the ESPP, including the Parent Options and as otherwise set forth
on <U>Section&nbsp;3.6(d)</U> of the Parent Disclosure Schedule, there is no: (i) outstanding subscription, option, call, warrant
or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of Parent or any
of its Subsidiaries; (ii) outstanding security, instrument or obligation that is or may become convertible into or exchangeable
for any shares of the capital stock or other securities of Parent or any of its Subsidiaries; or (iii) condition or circumstance
that is reasonably likely to give rise to or provide a basis for the assertion of a claim by any Person to the effect that such
Person is entitled to acquire or receive any shares of capital stock or other securities of Parent or any of its Subsidiaries.
There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect
to Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All outstanding shares of Parent Common Stock, Parent Options, Parent Warrants and other securities of Parent have been
issued and granted in material compliance with (i) all applicable securities Laws and other applicable Law, and (ii) all requirements
set forth in applicable Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>SEC Filings; Financial Statements</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent has delivered or made available to the Company accurate and complete copies of all registration statements, proxy
statements, Certifications (as defined below) and other statements, reports, schedules, forms and other documents filed by Parent
with the SEC since January 1, 2017 (the &ldquo;<B><I>Parent SEC Documents</I></B>&rdquo;), other than such documents that can be
obtained on the SEC&rsquo;s website at <U>www.sec.gov</U>. All statements, reports, schedules, forms and other documents (including
all exhibits, schedules and annexes thereto) required to have been filed by Parent or its officers with the SEC have been so filed
on a timely basis. As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this
Agreement, then on the date of such filing), each of the Parent SEC Documents complied in all material respects with the applicable
requirements of the Securities Act or the Exchange Act (as the case may be), including in each case, the rules and regulations
promulgated thereunder, and none of the Parent SEC Documents at the time they were filed, or if amended or superseded by a filing
prior to the date of this Agreement, on the date of the last such amendment or superseding filing prior to the date of this Agreement,
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The certifications
and statements required by (i) Rule 13a-14 under the Exchange Act and (ii) 18 U.S.C. &sect;1350 (Section 906 of the Sarbanes-Oxley
Act) relating to the Parent SEC Documents (collectively, the &ldquo;<B><I>Certifications</I></B>&rdquo;) are accurate and complete
and comply as to form and content with all applicable Laws, and no current or former executive officer of Parent has failed to
make the Certifications required of him or her. As of the date of this Agreement, there are no outstanding or unresolved comments
in comment letters received from the SEC or NYSE with respect to Parent SEC Documents. As of the date of this Agreement, to the
Knowledge of Parent, none of the Parent SEC Documents are the subject of ongoing SEC review and there are no inquiries or investigations
by the SEC or any internal investigations pending or threatened, including with regards to any accounting practices of Parent.
As used in this <U>Section&nbsp;3.7</U>, the term &ldquo;file&rdquo; and variations thereof shall be broadly construed to include
any manner in which a document or information is furnished, supplied or otherwise made available to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The financial statements (including any related notes) contained or incorporated by reference in the Parent SEC Documents:
(i) complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii) were
prepared in accordance with GAAP (except as may be indicated in the notes to such financial statements or, in the case of unaudited
financial statements, except as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain
footnotes and are subject to normal and recurring year-end adjustments) applied on a consistent basis unless otherwise noted therein
throughout the periods indicated; and (iii) fairly present, in all material respects, the financial position of Parent and its
consolidated Subsidiaries as of the respective dates thereof and the results of operations and cash flows of Parent for the periods
covered thereby. Other than as expressly disclosed in the Parent SEC Documents filed prior to the date hereof, there has been no
material change in Parent&rsquo;s accounting methods or principles that would be required to be disclosed in Parent&rsquo;s financial
statements in accordance with GAAP. Parent is and each of its Subsidiaries are in compliance in all material respects with the
applicable current listing and governance rules and regulations of the NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Since January 1, 2016, Parent&rsquo;s auditor has at all times since the date of enactment of the Sarbanes-Oxley Act
been: (i) a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii) to the Knowledge
of Parent, &ldquo;independent&rdquo; with respect to Parent within the meaning of Regulation S-X under the Exchange Act; and (iii)
to the Knowledge of Parent, in compliance with subsections (g) through (1) of Section 10A of the Exchange Act and the rules and
regulations promulgated by the SEC and the Public Company Accounting Oversight Board thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth in <U>Section 3.7(d)</U> of the Parent Disclosure Schedule, from January 1, 2016 through the date
hereof, Parent has not received any comment letter from the SEC or the staff thereof or any correspondence from NYSE or the staff
thereof relating to the delisting or maintenance of listing of the Parent Common Stock on The NYSE (or such other NYSE market on
which the Parent Common Stock then trades). Parent has not disclosed any unresolved comments in the Parent SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Since January 1, 2016, there have been no formal internal investigations regarding financial reporting or accounting
policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer or chief financial
officer of Parent, the Parent Board of Directors or any committee thereof, other than ordinary course audits or reviews of accounting
policies and practices or internal controls required by the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth on <U>Section 3.7(f)</U> of the Parent Disclosure Schedule, Parent is in compliance in all material
respects with the applicable provisions of the Sarbanes-Oxley Act and the applicable listing and governance rules and regulations
of NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)
of the regulations promulgated by the SEC under the Exchange Act) that is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and
to provide reasonable assurance (i) that transactions are recorded as necessary to permit preparation of financial statements in
accordance with GAAP, (ii) that receipts and expenditures are made only in accordance with authorizations of management and the
Parent Board and (iii) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Parent&rsquo;s
assets that could have a material effect on Parent&rsquo;s financial statements. Parent has evaluated the effectiveness of Parent&rsquo;s
internal control over financial reporting as of March 31, 2018, and, to the extent required by applicable Law, presented in any
applicable Parent SEC Document that is a report on Form 10-K or Form 10-Q (or any amendment thereto) its conclusions about the
effectiveness of the internal control over financial reporting as of the end of the period covered by such report or amendment
based on such evaluation. Parent has disclosed, based on its most recent evaluation of internal control over financial reporting,
to Parent&rsquo;s auditors and audit committee (and made available to the Company a summary of the significant aspects of such
disclosure) (A) all significant deficiencies, if any, in the design or operation of internal control over financial reporting that
are reasonably likely to adversely affect Parent&rsquo;s ability to record, process, summarize and report financial information
and (B) any known fraud that involves management or other employees who have a significant role in Parent&rsquo;s internal control
over financial reporting. To the Knowledge of Parent, there are no significant deficiencies or material weaknesses in the design
or operation of Parent&rsquo;s internal control over financial reporting and there is no change in the Parent&rsquo;s internal
control over financial reporting that has materially affected, or is reasonably likely to materially effect, the Parent&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent maintains an effective system of &ldquo;disclosure controls and procedures&rdquo; (as defined in Rules 13a-15(e)
and 15d-15(e) of the Exchange Act) that are designed to ensure that information required to be disclosed by Parent in the periodic
reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the required time
periods, and that all such information is accumulated and communicated to Parent&rsquo;s management as appropriate to allow timely
decisions regarding required disclosure and to make the Certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Changes</U></B>. Except as set forth on <U>Section&nbsp;3.8</U> of the Parent Disclosure Schedule, between
the date of the Parent Balance Sheet and the date of this Agreement, Parent and its Subsidiaries have conducted its business only
in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations
and transactions related thereto) and there has not been any (a) Parent Material Adverse Effect or (b) action, event or occurrence
that would have required the consent of the Company pursuant to <U>Section&nbsp;4.1(b)</U> had such action, event or occurrence
taken place after the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Absence of Undisclosed Liabilities</U>. </B> As of the date hereof, Parent and its Subsidiaries do not have any Liability
of a type required to be recorded or reflected on a balance sheet or disclosed in the footnotes thereto under GAAP, except for:
(a)&nbsp;Liabilities disclosed, reflected or reserved against in the Parent Balance Sheet; (b) Liabilities that have been incurred
by Parent or its Subsidiaries since the date of the Parent Balance Sheet in the Ordinary Course of Business; (c) Liabilities for
performance of obligations of Parent or its Subsidiaries under Parent Contracts; (d) Liabilities incurred in connection with the
Contemplated Transactions; (e) Liabilities which would not, individually or in the aggregate, reasonably be expected to have a
Parent Material Adverse Effect; and (f) Liabilities described in <U>Section&nbsp;3.9</U> of the Parent Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Title to Assets</U></B>. Each of Parent and its Subsidiaries owns, and has good and valid title to, or, in the case of
leased properties and assets, valid leasehold interests in, all material tangible properties or tangible assets and equipment used
or held for use in its business or operations or purported to be owned by it, including: (a) all tangible assets reflected on the
Parent Balance Sheet (other than assets disposed of in the Ordinary Course of Business since the date of the Parent Balance Sheet);
and (b) all other tangible assets reflected in the books and records of Parent or any of its Subsidiaries as being owned by Parent
or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by Parent or any of its Subsidiaries
free and clear of any Encumbrances, other than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Real Property; Leasehold</U></B>. Parent and its Subsidiaries do not own any real property. Parent has made available
to the Company (a) an accurate and complete list of all real properties with respect to which Parent or its Subsidiaries directly
or indirectly hold a valid leasehold interest as well as any other real estate that is in the possession of or leased by Parent
or its Subsidiaries, and (b) copies of all leases under which any such real property is possessed (the &ldquo;<B><I>Parent Real
Estate Leases</I></B>&rdquo;), each of which is in full force and effect, with no existing material default thereunder. Parent&rsquo;s
and its Subsidiaries&rsquo; use and operation of each such leased property conforms to all applicable Laws in all material respects,
and Parent or its Subsidiaries have exclusive possession of each such leased property and has not granted any occupancy rights
to tenants or licensees with respect to such leased property. In addition, each such leased property is free and clear of all Encumbrances
other than Permitted Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Intellectual Property</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 3.12(a)</U> of the Parent Disclosure Schedule identifies (i)&nbsp;the name of the applicant/registrant, (ii)&nbsp;the
jurisdiction of application/registration, (iii)&nbsp;the application or registration number and (iv) any other co-owners, for each
item of material Registered IP owned in whole or in part by Parent or its Subsidiaries. To the Knowledge of Parent, each of the
patents and patent applications included in the material Registered IP properly identifies by name each and every inventor of the
inventions claimed therein as determined in accordance with applicable Laws. As of the date of this Agreement, no interference,
opposition, reissue, reexamination or other proceeding of any nature (other than initial examination proceedings) is pending or,
to the Knowledge of Parent, threatened in writing, in which the scope, validity, enforceability or ownership of any Registered
IP listed on <U>Section 3.12(a)</U> of the Parent Disclosure Schedule is being or has been contested or challenged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent or its Subsidiaries own all right, title and interest in and to all material Parent IP (other than as disclosed
on <U>Section 3.12(a)</U> of the Parent Disclosure Schedule), free and clear of all Encumbrances other than Permitted Encumbrances,
and has the right, pursuant to enforceable agreements to use all other material Intellectual Property Rights used by Parent or
its Subsidiaries in its business as currently conducted. Each Parent Associate involved in the creation or development of any Parent
IP, pursuant to such Parent Associate&rsquo;s activities on behalf of Parent or its Subsidiaries, has signed a written agreement
containing an assignment of Intellectual Property Rights to Parent and confidentiality provisions protecting the Parent IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>To the Knowledge of Parent, no funding, facilities or personnel of any Governmental Body or any university, college,
research institute or other educational institution is being used to create Parent IP, except for any such funding or use of facilities
or personnel that does not result in such Governmental Body or institution obtaining ownership rights to such Parent IP or the
right to receive royalties for the practice of such Parent IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 3.12(d)</U> of the Parent Disclosure Schedule sets forth each Contract pursuant to which Parent or its Subsidiaries
(i) is granted a license under any material Intellectual Property Right owned by any third party that is used by Parent or its
Subsidiaries in its business as currently conducted (each a &ldquo;<B><I>Parent In-bound License</I></B>&rdquo;) or (ii) grants
to any third party a license under any material Company IP or material Intellectual Property Right licensed to Parent under a Parent
In-bound License (each a &ldquo;<B><I>Parent Out-bound License</I></B>&rdquo;) (<I>provided</I>, that, Parent In-bound Licenses
shall not include material transfer agreements, clinical trial agreements, non-disclosure agreements, commercially available Software-as-a-Service
offerings, or off-the-shelf software licenses entered into in the Ordinary Course of Business; and Parent Out-bound Licenses shall
not include limited, non-exclusive licenses granted under material transfer agreements, clinical trial agreements, non-disclosure
agreements, or non-exclusive outbound licenses entered into in the Ordinary Course of Business).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>To the Knowledge of Parent: (i)&nbsp;the operation of the businesses of Parent and its Subsidiaries as currently conducted
does not infringe any valid and enforceable Registered IP or misappropriate or otherwise violate any other Intellectual Property
Right owned by any other Person; and (ii)&nbsp;no other Person is infringing, misappropriating or otherwise violating any Parent
IP or any Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries. As of the date of this Agreement, no
Legal Proceeding is pending (or, to the Knowledge of Parent, is threatened in writing) (A)&nbsp;against Parent or its Subsidiaries
alleging that the operation of the business of Parent or its Subsidiaries infringes or constitutes the misappropriation or other
violation of any Intellectual Property Rights of another Person or (B)&nbsp;by Parent or its Subsidiaries alleging that another
Person has infringed, misappropriated or otherwise violated any of the Parent IP or any Intellectual Property Rights exclusively
licensed to Parent or its Subsidiaries. Since January 1, 2016, Parent and its Subsidiaries have not received any written notice
or other written communication alleging that the operation of the business of Parent or its Subsidiaries infringes or constitutes
the misappropriation or other violation of any Intellectual Property Right of another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and its Subsidiaries has taken reasonable security and other measures, including measures against unauthorized
disclosure, to protect the secrecy, confidentiality, and value of its trade secrets and other technical information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>None of the Parent IP or, to the Knowledge of Parent, any material Intellectual Property Rights exclusively licensed
to Parent or its Subsidiaries is subject to any pending or outstanding injunction, directive, order, judgment or other disposition
of dispute that adversely and materially restricts the use, transfer, registration or licensing by Parent or its Subsidiaries of
any such Parent IP or material Intellectual Property Rights exclusively licensed to Parent or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and its Subsidiaries maintains commercially reasonable policies regarding Sensitive Data that support compliance
by Parent and its Subsidiaries with all applicable Law. Parent and its Subsidiaries and the operation of Parent&rsquo;s business
are in substantial compliance with all such policies and other Laws pertaining to data privacy and data security of any Sensitive
Data except as would not reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect. To
the Knowledge of Parent, since January 1, 2016, there have been (i) no material losses or thefts of data or security breaches relating
to Sensitive Data used in the business of Parent or its Subsidiaries, (ii) no violations of any security policy of Parent regarding
any such Sensitive Data, (iii) no unauthorized access or unauthorized use of any Sensitive Data used in the business of Parent
or its Subsidiaries and (iv) no unintended or improper disclosure of any personally identifiable information in the possession,
custody or control of Parent or its Subsidiaries or a contractor or agent acting on behalf of Parent or its Subsidiaries, in each
case of (i) through (iv), except as would not reasonably be expected to, individually or in the aggregate, have a Parent Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agreements, Contracts and Commitments</U>. </B><U>Section&nbsp;3.13</U> of the Parent Disclosure Schedule identifies
each Parent Contract that is in effect as of the date of this Agreement (other than any Parent Benefit Plan) and is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>a material contract as defined in Item 601(b)(10) of Regulation S-K as promulgated under the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract containing (A) any covenant limiting the freedom of Parent or its Subsidiaries to engage in any line of
business or compete with any Person, (B) any most-favored pricing arrangement, (C) any exclusivity provision, or (D) any non-solicitation
provision applicable to Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract relating to capital expenditures and requiring payments after the date of this Agreement in excess of
$100,000 pursuant to its express terms and not cancelable without penalty;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract relating to the disposition or acquisition of material assets or any ownership interest in any Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract relating to any mortgages, indentures, loans, notes or credit agreements, security agreements or other
agreements or instruments relating to the borrowing of money or extension of credit or creating any material Encumbrances with
respect to any assets of Parent or its Subsidiaries or any loans or debt obligations with officers or directors of Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract requiring payment by or to Parent or its Subsidiaries after the date of this Agreement in excess of $100,000
pursuant to its express terms relating to: (A) any distribution agreement (identifying any that contain exclusivity provisions);
(B) any agreement involving provision of services or products with respect to any pre-clinical or clinical development activities
of Parent or its Subsidiaries; (C) any dealer, distributor, joint marketing, alliance, joint venture, cooperation, development
or other agreement currently in force under which Parent or its Subsidiaries has continuing obligations to develop or market any
product, technology or service, or any agreement pursuant to which Parent or its Subsidiaries has continuing obligations to develop
any Intellectual Property Rights that will not be owned, in whole or in part, by Parent; or (D) any Contract to license any third
party to manufacture or produce any product, service or technology of Parent or its Subsidiaries or any Contract to sell, distribute
or commercialize any products or service of Parent or its Subsidiaries, in each case, except for Contracts entered into in the
Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract with any Person, including any financial advisor, broker, finder, investment banker or other Person, providing
advisory services to Parent in connection with the Contemplated Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Parent Real Estate Lease;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract with any Governmental Body;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Parent Out-bound License and Parent In-bound License;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>each Contract containing any royalty, dividend or similar arrangement based on the revenues or profits of Parent or
its Subsidiaries; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>any other Contract that is not terminable at will (with no penalty or payment) by Parent or its Subsidiaries without
more than 30 days&rsquo; prior written notice, as applicable, and (A) which involves payment or receipt by Parent or its Subsidiaries
after the date of this Agreement under any such agreement, Contract or commitment of more than $100,000 in the aggregate, or obligations
after the date of this Agreement in excess of $100,000 in the aggregate, or (B) that is material to the business or operations
of Parent and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent has delivered or made available to the Company accurate and complete copies of all Contracts to which Parent
or its Subsidiaries is a party or by which it is bound of the type described in the foregoing clauses (a)-(m) (any such Contract,
a &ldquo;<B><I>Parent Material Contract</I></B>&rdquo;). There are no Parent Material Contracts that are not in written form. Neither
Parent nor any of its Subsidiaries has, nor, to Parent&rsquo;s Knowledge, as of the date of this Agreement, has any other party
to a Parent Material Contract, breached, violated or defaulted under, or received notice that it breached, violated or defaulted
under, any of the terms or conditions of any Parent Material Contract in such manner as would permit any other party to cancel
or terminate any such Parent Material Contract, or would permit any other party to seek damages which would reasonably be expected
to be material to Parent or its business. As to Parent and its Subsidiaries, as of the date of this Agreement, each Parent Material
Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating,
or has a right pursuant to the terms of any Parent Material Contract to change, any material amount paid or payable to Parent under
any Parent Material Contract or any other material term or provision of any Parent Material Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance; Permits</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and each of its Subsidiaries are, and since January 1, 2016 have been, in compliance in all material respects
with all applicable Laws, including the FDCA, the FDA regulations adopted thereunder, the Public Health Service Act and any other
similar Law administered or promulgated by the FDA or other Drug Regulatory Agency, except for any noncompliance, either individually
or in the aggregate, which would not be material to Parent. No investigation, claim, suit, proceeding, inspection, audit or other
action by any Governmental Body is pending or, to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries.
There is no agreement, judgment, injunction, order or decree binding upon Parent or any of its Subsidiaries which (i) has or would
reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Parent or any of its
Subsidiaries, any acquisition of material property by Parent or any of its Subsidiaries or the conduct of business by Parent or
any of its Subsidiaries as currently conducted, (ii) is reasonably likely to have a material adverse effect on Parent&rsquo;s ability
to comply with or perform any covenant or obligation under this Agreement, or (iii) is reasonably likely to have the effect of
preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and its Subsidiaries hold all required Governmental Authorizations that are material to the operation of the
business of Parent and its Subsidiaries, as the case may be, as currently conducted (the &ldquo;<B><I>Parent Permits</I></B>&rdquo;).
<U>Section&nbsp;3.14(b)</U> of the Parent Disclosure Schedule identifies each Parent Permit. Each of Parent and its Subsidiaries
is in material compliance with the terms of the Parent Permits. No Legal Proceeding is pending or, to the Knowledge of Parent,
threatened, which seeks to revoke, limit, suspend, or materially modify any Parent Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no proceedings pending or, to the Knowledge of Parent, threatened in writing with respect to an alleged material
violation by Parent or any of its Subsidiaries of the FDCA, FDA regulations adopted thereunder, the Public Health Service Act or
any other similar Law administered or promulgated by any Drug Regulatory Agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All clinical, pre-clinical and other studies and tests conducted by or on behalf of, or sponsored by, Parent or its
Subsidiaries, or in which Parent or its Subsidiaries or their respective current products or product candidates have participated,
were and, if still pending, are being conducted in all material respects in accordance with standard medical and scientific research
procedures and in compliance in all material respects with the applicable regulations of any applicable Drug Regulatory Agency
and other applicable Law, including 21 C.F.R. Parts 50, 54, 56, 58, 210, 211 and 312. No preclinical or clinical trial conducted
by or on behalf of Parent or any of its Subsidiaries has been terminated or suspended prior to completion for safety or non-compliance
reasons. Since January 1, 2016, neither Parent nor any of its Subsidiaries has received any notices, correspondence, or other communications
from any Drug Regulatory Agency requiring, or to the Knowledge of Parent threatening to initiate, the termination or suspension
of any clinical studies conducted by or on behalf of, or sponsored by, Parent or any of its Subsidiaries or in which Parent or
any of its Subsidiaries or their respective current products or product candidates have participated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries is the subject of any pending or, to the Knowledge of Parent, threatened
investigation in respect of its business or products by the FDA pursuant to its &ldquo;Fraud, Untrue Statements of Material Facts,
Bribery, and Illegal Gratuities&rdquo; Final Policy set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto.
To the Knowledge of Parent, neither Parent nor any of its Subsidiaries has committed any acts, made any statement, or failed to
make any statement, in each case in respect of its business or products that would violate the FDA&rsquo;s &ldquo;Fraud, Untrue
Statements of Material Facts, Bribery, and Illegal Gratuities&rdquo; Final Policy, and any amendments thereto. None of Parent,
any of its Subsidiaries or any of their respective officers, employees or agents has been convicted of any crime or engaged in
any conduct that could result in a debarment or exclusion (i) under 21 U.S.C. Section 335a or (ii) any similar applicable Law.
To the Knowledge of Parent or Merger Sub, no debarment or exclusionary claims, actions, proceedings or investigations in respect
of their business or products are pending or, threatened in writing against Parent, any of its Subsidiaries or any of their respective
officers, employees or agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and its Subsidiaries have complied with all Laws relating to patient, medical or individual health information,
including HIPAA, including the standards for the privacy of Individually Identifiable Health Information at 45 C.F.R. Parts 160
and 164, Subparts A and E, the standards for the protection of Electronic Protected Health Information set forth at 45 C.F.R. Part
160 and 45 C.F.R. Part 164, Subpart A and Subpart C, the standards for transactions and code sets used in electronic transactions
at 45 C.F.R. Part 160, Subpart A and Part 162, and the standards for Breach Notification for Unsecured Protected Health Information
at 45 C.F.R. Part 164, Subpart D, all as amended from time to time.&nbsp; Parent and its Subsidiaries have entered into, where
required, and are in compliance in all material respects with the terms of all Business Associate (as defined in HIPAA) agreements
to which Parent or a Subsidiary is a party or otherwise bound.&nbsp; Parent and its Subsidiaries have created and maintained written
policies and procedures to protect the privacy of all protected health information, provide training to all employees and agents
as required under HIPAA, and have implemented security procedures, including physical, technical and administrative safeguards,
intended to protect all personal information and Protected Health Information stored or transmitted in electronic form.&nbsp; Neither
Parent nor its Subsidiaries have received written notice from the Office for Civil Rights for the U.S. Department of Health and
Human Services or any other Governmental Body of any allegation regarding its failure to comply with HIPAA or any other state law
or regulation applicable to the protection of individually identifiable health information or personally identifiable information.&nbsp;
No successful Security Incident, Breach of Unsecured Protected Health Information or breach of personally identifiable information
under applicable state or federal laws have occurred with respect to information maintained or transmitted to Parent, any of its
Subsidiaries, or an agent or third party subject to a Business Associate Agreement with Parent or a Subsidiary of Parent.&nbsp;
Parent is currently submitting, receiving and handling or is capable of submitting receiving and handling transactions in accordance
with the Standard Transaction Rule.&nbsp; All capitalized terms in this <U>Section&nbsp;3.14(f)</U> not otherwise defined in this
Agreement shall have the meanings set forth under HIPAA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Proceedings; Orders</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As of the date of this Agreement, there is no material pending Legal Proceeding and, to the Knowledge of Parent, no
Person has threatened in writing to commence any Legal Proceeding: (i) that involves (A) Parent or its Subsidiaries, (B) any Parent
Associate (in his or her capacity as such) or (C) any of the material assets owned or used by Parent or its Subsidiaries; or (ii)
that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Contemplated
Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth in <U>Section&nbsp;3.15(b)</U> of the Parent Disclosure Schedule, since January 1, 2016 through
the date of this Agreement, no Legal Proceeding has been pending against Parent that resulted in material Liability to Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is no order, writ, injunction, judgment or decree to which Parent or any of its Subsidiaries, or any of the material
assets owned or used by Parent, is subject. To the Knowledge of Parent, no officer of Parent or any of its Subsidiaries is subject
to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct,
activity or practice relating to the business of Parent or any of its Subsidiaries or to any material assets owned or used by Parent
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and each of its Subsidiaries has timely filed all income Tax Returns and other material Tax Returns that they
were required to file under applicable Law. All such Tax Returns are correct and complete in all material respects and have been
prepared in compliance with all applicable Law. No claim has ever been made by any Governmental Body in any jurisdiction where
Parent or any of its Subsidiaries does not file a particular Tax Return or pay a particular Tax that Parent or such Subsidiary
is subject to taxation by that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All income and other material Taxes due and owing by Parent or any of its Subsidiaries on or before the date hereof
(whether or not shown on any Tax Return) have been fully paid. The unpaid Taxes of Parent and its Subsidiaries did not, as of the
date of the Parent Balance Sheet Date, materially exceed the reserve for Tax Liability (excluding any reserve for deferred Taxes
established to reflect timing differences between book and Tax items) set forth on the Parent Balance Sheet. Since the Parent Balance
Sheet Date, neither Parent nor any of its Subsidiaries has incurred any material Liability for Taxes outside the Ordinary Course
of Business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>All Taxes that Parent or any of its Subsidiaries are or were required by Law to withhold or collect have been duly and
timely withheld or collected in all material respects on behalf of its respective employees, independent contractors, stockholders,
or other third parties and, have been timely paid to the proper Governmental Body or other Person or properly set aside in accounts
for this purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no Encumbrances for material Taxes (other than Taxes not yet due and payable) upon any of the assets of Parent
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No deficiencies for income or other material Taxes with respect to Parent or any of its Subsidiaries have been claimed,
proposed or assessed by any Governmental Body in writing. There are no pending or ongoing, and to the Knowledge of Parent, threatened
audits, assessments or other actions for or relating to any Liability in respect of a material amount of Taxes of Parent or any
of its Subsidiaries. Neither Parent nor any its Subsidiaries (or any of their predecessors) has waived any statute of limitations
in respect of any income or other material Taxes or agreed to any extension of time with respect to any income or other material
Tax assessment or deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries has been a United States real property holding corporation within the meaning
of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity
agreement, or similar agreement or arrangement, other than customary commercial Contracts entered into in the Ordinary Course of
Business the principal subject matter of which is not Taxes or an agreement or arrangement between or among Parent and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries will be required to include any material item of income in, or exclude any
material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result
of any: (i) change in method of accounting for Tax purposes; (ii) use of an improper method of accounting for a Tax period ending
on or prior to the Closing Date; (iii) &ldquo;closing agreement&rdquo; as described in Section 7121 of the Code (or any similar
provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv) intercompany transaction or excess loss
account described in Treasury Regulations under Section 1502 of the Code (or any similar provision of state, local or foreign Law);
(v) installment sale or open transaction disposition made on or prior to the Closing Date; (vi) prepaid amount received or deferred
revenue accrued on or prior to the Closing Date; (vii) application of Sections 951, 951A or 965 of the Code to any income received
or accrued on or prior to the Closing Date by any Subsidiary owned by Parent prior to the Effective Time; or (viii) election under
Section 108(i) of the Code (or any similar provision of state, local or foreign Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries has ever been a member of a consolidated, combined or unitary Tax group (other
than such a group the common parent of which is Parent). Neither Parent nor any of its Subsidiaries has any Liability for any material
Taxes of any Person (other than Parent and any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any similar
provision of state, local, or foreign Law), or as a transferee or successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries has distributed stock of another Person, or has had its stock distributed
by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code
or Section 361 of the Code (or any similar provisions of state, local or foreign Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as provided in <U>Schedule 3.16(k)</U>, neither Parent nor any of its Subsidiaries (i) is a &ldquo;controlled
foreign corporation&rdquo; as defined in Section 957 of the Code, (ii) is a &ldquo;passive foreign investment company&rdquo; within
the meaning of Section 1297 of the Code, or (iii) has ever had a permanent establishment (within the meaning of an applicable Tax
treaty) or otherwise has an office or fixed place of business in a jurisdiction outside of the country in which it is incorporated
or organized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries has participated in or been a party to a transaction that, as of the date
of this Agreement, constitutes a &ldquo;listed transaction&rdquo; that is required to be reported to the IRS pursuant to Section
6011 of the Code and applicable Treasury Regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For purposes of this
<U>Section&nbsp;3.16</U>, each reference to Parent or any of its Subsidiaries shall be deemed to include any Person that was liquidated
into, merged with, or is otherwise a predecessor to, Parent or its Subsidiary (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employee and Labor Matters; Benefit Plans</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section&nbsp;3.17(a)</U> of the Parent Disclosure Schedule is a list of all material Parent Benefit Plans, including,
without limitation, each Parent Benefit Plan that provides for retirement, change in control, stay or retention deferred compensation,
incentive compensation, severance or retiree medical or life insurance benefits. &ldquo;<B><I>Parent Benefit Plan</I></B>&rdquo;
means each (i) &ldquo;employee benefit plan&rdquo; as defined in Section 3(3) of ERISA and (ii) other pension, retirement, deferred
compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based, phantom equity, employment (other than
at-will employment offer letters on Parent&rsquo;s standard form and other than individual Parent Options or other compensatory
equity award agreements made pursuant to the Parent&rsquo;s standard forms, in which case only representative standard forms of
such agreements shall be scheduled), consulting, severance, change-of-control, retention, health, life, disability, group insurance,
paid-time off, holiday, welfare and fringe benefit plan, program, Contract, or arrangement (whether written or unwritten, qualified
or nonqualified, funded or unfunded and including any that have been frozen or terminated), in any case, maintained, contributed
to, or required to be contributed to, by Parent or any of its Subsidiaries or Parent ERISA Affiliates for the benefit of any current
or former employee, director, officer or independent contractor of Parent or any of its Subsidiaries or under which Parent or any
of its Subsidiaries has any actual or contingent Liability (including, without limitation, as to the result of it being treated
as a single employer <U>under Code Section 414 with any other person).&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As applicable with respect to each material Parent Benefit Plan, Parent has made available to the Company, true and
complete copies of (i) each material Parent Benefit Plan, including all amendments thereto, and in the case of an unwritten material
Parent Benefit Plan, a written description thereof, (ii) all current trust documents, investment management Contracts, custodial
agreements, administrative services agreements and insurance and annuity Contracts relating thereto, (iii) the current summary
plan description and each summary of material modifications thereto, (iv) the most recently filed annual reports with any Governmental
Body (<I>e.g.</I>, Form 5500 and all schedules thereto), (v) the most recent IRS determination, opinion or advisory letter, (vi)
the most recent summary annual reports, nondiscrimination testing reports, actuarial reports, financial statements and trustee
reports, (vii) all records, notices and filings concerning IRS or Department of Labor or other Governmental Body audits or investigations,
 &ldquo;prohibited transactions&rdquo; within the meaning of Section 406 of ERISA or Section 4975 of the Code and (viii) all policies
and procedures established to comply with the privacy and security rules of HIPAA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each Parent Benefit Plan has been maintained, operated and administered in compliance in all material respects with
its terms and any related documents or agreements and the applicable provisions of ERISA, the Code and all other Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parent Benefit Plans which are &ldquo;employee pension benefit plans&rdquo; within the meaning of Section 3(2) of
ERISA and which are intended to meet the qualification requirements of Section 401(a) of the Code have received determination or
opinion letters from the IRS on which they may currently rely to the effect that such plans are qualified under Section 401(a)
of the Code and the related trusts are exempt from federal income Taxes under Section 501(a) of the Code, respectively, and to
the Knowledge of Parent nothing has occurred that would reasonably be expected to materially adversely affect the qualification
of such Parent Benefit Plan or the tax exempt status of the related trust.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent, any of its Subsidiaries, nor any Parent ERISA Affiliate maintains, contributes to, is required to contribute
to, or has any actual or contingent Liability with respect to, (i) any &ldquo;employee pension benefit plan&rdquo; (within the
meaning of Section 3(2) of ERISA) that is subject to Title IV or Section 302 of ERISA or Section 412 of the Code, (ii) any &ldquo;multiemployer
plan&rdquo; (within the meaning of Section 3(37) of ERISA), (iii) any &ldquo;multiple employer plan&rdquo; (within the meaning
of Section 413 of the Code) or (iv) any &ldquo;multiple employer welfare arrangement&rdquo; (within the meaning of Section 3(40)
of ERISA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There are no pending audits or investigations by any Governmental Body involving any Parent Benefit Plan, and no pending
or, to the Knowledge of Parent, threatened claims (except for individual claims for benefits payable in the normal operation of
the Parent Benefit Plans), suits or proceedings involving any Parent Benefit Plan, any fiduciary thereof or service provider thereto,
in any case except as would not be reasonably expected to result in material Liability to Parent or any of its Subsidiaries. All
contributions and premium payments required to have been made under any of the Parent Benefit Plans or by applicable Law (without
regard to any waivers granted under Section 412 of the Code), have been timely made and neither Parent nor any Parent ERISA Affiliate
has any liability for any unpaid contributions with respect to any Parent Benefit Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent, any of its Subsidiaries or any Parent ERISA Affiliates, nor to the Knowledge of Parent, any fiduciary,
trustee or administrator of any Parent Benefit Plan, has engaged in, or in connection with the transactions contemplated by this
Agreement will engage in, any transaction with respect to any Parent Benefit Plan which would subject any such Parent Benefit Plan,
Parent, any of its Subsidiaries or Parent ERISA Affiliates to a material Tax, material penalty or material Liability for a &ldquo;prohibited
transaction&rdquo; under Section 406 of ERISA or Section 4975 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No Parent Benefit Plan provides death, medical, dental, vision, life insurance or other welfare benefits beyond termination
of service or retirement other than coverage mandated by Law and neither Parent, any of its Subsidiaries or any Parent ERISA Affiliates
has made a written or oral representation promising the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the execution of, nor the performance of the transactions contemplated by, this Agreement will either alone
or in connection with any other event(s) (i)&nbsp;result in any payment becoming due to any current or former employee, director,
officer, or independent contractor of Parent, (ii) increase any amount of compensation or benefits otherwise payable under any
Parent Benefit Plan, (iii) result in the acceleration of the time of payment, funding or vesting of any benefits under any Parent
Benefit Plan, (iv) require any contribution or payment to fund any obligation under any Parent Benefit Plan or (v)&nbsp;limit the
right to merge, amend or terminate any Parent Benefit Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither the execution of, nor the consummation of the transactions contemplated by this Agreement (either alone or when
combined with the occurrence of any other event, including without limitation, a termination of employment) will result in the
receipt or retention by any person who is a &ldquo;disqualified individual&rdquo; (within the meaning of Code Section 280G) with
respect to Parent of any payment or benefit that is or could be characterized as a &ldquo;parachute payment&rdquo; (within the
meaning of Code Section 280G), determined without regard to the application of Code Section 280G(b)(5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The exercise price of each Parent Option is not, never has been and can never be less than the fair market value of
one share of Parent Common Stock as of the grant date of such Parent Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Section 3.17(l)</U> of the Parent Disclosure Schedule lists each Parent Benefit Plan that provides for deferred compensation
that constitutes a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined in Section 409A(d)(1) of the Code and the
regulations promulgated thereunder). Each Parent Benefit Plan providing for deferred compensation that constitutes a &ldquo;nonqualified
deferred compensation plan&rdquo; (as defined in Section 409A(d)(1) of the Code and the Treasury Regulations) is, and has been,
established, administered and maintained in compliance with the requirements of Section 409A of the Code and the regulations promulgated
thereunder in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No current or former employee, officer, director or independent contractor of Parent or any of its Subsidiaries has
any &ldquo;gross up&rdquo; agreements or other assurance of reimbursement for any Taxes imposed under Code Section 409A or Code
Section 4999.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Neither Parent nor any of its Subsidiaries is a party to, bound by, or has a duty to bargain under, any collective bargaining
agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees, and there
is no labor union, labor organization, or similar Person representing or, to the Knowledge of Parent, purporting to represent or
seeking to represent any employees of Parent or its Subsidiaries, including through the filing of a petition for representation
election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and each of its Subsidiaries are, and since January 1, 2016 have been, in material compliance with all applicable
Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification,
discrimination, harassment and retaliation, equal employment opportunities, fair employment practices, meal and rest periods, immigration,
employee safety and health, wages (including overtime wages), unemployment and workers&rsquo; compensation, leaves of absence,
and hours of work. Except as would not be reasonably likely to result in a material Liability to Parent or any of its Subsidiaries,
with respect to employees of Parent and its Subsidiaries, each of Parent and its Subsidiaries, since January 1, 2016: (i) has withheld
and reported all amounts required by Law or by agreement to be withheld and reported with respect to wages, salaries and other
payments, benefits, or compensation to employees, (ii) is not liable for any arrears of wages (including overtime wages), severance
pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any
trust or other fund governed by or maintained by or on behalf of any Governmental Body, with respect to unemployment compensation
benefits, disability, social security or other benefits or obligations for employees (other than routine payments to be made in
the Ordinary Course of Business). There are no actions, suits, claims, charges, lawsuits, investigations, audits or administrative
matters pending or, to the Knowledge of Parent, threatened in writing against Parent or any of its Subsidiaries relating to any
employee, applicant for employment, consultant, employment agreement or Parent Benefit Plan (other than routine claims for benefits).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as would not be reasonably likely to result in a material Liability to Parent or any of its Subsidiaries, with
respect to each individual who currently renders services to Parent or any of its Subsidiaries, Parent and each of its Subsidiaries
has accurately classified each such individual as an employee, independent contractor, or otherwise under all applicable Laws and,
for each individual classified as an employee, Parent and each of its Subsidiaries has accurately classified him or her as overtime
eligible or overtime ineligible under all applicable Laws. Neither Parent nor any of its Subsidiaries has any material Liability
with respect to any misclassification of: (a) any Person as an independent contractor rather than as an employee, (b) any employee
leased from another employer, or (c) any employee currently or formerly classified as exempt from overtime wages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is not and has not been in the past three years, nor is there or has there been in the past three years any threat
of, any strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, or any similar activity or dispute,
or, to the Knowledge of Parent, any union organizing activity, against Parent or any of its Subsidiaries. No event has occurred,
and no condition or circumstance exists, that might directly or indirectly be likely to give rise to or provide a basis for the
commencement of any such strike, slowdown, work stoppage, lockout, union election petition, demand for recognition, any similar
activity or dispute, or, to the Knowledge of Parent, any union organizing activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>There is no Legal Proceeding, claim, unfair labor practice charge or complaint, labor dispute or grievance pending or,
to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries relating to labor, employment, employment practices,
or terms and conditions of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As of the date hereof, no Key Employee has submitted his or her resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Matters</U></B>. Parent and each of its Subsidiaries are and since January 1, 2016 have complied with all
applicable Environmental Laws, which compliance includes the possession by Parent of all permits and other Governmental Authorizations
required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be
in such compliance that, either individually or in the aggregate, would not reasonably be expected to be material to Parent or
its business. Neither Parent nor any of its Subsidiaries has received since January 1, 2016 (or prior to that time, which is pending
and unresolved), any written notice or other communication (in writing or otherwise), whether from a Governmental Body or other
Person, that alleges that Parent or any of its Subsidiaries is not in compliance with or has Liability pursuant to any Environmental
Law and, to the Knowledge of Parent, there are no circumstances that would reasonably be expected to prevent or interfere with
Parent&rsquo;s or any of its Subsidiaries&rsquo; compliance in any material respects with any Environmental Law, except where such
failure to comply would not reasonably be expected to have a Parent Material Adverse Effect. No current or (during the time a prior
property was leased or controlled by Parent or any of its Subsidiaries) prior property leased or controlled by Parent or any of
its Subsidiaries has had a release of or exposure to Hazardous Materials in material violation of or as would reasonably be expected
to result in any material Liability of Parent or any of its Subsidiaries pursuant to Environmental Law. No Consent of or registration
or filing with any Governmental Body is required by Environmental Laws in connection with the execution and delivery of this Agreement
or the consummation of the Contemplated Transactions. Prior to the date hereof, Parent has provided or otherwise made available
to the Company true and correct copies of all material environmental reports, assessments, studies and audits in the possession
or control of Parent or any of its Subsidiaries with respect to any property leased or controlled by Parent or any of its Subsidiaries
or any business operated by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transactions with Affiliates</U></B>. Except as set forth in the Parent SEC Documents filed prior to the date of this
Agreement, since the date of Parent&rsquo;s last proxy statement filed in 2017 with the SEC, no event has occurred that would be
required to be reported by Parent pursuant to Item 404 of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance</U></B>. Parent has delivered or made available to the Company accurate and complete copies of all material
insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and
operations of Parent and each of its Subsidiaries. Each of such insurance policies is in full force and effect and Parent and each
of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications
from insurance carriers, since January 1, 2016, neither Parent nor any of its Subsidiaries has received any notice or other communication
regarding any actual or possible: (i) cancellation or invalidation of any insurance policy; or (ii) refusal or denial of any coverage,
reservation of rights or rejection of any material claim under any insurance policy. Parent and each of its Subsidiaries have provided
timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding that is currently pending against Parent
or any of its Subsidiaries for which Parent or such Subsidiary has insurance coverage, and no such carrier has issued a denial
of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed Parent or any of its Subsidiaries
of its intent to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Financial Advisors</U></B>. Except as set forth on <U>Section&nbsp;3.21</U> of the Parent Disclosure Schedule, no
broker, finder or investment banker is entitled to any brokerage fee, finder&rsquo;s fee, opinion fee, success fee, transaction
fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of
Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Anti-Bribery</U></B>. None of Parent or any of its Subsidiaries or any of their respective directors, officers, employees
or, to Parent&rsquo;s Knowledge, agents or any other Person acting on their behalf has directly or indirectly made any bribes,
rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form
of cash, gifts, or otherwise, or taken any other action, in violation of Anti-Bribery Laws. Neither Parent nor any of its Subsidiaries
is or has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery
Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Valid Issuance</U></B>. The Parent Common Stock to be issued in the Merger will, when issued in accordance with the provisions
of this Agreement, be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.24<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Opinion of Financial Advisor</U></B>. The Parent Board has received an opinion of Ladenburg Thalman &amp; Co., Inc.,
to the effect that, as of the date of such opinion and subject to the assumptions and limitations set forth therein, the Exchange
Ratio is fair, to the stockholders of Parent, from a financial point of view. It is agreed and understood that such opinion is
for the benefit of the Parent Board and may not be relied upon by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclaimer of Other Representations or Warranties</U></B>. Except as previously set forth in this <U>Section 3</U>, neither
Parent nor Merger Sub makes any representation or warranty, express or implied, at law or in equity, including with respect to
it or any of its assets, liabilities or operations, and any such other representations and warranties are hereby expressly disclaimed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">CERTAIN
COVENANTS OF THE PARTIES</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Operation of Parent&rsquo;s Business</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth on <U>Section&nbsp;4.1(a)</U> of the Parent Disclosure Schedule, as expressly permitted by this
Agreement, as required by applicable Law or unless the Company shall otherwise consent in writing (which consent shall not be unreasonably
withheld, delayed or conditioned), during the period commencing on the date of this Agreement and continuing until the earlier
to occur of the termination of this Agreement pursuant to <U>Section 9</U> and the Effective Time (the &ldquo;<B><I>Pre-Closing
Period</I></B>&rdquo;): Parent shall conduct its business and operations in the Ordinary Course of Business and in compliance in
all material respects with all applicable Laws and the requirements of all Contracts that constitute Parent Material Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except (i) as expressly permitted by this Agreement, (ii) as set forth in <U>Section&nbsp;4.1(b)</U> of the Parent Disclosure
Schedule, (iii) as required by applicable Law or (iv) with the prior written consent of the Company (which consent shall not be
unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, Parent shall not, nor shall it cause
or permit any of its Subsidiaries to, do any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital
stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with
the payment of the exercise price and/or withholding Taxes incurred upon the exercise, settlement or vesting of any award granted
under the Parent Stock Plans);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>sell, issue, grant, pledge or otherwise dispose of or encumber or authorize any of the foregoing with respect to: (A)
any capital stock or other security of Parent or any of its Subsidiaries (except for Parent Common Stock issued upon the valid
exercise of outstanding Parent Options or Parent Warrants); (B) any option, warrant or right to acquire any capital stock or any
other security; or (C) any instrument convertible into or exchangeable for any capital stock or other security of Parent or any
of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>except as required to give effect to anything in contemplation of the Closing, amend any of its Organizational Documents,
or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification
of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>form any Subsidiary or acquire any equity interest or other interest in any other Entity or enter into a joint venture
with any other Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>(A) lend money to any Person, (B) incur or guarantee any indebtedness for borrowed money, (C) guarantee any debt securities
of others, or (D) make any capital expenditure or commitment in excess of the budgeted capital expenditure and commitment amounts
set forth in the Parent operating budget delivered to the Company concurrently with the execution of this Agreement (the &ldquo;<B><I>Parent
Budget</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>other than as required by applicable Law or the terms of any Parent Benefit Plan as in effect on the date of this Agreement:
(A) adopt, terminate, establish or enter into any Parent Benefit Plan; (B) cause or permit any Parent Benefit Plan to be amended
in any material respect; (C) pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages,
salary, commissions, benefits or other compensation or remuneration payable to, any of its directors, officers or employees, other
than increases in base salary and annual cash bonus opportunities and payments made in the Ordinary Course of Business consistent
with past practice; (D) increase the severance or change of control benefits offered to any current or new employees, directors
or consultants or (E) hire, terminate or give notice of termination to any (x) officer or (y) employee whose annual base salary
is or is expected to be more than $125,000 per year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>recognize any labor union, labor organization, or similar Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>enter into any material transaction other than in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its assets or properties, or grant
any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>sell, assign, transfer, license, sublicense or otherwise dispose of any material Parent IP (other than pursuant to non-exclusive
licenses in the Ordinary Course of Business);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>make, change or revoke any material Tax election, fail to pay any income or other material Tax as such Tax becomes due
and payable, file any amendment making any material change to any Tax Return, settle or compromise any income or other material
Tax Liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary
commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request
or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other
material Taxes (other than in connection with any extension of time to file any Tax Return), or adopt or change any material accounting
method in respect of Taxes;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>enter into, materially amend or terminate any Parent Material Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>except as otherwise set forth in the Parent Budget, make any expenditures, incur any Liabilities or discharge or satisfy
any Liabilities, in each case, in amounts that exceed the aggregate amount of the Parent Budget by $100,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>other than as required by Law or GAAP, take any action to change Parent&rsquo;s or Merger Sub&rsquo;s accounting policies
or procedures;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>initiate or settle any Legal Proceeding; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>agree, resolve or commit to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Nothing contained in
this Agreement shall give the Company, directly or indirectly, the right to control or direct the operations of Parent prior to
the Effective Time. Prior to the Effective Time, Parent shall exercise, consistent with the terms and conditions of this Agreement,
complete unilateral control and supervision over its business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Operation of the Company&rsquo;s Business</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth on <U>Section&nbsp;4.2(a)</U> of the Company Disclosure Schedule, as expressly permitted by this
Agreement, as required by applicable Law or unless Parent shall otherwise consent in writing (which consent shall not be unreasonably
withheld, delayed or conditioned), during the Pre-Closing Period: each of the Company and its Subsidiary shall conduct its business
and operations in the Ordinary Course of Business and in compliance in all material respects with all applicable Laws and the requirements
of all Contracts that constitute Company Material Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except (i) as expressly permitted by this Agreement, (ii) as set forth in <U>Section&nbsp;4.2(b)</U> of the Company
Disclosure Schedule, (iii) as required by applicable Law or (iv) with the prior written consent of Parent (which consent shall
not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, the Company shall not, nor shall
it cause or permit any of its Subsidiaries to, do any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of capital stock;
or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except for shares of Company
Common Stock from terminated employees, directors or consultants of the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>sell, issue, grant, pledge or otherwise dispose of or encumber or authorize any of the foregoing with respect to: (A)
any capital stock or other security of the Company or its Subsidiary (except for shares of Company Common Stock issued upon the
valid exercise of Company Options or vesting of the Company RSAs); (B) any option, warrant or right to acquire any capital stock
or any other security; or (C) any instrument convertible into or exchangeable for any capital stock or other security of the Company
or its Subsidiary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>except as required to give effect to anything in contemplation of the Closing, amend any of its or its Subsidiary&rsquo;s
Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization,
reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated
Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>form any Subsidiary or acquire any equity interest or other interest in any other Entity or enter into a joint venture
with any other Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>(A) lend money to any Person, (B) incur or guarantee any indebtedness for borrowed money, (C) guarantee any debt securities
of others, or (D) make any capital expenditure or commitment in excess of the budgeted capital expenditure and commitment amounts
set forth in the Company operating budget delivered to Parent concurrently with the execution of this Agreement (the &ldquo;<B><I>Company
Budget</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>other than as required by applicable Law or the terms of any Benefit Plan as in effect on the date of this Agreement:
(A) adopt, terminate, establish or enter into any Benefit Plan; (B) cause or permit any Benefit Plan to be amended in any material
respect; (C) pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions,
benefits or other compensation or remuneration payable to, any of its directors, officers or employees, other than increases in
base salary and annual cash bonus opportunities and payments made in the Ordinary Course of Business consistent with past practice;
(D) increase the severance or change of control benefits offered to any current or new employees, directors or consultants or (E)
hire, terminate or give notice of termination to any (x) officer or (y) employee whose annual base salary is or is expected to
be more than $125,000 per year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>recognize any labor union, labor organization, or similar Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>enter into any material transaction other than in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its assets or properties, or grant
any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>sell, assign, transfer, license, sublicense or otherwise dispose of any material Company IP (other than pursuant to
non-exclusive licenses in the Ordinary Course of Business);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>make, change or revoke any material Tax election, fail to pay any income or other material Tax as such Tax becomes due
and payable, file any amendment making any material change to any Tax Return, settle or compromise any income or other material
Tax Liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (other than customary
commercial Contracts entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request
or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other
material Taxes (other than in connection with any extension of time to file any Tax Return), or adopt or change any material accounting
method in respect of Taxes;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>enter into, materially amend or terminate any Company Material Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>except as otherwise set forth in the Company Budget, make any expenditures, incur any Liabilities or discharge or satisfy
any Liabilities, in each case, in amounts that exceed the aggregate amount of the Company Budget by $100,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>other than as required by Law or GAAP, take any action to change accounting policies or procedures;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>initiate or settle any Legal Proceeding; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>agree, resolve or commit to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the operations
of the Company prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms
and conditions of this Agreement, complete unilateral control and supervision over its business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Access and Investigation</U>(i)</B>. Subject to the terms of the Confidentiality Agreement, which the Parties agree will
continue in full force following the date of this Agreement, during the Pre-Closing Period, upon reasonable notice, Parent, on
the one hand, and the Company, on the other hand, shall and shall use commercially reasonable efforts to cause such Party&rsquo;s
Representatives to: (a) provide the other Party and such other Party&rsquo;s Representatives with reasonable access, upon reasonable
notice and during normal business hours, to such Party&rsquo;s Representatives, personnel, property and assets and to all existing
books, records, Tax Returns, work papers and other documents and information relating to such Party and its Subsidiaries; (b) provide
the other Party and such other Party&rsquo;s Representatives with such copies of the existing books, records, Tax Returns, work
papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional
financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably
request; (c) permit the other Party&rsquo;s officers and other employees to meet, upon reasonable notice and during normal business
hours, with the chief financial officer and other officers and managers of such Party responsible for such Party&rsquo;s financial
statements and the internal controls of such Party to discuss such matters as the other Party may deem necessary or appropriate;
and (d) make available to the other Party copies of unaudited financial statements, material operating and financial reports prepared
for senior management or the board of directors of such Party, and any material notice, report or other document filed with or
sent to or received from any Governmental Body in connection with the Contemplated Transactions. Any investigation conducted by
either Parent or the Company pursuant to this <U>Section&nbsp;4.3</U> shall be conducted in such manner as not to interfere unreasonably
with the conduct of the business of the other Party. Each Party shall provide the other Party with its unaudited cash balances
and a statement of accounts payable as of the end of each calendar month, which shall be delivered within five Business Days after
the end of such calendar month, or such longer period as the Parties may agree to in writing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, any Party
may restrict the foregoing access to the extent that any Law applicable to such Party requires such Party to restrict or prohibit
access to any such properties or information or as may be necessary to preserve the attorney-client privilege under any circumstances
in which such privilege may be jeopardized by such disclosure or access.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Parent Non-Solicitation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any
of its Subsidiaries authorize any of its Representatives to, directly or indirectly: (i) solicit, initiate, respond to or take
any action to or knowingly encourage, induce or facilitate the communication, making, submission or announcement of any Acquisition
Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition
Inquiry; (ii) furnish any non-public information regarding Parent or any of its Subsidiaries to any Person in connection with or
in response to an Acquisition Proposal or Acquisition Inquiry; (iii) engage in discussions (other than to inform any Person of
the existence of the provisions contained in this <U>Section&nbsp;4.4</U>) or negotiations with any Person with respect to any
Acquisition Proposal or Acquisition Inquiry; (iv) approve, endorse or recommend any Acquisition Proposal (subject to <U>Section&nbsp;5.3</U>);
(v) execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction
(other than a confidentiality agreement permitted under this <U>Section 4.4(a)</U>); or (vi) publicly propose to do any of the
foregoing; <I>provided</I>, <I>however</I>, that, notwithstanding anything contained in this <U>Section&nbsp;4.4</U> and subject
to compliance with this <U>Section&nbsp;4.4</U>, prior to obtaining the Required Parent Stockholder Vote, Parent may furnish non-public
information regarding Parent and its Subsidiaries to, and enter into discussions or negotiations with, any Person in response to
a bona fide written Acquisition Proposal by such Person, which the Parent Board determines in good faith, after consultation with
Parent&rsquo;s outside financial advisors and outside legal counsel, constitutes, or would be reasonably likely to result in, a
Superior Offer (and is not withdrawn) if: (A) neither Parent nor any of its Representatives shall have breached this <U>Section&nbsp;4.4</U>
in any material respect, (B) the Parent Board concludes in good faith based on the advice of outside legal counsel, that the failure
to take such action would be reasonably likely to be inconsistent with the fiduciary duties of the Parent Board under applicable
Law; (C) Parent receives from such Person an executed confidentiality agreement containing provisions at least as favorable to
Parent as those contained in the Confidentiality Agreement; (D) at least 2 Business Days prior to furnishing any such non-public
information to, or entering into discussions with, such Person, Parent gives the Company written notice of the identity of such
Person and of Parent&rsquo;s intention to furnish non-public information to, or enter into discussions with, such Person; and (E)
substantially contemporaneously with furnishing any such nonpublic information to such Person, Parent furnishes such nonpublic
information to the Company (to the extent such information has not been previously furnished by Parent to the Company). Without
limiting the generality of the foregoing, Parent acknowledges and agrees that, in the event any Representative of Parent (whether
or not such Representative is purporting to act on behalf of Parent) takes any action that, if taken by Parent, would constitute
a breach of this <U>Section 4.4</U>, the taking of such action by such Representative shall be deemed to constitute a breach of
this <U>Section&nbsp;4.4</U> by Parent for purposes of this Agreement. Except as permitted by this <U>Section&nbsp;4.4</U>, Parent
will not approve an Acquisition Proposal or Acquisition Inquiry for purposes of Chapter 23B.19 of the WBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If Parent or any Representative of Parent receives an Acquisition Proposal or Acquisition Inquiry at any time during
the Pre-Closing Period, then Parent shall promptly (and in no event later than one Business Day after Parent becomes aware of such
Acquisition Proposal or Acquisition Inquiry) advise the Company orally and in writing of such Acquisition Proposal or Acquisition
Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry, and the material
terms thereof). Parent shall keep the Company reasonably informed with respect to the status and material terms of any such Acquisition
Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent shall immediately cease and cause to be terminated any existing discussions, negotiations and communications
with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the
destruction or return of any nonpublic information of Parent or any of its Subsidiaries provided to such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Non-Solicitation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company agrees that, during the Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or
any of its Subsidiaries authorize any of its Representatives to, directly or indirectly: (i) solicit, initiate or knowingly encourage,
induce or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or
take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii) furnish any non-public
information regarding the Company or its Subsidiary to any Person in connection with or in response to an Acquisition Proposal
or Acquisition Inquiry; (iii) engage in discussions (other than to inform any Person of the existence of the provisions contained
in this <U>Section&nbsp;4.5</U>) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry;
(iv) approve, endorse or recommend any Acquisition Proposal; (v) execute or enter into any letter of intent or any Contract contemplating
or otherwise relating to any Acquisition Transaction; or (vi) publicly propose to do any of the foregoing. Without limiting the
generality of the foregoing, the Company acknowledges and agrees that, in the event any Representative of the Company (whether
or not such Representative is purporting to act on behalf of the Company) takes any action that, if taken by the Company, would
constitute a breach of this <U>Section&nbsp;4.5</U>, the taking of such action by such Representative shall be deemed to constitute
a breach of this <U>Section&nbsp;4.5</U> by the Company for purposes of this Agreement. Except as permitted by this <U>Section&nbsp;4.5</U>,
the Company will not approve an Acquisition Proposal or Acquisition Inquiry for purposes of Chapter 23B.19 of the WBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If the Company or any Representative of the Company receives an Acquisition Proposal or Acquisition Inquiry at any time
during the Pre-Closing Period, then the Company shall promptly (and in no event later than one Business Day after the Company becomes
aware of such Acquisition Proposal or Acquisition Inquiry) advise Parent orally and in writing of such Acquisition Proposal or
Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry,
and the material terms thereof). The Company shall keep Parent reasonably informed with respect to the status and material terms
of any such Acquisition Proposal or Acquisition Inquiry and any material modification or proposed material modification thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company shall immediately cease and cause to be terminated any existing discussions, negotiations and communications
with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the
destruction or return of any nonpublic information of the Company or its Subsidiary provided to such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notification of Certain Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>During the Pre-Closing Period the Company shall promptly notify Parent (and, if in writing, furnish copies of) if any
of the following occurs: (i) any notice or other communication is received from any Person alleging that the Consent of such Person
is or may be required in connection with any of the Contemplated Transactions; (ii) any Legal Proceeding against or involving or
otherwise affecting the Company or its Subsidiary is commenced, or, to the Knowledge of the Company, threatened in writing against
the Company or its Subsidiary or, to the Knowledge of the Company, any director or officer of the Company or its Subsidiary; (iii)
the Company becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv) the failure
of the Company to comply with any covenant or obligation of the Company; in the case of (iii) and (iv) that could reasonably be
expected to make the timely satisfaction of any of the conditions set forth in <U>Section 6</U> or <U>7</U>, as applicable, impossible
or materially less likely. No notification given to Parent pursuant to this <U>Section&nbsp;4.6(a)</U> shall change, limit or otherwise
affect any of the representations, warranties, covenants or obligations of the Company or its Subsidiary contained in this Agreement
or the Company Disclosure Schedule for purposes of <U>Section 6</U> and <U>7</U>, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>During the Pre-Closing Period Parent shall promptly notify the Company (and, if in writing, furnish copies of) if any
of the following occurs: (i) any notice or other communication is received from any Person alleging that the Consent of such Person
is or may be required in connection with any of the Contemplated Transactions; (ii) any Legal Proceeding against or involving or
otherwise affecting Parent or its Subsidiaries is commenced, or, to the Knowledge of Parent, threatened against Parent or its Subsidiaries
or, to the Knowledge of Parent, any director or officer of Parent or its Subsidiaries; (iii) Parent becomes aware of any inaccuracy
in any representation or warranty made by it in this Agreement; or (iv) the failure of Parent to comply with any covenant or obligation
of Parent; in the case of (iii) and (iv) that could reasonably be expected to make the timely satisfaction of any of the conditions
set forth in <U>Section 6</U> or <U>Section 8</U>, as applicable, impossible or materially less likely. No notification given to
the Company pursuant to this <U>Section&nbsp;4.6(b)</U> shall change, limit or otherwise affect any of the representations, warranties,
covenants or obligations of Parent or any of its Subsidiaries contained in this Agreement or the Parent Disclosure Schedule for
purposes of <U>Section 6</U> and <U>Section 8</U>, as applicable.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">ADDITIONAL
AGREEMENTS OF THE PARTIES</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proxy Statement</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As promptly as practicable after the date of this Agreement, the Parties shall prepare, and Parent shall cause to be
filed with the SEC, the Proxy Statement. Parent covenants and agrees that the Proxy Statement, including any pro forma financial
statements included therein (and the letter to stockholders, notice of meeting and form of proxy included therewith), will not,
at the time that the Proxy Statement or any amendment or supplement thereto is filed with the SEC or is first mailed to the stockholders,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The Company
covenants and agrees that the written information provided by the Company or its Subsidiary to Parent for inclusion in the Proxy
Statement (including the Company Financials) will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make such information not misleading. Notwithstanding the foregoing,
Parent makes no covenant, representation or warranty with respect to statements made in the Proxy Statement (and the letter to
stockholders, notice of meeting and form of proxy included therewith), if any, based on written information provided by the Company
or its Subsidiary or any of their Representatives specifically for inclusion therein. The Company and its legal counsel shall be
given reasonable opportunity to review and comment on the Proxy Statement, including all amendments and supplements thereto, prior
to the filing thereof with the SEC, and on the response to any comments of the SEC on the Proxy Statement, prior to the filing
or submission thereof with the SEC. Parent shall use commercially reasonable efforts to cause the Proxy Statement to comply with
the applicable rules and regulations promulgated by the SEC and to respond promptly to any comments of the SEC or its staff. Parent
shall use commercially reasonable efforts to cause the Proxy Statement to be mailed to Parent&rsquo;s stockholders as promptly
as practicable after the resolution of SEC staff comments and the filing of the Definitive Proxy Statement on Schedule 14A. Each
Party shall promptly furnish to the other Party all information concerning such Party and such Party&rsquo;s Affiliates and such
Party&rsquo;s stockholders that may be required or reasonably requested in connection with any action contemplated by this <U>Section&nbsp;5.1</U>.
If Parent, Merger Sub or the Company become aware of any event or information that, pursuant to the Exchange Act, should be disclosed
in an amendment or supplement to the Proxy Statement, as the case may be, then such Party, as the case may be, shall promptly inform
the other Parties thereof and shall cooperate with such other Parties in filing such amendment or supplement with the SEC and,
if appropriate, in mailing such amendment or supplement to the Parent stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company shall reasonably cooperate with Parent and provide, and require its Representatives to provide, Parent and
its Representatives, with all true, correct and complete information regarding the Company and its Subsidiary that is required
by Law to be included in the Proxy Statement or reasonably requested by Parent to be included in the Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Stockholder Written Consent</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As promptly as reasonably practicable after the date of this Agreement, and in any event no later than five Business
Days thereafter, the Company shall, with the cooperation of Parent, obtain the approval by written consent from stockholders of
the Company sufficient for the Required Company Stockholder Vote in lieu of a meeting pursuant to Chapter 23B.13 of the WBCA, for
purposes of (i) adopting and approving this Agreement and the Contemplated Transactions, (ii) acknowledging that the approval given
thereby is irrevocable and that such stockholder is aware of its rights to demand appraisal for its shares pursuant to Chapter
23B.13 of the WBCA, a true and correct copy of which will be attached thereto, and that such stockholder has received and read
a copy of Chapter 23B.13 of the WBCA, and (iii) acknowledging that by its approval of the Merger it is not entitled to appraisal
rights with respect to its Dissenting Shares in connection with the Merger and thereby waives any rights to receive payment of
the fair value of its capital stock under the WBCA (collectively, the &ldquo;<B><I>Company Stockholder Matters</I></B>&rdquo;).
Under no circumstances shall the Company assert that any other approval or consent is necessary by its stockholders to approve
this Agreement and the Contemplated Transactions. All materials (including any amendments thereto) submitted to the stockholders
of the Company in accordance with this <U>Section 5.2(a)</U> shall be subject to Parent&rsquo;s advance review and reasonable approval,
which shall not be unreasonably conditioned, delayed, or withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent and the Company shall cooperate to cause to be mailed, distributed, or otherwise made available to those of its
stockholders that do not qualify as &ldquo;accredited investors&rdquo; within the meaning of Regulation D (the &ldquo;<B><I>Non-Accredited
Investors</I></B>&rdquo;), information meeting the requirements of Rule 502(b) of Regulation D (such information collectively being
referred to as the &ldquo;<B><I>Information Statement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent covenants and agrees that the Information Statement, including any pro forma financial statements included therein,
will not, at the time that the Information Statement or any amendment or supplement thereto is first mailed, distributed, or otherwise
made available to the Non-Accredited Investors, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which
they were made, not misleading. Notwithstanding the foregoing, Parent makes no covenant, representation or warranty with respect
to statements made in the Information Statement, if any, based on information furnished in writing by the Company specifically
for inclusion therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Reasonably promptly following receipt of the Required Company Stockholder Vote, the Company shall prepare and mail a
notice (the &ldquo;<B><I>Stockholder Notice</I></B>&rdquo;) to every stockholder of the Company that did not execute the Company
Stockholder Written Consent. The Stockholder Notice shall (i) be a statement to the effect that the Company Board determined that
the Merger is advisable in accordance with the WBCA and in the best interests of the stockholders of the Company and approved and
adopted this Agreement, the Merger and the other Contemplated Transactions, (ii) provide the stockholders of the Company to whom
it is sent with notice of the actions taken in the Company Stockholder Written Consent, including the adoption and approval of
this Agreement, the Merger and the other Contemplated Transactions in accordance with Chapter 23B.13 of the WBCA and the articles
of incorporation and bylaws of the Company and (iii) include a description of the Dissenting Shares of the Company&rsquo;s stockholders
available under the WBCA, along with such other information as is required thereunder and pursuant to applicable Law. All materials
(including any amendments thereto) submitted to the stockholders of the Company in accordance with this <U>Section 5.2(d)</U> shall
be subject to Parent&rsquo;s advance review and reasonable approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company agrees that: (i) the Company Board shall recommend that the Company&rsquo;s stockholders vote to approve
the Company Stockholder Matters and shall solicit and use best efforts to obtain such approval from each of the Company Signatories
within five Business Days of the date of this Agreement (the recommendation of the Company Board that the Company&rsquo;s stockholders
vote to adopt and approve this Agreement being referred to as the &ldquo;<B><I>Company Board Recommendation</I></B>&rdquo;); and
(ii) the Company Board Recommendation shall not be withdrawn or modified (and the Company Board shall not publicly propose to withdraw
or modify the Company Board Recommendation) in a manner adverse to Parent, and no resolution by the Company Board or any committee
thereof to withdraw or modify the Company Board Recommendation in a manner adverse to Parent or to adopt, approve or recommend
(or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth
in the foregoing clause (ii), collectively, a &ldquo;<B><I>Company Board Adverse Recommendation Change</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company&rsquo;s obligation to solicit the consent of its stockholders to sign the Company Stockholder Written Consent
in accordance with <U>Section&nbsp;5.2(a)</U> shall not be limited or otherwise affected by the commencement, disclosure, announcement
or submission of any Superior Offer or other Acquisition Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Parent Stockholders&rsquo; Meeting</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As promptly as reasonably practicable after the resolution of SEC staff comments and the filing of the Definitive Proxy
Statement on Schedule 14A, Parent shall take all action necessary under applicable Law to call, give notice of and hold a meeting
of the holders of Parent Common Stock for the purpose of seeking approval of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the amendment of Parent&rsquo;s articles of incorporation to effect the NYSE Reverse Split;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the Business Combination (as defined in Parent&rsquo;s Organizational Documents);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the change of control of Parent resulting from the Merger pursuant to the NYSE rules;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the Parent EIP Amendment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>in accordance with Section&nbsp;14A of the Exchange Act and the applicable SEC rules issued thereunder, seeking advisory
approval of a proposal to the Parent&rsquo;s stockholders for a non-binding, advisory vote to approve certain compensation that
may become payable to Parent&rsquo;s named executed officers in connection with the completion of the Merger, if applicable (the
matters contemplated by the clauses 5.3(a)(i), 5.3(a)(ii), and 5.3(a)(iii) are collectively referred to as the &ldquo;<B><I>Parent
Stockholder Matters</I></B>,&rdquo; and the matters contemplated by clauses&nbsp;5.3(a)(iv) and 5.3(a)(v) are collectively referred
to herein as collectively, the &ldquo;<B><I>Other Parent Stockholder Matters,</I></B>&rdquo; and such meeting, the &ldquo;<B><I>Parent
Stockholders&rsquo; Meeting</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parent Stockholders&rsquo; Meeting shall be held as promptly as practicable after the filing of a Definitive Proxy
Statement on Schedule 14A with the SEC. Parent shall take reasonable measures to ensure that all proxies solicited in connection
with the Parent Stockholders&rsquo; Meeting are solicited in compliance with all applicable Law. Notwithstanding anything to the
contrary contained herein, if on the date of the Parent Stockholders&rsquo; Meeting, or a date preceding the date on which the
Parent Stockholders&rsquo; Meeting is scheduled, Parent reasonably believes that (i) it will not receive proxies sufficient to
obtain the Parent Stockholder Vote, whether or not a quorum would be present or (ii) it will not have sufficient shares of Parent
Common Stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the Parent
Stockholders&rsquo; Meeting, Parent may postpone or adjourn, or make one or more successive postponements or adjournments of, the
Parent Stockholders&rsquo; Meeting as long as the date of the Parent Stockholders&rsquo; Meeting is not postponed or adjourned
more than an aggregate of 60 calendar days in connection with any postponements or adjournments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent agrees that, subject to <U>Section&nbsp;5.3(d)</U>: (i) the Parent Board shall recommend that the holders of
Parent Common Stock vote to approve the Parent Stockholder Matters and the Other Parent Stockholder Matters; (ii) the Proxy Statement
shall include a statement to the effect that the Parent Board recommends that Parent&rsquo;s stockholders vote to approve the Parent
Stockholder Matters and the Other Parent Stockholder Matters (the recommendation of the Parent Board with respect to the Parent
Stockholder Matters being referred to as the &ldquo;<B><I>Parent Board Recommendation</I></B>&rdquo;); and (iii) the Parent Board
Recommendation shall not be withheld, amended, withdrawn or modified (and the Parent Board shall not publicly propose to withhold,
amend, withdraw or modify the Parent Board Recommendation) in a manner adverse to the Company (the actions set forth in the foregoing
clause (iii), collectively, a &ldquo;<B><I>Parent Board Adverse Recommendation Change</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Notwithstanding anything to the contrary contained in this Agreement, if at any time prior to the approval of Parent
Stockholder Matters by the Required Parent Stockholder Vote, Parent has received a written Acquisition Proposal (which Acquisition
Proposal did not arise out of a material breach of <U>Section 4.4</U>) from any Person that has not been withdrawn and after consultation
with outside legal counsel, the Parent Board shall have determined, in good faith, that such Acquisition Proposal is a Superior
Offer, (x)&nbsp;the Parent Board may make a Parent Board Adverse Recommendation Change or (y)&nbsp;Parent may terminate this Agreement
pursuant to <U>Section 9.1(j)</U> to enter into a Permitted Alternative Agreement with respect to such Superior Offer, if and only
if: (A)&nbsp;the Parent Board determines in good faith, after consultation with Parent&rsquo;s outside legal counsel, that the
failure to do so is reasonably likely to be inconsistent with the fiduciary duties of the Parent Board to Parent&rsquo;s stockholders
under applicable Law; (B)&nbsp;Parent shall have given the Company prior written notice of its intention to consider making a Parent
Board Adverse Recommendation Change or terminate this Agreement pursuant to <U>Section 9.1(f)</U> at least five Business Days prior
to making any such Parent Board Adverse Recommendation Change or termination (a &ldquo;<B><I>Determination Notice</I></B>&rdquo;)
(which notice shall not constitute a Parent Board Adverse Recommendation Change); and (C)(1)&nbsp;Parent shall have provided to
the Company a summary of the material terms and conditions of the Acquisition Proposal in accordance with <U>Section 4.4(b)</U>,
(2)&nbsp;Parent shall have given the Company the five Business Days after the Determination Notice to propose revisions to the
terms of this Agreement or make another proposal so that such Determination Notice would no longer necessitate a Parent Board Adverse
Recommendation Change and shall have made its Representatives reasonably available to negotiate in good faith with the Company
(to the extent the Company desires to negotiate) with respect to such proposed revisions or other proposal, if any, and (3)&nbsp;after
considering the results of any such negotiations and giving effect to the proposals made by the Company, if any, after consultation
with outside legal counsel, the Parent Board shall have determined, in good faith, that such Acquisition Proposal is a Superior
Offer and that the failure to make the Parent Board Adverse Recommendation Change or terminate this Agreement pursuant to <U>Section
9.1(f)</U> is reasonably likely to be inconsistent with the fiduciary duties of the Parent Board to Parent&rsquo;s stockholders
under applicable Law. For the avoidance of doubt, the provisions of this <U>Section 5.3(d)</U> shall also apply to any material
change to the facts and circumstances relating to such Acquisition Proposal and require a new Determination Notice following any
such material change, except that the references to five Business Days shall be deemed to be three Business Days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>other than in connection with an Acquisition Proposal, the Parent Board may make a Parent Board Adverse Recommendation
Change in response to a Parent Change in Circumstance, if and only if: (A) the Parent Board determines in good faith, after consultation
with Parent&rsquo;s outside legal counsel, that the failure to do so could be inconsistent with the fiduciary duties of the Parent
Board to Parent&rsquo;s stockholders under applicable Law; (B) Parent shall have given the Company a Determination Notice at least
three Business Days prior to making any such Parent Board Adverse Recommendation Change; and (C) (1) Parent shall have specified
the Parent Change in Circumstance in reasonable detail, (2) Parent shall have given the Company the three Business Days after the
Determination Notice to propose revisions to the terms of this Agreement or make another proposal, and shall have made its Representatives
reasonably available to negotiate in good faith with the Company (to the extent the Company desires to do so) with respect to such
proposed revisions or other proposal, if any, and (3) after considering the results of any such negotiations and giving effect
to the proposals made by the Company, if any, after consultation with outside legal counsel, the Parent Board shall have determined,
in good faith, that the failure to make the Parent Board Adverse Recommendation Change in response to such Parent Change in Circumstance
could be inconsistent with the fiduciary duties of the Parent Board to Parent&rsquo;s stockholders under applicable Law. For the
avoidance of doubt, the provisions of this <U>Section 5.3(e)</U> shall also apply to any material change to the facts and circumstances
relating to such Parent Change in Circumstance and require a new Determination Notice, except that the references to three Business
Days shall be deemed to be two Business Days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Nothing contained in this Agreement shall prohibit Parent or the Parent Board from (i) complying with Rules 14d-9 and
14e-2(a) promulgated under the Exchange Act, (ii) issuing a &ldquo;stop, look and listen&rdquo; communication or similar communication
of the type contemplated by Section 14d-9(f) under the Exchange Act or (iii) otherwise making any disclosure to the Parent stockholders;
<I>provided however</I>, that in the case of the foregoing clause (iii) the Parent Board determines in good faith, after consultation
with its outside legal counsel, that failure to make such disclosure is reasonably likely to be inconsistent with applicable Law,
including its fiduciary duties under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regulatory Approvals</U></B>. Each Party shall use reasonable best efforts to file or otherwise submit, as soon as practicable
after the date of this Agreement, all applications, notices, reports and other documents reasonably required to be filed by such
Party with or otherwise submitted by such Party to any Governmental Body with respect to the Contemplated Transactions, and to
submit promptly any additional information requested by any such Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Options and Company RSAs</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>At the Effective Time, each Company Option that is outstanding and unexercised immediately prior to the Effective Time
under the 2006 Company Plan or the 2016 Company Plan, whether or not vested, shall be converted into and become an option to purchase
Parent Common Stock, and Parent shall assume the 2006 Company Plan and the 2016 Company Plan and each such Company Option in accordance
with the terms (as in effect as of the date of this Agreement) of the 2006 Company Plan or the 2016 Company Plan and the terms
of the stock option agreement by which such Company Option is evidenced (but with changes to such documents as Parent in good faith
determines are appropriate to reflect the substitution of the Company Options by Parent to purchase shares of Parent Common Stock).
All rights with respect to Company Common Stock under Company Options assumed by Parent shall thereupon be converted into rights
with respect to Parent Common Stock. Accordingly, from and after the Effective Time: (i) each Company Option assumed by Parent
may be exercised solely for shares of Parent Common Stock; (ii) the number of shares of Parent Common Stock subject to each Company
Option assumed by Parent shall be determined by multiplying (A) the number of shares of Company Common Stock that were subject
to such Company Option, as in effect immediately prior to the Effective Time, by (B) the Exchange Ratio, and rounding the resulting
number down to the nearest whole number of shares of Parent Common Stock; (iii) the per share exercise price for the Parent Common
Stock issuable upon exercise of each Company Option assumed by Parent shall be determined by dividing (A) the per share exercise
price of Company Common Stock subject to such Company Option, as in effect immediately prior to the Effective Time, by (B) the
Exchange Ratio and rounding the resulting exercise price up to the nearest whole cent; and (iv) any restriction on the exercise
of any Company Option assumed by Parent shall continue in full force and effect and the term, exercisability, vesting schedule
and other provisions of such Company Option shall otherwise remain unchanged; <I>provided, however</I>, that: (A) Parent may amend
the terms of the Company Options, the 2006 Company Plan and the 2016 Company Plan to reflect Parent&rsquo;s substitution of the
Company Options with options to purchase Parent Common Stock (such as by making any change in control or similar definition relate
to Parent and having any provision that provides for the adjustment of Company Options upon the occurrence of certain corporate
events relate to corporate events that relate to Parent and/or Parent Common Stock); and (B) the Parent Board or a committee thereof
shall succeed to the authority and responsibility of the Company Board or any committee thereof with respect to each Company Option
assumed by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent shall file with the SEC, promptly, but no later than thirty calendar days after the Effective Time, a registration
statement on Form S-8 (or any successor form), if available for use by Parent, relating to the shares of Parent Common Stock issuable
with respect to Company Options assumed by Parent in accordance with <U>Section 5.5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Prior to the Effective Time, the Company shall take all actions that may be necessary (under the 2006 Company Plan,
the 2016 Company Plan and otherwise) to effectuate the provisions of this <U>Section&nbsp;5.5</U> and to ensure that, from and
after the Effective Time, holders of Company Options have no rights with respect thereto other than those specifically provided
in this <U>Section&nbsp;5.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Subject to <U>Section 5.5(e)</U>, at the Effective Time, each Company RSA that is outstanding immediately prior to the
Effective Time under each Restricted Stock Agreement shall be assumed by Parent and converted into restricted stock awards with
respect to Parent Common Stock, and Parent shall assume the Restricted Stock Agreements and each such Company RSA in accordance
with the terms (as in effect as of the date of this Agreement) of such Restricted Stock Agreements. All rights with respect to
Company Common Stock under Company RSAs assumed by Parent shall thereupon be converted into rights with respect to Parent Common
Stock. Accordingly, from and after the Effective Time: (i) each Company RSA assumed by Parent shall relate to shares of Parent
Common Stock; (ii) the number of shares of Parent Common Stock subject to each Company RSA assumed by Parent shall be determined
by multiplying (A) the number of Company RSAs that were subject to such Company RSA, as in effect immediately prior to the Effective
Time, by (B) the Exchange Ratio and rounding the resulting number down to the nearest whole number of shares of Parent Common Stock;
and (iii) any restriction on any Company RSA assumed by Parent shall continue in full force and effect and the vesting schedule
and other provisions of such Company RSA shall otherwise remain unchanged; <I>provided</I>, <I>however</I>, that: (A) to the extent
provided under the terms of a Company RSA, such Company RSA assumed by Parent in accordance with this <U>Section 5.5(d)</U> shall,
in accordance with its terms, be subject to further adjustment as appropriate to reflect any stock split, division or subdivision
of shares, stock dividend, reverse stock split, consolidation of shares, reclassification, recapitalization or other similar transaction
with respect to Parent Common Stock subsequent to the Effective Time; and (B) the Parent Board of Directors or a committee thereof
shall succeed to the authority and responsibility of the Company Board of Directors or any committee thereof with respect to each
Company RSA assumed by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Prior to the Effective Time, the Company shall take all actions that may be necessary (under any Restricted Stock Agreement
and otherwise) to effectuate the provisions of this <U>Section 5.5</U> and to ensure that, from and after the Effective Time, holders
of Company RSAs have no rights with respect thereto other than those specifically provided in this <U>Section 5.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employee Benefits</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>For purposes of vesting, eligibility to participate, and level of benefits under the benefit plans, programs, Contracts
or arrangements of Parent or any of its Subsidiaries (including, following the Closing, the Company and its Subsidiary) providing
benefits to any Continuing Employee after the Closing (the &ldquo;<B><I>Post-Closing Plans</I></B>&rdquo;), each employee who continues
to be employed by Parent, the Company or any of their respective Subsidiaries immediately following the Closing (&ldquo;<B><I>Continuing
Employees</I></B>&rdquo;) shall be credited with his or her years of service with Parent, the Company or any of their respective
Subsidiaries and their respective predecessors; provided that the foregoing shall not apply to the extent that its application
would result in a duplication of benefits. In addition, and without limiting the generality of the foregoing, for purposes of each
Post-Closing Plan providing medical, dental, pharmaceutical and/or vision benefits to a Continuing Employee, Parent shall cause
all pre-existing condition exclusions and actively-at-work requirements of such Post-Closing Plan to be waived for such Continuing
Employee and his or her covered dependents to the extent and unless such conditions would have been waived or satisfied under the
employee benefit plan whose coverage is being replaced under the Post-Closing Plan, and Parent shall use commercially reasonable
efforts to cause any eligible expenses incurred by a Continuing Employee and his or her covered dependents during the portion of
such plan year in which coverage is replaced with coverage under a Post-Closing Plan to be taken into account under such Post-Closing
Plan with respect to the plan year in which participation in such Post-Closing Plan begins for purposes of satisfying all deductible,
coinsurance and maximum out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for
such plan year as if such amounts had been paid in accordance with such Post-Closing Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The provisions of this <U>Section 5.6 </U>are for the sole benefit of Parent, the Company and their respective Subsidiaries,
and no provision of this Agreement shall (i) create any third-party beneficiary or other rights in any Person, including rights
in respect of any benefits that may be provided, directly or indirectly, under any Company Benefit Plan, Parent Benefit Plan or
Post-Closing Plan or rights to continued employment or service with the Company or the Parent (or any Subsidiary thereof), (ii)
be construed as an amendment, waiver or creation of or limitation on the ability to terminate any Company Benefit Plan, Parent
Benefit Plan or Post-Closing Plan, or (iii) limit the ability of the Parent to terminate the employment of any Continuing Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification of Officers and Directors</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>From the Effective Time through the sixth anniversary of the date on which the Effective Time occurs, each of Parent
and the Surviving Corporation shall, jointly and severally, indemnify and hold harmless each Person who is now, or has been at
any time prior to the date hereof, or who becomes prior to the Effective Time, a director, officer, fiduciary or agent of Parent
and its Subsidiaries or the Company, respectively (the &ldquo;<B><I>D&amp;O Indemnified Parties</I></B>&rdquo;), against all claims,
losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&rsquo; fees and disbursements,
incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative,
arising out of or pertaining to the fact that the D&amp;O Indemnified Party is or was a director, officer, fiduciary or agent of
Parent or of the Company or any of their respective Subsidiaries, whether asserted or claimed prior to, at or after the Effective
Time, in each case, to the fullest extent permitted under applicable Law. Each D&amp;O Indemnified Party will be entitled to advancement
of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Parent and the Surviving
Corporation, jointly and severally, upon receipt by Parent or the Surviving Corporation from the D&amp;O Indemnified Party of a
request therefor; <I>provided</I> that any such Person to whom expenses are advanced provides an undertaking to Parent, to the
extent then required by the WBCA, as applicable, to repay such advances if it is ultimately determined that such Person is not
entitled to indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The provisions of the articles of incorporation and bylaws of Parent with respect to indemnification, advancement of
expenses and exculpation of present and former directors and officers of Parent that are presently set forth in the articles of
incorporation and bylaws of Parent shall not be amended, modified or repealed for a period of six years from the Effective Time
in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers
or directors of Parent. The articles of incorporation and bylaws of the Surviving Corporation shall contain, and Parent shall cause
the articles of incorporation and bylaws of the Surviving Corporation to so contain, provisions no less favorable with respect
to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set
forth in the articles of incorporation and bylaws of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>From and after the Effective Time, (i) the Surviving Corporation shall fulfill and honor in all respects the obligations
of the Company to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions
under the Company&rsquo;s Organizational Documents and pursuant to any indemnification agreements between the Company and such
D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)
Parent shall fulfill and honor in all respects the obligations of Parent to its D&amp;O Indemnified Parties as of immediately prior
to the Closing pursuant to any indemnification provisions under Parent&rsquo;s Organizational Documents and pursuant to any indemnification
agreements between Parent and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior
to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>From and after the Effective Time, Parent shall maintain directors&rsquo; and officers&rsquo; liability insurance policies,
with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary
for U.S. public companies similarly situated to Parent. In addition, Parent shall purchase, prior to the Effective Time, a six-year
prepaid &ldquo;tail policy&rdquo; (the cost of which shall be reimbursed by the Company) for the non-cancellable extension of the
directors&rsquo; and officers&rsquo; liability coverage of Parent&rsquo;s existing directors&rsquo; and officers&rsquo; insurance
policies for a claims reporting or discovery period of at least six years from and after the Effective Time with respect to any
claim related to any period of time at or prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>From and after the Effective Time, Parent shall pay all expenses, including reasonable attorneys&rsquo; fees, that are
incurred by the Persons referred to in this <U>Section&nbsp;5.7</U> in connection with their successful enforcement of the rights
provided to such Persons in this <U>Section&nbsp;5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The provisions of this <U>Section&nbsp;5.7</U> are intended to be in addition to the rights otherwise available to the
current and former officers and directors of Parent and the Company by Law, charter, statute, bylaw or agreement, and shall operate
for the benefit of, and shall be enforceable by, each of the D&amp;O Indemnified Parties, their heirs and their representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>In the event Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with
or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger,
or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision
shall be made so that the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall succeed to the
obligations set forth in this <U>Section&nbsp;5.7</U>. Parent shall cause the Surviving Corporation to perform all of the obligations
of the Surviving Corporation under this <U>Section&nbsp;5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Agreements</U></B>. The Parties shall use commercially reasonable efforts to cause to be taken all actions
necessary to consummate the Contemplated Transactions. Without limiting the generality of the foregoing, each Party to this Agreement:
(a) shall make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such Party
in connection with the Contemplated Transactions; (b) shall use reasonable best efforts to obtain each Consent (if any) reasonably
required to be obtained (pursuant to any applicable Law or Contract, or otherwise) by such Party in connection with the Contemplated
Transactions or for such Contract (with respect to Contracts set forth in <B><U>Schedule 5.8</U></B>) to remain in full force and
effect; (c) shall use commercially reasonable efforts to lift any injunction prohibiting, or any other legal bar to, the Contemplated
Transactions; and (d) shall use commercially reasonable efforts to satisfy the conditions precedent to the consummation of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclosure</U></B>. The initial press release relating to this Agreement shall be a joint press release issued by the
Company and Parent and thereafter Parent and the Company shall consult with each other before issuing any further press release(s)
or otherwise making any public statement or making any announcement to Parent Associates or Company Associates (to the extent not
previously issued or made in accordance with this Agreement) with respect to the Contemplated Transactions and shall not issue
any such press release, public statement or announcement to Parent Associates or Company Associates without the other Party&rsquo;s
written consent (which shall not be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing: (a)&nbsp;each
Party may, without such consultation or consent, make any public statement in response to questions from the press, analysts, investors
or those attending industry conferences, make internal announcements to employees and make disclosures in Parent SEC Documents,
so long as such statements are consistent with previous press releases, public disclosures or public statements made jointly by
the Parties (or individually, if approved by the other Party); (b)&nbsp;a Party may, without the prior consent of the other Party
hereto but subject to giving advance notice to the other Party, issue any such press release or make any such public announcement
or statement as may be required by any Law; and (c) Parent need not consult with the Company in connection with such portion of
any press release, public statement or filing to be issued or made pursuant to <U>Section 5.3(f)</U> or with respect to any Acquisition
Proposal or Parent Board Adverse Recommendation Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Listing</U></B>. Parent shall (a) to the extent required by the rules and regulations of the NYSE, prepare and submit
to the NYSE a notification form for the listing of the shares of Parent Common Stock to be issued in connection with the Contemplated
Transactions, and use its best efforts to cause such shares to be approved for listing (subject to official notice of issuance);
(b) effect the NYSE Reverse Split subject to the receipt of the applicable Parent Stockholder Vote, and (c) to the extent required
by the rules of the NYSE, file a supplemental listing application for the Parent Common Stock on the NYSE (the &ldquo;<B><I>NYSE
Listing Application</I></B>&rdquo;) and use its best efforts to cause such NYSE Listing Application to be conditionally approved
prior to the Effective Time. The Parties shall coordinate in good faith with respect to compliance with NYSE rules and regulations.
The Parties agree to each pay 50% of all NYSE fees associated with the NYSE Listing Application. The Company will cooperate with
Parent as reasonably requested by Parent with respect to the NYSE Listing Application and promptly furnish to Parent all information
concerning the Company and its stockholders that may be required or reasonably requested in connection with any action contemplated
by this <U>Section&nbsp;5.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Tax Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>For United States federal income Tax purposes, (i) the Parties intend that the Merger qualify as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code (the &ldquo;<B><I>Intended Tax Treatment</I></B>&rdquo;), and (ii) this Agreement
is intended to be, and is hereby adopted as, a &ldquo;plan of reorganization&rdquo; for purposes of Section 354 and 361 of the
Code and Treasury Regulations Section 1.368-2(g) and 1.368-3(a), to which the Parent, Merger Sub and the Company are parties under
Section 368(b) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parties shall use their respective reasonable best efforts to cause the Merger to qualify, and will not take any
action or cause any action to be taken which action would reasonably be expected to prevent the Merger from qualifying, for the
Intended Tax Treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legends</U></B>. Parent shall be entitled to place appropriate legends on the book entries and/or certificates evidencing
any shares of Parent Common Stock to be received in the Merger by equity holders of the Company who may be considered &ldquo;affiliates&rdquo;
of Parent for purposes of Rules 144 and 145 under the Securities Act reflecting the restrictions set forth in Rules 144 and 145
and to issue appropriate stop transfer instructions to the transfer agent for Parent Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Directors and Officers</U></B>. The Parties shall use reasonable best efforts and take all necessary action so that immediately
after the Effective Time, (a) the Parent Board is comprised of 7 members, with 2 such members designated by Parent and 5 such members
designated by the Company, and (b) the Persons listed in <B>Exhibit E</B> under the heading &ldquo;Officers&rdquo; are elected
or appointed, as applicable, to the positions of officers of Parent, as set forth therein, to serve in such positions effective
as of the Effective Time until successors are duly appointed and qualified in accordance with applicable Law. If any Person listed
in <B>Exhibit E</B> is unable or unwilling to serve as an officer of Parent, as set forth therein, as of the Effective Time, the
Parties shall mutually agree upon a successor. The Persons listed in <B>Exhibit E</B> under the heading &ldquo;Board Designees
 &ndash; Parent&rdquo; shall be Parent&rsquo;s designees pursuant to clause (a) of this <U>Section&nbsp;5.13</U> (which list may
be changed by Parent at any time prior to the Closing by written notice to the Company to include different board designees who
are reasonably acceptable to the Company) (the &ldquo;<B><I>Parent Designees</I></B>&rdquo;). To the extent the Second Parent Designee
is currently classified as a Class I director of Parent, Parent shall following the Closing and at an appropriate time prior to
Parent&rsquo;s 2019 annual meeting of shareholders, nominate such Second Parent Designee for reelection at Parent&rsquo;s 2019
annual meeting of shareholders. The Persons listed in <B>Exhibit E</B> under the heading &ldquo;Board Designees &ndash; Company&rdquo;
shall be the Company&rsquo;s designees pursuant to clause (a) of this <U>Section&nbsp;5.13</U> (which list may be changed by the
Company at any time prior to the Closing by written notice to Parent to include different board designees who are reasonably acceptable
to Parent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Certain Agreements and Rights</U></B>. The Company shall cause any Investor Agreements to be terminated
immediately prior to the Effective Time, without any liability being imposed on the part of Parent or the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 16 Matters</U></B>. Prior to the Effective Time, Parent and the Company shall take all such steps as may be required
(to the extent permitted under applicable Laws) to cause any acquisitions of Parent Common Stock, restricted stock awards to purchase
Parent Common Stock and any options to purchase Parent Common Stock in connection with the Contemplated Transactions, by each individual
who is reasonably expected to become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to
Parent, to be exempt under Rule 16b-3 promulgated under the Exchange Act. At least 30 calendar days prior to the Closing Date,
the Company shall furnish the following information to Parent for each individual who, immediately after the Effective Time, will
become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to Parent: (a) the number of shares
of Company Common Stock owned by such individual and expected to be exchanged for shares of Parent Common Stock pursuant to the
Merger, and (b) the number of other derivative securities (if any) with respect to Company Common Stock owned by such individual
and expected to be converted into shares of Parent Common Stock, restricted stock awards to purchase Parent Common Stock or derivative
securities with respect to Parent Common Stock in connection with the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cooperation</U></B>. Each Party shall cooperate reasonably with the other Party and shall provide the other Party with
such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective
obligations under this Agreement and to enable the combined entity to continue to meet its obligations following the Effective
Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificates</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Parent will prepare and deliver to the Company at least five Business Days prior to the Closing Date a certificate signed
by the Chief Financial Officer of Parent in a form reasonably acceptable to the Company, setting forth, as of immediately prior
to the Effective Time (prior to giving effect to the closing of the Parent Post-Closing Financing) (a) each record holder of Parent
Common Stock, Parent Options or Parent Warrants, (b) such record holder&rsquo;s name and address; (c) the number of shares of Parent
Common Stock held and/or underlying the Parent Options or Parent Warrants as of the Effective Time for each such holder (the &ldquo;<B><I>Parent
Outstanding Shares Certificate</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Company will prepare and deliver to Parent at least five Business Days prior to the Closing Date a certificate signed
by the Chief Financial Officer of the Company in a form reasonably acceptable to Parent setting forth, as of immediately prior
to the Effective Time (a) each holder of Company Common Stock, Company Options and Company RSAs, (b) such holder&rsquo;s name and
address; (c) the number and type of Company Common Stock held and/or underlying the Company Options or Company RSAs as of the Effective
Time for each such holder; (d) the number of shares of Parent Common Stock to be issued to such holder, or to underlie any Parent
Option to be issued to such holder, pursuant to this Agreement in respect of the Company Common Stock, Company Options or Company
RSAs held by such holder (the &ldquo;<B><I>Allocation Certificate</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Financial Statements</U></B>. As promptly as reasonably practicable following the date of this Agreement, the
Company will furnish to Parent (i) audited financial statements for the fiscal years ended 2016 and 2017 and, to the extent required
by the Securities Act or Exchange Act, as applicable, for inclusion in the Proxy Statement, 2018, for inclusion in the Proxy Statement
(the &ldquo;<B><I>Company Audited Financial Statements</I></B>&rdquo;) and (ii) unaudited interim financial statements for each
interim period completed prior to Closing that would be required to be included in the Proxy Statement or any periodic report due
prior to the Closing if the Company were subject to the periodic reporting requirements under the Securities Act or the Exchange
Act (the &ldquo;<B><I>Company Interim Financial Statements</I></B>&rdquo;). Each of the Company Audited Financial Statements and
the Company Interim Financial Statements will be suitable for inclusion in the Proxy Statement and prepared in accordance with
GAAP as applied on a consistent basis during the periods involved (except in each case as described in the notes thereto) and on
that basis will present fairly, in all material respects, the financial position and the results of operations, changes in stockholders&rsquo;
equity, and cash flows of the Company as of the dates of and for the periods referred to in the Company Audited Financial Statements
or the Company Interim Financial Statements, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Takeover Statutes</U></B>. If any Takeover Statute is or may become applicable to the Contemplated Transactions, each
of the Company, the Company Board, Parent and the Parent Board, as applicable, shall grant such approvals and take such actions
as are necessary so that the Contemplated Transactions may be consummated as promptly as practicable on the terms contemplated
by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stockholder Litigation</U></B>. Parent shall conduct and control the settlement and defense of any stockholder litigation
against Parent or any of its directors relating to this Agreement or the Contemplated Transactions; <I>provided</I><FONT STYLE="background-color: white">,
that any settlement or other resolution of any such stockholder litigation agreed to by Parent after the Closing shall be approved
in advance by a majority of the Parent Designees for so long as any Parent Designees are still members of the Parent Board. </FONT>Without
limiting the foregoing, prior to the Closing, Parent shall give the Company the opportunity to consult with Parent in connection
with the defense and settlement of any such stockholder litigation, and Parent shall keep the Company reasonably apprised of any
material developments in connection with any such stockholder litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Lock-Up</U></B>. The Company shall use commercially reasonable efforts to obtain execution of a Lock-Up Agreement
and a Support Agreement by no less than 75% of the Company stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">CONDITIONS
PRECEDENT TO OBLIGATIONS OF EACH PARTY</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of
each Party to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are subject
to the satisfaction or, to the extent permitted by applicable Law, the written waiver by each of the Parties, at or prior to the
Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Restraints</U></B>. No temporary restraining order, preliminary or permanent injunction or other order preventing
the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental
Body of competent jurisdiction and remain in effect, and there shall not be any Law which has the effect of making the consummation
of the Contemplated Transactions illegal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stockholder Approval</U></B>. (a) Parent shall have obtained the Required Parent Stockholder Vote and (b) the Company
shall have obtained the Required Company Stockholder Vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Legal Proceedings</U></B>. There shall not be any Legal Proceeding initiated by any Governmental Body pending: (a)
challenging or seeking to restrain or prohibit the consummation of the Contemplated Transactions; (b) seeking to prohibit or limit
in any material and adverse respect a Party&rsquo;s ability to vote, transfer, receive dividends with respect to or otherwise exercise
ownership rights with respect to the Parent Common Stock; (c) that would materially and adversely affect the right or ability of
Parent or the Company to own the assets or operate the business of Parent or the Company, in each case, in the respective manner
such ownership or operations are conducted immediately prior to Closing; or (d) seeking to compel Parent or the Company (or any
of their respective Subsidiaries) to dispose of or hold separate any material assets as a result of the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Listing</U></B>. The shares of Parent Common Stock to be issued in the Merger pursuant to this Agreement shall have been
approved for listing (subject to official notice of issuance) on the NYSE prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">ADDITIONAL
CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of
Parent and Merger Sub to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject
to the satisfaction or the written waiver by Parent, at or prior to the Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accuracy of Representations</U></B>. The Company Fundamental Representations shall have been true and correct as of the
date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on
and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in
which case such representations and warranties shall be true and correct as of such date). The representations and warranties of
the Company contained in this Agreement (other than the Company Fundamental Representations) shall have been true and correct as
of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if
made on the Closing Date except (a) in each case, or in the aggregate, where the failure to be true and correct would not reasonably
be expected to have a Company Material Adverse Effect (without giving effect to any references therein to any Company Material
Adverse Effect or other materiality qualifications), or (b) for those representations and warranties which address matters only
as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in
the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such
representations and warranties, any update of or modification to the Company Disclosure Schedule made or purported to have been
made after the date of this Agreement shall be disregarded).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance of Covenants</U></B>. The Company shall have performed or complied with in all material respects all agreements
and covenants required to be performed or complied with by it under this Agreement at or prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Documents</U></B>. Parent shall have received the following documents, each of which shall be in full force and effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>a certificate executed by the Chief Executive Officer or Chief Financial Officer of the Company certifying (i) that
the conditions set forth in <U>Sections&nbsp;7.1</U>, <U>7.2</U>, <U>7.5</U> and <U>7.6</U> have been duly satisfied and (ii) that
the information set forth in the Allocation Certificate delivered by the Company in accordance with <U>Section&nbsp;5.17(a)</U>
is true and accurate in all respects as of the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>a written resignation, in a form reasonably satisfactory to Parent, dated as of the Closing Date and effective as of
the Closing, executed by each of the officers and directors of the Company listed in <U>Section&nbsp;7.3(b)</U> of the Company
Disclosure Schedule; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the Allocation Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>FIRPTA Certificate</U></B>. Parent shall have received (i) an original signed statement from the Company that the Company
is not, and has not been at any time during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code, a &ldquo;United
States real property holding corporation,&rdquo; as defined in Section 897(c)(2) of the Code, conforming to the requirements of
Treasury Regulations Section 1.1445-2(c)(3) and 1.897-2(h), and (ii) an original signed notice to be delivered to the IRS in accordance
with the provisions of Treasury Regulations Section 1.897-2(h)(2), together with written authorization for Parent to deliver such
notice to the IRS on behalf of the Company following the Closing, each dated as of the Closing Date, duly executed by an authorized
officer of the Company, and in form and substance reasonably acceptable to Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Company Material Adverse Effect</U></B>. Since the date of this Agreement, there shall not have occurred any Company
Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Investor Agreements</U></B>. The Investor Agreements shall have been terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Lock-Up Agreements</U></B>. Parent shall have received a copy of a Company Lock-Up Agreement duly executed by
each Company Signatory, each of which shall be in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accredited Investors</U></B>. The number of stockholders of the Company who have not executed an Investor Questionnaire
certifying that such stockholder of the Company is an &ldquo;accredited investor&rdquo; pursuant to Regulation D under the Securities
Act, is less than 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stock Purchase Agreement</U></B>. The Stock Purchase Agreement shall be in full force and effect and the proceeds to
be received under the terms and conditions set forth in the Stock Purchase Agreement shall be no less than $10,000,000 pursuant
to the consummation of the transactions contemplated by the Stock Purchase Agreement immediately following the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Stockholder Written Consent</U></B>. The Company Stockholder Written Consent executed by each Company Signatory
shall be in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Company Cash</U></B>. If the Closing occurs prior to March 31, 2019, the Company shall maintain a minimum of $6,000,000
in Cash as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="background-color: white"><U>Dissenting </U></FONT><U>Shares</U></B><FONT STYLE="background-color: white">.
No more than 10% of the Company Common Stock shall be Dissenting Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">ADDITIONAL
CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of
the Company to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the
satisfaction or the written waiver by the Company, at or prior to the Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accuracy of Representations</U></B>. The Parent Fundamental Representations shall have been true and correct as of the
date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on
and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in
which case such representations and warranties shall be true and correct as of such date) <FONT STYLE="background-color: white">other
than, with respect to the representations and warranties set forth in <U>Section 3.6</U>, for inaccuracies that are&nbsp;<I>de
minimis&nbsp;</I>in nature and amount </FONT>as of such date <FONT STYLE="background-color: white">(for the avoidance of doubt,
only amounts that are less than $100,000 in the aggregate shall be deemed&nbsp;<I>de minimis</I></FONT>). The representations and
warranties of Parent and Merger Sub contained in this Agreement (other than the Parent Fundamental Representations) shall have
been true and correct as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same
force and effect as if made on the Closing Date except (a) in each case, or in the aggregate, where the failure to be true and
correct would not reasonably be expected to have a Parent Material Adverse Effect (without giving effect to any references therein
to any Parent Material Adverse Effect or other materiality qualifications), or (b) for those representations and warranties which
address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications
as set forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the
accuracy of such representations and warranties, any update of or modification to the Parent Disclosure Schedule made or purported
to have been made after the date of this Agreement shall be disregarded).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Performance of Covenants</U></B>. Parent and Merger Sub shall have performed or complied with in all material respects
all of their agreements and covenants required to be performed or complied with by each of them under this Agreement at or prior
to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Documents</U></B>. The Company shall have received the following documents, each of which shall be in full force and
effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>a certificate executed by the Chief Executive Officer or Chief Financial Officer of Parent confirming that the conditions
set forth in <U>Sections&nbsp;8.1</U>, <U>8.2</U>, and <U>8.4</U> have been duly satisfied;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>a written resignation, in a form reasonably satisfactory to the Company, dated as of the Closing Date and effective
as of the Closing, executed by each of the officers and directors of Parent who are not to continue as officers or directors of
Parent after the Closing pursuant to <U>Section&nbsp;5.13</U> hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>the Parent Outstanding Shares Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Parent Material Adverse Effect</U></B>. Since the date of this Agreement, there shall not have occurred any Parent
Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Parent Cash</U></B>. If the Closing occurs prior to March 31, 2019, Parent shall maintain a minimum of $2,000,000 in
Cash as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">TERMINATION</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>9.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination</U></B>. This Agreement may be terminated prior to the Effective Time (whether before or after adoption of
this Agreement by the Company&rsquo;s stockholders and whether before or after approval of the Parent Stockholder Matters by Parent&rsquo;s
stockholders, unless otherwise specified below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by mutual written consent of Parent and the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by either Parent or the Company if the Contemplated Transactions shall not have been consummated by May 3, 2019 (subject
to possible extension as provided in this <U>Section&nbsp;9.1(b)</U>, the &ldquo;<B><I>End Date</I></B>&rdquo;); <I>provided</I>,
<I>however</I>, that the right to terminate this Agreement under this <U>Section&nbsp;9.1(b)</U> shall not be available to the
Company, on the one hand, or to Parent, on the other hand, if such Party&rsquo;s action or failure to act has been a principal
cause of the failure of the Contemplated Transactions to occur on or before the End Date and such action or failure to act constitutes
a breach of this Agreement; <I>provided</I>, <I>further</I>, <I>however</I>, that, in the event that a request for additional information
has been made by any Governmental Body (including, via a comment letter or other communication from the SEC), then either the Company
or Parent shall be entitled to extend the End Date for an additional 30 calendar days by written notice to the other the Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by either Parent or the Company if a court of competent jurisdiction or other Governmental Body shall have issued a
final and nonappealable order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining,
enjoining or otherwise prohibiting the Contemplated Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by Parent if the Company Stockholder Written Consent executed by each Company Signatory shall not have been obtained
within five Business Days of the date of this Agreement; <I>provided</I>, <I>however</I>, that once the Company Stockholder Written
Consent has been obtained, Parent may not terminate this Agreement pursuant to this <U>Section&nbsp;9.1(d)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by either Parent or the Company if (i) the Parent Stockholders&rsquo; Meeting (including any adjournments and postponements
thereof) shall have been held and completed and Parent&rsquo;s stockholders shall have taken a final vote on the Parent Stockholder
Matters and (ii) the Parent Stockholder Matters shall not have been approved at the Parent Stockholders&rsquo; Meeting (or at any
adjournment or postponement thereof) by the Required Parent Stockholder Vote;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by the Company (at any time prior to the approval of the Parent Stockholder Matters by the Required Parent Stockholder
Vote) if a Parent Triggering Event shall have occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by Parent (at any time prior to the Required Company Stockholder Vote being obtained) if a Company Triggering Event
shall have occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by the Company, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by
Parent or Merger Sub or if any representation or warranty of Parent or Merger Sub shall have become inaccurate, in either case,
such that the conditions set forth in <U>Section&nbsp;8.1</U> or <U>Section&nbsp;8.2</U> would not be satisfied as of the time
of such breach or as of the time such representation or warranty shall have become inaccurate; <I>provided</I> that the Company
is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; <I>provided</I>, <I>further</I>,
that if such inaccuracy in Parent&rsquo;s or Merger Sub&rsquo;s representations and warranties or breach by Parent or Merger Sub
is curable by the End Date by Parent or Merger Sub, then this Agreement shall not terminate pursuant to this <U>Section&nbsp;9.1(h)</U>
as a result of such particular breach or inaccuracy until the expiration of a 30-day period commencing upon delivery of written
notice from the Company to Parent or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this <U>Section&nbsp;9.1(h)</U>
(it being understood that this Agreement shall not terminate pursuant to this <U>Section&nbsp;9.1(h)</U> as a result of such particular
breach or inaccuracy if such breach by Parent or Merger Sub is cured prior to such termination becoming effective);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by Parent, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by the Company
or if any representation or warranty of the Company shall have become inaccurate, in either case, such that the conditions set
forth in <U>Section&nbsp;7.1</U> or <U>Section&nbsp;7.2</U> would not be satisfied as of the time of such breach or as of the time
such representation or warranty shall have become inaccurate; <I>provided</I> that Parent is not then in material breach of any
representation, warranty, covenant or agreement under this Agreement; <I>provided</I>, <I>further</I>, that if such inaccuracy
in the Company&rsquo;s representations and warranties or breach by the Company is curable by the End Date by the Company then this
Agreement shall not terminate pursuant to this <U>Section&nbsp;9.1(i)</U> as a result of such particular breach or inaccuracy until
the expiration of a 30-day period commencing upon delivery of written notice from Parent to the Company of such breach or inaccuracy
and its intention to terminate pursuant to this <U>Section&nbsp;9.1(i)</U> (it being understood that this Agreement shall not terminate
pursuant to this <U>Section&nbsp;9.1(i)</U> as a result of such particular breach or inaccuracy if such breach by the Company is
cured prior to such termination becoming effective); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>by Parent, at any time, if (i) Parent has received a Superior Offer, (ii) Parent has complied with its obligations under
<U>Section&nbsp;5.3(d)</U> in order to accept such Superior Offer, (iii) Parent concurrently terminates this Agreement and enters
into a Permitted Alternative Agreement with respect to such Superior Offer and (iv) within two Business Days of such termination,
Parent pays to the Company the amount contemplated by <U>Section&nbsp;9.3(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>9.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Effect of Termination</U></B>. In the event of the termination of this Agreement as provided in <U>Section&nbsp;9.1</U>,
this Agreement shall be of no further force or effect; <I>provided</I>, <I>however</I>, that (a) this <U>Section 9.2</U>, <U>Section
5.9</U>, <U>Section&nbsp;9.3</U>, <U>Section 10</U> and the definitions of the defined terms in such Sections (including the definitions
of such defined terms on <B>Exhibit A</B>) shall survive the termination of this Agreement and shall remain in full force and effect,
and (b) the termination of this Agreement and the provisions of <U>Section&nbsp;9.3</U> shall not relieve any Party of any liability
for fraud or for any willful and material breach of any representation, warranty, covenant, obligation or other provision contained
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>9.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expenses; Termination Fees</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as set forth in this <U>Section&nbsp;9.3</U>, <U>Section&nbsp;5.7(d)</U>, and <U>Section&nbsp;5.10</U>, all fees
and expenses incurred in connection with this Agreement and the Contemplated Transactions shall be paid by the Party incurring
such expenses, whether or not the Merger is consummated; <I>provided</I>, that Parent and the Company shall share equally all fees
and expenses incurred in relation to the printing and filing with the SEC of the Proxy Statement and any amendments and supplements
thereto and paid to a financial printer or the SEC. It is understood and agreed that all fees and expenses incurred or to be incurred
by the Company in connection with the Contemplated Transactions and preparing, negotiating and entering into this Agreement and
the performance of its obligations under this Agreement shall be paid by the Company in Cash at or prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If (i) this Agreement is terminated by the Company pursuant to <U>Section&nbsp;9.1(f)</U>, (ii) an Acquisition Proposal
with respect to Parent shall have been publicly announced or disclosed or otherwise communicated to Parent or the Parent Board
after the date of this Agreement but prior to the termination of this Agreement and (iii) within 9 months after the date of such
termination, Parent enters into a definitive agreement for a Subsequent Transaction in respect of the Acquisition Proposal referred
to in clause (ii), then Parent shall pay to the Company an amount equal to $1,000,000 (the &ldquo;<B><I>Company Termination Fee</I></B>&rdquo;)
within two Business Days of consummation of such Subsequent Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If (i) this Agreement is terminated by Parent pursuant to <U>Section&nbsp;9.1(g)</U>, (ii) an Acquisition Proposal with
respect to the Company shall have been publicly announced or disclosed or otherwise communicated to the Company or the Company
Board after the date of this Agreement but prior to the termination of this Agreement and (iii) within 9 months after the date
of such termination, the Company consummates a Subsequent Transaction in respect of the Acquisition Proposal referred to in clause
(ii), then the Company shall pay to Parent an amount equal to $1,000,000 (the &ldquo;<B><I>Parent Termination Fee</I></B>&rdquo;)
within ten Business Days of consummation of such Subsequent Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>If this Agreement is terminated by Parent pursuant to <U>Section&nbsp;9.1(j)</U>, Parent shall pay to the Company within
two Business Days of such termination the Company Termination Fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Any Company Termination Fee or Parent Termination Fee due under this <U>Section&nbsp;9.3</U> shall be paid by wire transfer
of same day funds. If a Party fails to pay when due any amount payable by it under this <U>Section&nbsp;9.3</U>, then such Party
shall (i) reimburse the other Party for reasonable costs and expenses (including reasonable fees and disbursements of counsel)
incurred by it in connection with the collection of such overdue amount and the enforcement by such Party of its rights under this
<U>Section 9.3</U>, and (ii) pay to the other Party interest on such overdue amount (for the period commencing as of the date such
overdue amount was originally required to be paid and ending on the date such overdue amount is actually paid to the Company in
full) at a rate per annum equal to the &ldquo;prime rate&rdquo; (as published in <I>The Wall Street Journal</I> or any successor
thereto) in effect on the date such overdue amount was originally required to be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parties agree that, subject to <U>Section&nbsp;9.2</U>, payment of the Company Termination Fee shall, in the circumstances
in which it is owed in accordance with the terms of this Agreement, constitute the sole and exclusive remedy of the Company following
the termination of this Agreement, it being understood that in no event shall (i) Parent be required to pay the amounts payable
pursuant to this <U>Section 9.3</U> on more than one occasion and (ii) following payment of the Company Termination Fee (x) Parent
shall have no further liability to the Company in connection with or arising out of this Agreement or the termination thereof,
any breach of this Agreement by Parent giving rise to such termination, or the failure of the Contemplated Transactions to be consummated,
(y) neither the Company nor any of its Affiliates shall be entitled to bring or maintain any other claim, action or proceeding
against Parent or Merger Sub or seek to obtain any recovery, judgment or damages of any kind against such Parties (or any partner,
member, stockholder, director, officer, employee, Subsidiary, Affiliate, agent or other Representative of such Parties) in connection
with or arising out of this Agreement or the termination thereof, any breach by any such Parties giving rise to such termination
or the failure of the Contemplated Transactions to be consummated and (z) the Company and its Affiliates shall be precluded from
any other remedy against Parent, Merger Sub and their respective Affiliates, at law or in equity or otherwise, in connection with
or arising out of this Agreement or the termination thereof, any breach by such Party giving rise to such termination or the failure
of the Contemplated Transactions to be consummated; <I>provided</I>, <I>however</I>, that nothing in this <U>Section 9.3(f)</U>
shall limit the rights of Parent and Merger Sub under <U>Section 10.11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parties agree that, subject to <U>Section 9.2</U>, payment of the Parent Termination Fee shall, in the circumstances
in which it is owed in accordance with the terms constitute the sole and exclusive remedy of Parent following the termination it
being understood that in no event shall (i) the Company be required to pay the amounts payable pursuant to this <U>Section 9.3</U>
on more than one occasion and (ii) following payment of the Parent Termination Fee (x) the Company shall have no further liability
to Parent in connection with or arising out of this Agreement or the termination thereof, any breach of this Agreement by the Company
giving rise to such termination, or the failure of the Contemplated Transactions to be consummated, (y) neither Parent nor any
of its Affiliates shall be entitled to bring or maintain any other claim, action or proceeding against the Company or seek to obtain
any recovery, judgment or damages of any kind against such Parties (or any partner, member, stockholder, director, officer, employee,
Subsidiary, Affiliate, agent or other Representative of such Parties) in connection with or arising out of this Agreement or the
termination thereof, any breach by any such Parties giving rise to such termination or the failure of the Contemplated Transactions
to be consummated and (z) Parent and its Affiliates shall be precluded from any other remedy against the Company and its Affiliates,
at law or in equity or otherwise, in connection with or arising out of this Agreement or the termination thereof, any breach by
such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated; <I>provided</I>,
<I>however</I>, that nothing in this <U>Section 9.3(g)</U> shall limit the rights of the Company under <U>Section 10.11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of the Parties acknowledges that (i) the agreements contained in this <U>Section&nbsp;9.3</U> are an integral part
of the Contemplated Transactions, (ii) without these agreements, the Parties would not enter into this Agreement and (iii) any
amount payable pursuant to this <U>Section&nbsp;9.3</U> is not a penalty, but rather is liquidated damages in a reasonable amount
that will compensate the Company in the circumstances in which such amount is payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B><FONT STYLE="font-variant: small-caps">MISCELLANEOUS
PROVISIONS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Survival of Representations and Warranties</U></B>. The representations and warranties of the Company, Parent and
Merger Sub contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement shall terminate at
the Effective Time, and only the covenants that by their terms survive the Effective Time and this <U>Section 10</U> shall survive
the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment</U></B>. This Agreement may be amended with the approval of the respective Boards of Directors of the Company,
Merger Sub and Parent at any time (whether before or after the adoption and approval of this Agreement by the Company&rsquo;s stockholders
or before or after obtaining the Required Parent Stockholder Vote); <I>provided</I>, <I>however</I>, that after any such approval
of this Agreement by a Party&rsquo;s stockholders, no amendment shall be made which by Law requires further approval of such stockholders
without the further approval of such stockholders. This Agreement may not be amended except by an instrument in writing signed
on behalf of each of the Company, Merger Sub and Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Waiver</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay
on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of
such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude
any other or further exercise thereof or of any other power, right, privilege or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy
under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument
duly executed and delivered on behalf of such Party and any such waiver shall not be applicable or have any effect except in the
specific instance in which it is given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement; Counterparts; Exchanges by Electronic Transmission</U></B>. This Agreement and the other agreements
referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written
and oral, among or between any of the Parties with respect to the subject matter hereof and thereof; <I>provided</I>, <I>however</I>,
that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms.
This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute
one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by electronic
transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Applicable Law; Jurisdiction</U></B>. This Agreement shall be governed by, and construed in accordance with, the Laws
of the State of Washington, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws.
In any action or proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated
Transactions, each of the Parties: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue
of the King County West Division of the State of Washington or, to the extent such court does not have subject matter jurisdiction,
the United States District Court for the District of Washington or, to the extent that neither of the foregoing courts has jurisdiction,
the Superior Court of the State of Washington; (b) agrees that all claims in respect of such action or proceeding shall be heard
and determined exclusively in accordance with clause (a) of this <U>Section&nbsp;10.5</U>; (c) waives any objection to laying venue
in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not
have jurisdiction over any Party; (e) agrees that service of process upon such Party in any such action or proceeding shall be
effective if notice is given in accordance with <U>Section&nbsp;10.8</U> of this Agreement; and (f) irrevocably and unconditionally
waives the right to trial by jury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Attorneys&rsquo; Fees</U></B>. In any action at law or suit in equity to enforce this Agreement or the rights of any
of the Parties, shall be paid by the Party, including but not limited to out-of-pocket attorneys&rsquo; fees and all other reasonable
costs and expenses incurred in such action or suit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Assignability</U></B>. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit
of, the Parties and their respective successors and permitted assigns; <I>provided</I>, <I>however</I>, that neither this Agreement
nor any of a Party&rsquo;s rights or obligations hereunder may be assigned or delegated by such Party without the prior written
consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by
such Party without the other Party&rsquo;s prior written consent shall be void and of no effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U></B>. All notices and other communications hereunder shall be in writing and shall be deemed to have been
duly delivered and received hereunder (a) one Business Day after being sent for next Business Day delivery, fees prepaid, via a
reputable international overnight courier service, (b) upon delivery in the case of delivery by hand, or (c) on the date delivered
in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00 p.m. San Diego
time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">if to Parent or Merger Sub:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">AmpliPhi Biosciences Corporation<BR>
3579 Valley Centre Drive, Suite 100<BR>
San Diego, CA 92130<BR>
Attention: Chief Financial Officer<BR>
Email: sm@ampliphibio.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">with a copy to (which shall not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Cooley LLP<BR>
4401 Eastgate Mall<BR>
San Diego, CA 92121<BR>
Attention: Tom Coll and Rama Padmanabhan<BR>
Email:collta@cooley.com; rama@cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">C3J Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">4503 Glencoe Ave</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Marina del Rey, CA 90292<BR>
Attention: Chief Executive Officer<BR>
Email: tpatrick@c3jtherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">with a copy to (which shall not constitute
notice):&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><BR>
Thompson Hine LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">335 Madison Ave</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">12th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, NY 10017-4611</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Faith L. Charles<BR>
Email: faith.charles@thompsonhine.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cooperation</U></B>. Each Party agrees to cooperate fully with the other Party and to execute and deliver such further
documents, certificates, agreements and instruments and to take such other actions as may be reasonably requested by the other
Party to evidence or reflect the Contemplated Transactions and to carry out the intent and purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U></B>. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any
jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity
or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of
a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties
agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or
phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing
the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified.
In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid
or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the
economic, business and other purposes of such invalid or unenforceable term or provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Remedies; Specific Performance</U></B>. Except as otherwise provided herein, any and all remedies herein expressly
conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity
upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties
agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the
event that any Party does not perform the provisions of this Agreement (including failing to take such actions as are required
of it hereunder to consummate this Agreement) in accordance with its specified terms or otherwise breaches such provisions. Accordingly,
the Parties acknowledge and agree that the Parties shall be entitled to an injunction, specific performance and other equitable
relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other
remedy to which they are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction,
specific performance or other equitable relief on the basis that any other Party has an adequate remedy at law or that any award
of specific performance is not an appropriate remedy for any reason at law or in equity. Any Party seeking an injunction or injunctions
to prevent breaches of this Agreement shall not be required to provide any bond or other security in connection with any such order
or injunction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Third Party Beneficiaries</U></B>. Nothing in this Agreement, express or implied, is intended to or shall confer upon
any Person (other than the Parties and the D&amp;O Indemnified Parties to the extent of their respective rights pursuant to <U>Section&nbsp;5.7</U>)
any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Construction</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>References to &ldquo;cash,&rdquo; &ldquo;dollars&rdquo; or &ldquo;$&rdquo; are to U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice
versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and
neuter genders; and the neuter gender shall include masculine and feminine genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parties have participated jointly in the negotiating and drafting of this Agreement and agree that any rule of construction
to the effect that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or interpretation
of this Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship
of any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>As used in this Agreement, the words &ldquo;include&rdquo; and &ldquo;including,&rdquo; and variations thereof, shall
not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &ldquo;without limitation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Except as otherwise indicated, all references in this Agreement to &ldquo;Sections,&rdquo; &ldquo;Exhibits&rdquo; and
 &ldquo;Schedules&rdquo; are intended to refer to Sections of this Agreement and Exhibits and Schedules to this Agreement, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Any reference to legislation or to any provision of any legislation shall include any modification, amendment, re-enactment
thereof, any legislative provision substituted therefore and all rules, regulations, and statutory instruments issued or related
to such legislations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The bold-faced headings and table of contents contained in this Agreement are for convenience of reference only, shall
not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Parties agree that each of the Company Disclosure Schedule and the Parent Disclosure Schedule shall be arranged
in sections and subsections corresponding to the numbered and lettered sections and subsections contained in this Agreement. The
disclosures in any section or subsection of the Company Disclosure Schedule or the Parent Disclosure Schedule shall qualify other
sections and subsections in this Agreement to the extent it is readily apparent on its face from a reading of the disclosure that
such disclosure is applicable to such other sections and subsections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Each of &ldquo;delivered&rdquo; or &ldquo;made available&rdquo; means, with respect to any documentation, that prior
to 11:59 p.m. (San Diego time) on the date that is two calendar days prior to the date of this Agreement (i) a copy of such material
has been posted to and made available by a Party to the other Party and its Representatives in the electronic data room maintained
by such disclosing Party or (ii) such material is disclosed in the Parent SEC Documents filed with the SEC prior to the date hereof
and publicly made available on the SEC&rsquo;s Electronic Data Gathering Analysis and Retrieval system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Whenever the last day for the exercise of any privilege or the discharge of any duty hereunder shall fall upon a Saturday,
Sunday, or any date on which banks in San Diego, California are authorized or obligated by Law to be closed, the Party having such
privilege or duty may exercise such privilege or discharge such duty on the next succeeding day which is a regular Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<I>Remainder of page intentionally left
blank</I>)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Parties have caused this Agreement to be executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2"><B>AMPLIPHI BIOSCIENCES CORPORATION</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify"><I>/s/ Paul C. Grint</I></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Paul C. Grint, M.D.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>CERES MERGER SUB, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify"><I>/s/ Steve R. Martin</I></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Steve R. Martin</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Director</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>C3J THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: justify"><I>/s/ Todd R. Patrick</I></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Name:&nbsp;&nbsp;Todd R. Patrick</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Title:&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTAIN DEFINITIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">For purposes
of this Agreement (including this <B>Exhibit A</B>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Acquisition
Inquiry</I></B>&rdquo; means, with respect to a Party, an inquiry, indication of interest or request for information (other than
an inquiry, indication of interest or request for information made or submitted by the Company, on the one hand, or Parent, on
the other hand, to the other Party) with respect to or that is reasonably likely to lead to an Acquisition Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Acquisition
Proposal</I></B>&rdquo; means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or
proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of Parent
or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction
with such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Acquisition
Transaction</I></B>&rdquo; means any transaction or series of related transactions involving:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization,
recapitalization, tender offer, exchange offer or other similar transaction: (i) in which a Party is a constituent Entity; (ii)
in which a Person or &ldquo;group&rdquo; (as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly
or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of
any class of voting securities of a Party or any of its Subsidiaries; or (iii) in which a Party or any of its Subsidiaries issues
securities representing more than 20% of the outstanding securities of any class of voting securities of such Party or any of its
Subsidiaries; <I>provided</I>, that in the case of Parent, the Parent Post-Closing Financing shall not be an &ldquo;Acquisition
Transaction&rdquo;; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or
account for 20% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries,
taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Affiliate</I></B>&rdquo;
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by,
or is under common control with, such Person. The term &ldquo;control&rdquo; (including the terms &ldquo;controlled by&rdquo; and
 &ldquo;under common control with&rdquo;) means the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Agreement</I></B>&rdquo;
means the Agreement and Plan of Merger and Reorganization to which this <B>Exhibit A</B> is attached, as it may be amended from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Business
Day</I></B>&rdquo; means any day other than a Saturday, Sunday or other day on which banks in San Diego, California are authorized
or obligated by Law to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Cash</I></B>&rdquo;
means all (a) cash and cash equivalents and (b) marketable securities, in each case determined in accordance with GAAP, consistently
applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Associate</I></B>&rdquo; means any current or former employee, independent contractor, officer or director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Board</I></B>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Common Stock</I></B>&rdquo; means the Common Stock, no par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Contract</I></B>&rdquo; means any Contract: (a) to which the Company or its Subsidiary is a Party; (b) by which the Company or
its Subsidiary or any Company IP or any other asset of the Company or its Subsidiary is or may become bound or under which the
Company has, or may become subject to, any obligation; or (c) under which the Company or its Subsidiary has or may acquire any
right or interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
ERISA Affiliate</I></B>&rdquo; means any corporation or trade or business (whether or not incorporated) that is (or at any relevant
time was) treated with the Company or its Subsidiary as a single employer within the meaning of Section 414 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Fundamental Representations</I></B>&rdquo; means the representations and warranties of the Company set forth in <U>Sections&nbsp;2.1</U>
(Due Organization; Subsidiaries), <U>2.3</U> (Authority; Binding Nature of Agreement), <U>2.4</U> (Vote Required), <U>2.6(a)</U>
and <U>(c)</U> (Capitalization) and <U>2.20</U> (No Financial Advisors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
IP</I></B>&rdquo; means all Intellectual Property Rights that are owned or purported to be owned by or licensed to the Company
or its Subsidiary that is used in the business of the Company or its Subsidiary as presently conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Material Adverse Effect</I></B>&rdquo; means any Effect that, considered together with all other Effects that have occurred prior
to the date of determination of the occurrence of a Company Material Adverse Effect, has or would reasonably be expected to have
a material adverse effect on the business, condition (financial or otherwise), assets, liabilities or results of operations of
the Company or its Subsidiary, taken as a whole; <I>provided</I>, <I>however</I>, that Effects arising or resulting from the following
shall not be taken into account in determining whether there has been a Company Material Adverse Effect: (a) general business or
economic conditions affecting the industry in which the Company and its Subsidiary operate, (b) acts of war, armed hostilities
or terrorism, (c) changes in financial, banking or securities markets, (d) any change in, or any compliance with or action taken
for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP) or (e) the taking of any action required
to be taken by this Agreement; except in each case with respect to clauses (a) through (d), to the extent disproportionately affecting
the Company and its Subsidiary, taken as a whole, relative to other similarly situated companies in the industries in which the
Company and its Subsidiary operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Options</I></B>&rdquo; means options or other rights to purchase shares of Company Common Stock issued by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
RSAs</I></B>&rdquo; means restricted stock awards to purchase shares of Company Common Stock issued or granted by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Triggering Event</I></B>&rdquo; shall be deemed to have occurred if: (a) the Company shall have made a Company Board Adverse Recommendation
Change; (b) the Company Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal;
or (c) the Company shall have entered into any letter of intent or similar document relating to any Acquisition Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company
Unaudited Interim Balance Sheet</I></B>&rdquo; means the unaudited consolidated balance sheet of the Company and its consolidated
Subsidiary for the period ended November 30, 2018 provided to Parent prior to the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Confidentiality
Agreement</I></B>&rdquo; means the Mutual Non-Disclosure Agreement, dated as of October 8, 2018, between the Company and Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Consent</I></B>&rdquo;
means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Contemplated
Transactions</I></B>&rdquo; means the Merger, the Parent Post-Closing Financing, the NYSE Reverse Split and the other transactions
and actions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Contract</I></B>&rdquo;
means, with respect to any Person, any agreement, contract, subcontract, lease (whether for real or personal property), mortgage,
license, sublicense or other legally binding commitment or undertaking of any nature to which such Person is a party or by which
such Person or any of its assets are bound or affected under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Effect</I></B>&rdquo;
means any effect, change, event, circumstance, or development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Encumbrance</I></B>&rdquo;
means any lien, pledge, hypothecation, charge, mortgage, security interest, lease, license, option, easement, reservation, servitude,
adverse title, infringement, interference, option, right of first refusal, preemptive right, community property interest or restriction
or encumbrance of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security
or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and
any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&ldquo;<I>Enforceability
Exceptions</I>&rdquo;</B> means the (a) Laws of general application relating to bankruptcy, insolvency and the relief of debtors;
and (b) rules of law governing specific performance, injunctive relief and other equitable remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Entity</I></B>&rdquo;
means any corporation (including any non-profit corporation), partnership (including any general partnership, limited partnership
or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability
company or joint stock company), firm, society or other enterprise, association, organization or entity, and each of its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Environmental
Law</I></B>&rdquo; means any federal, state, local or foreign Law relating to pollution or protection of human health or the environment
(including ambient air, surface water, ground water, land surface or subsurface strata), including any Law or regulation relating
to emissions, discharges, releases or threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>ERISA</I></B>&rdquo;
means the Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>ESPP</I></B>&rdquo;
means Parent&rsquo;s 2016 Employee Stock Purchase Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Exchange
Ratio</I></B>&rdquo; means, subject to <U>Section&nbsp;1.5(g)</U>, the following ratio (rounded to four decimal places): the quotient
obtained by dividing (a) the Company Merger Shares by (b) the Company Outstanding Shares, in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Aggregate Valuation</I></B>&rdquo; means the sum of (a) the Company Valuation, plus
(b) the Parent Valuation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Company Valuation</I></B>&rdquo; means $28,000,000.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Company Allocation Fraction</I></B>&rdquo; the quotient (rounded to two decimal places)
determined by dividing (i) the Company Valuation <I>by</I> (ii) the Aggregate Valuation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Company Merger Shares</I></B>&rdquo; means the product determined by multiplying (i)
the Post-Closing Parent Shares <I>by</I> (ii) the Company Allocation Fraction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Company Outstanding Shares</I></B>&rdquo; means the total number of shares of Company
Common Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted and as-converted to Company Common
Stock basis, calculated based on the treasury stock method and assuming, without limitation or duplication, (i) the exercise of
all Company Options outstanding as of immediately prior to the Effective Time and (ii) the issuance of shares of Company Common
Stock in respect of all other outstanding options, restricted stock awards, warrants or rights to receive such shares, whether
conditional or unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation
of the Merger (but excluding any shares of Company Common Stock reserved for issuance other than with respect to outstanding Company
Options and Company RSAs under the 2006 Stock Plan or the 2016 Stock Plan, as applicable, as of immediately prior to the Effective
Time). For the avoidance of doubt, no out-of-the-money Company Options shall be included in the total number of shares of Company
Common Stock outstanding for purposes of determining the Company Outstanding Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Parent Allocation Fraction</I></B>&rdquo; means the quotient (rounded to two decimal
places) determined by dividing (i) the Parent Valuation <I>by</I> (ii) the Aggregate Valuation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Parent Outstanding Shares</I></B>&rdquo; means the total number of shares of Parent
Common Stock outstanding immediately prior to the Effective Time expressed on a fully-diluted basis and using the treasury stock
method, but assuming, without limitation or duplication, the issuance of shares of Parent Common Stock in respect of all Parent
Options, Parent Warrants and other outstanding options, warrants or rights to receive such shares, in each case, outstanding as
of immediately prior to the Effective Time (assuming cashless exercise using the Parent Closing Price), whether conditional or
unconditional and including any outstanding options, warrants or rights triggered by or associated with the consummation of the
Merger, (but excluding any shares of Parent Common Stock reserved for issuance other than with respect to outstanding Parent Options
and Parent Warrants as of immediately prior to the Effective Time and as set forth above); <I>provided</I> that all shares of Parent
Common Stock issued in the Parent Post-Closing Financing and reserved pursuant to the New Option Pool shall be excluded from such
total (i.e. the Parent Allocation Fraction and Company Allocation Fraction contemplated by the Exchange Ratio are intended to be
determined in the absence of the Parent Post-Closing Financing and the Parent EIP Amendment and shares issuable in connection with
out-of-the-money options and out-of-the-money warrants). For the avoidance of doubt, no out-of-the-money Parent Options or Parent
Warrants shall be included in the total number of shares of Parent Common Stock outstanding for purposes of determining the Parent
Outstanding Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Parent Valuation</I></B>&rdquo; means $12,000,000.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B><I>Post-Closing Parent Shares</I></B>&rdquo; means the quotient determined by dividing
(i) the Parent Outstanding Shares <I>by</I> (ii) the Parent Allocation Fraction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>GAAP</I></B>&rdquo;
means generally accepted accounting principles and practices in effect from time to time within the United States applied consistently
throughout the period involved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Governmental
Authorization</I></B>&rdquo; means any: (a) permit, license, certificate, franchise, permission, variance, exception, order, clearance,
registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any
Governmental Body or pursuant to any Law; or (b) right under any Contract with any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Governmental
Body</I></B>&rdquo; means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction
of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority
of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official, ministry,
fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any
taxing authority); or (d) self-regulatory organization (including the NYSE).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Hazardous
Materials</I></B>&rdquo; means any pollutant, chemical, substance and any toxic, infectious, carcinogenic, reactive, corrosive,
ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas,
that is subject to regulation, control or remediation under any Environmental Law, including without limitation, crude oil or any
fraction thereof, and petroleum products or by-products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Intellectual
Property Rights</I></B>&rdquo; means and includes all past, present, and future rights of the following types, which may exist
or be created under the Laws of any jurisdiction in the world: (a)&nbsp;rights associated with works of authorship, including exclusive
exploitation rights, copyrights, moral rights, software, databases, and mask works; (b)&nbsp; trademarks, service marks, trade
dress, logos, trade names and other source identifiers, domain names and URLs and similar rights and any goodwill associated therewith;
(c)&nbsp;rights associated with trade secrets, know how, inventions, invention disclosures, methods, processes, protocols, specifications,
techniques and other forms of technology; (d)&nbsp;patents and industrial property rights; (e)&nbsp;other proprietary rights in
intellectual property of every kind and nature; (f)&nbsp;rights of privacy and publicity; and (g)&nbsp;all registrations, renewals,
extensions, statutory invention registrations, provisionals, continuations, continuations-in-part, provisionals, divisions, or
reissues of, and applications for, any of the rights referred to in clauses &ldquo;(a)&rdquo; through &ldquo;(f)&rdquo; above (whether
or not in tangible form and including all tangible embodiments of any of the foregoing, such as samples, studies and summaries),
along with all rights to prosecute and perfect the same through administrative prosecution, registration, recordation or other
administrative proceeding, and all causes of action and rights to sue or seek other remedies arising from or relating to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IRS</I></B>&rdquo;
means the United States Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Key Employee</I></B>&rdquo;
means, an employee who is an executive officer of such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Knowledge</I></B>&rdquo;
means, with respect to an individual, that such individual is actually aware of the relevant fact or such individual would reasonably
be expected to know, or after reasonable due inquiry would learn of, such fact in the ordinary course of the performance of such
individual&rsquo;s responsibilities as an officer, director and/or employee. Any Person that is an Entity shall have Knowledge
if any officer or director of such Person as of the date such knowledge is imputed has Knowledge of such fact or other matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Law</I></B>&rdquo;
means any federal, state, national, foreign, material local or municipal or other law, statute, constitution, principle of common
law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated,
implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of the
NYSE or the Financial Industry Regulatory Authority).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Legal Proceeding</I></B>&rdquo;
means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate
proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise
involving, any court or other Governmental Body or any arbitrator or arbitration panel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Liability</I></B>&rdquo;
means any liability, indebtedness, obligation or expense of any kind, whether accrued, absolute, contingent, matured or unmatured
(whether or not required to be reflected in the financial statements in accordance with GAAP).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Merger Sub
Board</I></B>&rdquo; means the board of directors of Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>NYSE</I></B>&rdquo;
means the New York Stock Exchange, including the NYSE American or such other New York Stock Exchange market on which shares of
Parent Common Stock are then listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>NYSE Reverse
Split</I></B>&rdquo; means a reverse stock split of all outstanding shares of Parent Common Stock at a reverse stock split ratio
to be mutually agreed to prior to filing the Proxy Statement by Parent and the Company that is effected by Parent for the purpose
of maintaining compliance with NYSE listing standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Ordinary
Course of Business</I></B>&rdquo; means, in the case of each of the Company and Parent, such actions taken in the ordinary course
of its normal operations and consistent with its past practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Organizational
Documents</I></B>&rdquo; means, with respect to any Person (other than an individual), (a) the certificate or articles of association
or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability
company, operating or partnership agreement and other similar documents adopted or filed in connection with the creation, formation
or organization of such Person and (b) all bylaws, regulations and similar documents or agreements relating to the organization
or governance of such Person, in each case, as amended or supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Associate</I></B>&rdquo;
means any current or former employee, independent contractor, officer or director of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Balance
Sheet</I></B>&rdquo; means the unaudited balance sheet of Parent as of September 30, 2018 (the &ldquo;<B><I>Parent Balance Sheet
Date</I></B>&rdquo;), included in Parent&rsquo;s Report on Form 10-Q for the quarterly period ended September 30, 2018, as filed
with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Board</I></B>&rdquo;
means the board of directors of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><I>&ldquo;<B>Parent Change
in Circumstance</B></I>&rdquo; means a material development or change in circumstances (other than an Acquisition Proposal) that
affects the business, assets or operations of Parent that occurs or arises after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Closing
Price</I></B>&rdquo; means the volume weighted average closing trading price of a share of Parent Common Stock on the NYSE for
the five trading days ending five trading days immediately prior to the date upon which the Merger becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Common
Stock</I></B>&rdquo; means the Common Stock, $0.01 par value per share, of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Contract</I></B>&rdquo;
means any Contract: (a) to which Parent or any of its Subsidiaries is a Party; (b) by which Parent or any of its Subsidiaries or
any Parent IP or any other asset of Parent or its Subsidiaries is or may become bound or under which Parent or any of its Subsidiaries
has, or may become subject to, any obligation; or (c) under which Parent or any of its Subsidiaries has or may acquire any right
or interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent EIP
Amendment</I></B>&rdquo; means an amendment to the Parent 2016 Equity Incentive Plan to increase the shares available for issuance
thereunder by 13,822,963 shares of Parent Common Stock (the &ldquo;<B>New Option Pool</B>&rdquo;), substantially in the form attached
hereto as <B>Exhibit F</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent ERISA
Affiliate</I></B>&rdquo; means any corporation or trade or business (whether or not incorporated) which is (or at any relevant
time was) treated with Parent or any of its Subsidiaries as a single employer within the meaning of Section 414 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Fundamental
Representations</I></B>&rdquo; means the representations and warranties of Parent and Merger Sub set forth in <U>Sections&nbsp;3.1(a)</U>
(Due Organization; Subsidiaries), <U>3.3</U> (Authority; Binding Nature of Agreement), <U>3.4</U> (Vote Required), <U>3.6(a), (b)</U>
and <U>(c)</U> (Capitalization) and <U>3.21</U> (No Financial Advisors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent IP</I></B>&rdquo;
means all Intellectual Property Rights that are owned or purported to be owned by Parent or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Material
Adverse Effect</I></B>&rdquo; means any Effect that, considered together with all other Effects that have occurred prior to the
date of determination of the occurrence of a Parent Material Adverse Effect, has or would reasonably be expected to have a material
adverse effect on the business, condition (financial or otherwise), assets, liabilities or results of operations of Parent; <I>provided</I>,
<I>however</I>, that Effects arising or resulting from the following shall not be taken into account in determining whether there
has been a Parent Material Adverse Effect: (a) general business or economic conditions affecting the industry in which Parent operates,
(b) acts of war, armed hostilities or terrorism, (c) changes in financial, banking or securities markets, (d) the taking of any
action required to be taken by this Agreement, (e) any change in the stock price or trading volume of Parent Common Stock (it being
understood, however, that any Effect causing or contributing to any change in stock price or trading volume of Parent Common Stock
may be taken into account in determining whether a Parent Material Adverse Effect has occurred, unless such Effects are otherwise
excepted from this definition), (f) the failure of Parent to meet analysts&rsquo; expectations or projections; (g) any clinical
trial programs or studies, including any adverse data, event or outcome arising out of or related to any such programs or studies
(h) any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations
of any Law or GAAP) or (i) resulting from the announcement of this Agreement or the pendency of the Contemplated Transactions except
in each case with respect to clauses (a) through (c), to the extent disproportionately affecting Parent relative to other similarly
situated companies in the industries in which Parent operates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Options</I></B>&rdquo;
means options or other rights to purchase shares of Parent Common Stock issued by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Post-Closing
Financing</I></B>&rdquo; means an acquisition of Parent Common Stock to be consummated immediately following the Closing pursuant
to the Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Stock
Plans</I></B>&rdquo; means the Targeted Genetics Corporation 2009 Stock Incentive Plan, the Parent 2012 Stock Incentive Plan, the
Parent 2013 Stock Incentive Plan and the Parent 2016 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Triggering
Event</I></B>&rdquo; shall be deemed to have occurred if: (a) Parent shall have failed to include in the Proxy Statement the Parent
Board Recommendation or shall have made a Parent Board Adverse Recommendation Change; (b) the Parent Board or any committee thereof
shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c) Parent shall have entered into any letter
of intent or similar document or any Contract relating to any Acquisition Proposal (other than a confidentiality agreement permitted
pursuant to <U>Section&nbsp;4.4</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Parent Warrants&rdquo;</I></B>
means the warrants to purchase capital stock of the Parent listed on <B>Exhibit G</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Party</I></B>&rdquo;
or &ldquo;<B><I>Parties</I></B>&rdquo; means the Company, Merger Sub and Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Permitted
Alternative Agreement</I></B>&rdquo; means a definitive agreement that contemplates or otherwise relates to an Acquisition Transaction
that constitutes a Superior Offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Permitted
Encumbrance</I></B>&rdquo; means: (a) any liens for current Taxes not yet due and payable or for Taxes that are being contested
in good faith and for which adequate reserves have been made on the Company Unaudited Interim Balance Sheet or the Parent Balance
Sheet, as applicable; (b) minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the
aggregate) materially detract from the value of the assets or properties subject thereto or materially impair the operations of
the Company or its Subsidiary or Parent, as applicable; (c) statutory liens to secure obligations to landlords, lessors or renters
under leases or rental agreements; (d) deposits or pledges made in connection with, or to secure payment of, workers&rsquo; compensation,
unemployment insurance or similar programs mandated by Law; (e) non-exclusive licenses of Intellectual Property Rights granted
by the Company or its Subsidiary or Parent, as applicable, in the Ordinary Course of Business and that do not (in any case or in
the aggregate) materially detract from the value of the Intellectual Property Rights subject thereto; and (f) statutory liens in
favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Person</I></B>&rdquo;
means any individual, Entity or Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Proxy Statement</I></B>&rdquo;
means the proxy statement to be sent to Parent&rsquo;s stockholders in connection with the Parent Stockholders&rsquo; Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Reference
Date</I></B>&rdquo; means January 2, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Registered
IP</I></B>&rdquo; means all Intellectual Property Rights that are registered or issued under the authority of any Governmental
Body, including all patents, registered copyrights, registered mask works, and registered trademarks, service marks and trade dress,
registered domain names, and all applications for any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Representatives</I></B>&rdquo;
means directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors and representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Restricted
Stock Agreement</I></B>&rdquo; means, with respect to any Company RSA granted by the Company, the restricted stock agreement between
the Company and the grantee evidencing such Company RSA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Sarbanes-Oxley
Act</I></B>&rdquo; means the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SEC</I></B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Securities
Act</I></B>&rdquo; means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Subsequent
Transaction</I></B>&rdquo; means any Acquisition Transaction (with all references to 20% in the definition of Acquisition Transaction
being treated as references to 80% for these purposes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">An Entity shall be deemed
to be a &ldquo;<B><I>Subsidiary</I></B>&rdquo; of a Person if such Person directly or indirectly owns or purports to own, beneficially
or of record, (a) an amount of voting securities or other interests in such Entity that is sufficient to enable such Person to
elect at least a majority of the members of such Entity&rsquo;s board of directors or other governing body, or (b) at least 50%
of the outstanding equity, voting, beneficial or financial interests in such Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Superior
Offer</I></B>&rdquo; means an unsolicited bona fide written Acquisition Proposal (with all references to 20% in the definition
of Acquisition Transaction being treated as references to greater than 80% for these purposes) that: (a) was not obtained or made
as a direct or indirect result of a breach of (or in violation of) this Agreement; and (b) is on terms and conditions that the
Parent Board or the Company Board, as applicable, determines in good faith, based on such matters that it deems relevant (including
the likelihood of consummation thereof), as well as any written offer by the other Party to this Agreement to amend the terms of
this Agreement, and following consultation with its outside legal counsel and outside financial advisors, if any, are more favorable,
from a financial point of view, to Parent&rsquo;s stockholders or the Company&rsquo;s stockholders, as applicable, than the terms
of the Contemplated Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Takeover
Statute</I></B>&rdquo; means any &ldquo;fair price,&rdquo; &ldquo;moratorium,&rdquo; &ldquo;control share acquisition&rdquo; or
other similar anti-takeover Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Tax</I></B>&rdquo;
means any federal, state, local, foreign or other tax, including any income, capital gain, gross receipts, capital stock, profits,
transfer, estimated, registration, stamp, premium, escheat, unclaimed property, customs duty, ad valorem, occupancy, occupation,
alternative, add-on, windfall profits, value added, severance, property, business, production, sales, use, license, excise, franchise,
employment, payroll, social security, disability, unemployment, workers&rsquo; compensation, national health insurance, withholding
or other taxes, duties, fees, assessments or governmental charges, surtaxes or deficiencies thereof of any kind whatsoever, however
denominated, and including any fine, penalty, addition to tax or interest imposed by a Governmental Body with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Tax Return</I></B>&rdquo;
means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification,
form, election, certificate or other document, and any amendment or supplement to any of the foregoing, filed with or submitted
to, or required to be filed with or submitted to, any Governmental Body in connection with the determination, assessment, collection
or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law relating
to any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Treasury
Regulations</I></B>&rdquo; means the United States Treasury regulations promulgated under the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each of the following terms is defined in
the Section set forth opposite such term:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 62%; border-bottom: black 1pt solid; padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify"><B>Term</B></TD>
    <TD STYLE="width: 3%; padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 35%; border-bottom: black 1pt solid; padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify"><B>Section</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2006 Company Plan</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.6(c)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2016 Company Plan </TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.6(c)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Allocation Certificate</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.17(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Anti-Bribery Laws</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.21</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Articles of Merger</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Certifications</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Closing</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Closing Date</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Preamble</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Audited Financial Statements</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.18</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">Company Benefit Plan</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.17(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">Company Board Adverse Recommendation Change</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(e)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Board Recommendation</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(e)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Budget</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">4.2(b)(v)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Disclosure Schedule</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Section 2</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Financials</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company In-bound License</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.12(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Interim Financial Statements</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.18</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Lock-Up Agreement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt">Company Material Contract or <BR>
Company Material Contracts</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.13(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Out-bound License</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.12(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Permits</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.14(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Real Estate Leases</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.11</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Signatories</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Stock Certificate</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.6</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Stockholder Matters</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Stockholder Support Agreement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Stockholder Written Consent</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Company Termination Fee</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">9.3(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Continuing Employees</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.6(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">D&amp;O Indemnified Parties</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Determination Notice</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Dissenting Shares</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.8(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Drug Regulatory Agency</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.14(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Effective Time</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.3</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 62%"><B>Term</B></TD>
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 35%"><B>Section</B></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">End Date</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">9.1(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Exchange Agent</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Exchange Fund</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">FDA</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.14(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">FDCA</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.14(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">HIPAA</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.14(f)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Information Statement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Intended Tax Treatment</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.11(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Investor Agreements</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.21(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Investor Questionnaire</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Merger</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Merger Consideration</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.5(a)(ii)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Merger Sub</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Preamble</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Non-Accredited Investors</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">NYSE Listing Application</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.10</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Other Parent Stockholder Matters</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(a)(v)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Other Parent Stockholder Votes</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Preamble</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Benefit Plan</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.17(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Board Adverse Recommendation Change</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(c)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Board Recommendation</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(c)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Budget</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">4.1(b)(v)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Designees</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.13</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Disclosure Schedule</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Section 3</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent In-bound License</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.12(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Lock-Up Agreement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Material Contract</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.13(n)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Out-bound License</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.12(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Outstanding Shares Certificate</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.17(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Permits</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.14(b)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Real Estate Leases</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.11</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent SEC Documents</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.7(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Signatories</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Stockholder Matters</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(a)(v)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Stockholder Support Agreement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Stockholder Votes</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Stockholders&rsquo; Meeting</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.3(a)(v)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Parent Termination Fee</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">9.3(c)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Post-Closing Plans</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.6(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Pre-Closing Period</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">4.1(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Regulation D</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Required Company Stockholder Votes</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Required Parent Stockholder Votes</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">3.4</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Second Parent Designee</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Exhibit E</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Sensitive Data</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">2.12(h)</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 62%"><B>Term</B></TD>
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-bottom: 6pt; padding-left: 3pt; text-align: justify; width: 35%"><B>Section</B></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; width: 62%">Stock Purchase Agreement</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify; width: 35%">Recitals</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Stockholder Notice</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">5.2(d)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Surviving Corporation</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">1.1</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">WBCA</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt; padding-left: 3pt; text-align: justify">Recitals</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 93 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT E</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Officers</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Name </U></FONT></TD>
    <TD STYLE="width: 65%; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Title </U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Todd Patrick</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Brian Varnum </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">President &amp; Chief Development Officer </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Steve Martin</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Financial Officer </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Duane Morris</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Vice President of Operations</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">David Goesling</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Vice President of Accounting and Administration</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Board Designees &ndash; Company</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">Todd Patrick
(Class III)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">Rich Bastiani
(Class III)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">H. Stewart
Parker (Class II)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">[reserved]
(Class I)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">[reserved]
(Class II*)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Board Designees &ndash; Parent</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">Jeremy Curnock
Cook (Class III)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">[reserved]
(either Class I or Class II) (the &ldquo;Second Parent Designee&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Or, if the Second Parent Designee is a Class II director, Class
I.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 94 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>FIRST AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B><BR>
<B>AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <FONT STYLE="font-variant: small-caps"><B>First
Amendment to Agreement and Plan of Merger and Reorganization </B></FONT>(this &ldquo;<B><I>Amendment</I></B>&rdquo;), dated as
of March 25, 2019, is entered into by and between by and among <B>AmpliPhi Biosciences Corporation</B>, a Washington corporation,
<B>Ceres Merger Sub, Inc.</B>, a Washington corporation, and <B>C3J Therapeutics, Inc.</B>, a Washington corporation. Capitalized
terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
parties hereto entered into that certain Agreement and Plan of Merger and Reorganization, dated as of January 3, 2019 (as amended
hereby, the &ldquo;<B><I>Merger Agreement</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the
parties hereto desire to amend the Merger Agreement as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of the covenants and agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment
to Merger Agreement. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Section
9.1(b)</U> of the Merger Agreement is hereby amended and restated in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">&ldquo;by
either Parent or the Company if the Contemplated Transactions shall not have been consummated by June 1, 2019 (subject to possible
extension as provided in this <U>Section 9.1(b)</U>, the &ldquo;<B><I>End Date</I></B>&rdquo;); <I>provided</I>, <I>however</I>,
that the right to terminate this Agreement under this <U>Section&nbsp;9.1(b)</U> shall not be available to the Company, on the
one hand, or to Parent, on the other hand, if such Party&rsquo;s action or failure to act has been a principal cause of the failure
of the Contemplated Transactions to occur on or before the End Date and such action or failure to act constitutes a breach of this
Agreement; <I>provided</I>, <I>further</I>, <I>however</I>, that, in the event that a request for additional information has been
made by any Governmental Body (including, via a comment letter or other communication from the SEC), then either the Company or
Parent shall be entitled to extend the End Date for an additional 30 calendar days by written notice to the other the Party;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 95 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect
of Amendment</U>. Pursuant to <U>Section 10.2</U> of the Merger Agreement, the Merger Agreement not be amended except by an instrument
in writing signed on behalf of each of the Company, Merger Sub and Parent. The Merger Agreement is amended by this Amendment only
as specifically provided herein, and the Merger Agreement, as so amended, shall continue in full force and effect. Each reference
in the Merger Agreement to &ldquo;this Agreement&rdquo;, &ldquo;herein,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereunder&rdquo; or
words of similar import shall hereafter be deemed to refer to the Merger Agreement as amended hereby (except that references in
the Merger Agreement to the &ldquo;date hereof&rdquo; or &ldquo;date of this Agreement&rdquo; or words of similar import shall
continue to mean January 3, 2019). References to the Merger Agreement in this Amendment and in any ancillary agreements or documents
delivered in connection with the Merger Agreement or contemplated thereby, shall refer to the Merger Agreement as amended hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization
and Validity</U>. Each party to this Amendment hereby represents and warrants to the other party hereto that: (a) such party has
the requisite power and authority to execute and deliver this Amendment, to perform their obligations hereunder and to consummate
the transactions contemplated hereby, (b) the execution and delivery of this Amendment has been duly and validly authorized by
all necessary action of such party, and (c) this Amendment will be duly executed and delivered by such party and, assuming due
execution and delivery by each of the other parties hereto, constitutes the legal, valid and binding obligation of such party,
enforceable against such party in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors&rsquo; rights generally and by general principles of equity (regardless
of whether considered in a proceeding in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous.
Sections 10.2</U>, <U>10.4</U>, <U>10.5</U>, <U>10.7</U> through <U>10.13</U> of the Merger Agreement shall apply <I>mutatis mutandis</I>
to this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
each party has caused this Amendment to be duly executed on its behalf by its duly authorized officer, as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>AMPLIPHI BIOSCIENCES CORPORATION</B></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 5%; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 45%; text-indent: 0in">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">By:</TD>
    <TD STYLE="text-indent: 0in; border-bottom: Black 1pt solid">/s/ Paul C. Grint</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name: Paul C. Grint, M.D.</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title: Chief Executive Officer</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>CERES MERGER SUB, INC.</B></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">By:</TD>
    <TD STYLE="text-indent: 0in; border-bottom: Black 1pt solid">/s/ Steve R. Martin</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name: Steve R. Martin</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title: Director</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in"><B>C3J THERAPEUTICS, INC.</B></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">By:</TD>
    <TD STYLE="text-indent: 0in; border-bottom: Black 1pt solid">/s/ Todd R. Patrick</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Name: Todd R. Patrick</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Title: Chief Executive Officer</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 220.5pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 220.5pt; text-indent: -0.3in"></P>

<!-- Field: Page; Sequence: 97 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 220.5pt; text-indent: -0.3in">&nbsp;</P>



<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><IMG SRC="tv521048_ex3-2img03.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: right">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Washington Secretary of State</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Corporations and Charities Division</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">801 Capitol Way South</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">PO Box 40234</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Olympia, WA 98504-0234</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(360) 725-0377</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><U>corps@sos.wa.gov</U></P></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">05/09/2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">C3J THERAPEUTICS,
INC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">FAIRCHILD RECORD
SEARCH, LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">PO BOX 1368</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">OLYMPIA WA 98507-1368</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">UBI Number: 603 589 506</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; background-color: transparent">Business Name: C3J THERAPEUTICS,
INC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Dear FAIRCHILD
RECORD SEARCH, LTD.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Thank you for your
recent submission. This letter is to confirm that the following documents have been received and successfully filed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">MERGER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">You can view and
download your filed document(s) for no charge at our website, <U>www.sos.wa.gov/ccfs</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">If you haven&rsquo;t
already, please sign up for a user account on our website, <U>www.sos.wa.gov/ccfs</U>, to file online, conduct searches, and receive
status updates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Please contact
our office at <U>corps@sos.wa.gov</U> or (360) 725-0377 if you have any questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Corporations and
Charities Division</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">Office of the Secretary
of State</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent"><U>www.sos.wa.gov/corps</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; background-color: transparent">&nbsp;</P>


<!-- Field: Page; Sequence: 98; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>tv521048_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="tv521048_ex4-1img01.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 1pt; color: White">ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS#
    COMMON STOCK PAR VALUE $0.01 COMMON STOCK Certificate Number ZQ00000000 ARMATA PHARMACEUTICALS PURPOSEFUL &bull; PRECISE *
    POWERFUL ARMATA PHARMACEUTICALS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF WASHINGTON Shares **000000*********** ***000000**********
    ****000000********* *****000000******** ******000000******* SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 04216R 10 2 This certifies
    that MR. SAMPLE &amp; MRS. SAMPLE &amp; MR. SAMPLE &amp; MRS. SAMPLE is the record holder of ***ZERO HUNDRED THOUSAND ZERO
    HUNDRED AND ZERO*** THIS CERTIFICATE IS TRANSFERABLE IN CITIES DESIGNATED BY THE TRANSFER AGENT, AVAILABLE ONLINE AT www.computershare.com
    FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $.01 PAR VALUE, OF ARMATA PHARMACEUTICALS, INC. transferable on the books
    of the corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed. This Certificate
    is not valid until countersigned by the Transfer Agent and registered by the Registrar. WITNESS the facsimile seal of the
    Corporation and the facsimile signatures of its duly authorized officers. DATED DD-MMM-YYYY COUNTERSIGNED AND REGISTERED:
    COMPUTERSHARE INC. TRANSFER AGENT AND REGISTRAR, By Authorized signature Chief Executive Officer Chief Financial Officer PO
    BOX 43004, Providence, RI 02940-3004 MR A SAMPLE DESINATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 CUSIP XXXXXX XX X Holder ID XXXXXXXXXX
    Insurance Value 1,000,000.00 Number of Shares 123456 DTC 12345678 123456789012345 Certificate Numbers 1234567890/1234567890
    Total Transaction Num/No. 1 2 3 4 5 6 Denom. 1 2 3 4 5 6 Total 1 2 3 4 5 6 7 &emsp;</FONT></TD></TR>
</TABLE>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B><IMG SRC="tv521048_ex4-1img02.jpg" ALT="">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 1pt; color: White">ARMATA
    PHARMACEUTICALS, INC. This Certificate evidences shares of Common Stock of the Corporation. Other classes of shares of the
    Corporation are or may in the future be authorized, and those classes may consist of one or more series of shares, each with
    different rights, preferences and limitations. The Corporation will furnish any shareholder upon request and without charge
    a full statement of the designations, preferences, limitations and relative rights of the shares of each class authorized
    to be issued, and the variations in the relative rights and preferences between the shares of each series so far as the same
    have been fixed and determined, and the authority of the board of directors to fix and determine the relative rights and preferences
    of subsequent series. The following abbreviations, when used in the inscription on the face of this certificate, shall be
    construed as though they were written out in full according to applicable laws or regulations: TEN COM - as tenants in common
    UNIF GIFT MIN ACT - Custodian (Cust) (Minor) TEN ENT - as tenants by the entireties under Uniform Gifts to Minors Act (State)
    JT TEN - as joint tenants with right of survivorship UNIF TRF MIN ACT - Custodian (until age) and not as tenants in common
    (Cust) under Uniform Transfers to Minors Act (Minor) (State) Additional abbreviations may also be used though not in the above
    list. PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE For value received, hereby sell, assign and transfer
    unto (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE) shares of the capital stock represented
    by the within Certificate, and do hereby irrevocably constitute and appoint attorney-in-fact to transfer the said stock on
    the books of the within named Corporation with full power of substitution in the premises. Signature(s) Guaranteed: Medallion
    Guarantee Stamp Dated: 20 THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (Banks. Stockbrokers,
    Savings and Loan Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT
    TO S.E.C. RULE 17Ad-15. Signature: Signature: Notice: The signature to this assignment must correspond with the name as written
    upon the face of the certificate, in every particular, without alteration or enlargement, or any change whatever. SECURITY
    INSTRUCTI ONS THIS IS WATERMARDED PAPER, DO NOT ACCEPT WITHOUT NOTHING WATERMARK. HOLD TO LIGHT TO VERIFY WATERMARK. The IRS
    requires that we report the cost basis of certain shares acquired after January 1, 2011. If your shares were covered by the
    legislation and you have sold or transferred the shares and requested a specific cost basis calculation method, we have processed
    as requested. If you did not specify a cost basis calculation method, we have defaulted to the first in, first out (FIFO)
    method. Please visit our website or consult your tax advisor if you need additional information about cost basis. If you do
    not keep in contact with us or do not have any activity in your account for the time periods specified by state law, your
    property could become subject to state unclaimed property laws and transferred to the appropriate state. 1234567 &emsp;</FONT></TD></TR>
</TABLE>





<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>tv521048_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXECUTION VERSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ARMATA PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;)
is made and entered into as of May 9, 2019, by and among Armata Pharmaceuticals, Inc., a Washington corporation (the&nbsp;&ldquo;<U>Company</U>&rdquo;),
and the other parties hereto (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;). The Company
and the Holders are referred to collectively herein as the &ldquo;<U>Parties</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In consideration of the mutual covenants and
agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged
by each Party, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;<U>Definitions</U>.</B> As used in this Agreement, the following terms shall have the respective meanings set
forth in this <U>Section&nbsp;1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo; means, with respect
to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with, such Person as
of the date on which, or at any time during the period for which, the determination of affiliation is being made; <U>provided</U>,
that for purposes of this Agreement, no Holder shall be deemed an Affiliate of the Company or any of its Subsidiaries. For purposes
of this definition, the term &ldquo;control&rdquo; (including the correlative meanings of the terms &ldquo;controlled by&rdquo;
and &ldquo;under common control with&rdquo;), as used with respect to any Person, means the possession, directly or indirectly,
of the power to direct or cause the direction of the management policies of such Person, whether through the ownership of voting
securities, by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Agreement</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Approved Transferee</U>&rdquo; means
any Affiliate of any Holder who acquires Registrable Securities from such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Board</U>&rdquo; means the board of
directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo; means any
day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to remain closed for the entirety
of such day in New&nbsp;York, New&nbsp;York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Chosen Courts</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Close of Business</U>&rdquo; means
5:00 p.m. Eastern Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo; means the Securities
and Exchange Commission or any other federal agency then administering the Securities Act or Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Company</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Company Common Stock</U>&rdquo; means
the shares of common stock, par value $0.01 per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Company Indemnified Persons</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means the
Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>FINRA</U>&rdquo; means the Financial
Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Form S-1 Shelf</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Form S-3 Shelf</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo; has the meaning
set forth in the preamble. A Person shall cease to be a Holder hereunder at such time as it ceases to hold any Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Holder Indemnified Persons</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Holders of a Majority of Included
Registrable Securities</U>&rdquo; means Holders of a majority of the Registrable Securities included in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Indemnified Persons</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Merger Agreement</U>&rdquo; means
the Agreement and Plan of Merger and Reorganization, dated as of January 3, 2019, by and among AmpliPhi Biosciences Corporation,
Ceres Merger Sub, Inc., a Washington corporation, and C3J Therapeutics, Inc., a Washington corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Merger Effective Time</U>&rdquo; means
the Effective Time as defined in the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Parties</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means any individual,
partnership, corporation, company, association, trust, joint venture, limited liability company, unincorporated organization, entity
or division, or any government, governmental department or agency or political subdivision thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo; means any action,
claim, suit, proceeding or investigation (including a preliminary investigation or partial proceeding, such as a deposition) pending
or known to the Company to be threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo; means the prospectus
included in a Registration Statement (including a prospectus that includes any information previously omitted from a prospectus
filed as part of an effective Registration Statement in reliance upon Rule&nbsp;430A), all amendments and supplements to the Prospectus,
including post-effective amendments, all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Registrable Securities</U>&rdquo;
means (a)&nbsp;any Company Common Stock originally issued to the Holder pursuant to the Share Purchase Agreement, (b)&nbsp;any
securities issued or issuable with respect to, on account of or in exchange for Company Common Stock described in clause (a), whether
by stock split, stock dividend, recapitalization, merger, consolidation or other reorganization, charter amendment or otherwise
and (c)&nbsp;any options, warrants or other rights to acquire, and any securities received as a dividend or distribution in respect
of, any of the securities described in clauses (a) and (b) above, in each case that are held by the Holders and their Affiliates
or any transferee or assignee of any Holder or its Affiliates, all of which securities are subject to the rights provided herein
until such rights terminate pursuant to the provisions of this Agreement. As to any particular Registrable Securities, such securities
shall not be Registrable Securities when (i)&nbsp;a Registration Statement registering such Registrable Securities under the Securities
Act has been declared effective and such Registrable Securities have been sold, transferred or otherwise disposed of by the Holder
thereof pursuant to such effective Registration Statement, (ii)&nbsp;such Registrable Securities are sold, transferred or otherwise
disposed of pursuant to Rule&nbsp;144, (iii)&nbsp;such securities cease to be outstanding, or (iv) such securities have become
eligible for sale by the applicable Holder pursuant to Rule&nbsp;144 without any restriction on the volume or manner of such sale
and all restrictive legends and stop transfer instructions have been removed with respect to all book entries representing the
applicable Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Registration Expenses</U>&rdquo; means
all expenses incurred by the Company in complying with Section 2.1 hereof, including, without limitation, all registration, qualification
and filing fees, printing expenses, escrow fees, fees and expenses of counsel for the Company, blue sky fees and expenses and the
expense of any special audits incident to or required by any such registration (but excluding the fees of legal counsel for any
Holder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means a registration statement of the Company filed with or to be filed with the Commission under the Securities Act that covers
the resale of any of the Registrable Securities pursuant to the provisions of this Agreement, and including any Prospectus, amendments
and supplements to each such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto,
and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Related Person</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;7(m)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Representatives</U>&rdquo; of a Holder
means its partners, shareholders, members, directors, officers, employees, agents, counsel, accountants, consultants, investment
advisers or other professionals or representatives, or its affiliates or wholly owned subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo; means Rule&nbsp;144
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;145</U>&rdquo; means Rule&nbsp;145
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;158</U>&rdquo; means Rule&nbsp;158
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;405</U>&rdquo; means Rule&nbsp;405
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;415</U>&rdquo; means Rule&nbsp;415
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo; means Rule&nbsp;424
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;430A</U>&rdquo; means Rule&nbsp;430A
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;433</U>&rdquo; means Rule&nbsp;433
promulgated by the Commission pursuant to the Securities Act, or any similar rule or regulation hereafter adopted by the Commission
having substantially the same effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Seasoned Issuer</U>&rdquo; means an
issuer eligible to use Form S-3 under the Securities Act and who is not an &ldquo;ineligible issuer&rdquo; as defined in Rule&nbsp;405.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo; means the
Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Selling Expenses</U>&rdquo; means
all underwriting fees, discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities
and related legal and other fees of a Holder not included within the definition of Registration Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Share Purchase Agreement</U>&rdquo;
means that certain Share Purchase Agreement, dated February 5, 2019, by and among AmpliPhi Biosciences Corporation, C3J Therapeutics,
Inc. and the other individuals and/or entities listed on Exhibit A thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Shelf Period</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Shelf Registration</U>&rdquo; means
the registration of an offering of Registrable Securities on a Form&nbsp;S-1 Shelf or a Form&nbsp;S-3 Shelf, as applicable, on
a delayed or continuous basis under Rule&nbsp;415, pursuant to <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Shelf Registration Statement</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo; means, when
used with respect to any Person, any corporation or other entity, whether incorporated or unincorporated, (a)&nbsp;of which such
Person or any other Subsidiary of such Person is a general partner (excluding partnerships, the general partnership interests of
which held by such Person or any Subsidiary of such Person do not have a majority of the voting interests in such partnership)
or (b)&nbsp;at least a majority of the securities or other interests of which having by their terms ordinary voting power to elect
a majority of the board of directors or others performing similar functions with respect to such corporation or other entity is
directly or indirectly owned or controlled by such Person or by any one or more of its Subsidiaries, or by such Person and one
or more of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Suspension Period</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo; means the
principal national securities exchange in the United States on which Registrable Securities are (or are to be) listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Unless the context requires otherwise: (a)&nbsp;any
pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms; (b)&nbsp;references to Sections,
paragraphs and clauses refer to Sections, paragraphs and clauses of this Agreement; (c)&nbsp;the terms &ldquo;include,&rdquo; &ldquo;includes,&rdquo;
 &ldquo;including&rdquo; or words of like import shall be deemed to be followed by the words &ldquo;without limitation&rdquo;; (d)&nbsp;the
terms &ldquo;hereof,&rdquo; &ldquo;herein&rdquo; or &ldquo;hereunder&rdquo; refer to this Agreement as a whole and not to any particular
provision of this Agreement; (e)&nbsp;unless the context otherwise requires, the term &ldquo;or&rdquo; is not exclusive and shall
have the inclusive meaning of &ldquo;and/or&rdquo;; (f)&nbsp;defined terms herein will apply equally to both the singular and plural
forms and derivative forms of defined terms will have correlative meanings; (g)&nbsp;references to any law or statute shall be
deemed to refer to such law or statute as amended or supplemented from time to time and shall include all rules and regulations
and forms promulgated thereunder, and references to any law, rule, form or statute shall be construed as including any legal and
statutory provisions, rules or forms consolidating, amending, succeeding or replacing the applicable law, rule, form or statute;
(h)&nbsp;references to any Person include such Person&rsquo;s successors and permitted assigns; and (i)&nbsp;references to &ldquo;days&rdquo;
are to calendar days unless otherwise indicated. Each of the Parties hereto acknowledges that each Party was actively involved
in the negotiation and drafting of this Agreement and that no law or rule of construction shall be raised or used in which the
provisions of this Agreement shall be construed in favor or against any Party hereto because one is deemed to be the author thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shelf
Registration</U>. No later than sixty (60) days after the Merger Effective Time, the Company shall file a Registration Statement
for a Shelf Registration covering the resale of the Registrable Securities with the SEC for an offering to be made on a continuous
basis pursuant to Rule 415, or if Rule 415 is not available for offers and sales of the Registrable Securities, by such other means
of distribution of Registrable Securities as the Holders of a majority of the Registrable Securities may reasonably specify (the
 &ldquo;<U>Initial Registration Statement</U>&rdquo;). The Initial Registration Statement shall be on Form S-3 (or any successor
to Form S-3) covering the resale of all of the Registrable Securities held by the Holders (the &ldquo;<U>Form&nbsp;S-3 Shelf</U>&rdquo;),
or if the Company is not a Seasoned Issuer at the time of filing, the Company shall file a Registration Statement for a Shelf Registration
on Form&nbsp;S-1 (or any successor to Form S-1) (the &ldquo;<U>Form&nbsp;S-1 Shelf</U>&rdquo; and, together with the Form&nbsp;S-3
Shelf, the &ldquo;<U>Shelf Registration Statement</U>&rdquo;). Subject to the terms of this Agreement, including any applicable
Suspension Period, the Company shall use its commercially reasonable efforts to cause the Shelf Registration Statement to be declared
effective under the Securities Act as promptly as possible after the filing thereof, but in any event (x)&nbsp;no later than the
fifteenth (15th) day following the filing of the Shelf Registration Statement in the event of no &ldquo;review&rdquo; by the Commission,
(y)&nbsp;no later than the sixtieth (60th) day following the filing of the Shelf Registration Statement in the event of &ldquo;limited
review&rdquo; by the Commission, or (z)&nbsp;in the event of a &ldquo;review&rdquo; by the Commission, the one hundred and twentieth
(120th) day following the filing of the Shelf Registration Statement (the number of days in (x), (y) and (z) each being a &ldquo;<U>Review
Period</U>,&rdquo; depending on the nature of the Commission&rsquo;s review, and provided, for any days during the period following
the initial filing of the Shelf Registration Statement and prior to the effectiveness of the Shelf Registration Statement, the
Commission is unable to review or declare effective registration statements filed with the Commission due to a shutdown or partial
shutdown of the U.S. Government (such days, &ldquo;<U>Tolled Days</U>&rdquo;), the applicable number of days in such Review Period
shall be extended by the number of Tolled Days), and shall use its commercially reasonable efforts to keep such Shelf Registration
Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration
Statement are no longer Registrable Securities, including (the period during which the Company shall use its commercially reasonable
efforts to keep the Shelf Registration Statement continuously effective under the Securities Act in accordance with this clause
(i), the &ldquo;<U>Shelf Period</U>&rdquo;). The Company shall notify the Holders named in the Shelf Registration Statement via
facsimile or by e-mail of the effectiveness of the Shelf Registration Statement as promptly as practicable, and in any event within
twenty-four (24) hours, after the Company telephonically or otherwise confirms effectiveness with the Commission. The Company shall
file a final Prospectus with the Commission to the extent required by Rule&nbsp;424. The &ldquo;Plan of Distribution&rdquo; section
of such Shelf Registration Statement shall provide for all permitted means of disposition of Registrable Securities, including
firm-commitment underwritten public offerings, agented transactions, sales directly into the market, purchases or sales by brokers
and sales not involving a public offering. Notwithstanding anything to the contrary contained herein, in the event the Commission
informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for
resale as a secondary offering on a single registration statement, the Company agrees to promptly (A) inform each of the Holders
thereof, (B) use its reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission
and/or (C) withdraw the Initial Registration Statement and file a new Registration Statement (a &ldquo;<U>New Registration Statement</U>&rdquo;),
in either case covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form&nbsp;S-3
or, if the Company is ineligible to register for resale the Registrable Securities on Form S-3, such other form available to register
for resale the Registrable Securities as a secondary offering; <U>provided</U>, <U>however</U>, that prior to filing such amendment
or New Registration Statement, the Company shall be obligated to use its reasonable efforts to advocate with the Commission for
the registration of all of the Registrable Securities. In the event the Company amends the Initial Registration Statement or files
a New Registration Statement, as the case may be, under clauses (B) or (C) above, the Company will use its reasonable efforts to
file with the Commission, as promptly as allowed by the Commission, one or more Registration Statements on Form S-3 or, if the
Company is ineligible to register for resale the Registrable Securities on Form S-3, such other form available to register for
resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, or the
New Registration Statement (the &ldquo;<U>Remainder Registration Statements</U>&rdquo;). Notwithstanding any other provision of
this Agreement, if the Commission limits the number of Registrable Securities permitted to be registered on a particular Registration
Statement (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all
or a greater number of Registrable Securities), any required cutback of Registrable Securities shall be applied to the Holders
pro rata in accordance with the number of such Registrable Securities sought to be included in such Registration Statement by reference
to the amount of Registrable Securities purchased by such Holder pursuant to the Share Purchase Agreement as set forth opposite
such Holder&rsquo;s name on Exhibit A thereto (and in the case of a subsequent transfer, the initial Holder&rsquo;s transferee)
relative to the aggregate amount of all Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Suspension
Period.</U> Notwithstanding any other provision of this <U>Section&nbsp;2</U>, the Company shall have the right, but not the obligation,
to defer the filing of (but not the preparation of), or suspend the use by the Holders of, any Registration Statement for a period
of up to sixty (60) days (unless a longer period is consented to by Holders of a Majority of Included Registrable Securities) (i)
upon issuance by the Commission of a stop order suspending the effectiveness of such Registration Statement with respect to Registrable
Securities or the initiation of proceedings with respect to such Registration Statement under Section 9(d) or 8(e) of the Securities
Act; (ii)&nbsp;if the Company believes in good faith that any such registration or offering (x)&nbsp;should not be undertaken because
it would reasonably be expected to materially interfere with any material corporate development or plan of the Company or (y)&nbsp;would
require the Company (after consultation with external legal counsel), under applicable securities laws and other laws, to make
disclosure of material nonpublic information that would not otherwise be required to be disclosed at that time and the Company
believes in good faith that such disclosures at that time would not be in the Company&rsquo;s best interests; <U>provided</U> that
this exception (y) shall continue to apply only during the time that such material nonpublic information has not been disclosed
and remains material; (iii)&nbsp;if the Company elects at such time to offer Company Common Stock or other equity securities of
the Company to (x)&nbsp;fund a merger, third-party tender offer or other business combination, acquisition of assets or similar
transaction or (y)&nbsp;meet rating agency and other capital funding requirements; or (iv) if the Company is pursuing a primary
underwritten offering of Company Common Stock pursuant to a registration statement (any such period, a &ldquo;<U>Suspension Period</U>&rdquo;);
<U>provided</U><I>, </I>that in no event shall the Company declare a Suspension Period more than three times in any twelve (12)
month period. The Company shall (i)&nbsp;give prompt written notice to the Holders of its declaration of a Suspension Period and
of the expiration or termination of the relevant Suspension Period and (ii)&nbsp;promptly resume the process of filing or requesting
for effectiveness, or update the suspended Registration Statement, as the case may be, as may be necessary to permit the Holders
to offer and sell their Registrable Securities in accordance with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Information.</U> The Company may require each Holder of Registrable Securities as to which any Registration Statement is being
filed or sale is being effected to furnish to the Company such information regarding the intended method of distribution of such
securities and such other information relating to such Holder and its ownership of Registrable Securities as the Company may from
time to time reasonably request in writing (<U>provided</U> that such information shall be used only in connection with such registration)
and the Company may exclude from such registration or sale the Registrable Securities of any such Holder who fails to furnish such
information within a reasonable time after receiving such request. Each Holder agrees to furnish such information to the Company
and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cessation
of Registration Rights.</U> All registration rights granted under this <U>Section&nbsp;2</U> shall continue to be applicable with
respect to any Holder until such Holder no longer holds any Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>3.&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Procedures</U>.</B> The procedures to be followed by the Company
and each participating Holder to register the sale of Registrable Securities pursuant to a Registration Statement in
accordance with this Agreement, and the respective rights and obligations of the Company and such Holders with respect to the
preparation, filing and effectiveness of such Registration Statement, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will (i)&nbsp;prepare and file a Registration Statement with the Commission (within the time period specified in <U>Section&nbsp;2(a)</U>)
which Registration Statement (A)&nbsp;shall be on a form required by this Agreement (or if not so required, selected by the Company)
for which the Company qualifies, (B)&nbsp;shall be available for the sale of the Registrable Securities in accordance with the
intended method or methods of distribution, and (C)&nbsp;shall comply as to form in all material respects with the requirements
of the applicable form and include and/or incorporate by reference all financial statements required by the Commission to be filed
therewith, (ii)&nbsp;use its commercially reasonable efforts to cause such Registration Statement to become effective and remain
effective for the period provided under <U>Section&nbsp;2(a)</U>, (iii)&nbsp;use its commercially reasonable efforts to prevent
the occurrence of any event that would cause a Registration Statement to contain a material misstatement or omission or to be not
effective and usable for resale of the Registrable Securities registered pursuant thereto (during the period that such Registration
Statement is required to be effective as provided under <U>Section&nbsp;2(a)</U>), and (iv)&nbsp;cause each Registration Statement
and the related Prospectus and any amendment or supplement thereto, as of the effective date of such Registration Statement, amendment
or supplement, (x)&nbsp;to comply in all material respects with any requirements of the Securities Act and the rules and regulations
of the Commission and (y)&nbsp;not to contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading (provided, however, the Company shall have no liability
for any information furnished in writing by or on behalf of a Holder to the Company specifically for inclusion in (including by
incorporation by reference) any such Registration Statement that has not been corrected in a subsequent writing to the Company
prior to the filing or other disclosure of such information). The Company will, (1)&nbsp;at least three (3)&nbsp;Business Days
prior to the anticipated filing of a Registration Statement or any related Prospectus or any amendment or supplement thereto (including
any documents incorporated by reference therein), furnish to such Holders and such Holders&rsquo; counsel copies of all such documents
proposed to be filed and make such representatives of the Company as shall be reasonably requested by the Holders available for
discussion of such documents, (2)&nbsp;use its commercially reasonable efforts to address in each such document prior to being
so filed with the Commission such comments as each such Holder or its counsel reasonably shall propose within two (2)&nbsp;Business
Days of receipt of such copies by the Holders and (3)&nbsp;not file any Registration Statement or any related Prospectus or any
amendment or supplement thereto containing information regarding a participating Holder to which such participating Holder objects,
unless such information is required by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will as promptly as reasonably practicable (i)&nbsp;prepare and file with the Commission such amendments, including post-effective
amendments, and supplements to each Registration Statement and the Prospectus used in connection therewith as (A)&nbsp;may be reasonably
requested by any Holder of Registrable Securities covered by such Registration Statement necessary to permit such Holder to sell
in accordance with its intended method of distribution or (B)&nbsp;may be necessary under applicable law to keep such Registration
Statement continuously effective with respect to the disposition of all Registrable Securities covered thereby for the period provided
under <U>Section&nbsp;2(a)</U> in accordance with the intended method of distribution and, subject to the limitations contained
in this Agreement, prepare and file with the Commission such additional Registration Statements in order to register for resale
under the Securities Act all of the Registrable Securities held by the Holders, (ii)&nbsp;cause the related Prospectus to be amended
or supplemented by any required prospectus supplement, and as so supplemented or amended, to be filed pursuant to Rule 424, (iii)&nbsp;respond
to any comments received from the Commission with respect to each Registration Statement or Prospectus or any amendment thereto,
and (iv)&nbsp;as promptly as reasonably practicable, provide such Holders true and complete copies of all correspondence from and
to the Commission relating to such Registration Statement or Prospectus other than any comments that the Company determines in
good faith would result in the disclosure to such Holders of material non-public information concerning the Company that is not
already in the possession of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will comply in all material respects with the provisions of the Securities Act and the Exchange Act (including Regulation
M under the Exchange Act) with respect to each Registration Statement and the disposition of all Registrable Securities covered
by each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will notify such Holders that hold Registrable Securities as promptly as reasonably practicable: (i)(A) when a Registration
Statement, any pre-effective amendment, any Prospectus or any prospectus supplement or post-effective amendment to a Registration
Statement is proposed to be filed; (B)&nbsp;when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments on such Registration Statement (in which case the Company shall
provide true and complete copies thereof and all written responses thereto to each Holder and its counsel, other than information
which the Company determines in good faith would constitute material non-public information that is not already in the possession
of such Holder); and (C)&nbsp;with respect to each Registration Statement or any post-effective amendment thereto, when the same
has been declared effective; (ii)&nbsp;of any request by the Commission or any other federal or state governmental or regulatory
authority for amendments or supplements to a Registration Statement or Prospectus or for additional information (whether before
or after the effective date of the Registration Statement) or any other correspondence with the Commission or any such authority
relating to, or which may affect, the Registration Statement; (iii)&nbsp;of the issuance by the Commission or any other governmental
or regulatory authority of any stop order, injunction or other order or requirement suspending the effectiveness of a Registration
Statement covering any or all of the Registrable Securities or preventing or suspending the use of any Prospectus or the initiation
or threatening of any Proceedings for such purpose; (iv)&nbsp;of the receipt by the Company of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction,
or the initiation or threatening of any Proceeding for such purpose; or (v)&nbsp;of the occurrence of any event that makes any
statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or if, as a result of such event or the passage of time, such Registration Statement,
Prospectus or other documents requires revisions so that, in the case of such Registration Statement or the Prospectus, as the
case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein (in the case of the Prospectus, in light of the circumstances under which they
were made) not misleading, or if, for any other reason, it shall be necessary during such time period to amend or supplement such
Registration Statement or Prospectus in order to comply with the Securities Act, which shall correct such misstatement or omission
or effect such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will use its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i)&nbsp;any
stop order or other order suspending the effectiveness of a Registration Statement, or preventing or suspending the use of any
Prospectus, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, as soon as reasonable practicable, or if any such order or suspension is made effective during any
Suspension Period, as soon as reasonable practicable after the Suspension Period is over.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the Shelf Period, the Company will furnish to each selling Holder and its counsel upon their request, without charge, at least
one conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such selling
Holder or counsel (including those incorporated by reference) promptly after the filing of such documents with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will promptly deliver to each selling Holder and its counsel as many copies of each Prospectus or Prospectuses (including
each form of prospectus) and each amendment or supplement thereto as such selling Holder or counsel may reasonably request in order
to facilitate the disposition of the Registrable Securities by such selling Holder. The Company hereby consents to the use of such
Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of
the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, so long as the same are used in
compliance with the Securities Act and all other applicable laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the Company has certificated shares of Company Common Stock, the Company will cooperate with each selling Holder
to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee
pursuant to a Registration Statement, which certificates shall be free of all restrictive legends indicating that the Registrable
Securities are unregistered or unqualified for resale under the Securities Act, Exchange Act or other applicable securities laws,
and to enable such Registrable Securities to be in such denominations and registered in such names as each selling Holder may request
in writing. In connection therewith, if required by the Company&rsquo;s transfer agent, the Company will promptly, after the effective
date of the Registration Statement, cause an opinion of counsel as to the effectiveness of the Registration Statement to be delivered
to and maintained with such transfer agent, together with any other authorizations, certificates and directions required by the
transfer agent which authorize and direct the transfer agent to issue such Registrable Securities without any such legend upon
sale by the Holder of such Registrable Securities pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any event contemplated by <U>Section&nbsp;3(d)(v)</U>, as promptly as reasonably practicable, the Company will
prepare a supplement or amendment, including a post-effective amendment, if required by applicable law, to the affected Registration
Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference,
and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein (in the case of a Prospectus, in light of the circumstances under which they were made) not misleading, such
that each selling Holder can resume disposition of such Registrable Securities covered by such Registration Statement or Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission, the
Trading Market and FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Holder agrees by its acquisition of Registrable Securities that, upon receipt of a notice from the Company of the occurrence of
any event of the kind described in clauses (ii)&nbsp;through (v)&nbsp;of <U>Section&nbsp;3(d)</U> or the occurrence of a Suspension
Period, such Holder will forthwith discontinue disposition of such Registrable Securities under the applicable Registration Statement
until such Holder&rsquo;s receipt of the copies of the supplemental Prospectus or amended Registration Statement or until it is
advised in writing by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies
of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or
Registration Statement.&nbsp; In the event the Company shall give any such notice, the period during which the applicable Registration
Statement is required to be maintained effective shall be extended by the number of days during the period from and including the
date of the giving of such notice to and including the date when each seller of Registrable Securities covered by such Registration
Statement either receives the copies of the supplemented Prospectus or amended Registration Statement or is advised in writing
by the Company that the use of the Prospectus may be resumed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Holder hereby covenants with the Company (i) not to make any sale of any Registrable Securities without effectively causing the
prospectus delivery requirements under the Securities Act to be satisfied, and (ii) if such Registrable Securities are to be sold
by any method or in any transaction other than on a national securities exchange or in the over-the-counter market, in privately
negotiated transactions, or in a combination of such methods, to notify the Company at least five Business Days prior to the date
on which the Holder first offers to sell any such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Expenses</U>.</B> All Registration Expenses incurred in connection with any
registration, qualification, exemption or compliance pursuant to Section 2.1(a) hereof shall be borne by the Company. All
Selling Expenses relating to the sale of securities registered by or on behalf of Holders shall be borne by such Holders pro
rata on the basis of the number of securities so registered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall indemnify and hold harmless each Holder, its partners, stockholders, equity holders, general partners, managers,
members, and Affiliates and each of their respective officers and directors and any Person who controls any such Holder (within
the meaning of the Securities Act or the Exchange Act) and any employee or Representative thereof (collectively, each, an &ldquo;<U>Company
Indemnified Person</U>&rdquo; and collectively, &ldquo;<U>Company Indemnified Persons</U>&rdquo;), to the fullest extent permitted
by law, from and against any and all losses, claims, damages, liabilities, joint or several, costs (including reasonable costs
of preparation and reasonable attorneys&rsquo;, accountants&rsquo; and experts&rsquo; fees) and expenses, judgments, fines, penalties,
interest, settlements or other amounts arising from any and all claims, demands, actions, suits or proceedings, whether civil,
criminal, administrative or investigative, in which any Company Indemnified Person may be involved, or is threatened to be involved,
as a party or otherwise, under the Securities Act, the Exchange Act or otherwise (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of, based upon, resulting from or relating to (i)&nbsp;any untrue or alleged untrue statement of a material
fact contained in any Registration Statement under which any Registrable Securities were registered, Prospectus (including in any
preliminary prospectus (if used prior to the effective date of such Registration Statement)), or in any summary or final prospectus
or in any amendment or supplement thereto or in any documents incorporated or deemed incorporated by reference in any of the foregoing
or (ii)&nbsp;any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make
the statements made therein (in the case of the Prospectus, in light of the circumstances under which they were made) not misleading,
or (iii) any violation or alleged violation by the Company or any of its Subsidiaries of the Securities Act, the Exchange Act,
any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any federal, state,
foreign or common law rule or regulation in connection with such Registration Statement, disclosure document or related document
or report or any offering covered by such Registration Statement, and the Company shall reimburse such Company Indemnified Person
for any reasonable legal or other expenses reasonably incurred by it in connection with investigating or defending any such loss,
claim, damage, liability, demand, action, suit or proceeding; <U>provided</U><I>, </I><U>however</U>, that the Company shall not
be liable to any Company Indemnified Person to the extent that any such Losses arise out of, are based upon or results from an
untrue or alleged untrue statement or omission or alleged omission made in such Registration Statement, such preliminary, summary
or final prospectus or such amendment or supplement, or other disclosure document, in reliance upon and in conformity with written
information furnished to the Company by or on behalf of such Company Indemnified Person specifically for use therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with any Registration Statement filed by the Company pursuant to <U>Section&nbsp;2(a)</U> hereof in which a Holder has
registered for sale its Registrable Securities, each such selling Holder agrees (severally and not jointly) to indemnify and hold
harmless, to the fullest extent permitted by law, the Company, its directors and officers, employees, agents and each Person who
controls the Company (within the meaning of the Securities Act or the Exchange Act) and any other Holder selling securities under
such Registration Statement, its partners, stockholders, equity holders, general partners, managers, members, and Affiliates and
each of their respective officers and directors and any Person who controls such other Holder (within the meaning of the Securities
Act or the Exchange Act) and any employee or Representative thereof (collectively, &ldquo;<U>Holder Indemnified Persons</U>&rdquo;,
and together with the Company Indemnified Persons, each an &ldquo;<U>Indemnified Person</U>&rdquo;, and collectively, the &ldquo;<U>Indemnified
Persons</U>&rdquo;) from and against any Losses resulting from (i)&nbsp;any untrue or alleged untrue statement of a material fact
contained in any Registration Statement under which such Registrable Securities were registered or sold under the Securities Act,
Prospectus (including in any preliminary prospectus (if used prior to the effective date of such Registration Statement)), or in
any summary or final prospectus or in any amendment or supplement thereto or in any documents incorporated by reference in any
of the foregoing, (ii)&nbsp;any omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein (in the case of the Prospectus, in light of the circumstances under which they were made)
not misleading, or (iii) any violation or alleged violation by such Holder of any federal, state or common law rule or regulation
relating to action or inaction in connection with any information provided by such Holder in such registration, disclosure document
or related document or report in the case of clauses (i) and (ii) to the extent, but only to the extent, that such untrue statement
or omission occurs in reliance upon and in conformity with any information furnished in writing by or on behalf of such Holder
Indemnified Person specifically for inclusion in such registration, disclosure document or related document or report and has not
been corrected in a subsequent writing prior to the sale of the Registrable Securities thereunder, and the Holder will reimburse
the Company for any legal or other expenses reasonably incurred by it in connection with investigating or defending such Losses.
In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds
received by such Holder under the sale of Registrable Securities giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Indemnified Person under paragraph (a) or (b) of this <U>Section 5</U> shall (i)&nbsp;give prompt written notice to the indemnifying
person under paragraph (a) or (b) of this <U>Section&nbsp;5</U> of any claim with respect to which it seeks indemnification (<U>provided</U>
that any delay or failure to so notify the indemnifying person shall not relieve the indemnifying party of its obligations hereunder
except to the extent, if at all, that the indemnifying person&rsquo;s ability to defend such claim (through the forfeiture of substantive
rights or defenses) is actually and materially prejudiced by reason of such delay or failure) and (ii)&nbsp;permit such indemnifying
person to assume the defense of such claim with counsel reasonably satisfactory to the Indemnified Person; <U>provided</U>, <U>however</U>,
that any Indemnified Person shall have the right to select and employ separate counsel and to participate in the defense of such
claim, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (A)&nbsp;the indemnifying
person has agreed in writing to pay such fees or expenses, (B)&nbsp;the Indemnified Person has reasonably concluded (based upon
advice of its counsel) that there may be legal defenses available to it or other Indemnified Persons that are different from or
in addition to those available to the indemnifying person, or (C)&nbsp;in the reasonable judgment of any such Indemnified Person
(based upon advice of its counsel) a conflict of interest may exist between such Indemnified Person and the indemnifying person
with respect to such claims (in which case, if the Indemnified Person notifies the indemnifying person in writing that such Indemnified
Person elects to employ separate counsel at the expense of the indemnifying person, the indemnifying person shall not have the
right to assume the defense of such claim on behalf of such Indemnified Person). If any action is settled or if there be a final
judgment for the plaintiff, the indemnifying person agrees to indemnify each Indemnified Person from and against any loss or liability
by reason of such settlement or judgment. No action may be settled without the written consent of the Indemnified Person (which
consent shall not be unreasonably withheld, delayed or conditioned), <U>provided</U> that the consent of the Indemnified Person
shall not be required if (A)&nbsp;such settlement includes an unconditional release of such Indemnified Person in form and substance
satisfactory to such Indemnified Person from all liability on the claims that are the subject matter of such settlement; (B)&nbsp;such
settlement provides for the payment by the indemnifying person of money as the sole relief for such action and (C)&nbsp;such settlement
does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified
Person. It is understood that the indemnifying person or persons shall not, except as specifically set forth in this <U>Section&nbsp;5(c)</U>,
in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements
or other charges of more than one separate firm (in addition to any local counsel that is required to effectively defend against
any such proceeding) for all Indemnified Persons and that all such fees and expenses shall be paid or reimbursed promptly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the indemnification provided for in this <U>Section&nbsp;5</U> is held by a court of a competent jurisdiction to be unavailable
to an Indemnified Person with respect to any loss, damage, claim or liability, the indemnifying party, in lieu of indemnifying
such Indemnified Person thereunder, shall to the extent permitted by law, contribute to the amount paid or payable by such Indemnified
Person as a result of such loss, damage, claim or liability in such proportion as is appropriate to reflect the relative fault
of the indemnifying party on the one hand and of the Indemnified Person on the other in connection with the actions that resulted
in such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the indemnifying
person and of the Indemnified Person shall be determined by a court of law by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the
indemnifying person or Indemnified Person and the parties&rsquo; relative intent, knowledge, access to information and opportunity
to correct or prevent such statement or omission. The Parties agree that it would not be just and equitable if contribution pursuant
to this <U>Section 5(d)</U> were determined by pro rata allocation or by any other method of allocation that does not take account
of the equitable considerations referred to in the immediately preceding sentences. Notwithstanding the provisions of this <U>Section&nbsp;5(d)</U>,
no selling Holder shall be required to contribute any amount in excess of the net proceeds (after deducting the underwriters&rsquo;
discounts and commissions) received by such selling Holder in the offering. No Person guilty of fraudulent misrepresentation (within
the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of
such fraudulent misrepresentation. Each selling Holder&rsquo;s obligation to contribute pursuant to this <U>Section&nbsp;5(d)</U>
is several in the proportion that the net proceeds of the offering received by such selling Holder bears to the total net proceeds
of the offering received by all such selling Holders and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
remedies provided for in this <U>Section&nbsp;5</U> are not exclusive and shall not limit any rights or remedies which may otherwise
be available to any Indemnified Person at law or in equity. The obligations of the Company and Holders under this <U>Section&nbsp;5</U>
shall survive completion of any offering of Registrable Securities pursuant to a Registration Statement and the termination of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;<U>Facilitation of Sales Pursuant to Rule 144</U>.</B> The Company shall use its commercially
reasonable efforts to timely file the reports required to be filed by it under the Exchange Act or the Securities Act and the
rules adopted by the Commission thereunder (including the reports under Sections&nbsp;13 and 15(d) of the Exchange Act
referred to in subparagraph (c)(1) of Rule&nbsp;144), all to the extent required from time to time to enable the Holders to
sell Registrable Securities without registration under the Securities Act within the limitations of the exemption provided by
Rule&nbsp;144. Upon the written request of any Holder in connection with that Holder&rsquo;s sale pursuant to Rule&nbsp;144,
the Company shall deliver to such Holder a written statement as to whether it has complied with such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
In the event of a breach by the Company or a Holder of any of its obligations under this Agreement, any Party, in addition to being
entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific
performance of its rights under this Agreement. The Parties agree that monetary damages would not provide adequate compensation
for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and further agrees that, in the
event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be
adequate and shall waive any requirement for the posting of a bond. No failure or delay by any Person in exercising any right,
power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other
or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall
be cumulative and not exclusive of any rights or remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment;
Modification; Waivers</U>. This Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and
signed by the Company and holders of a majority of the Registrable Securities then owned by the Holders and such amendment or waiver
treats all holders of capital stock equally in all respects, which writing shall specifically reference this Agreement, specify
the provision(s) hereof that it is intended to amend or waive and further specify that it is intended to amend or waive such provision(s).
No amendment or waiver is permitted if such amendment or waiver would adversely affect a Holder relative to the other Holders without
such Holder&rsquo;s written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
All notices and other communications hereunder shall be in writing and shall be deemed duly given (a)&nbsp;upon delivery, if served
by personal delivery upon the Person for whom it is intended, (b)&nbsp;on the third Business Day after the date mailed if delivered
by registered or certified mail, return receipt requested, postage prepaid, (c)&nbsp;on the following Business Day if delivered
by a nationally-recognized, overnight courier or (d)&nbsp;when delivered or, if sent after the Close of Business, on the following
Business Day if sent by facsimile transmission or email with electronic confirmation, in each case, to the address set forth on
the signature page of this Agreement or to such other address as may be designated in writing, in the same manner, by such Person.
If to any other Person who is then a Holder, to the address of such Holder as it appears on the signature pages hereto or such
other address as may be designated in writing hereafter by such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law; Jurisdiction; Waiver of Jury Trial</U>. This Agreement shall be governed by, and construed in accordance with, the laws of
the State of Washington, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In
any action or proceeding between any of the parties arising out of or relating to this Agreement, each of the parties: (a) irrevocably
and unconditionally consents and submits to the exclusive jurisdiction and venue of the King County West Division of the State
of Washington or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the
District of Washington or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State
of Washington; (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in
accordance with clause (a) of this Section 7(d); (c)&nbsp;waives any objection to laying venue in any such action or proceeding
in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any party
hereto; and (e) irrevocably and unconditionally waives the right to trial by jury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective heirs,
executors, administrators, successors, legal representatives, and Approved Transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver
of Venue</U>. The Parties irrevocably and unconditionally waive, to the fullest extent permitted by applicable law, (i)&nbsp;any
objection that they may now or hereafter have to the laying of venue of any action or proceeding arising out of or relating to
this Agreement in any court referred to in <U>Section&nbsp;7(d)</U> and (ii)&nbsp;the defense of an inconvenient forum to the maintenance
of such action or proceeding in any such court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver
of Trial by Jury</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PERSON HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT
SUCH PERSON MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PERSON HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii)&nbsp;SUCH
PERSON UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii)&nbsp;SUCH PERSON MAKES THIS WAIVER VOLUNTARILY, AND
(iv)&nbsp;SUCH PERSON HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND EACH ANCILLARY AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL
WAIVERS AND CERTIFICATIONS IN THIS SECTION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision hereof shall
not affect the validity or enforceability of any other provision. Whenever possible, each provision or portion of any provision
of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of
this Agreement, or the application thereof to any Person or any circumstance, is invalid or unenforceable, (i)&nbsp;a suitable
and equitable provision shall be substituted therefor to carry out, so far as may be valid and enforceable, the intent and purpose
of such invalid or unenforceable provision and (ii)&nbsp;the remainder of this Agreement and the application of such provision
to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability
affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction; provided, that,
if any one or more of the provisions contained in this Agreement shall be determined to be excessively broad as to activity, subject,
duration or geographic scope, it shall be reformed by limiting and reducing it to the minimum extent necessary, so as to be enforceable
under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Business
Days</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall
be a day other than a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. This Agreement constitutes the entire agreement among the Parties with respect to the subject matter hereof and
supersedes all prior contracts or agreements with respect to the subject matter hereof and supersedes any and all prior or contemporaneous
discussions, agreements and understandings, whether oral or written, that may have been made or entered into by or among any of
the Parties or any of their respective Affiliates relating to the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Execution
of Agreement</U>. This Agreement may be executed and delivered (by facsimile, by electronic mail in Adobe Portable Document Format
(.pdf) or otherwise) in any number of counterparts, each of which, when executed and delivered, shall be deemed an original, and
all of which together shall constitute the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Determination
of Ownership</U>. In determining ownership of Company Common Stock hereunder for any purpose, the Company may rely solely on the
records of the transfer agent for the Company Common Stock from time to time, or, if no such transfer agent exists, the Company&rsquo;s
stock ledger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Recourse</U>. Notwithstanding anything that may be expressed or implied in this Agreement, and notwithstanding the fact that certain
of the Holders may be partnerships or limited liability companies, each Holder covenants, agrees and acknowledges that no recourse
under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any of the
Company&rsquo;s or the Holder&rsquo;s former, current or future direct or indirect equity holders, controlling persons, stockholders,
directors, officers, employees, agents, Affiliates, members, financing sources, managers, general or limited partners or assignees
(each, a &ldquo;<U>Related Person</U>&rdquo; and collectively, the &ldquo;<U>Related Persons</U>&rdquo;), in each case other than
the Company, the Holders or any of their permitted assigns under this Agreement, whether by the enforcement of any assessment or
by any legal or equitable proceeding, or by virtue of any applicable law, it being expressly agreed and acknowledged that no personal
liability whatsoever shall attach to, be imposed on or otherwise be incurred by any of the Related Persons, as such, for any obligation
or liability of the Company or the Holders under this Agreement or any documents or instruments delivered in connection herewith
for any claim based on, in respect of or by reason of such obligations or liabilities or their creation; provided, however, nothing
in this <U>Section&nbsp;7(m)</U> shall relieve or otherwise limit the liability of the Company or any Holder, as such, for any
breach or violation of its obligations under this Agreement or such agreements, documents or instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Third-Party
Beneficiaries</U>. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than a Party and
their respective successors and permitted assigns any rights, benefits or remedies of any nature whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings;
Section&nbsp;References; Signatories</U>. All heading references contained in this Agreement are for convenience purposes only
and shall not be deemed to limit or affect any of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties have executed
this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARMATA PHARMACEUTICALS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Todd R. Patrick&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;Todd R. Patrick</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4503 Glencoe Avenue &nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marina del Rey, California 90292</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[<I>Signature Page to Registration Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">IN WITNESS WHEREOF, the Parties have
executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delta Dental of Wisconsin</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dennis L. Peterson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Dennis L. Peterson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President &amp; CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: 2801 Hoover Road, Stevens Point, WI 54481</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delta Dental of South Dakota</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Scott Jones</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Scott Jones</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President and CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: 720 N Euclid Ave, PO Box 1157, Pierre, SD 57501</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delta Dental of California</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael G. Hankinson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Michael G. Hankinson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Executive VP and Chief Legal Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: 560 Mission Street, Suite 1300, San Francisco, CA 94105</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[<I>Signature Page to Registration Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>tv521048_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="4"><IMG SRC="tv521048_ex10-2img01.jpg" ALT=""></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C3J Therapeutics, Inc</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">4503 Glencoe Avenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2928 Tel.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Marina del Rey, CA 90292</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2963 Fax.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">www.c3-jian.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Mr. Todd Patrick</TD>
    <TD STYLE="width: 50%; text-align: right">October 1, 2018</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>9029 NE 36<SUP>th </SUP>Street</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Yarrow Point, WA 98004</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Re: Extension of your Employment Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Todd:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.75pt">On behalf of C3J Therapeutics,
Inc., (the &quot;Company&quot;), I am pleased to confirm the continued employment of you as the Company&rsquo;s President and Chief
Executive Officer, reporting to our board of directors (the &quot;Board&quot;). This letter sets out the terms of your employment
with the Company, which will continue uninterrupted in the same manner as you have been employed since November 1, 2010, subject
now to the terms of this letter starting on October 1, 2018 the (&quot;Start Date&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.1pt">You will be paid an annual
Base Salary of $412,000 for each year (payable bi-weekly) less applicable tax and other withholdings. Other than as outlined below,
any future adjustments to compensation, if any, will be made by the Company in its sole discretion. You may also be eligible to
earn an annual cash bonus, in accordance with a milestone based structure to be established by the Board, enabling you to earn
between 50% and 100% of the amount of your Base Salary based on your achievement of such milestones, as determined by the Board
in its sole discretion. You must be an employee of the Company on December 31st of a particular calendar year in order to be eligible
to receive a cash bonus for such year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.95pt">Upon the completion of
a corporate partnership, equity financing, debt, grants or a combination of one or more of various financing structures, sufficient
to fund the Company for at least twenty-four (24) months, your Base Salary shall be increased to $550,000 paid retroactively to
January 1, 2018. The increased Base Salary and retroactive payment must be included in the calculation when determining whether
the funds received provides a 24 month run way for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All stock options and Restricted
Share Awards that you have previously been granted will continue in effect. There are no new grants or awards in connection with
this revised employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As President and Chief Executive Officer, you also agree to serve as the &quot;then-sitting
Chief Executive Officer&quot; member of the Board in accordance with Section 3.1(e) of that certain Second Amended and Restated
Investors' Rights Agreement by and among the Company and the other parties thereto, dated December 21, 2009.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="4"><IMG SRC="tv521048_ex10-2img01.jpg" ALT=""></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C3J Therapeutics, Inc</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">4503 Glencoe Avenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2928 Tel.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Marina del Rey, CA 90292</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2963 Fax.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">www.c3-jian.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You will also be eligible
for all fringe benefit plans available to other full-time Company employees, including health and dental insurance coverage for
you, your spouse and your dependent children, 40l(k) plan and benefit programs, in accordance with the Company's benefit plans
and policies. You will receive 5 weeks of vacation annually. To the extent that you do not use all of your vacation in a given
year, you will be permitted to accrue up to a cap of 1.5 times your annual accrual rate of vacation, at which time you will cease
accruing any vacation until you use some and drop below the cap. The Company reserves the right to change or eliminate these benefits
on a prospective basis at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.9pt">As a condition of your
employment, the Company's standard form of employee nondisclosure and assignment agreement, which you have already executed, will
remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The term of this employment
agreement is for three (3) years from the start date of October 1, 2018. If the Company terminates you without Cause (as defined
in the stock option plan) or you resign for Good Reason (as defined below), then the Company shall compensate you with a severance
payment equal to your Base Salary plus 50% bonus (the bonus to be paid whether earned or unearned) for the then remaining term
of this contract, or through September 30, 2021. Such payment to be lengthened to a minimum of one year or twelve (12) months of
Base Salary and bonus, if your termination occurs during any month during the 2021 calendar year. Any such severance payment will
be made in full at the next normal payroll period of the Company, less applicable taxandother withholdings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt"><FONT STYLE="font-size: 10pt"><I>&quot;Good
Reason&quot; </I></FONT>shall mean your resignation due to either a) a Change of Control or in the event of a consolidation or
merger with a third party even if there is no Change of Control (in either case a &ldquo;Corporate Transaction&rdquo;) <B>or </B>b)
either of the following (i) a material diminution of your title, position, duties or responsibilities; or (ii) the involuntary
relocation of your primary office location to more than fifty (50) miles from your present home in Yarrow Point, WA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">If in the reasonable opinion
of the Board, the severance payment outlined above would have a negative impact on a potential Corporate Transaction, then you
and the Board will work out a payment schedule that could extend the severance payments to match monthly payments running the full
length of this agreement. In this case, you will continue to earn fringe benefits for the length of the agreement and will be offered
a prestigious position (board or consulting) in the new entity that results from the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">In the event of any dispute or claim relating
to or arising out of your employment relationship with the Company, this agreement, or the termination of your employment with
the Company for any reason (including, but not limited to, any claim of breach of contract, defamation, wrongful termination or
age, sex, sexual orientation, race, color, national origin, ancestry, marital status, religious creed, physical or mental disability
or medical condition or other discrimination, retaliation or harassment), you and the Company agree that such dispute or claim
shall be fully resolved by confidential, binding arbitration conducted by a single arbitrator through the American Arbitration
Association (&quot;AAA&quot;) under the AAA's National Rules for the Resolution of Employment Disputes then in effect, which are
available online at the AAA's website at www.adr.org. You and the Company hereby waive your respective rights to have any such
dispute or claim tried before a judge or jury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="4"><IMG SRC="tv521048_ex10-2img01.jpg" ALT=""></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C3J Therapeutics, Inc</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">4503 Glencoe Avenue</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2928 Tel.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">Marina del Rey, CA 90292</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(310) 665-2963 Fax.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">www.c3-jian.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">This agreement, and
the non-disclosure and assignment agreement referred to above, constitute the entire agreement between you and the Company
regarding the terms and conditions of your employment, and they supersede all prior negotiations, representations or
agreements between you and the Company (with the exception of your existing stock option agreements, Restricted Share Award
agreements, which shall remain in force in accordance with their terms). The provisions of this agreement may only be
modified by a document signed by you and an authorized representative of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">This agreement shall be binding upon you and the Company and any
its successors or assigns. This agreement will be binding upon the remaining entity resulting from any Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.7pt">Todd, we look forward to continuing your role as the full-time leader
of the management team at C3J Therapeutics and our wholly owned subsidiary C3 Jian, LLC. Please sign and date this letter in the
space provided below to acknowledge your acceptance of the terms of this agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Sincerely, C3J Therapeutics, Inc.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">By, </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%">/s/ H. Stewart Parker</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">H. Stewart Parker</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Chair of the Board of Directors</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I agree to and accept employment with C3J Therapeutics,
Inc. on the terms and conditions set forth in this letter agreement, effective as of October 1, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Date: October 1, 2018</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Todd Patrick</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Todd Patrick</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>tv521048_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: transparent">Exhibit 10.3</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: transparent">AMENDMENT
TO</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: transparent">EMPLOYMENT
AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in; background-color: transparent">The
Employment Agreement between C3J Therapeutics, Inc. (the &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Company</U></FONT>&rdquo;)
and Todd Patrick (&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Executive&rdquo;</U></FONT>)
dated as of October 1, 2018 (the &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><U>Agreement&rdquo;</U></FONT>)
is hereby amended, effective as of the &ldquo;Effective Time&rdquo;, as defined in the Agreement and Plan of Merger and Reorganization
dated as of January 3, 2019, by and among AmpliPhi Biosciences Corporation, Ceres Merger Sub, Inc. and the Company, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD>The tenth paragraph of the Agreement is hereby deleted
in its entirety and replaced with the following:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: left; text-indent: 0in; background-color: transparent">&ldquo;The
severance pay provided in this agreement is intended to qualify for an exemption from application of Section 409A of the Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;) and the regulations and other guidance thereunder and any state law of
similar effect (collectively &ldquo;Section 409A&rdquo;) or to comply with its requirements to the extent necessary to avoid adverse
personal tax consequences under Section 409A, and any ambiguities herein shall be interpreted accordingly. Each installment of
severance pay is a separate &ldquo;payment&rdquo; for purposes of Section 409A. If no exemptions to Section 409A are available
and you are, upon separation from service, a &ldquo;specified employee&rdquo; for purposes of Section 409A, then, solely to the
extent necessary to avoid adverse personal tax consequences under Section 409A, the timing of the severance pay shall be delayed
until the earlier of (i) six (6) months and one day after your separation from service, or (ii) your death. Except to the minimum
extent that payments must be delayed because you are a &ldquo;specified employee&rdquo;, all amounts of severance pay will be paid
as soon as practicable in accordance with the schedule provided herein and in accordance with the Company&rsquo;s normal payroll
practices.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD>Except as explicitly set forth herein, the Agreement
will remain in full force and effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: transparent">IN
WITNESS WHEREOF, the parties have executed this amendment effective as of the date written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in; background-color: transparent">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">C3J THERAPEUTICS, INC.</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 50%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 46%; text-indent: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ H Stewart Parker / Board Chair</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">H Stewart Parker</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in; text-align: justify">EXECUTIVE</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Todd Patrick</TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Todd Patrick</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>tv521048_ex10-4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Form of Director Appointment Letter</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
], 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">RE: <U>Armata Pharmaceuticals,
Inc., a Washington Corporation (the &ldquo;Company&rdquo;)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dear [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
],</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I am writing to you on behalf of the board
of directors of the Company to confirm arrangements with regard to the terms of appointment to office as a director of the Company
from the date of this letter (this &ldquo;Letter&rdquo;).</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">1.</FONT></TD><TD STYLE="text-align: justify">Definitions</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the purposes of this Letter, the following
words or expressions shall have the following meanings respectively:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify">&ldquo;<B>Board</B>&rdquo;</TD>
    <TD STYLE="width: 75%; text-align: justify">means the board of directors of the Company, including any committee of the Board duly constituted by it;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Businesses</B>&rdquo;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">means:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the         business of the research, development, design, production, manufacturing, marketing, sale,
        distribution and other commercial activities         of any Group Company in relation to the Group&rsquo;s proprietary and/or
        licensed technology concerning the development of bacteriophage         therapeutics; and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
        other business that any Group Company shall at the relevant date:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>be
        engaged in and with which you shall have been concerned or involved to any material extent at any time during Your Appointment;
        or</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>have
        determined to carry on with a view to developing any other biotechnical technology for commercial exploitation in the future and
        in relation to which determination you shall at the Termination Date possess any material Confidential Business Information;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Confidential Business</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means all and any Corporate Information, Marketing Information, and Technical Information.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Information</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">Technical Information and other information (whether or not recorded in documentary form or on computer disk or tape) which the Company or any Group Company treats as confidential or in respect of which it owes an obligation of confidentiality to any third party, which is not in the public domain:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 75%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp;&nbsp;&nbsp;&nbsp;</FONT>which         you shall have acquired or shall hereafter acquire at any time during Your
        Appointment but which does not form part of your own         stock in trade; and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.1pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        &nbsp;&nbsp;&nbsp;&nbsp;</FONT>which         is not readily ascertainable to persons not connected with the Company or
        any Group Company;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Corporate Information</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means all and any information (whether or not recorded in documentary form or on computer disk or tape) relating to the business methods, corporate plans, management systems, finances, maturing new business opportunities or research and development projects of the Company or any Group Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Group</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the Company and its affiliates, including any company that controls, is controlled by, or is under common control with the Company, as defined in Rule 3b-18 of the Securities Exchange Act of 1934, as amended from time to time;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Group Company</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means a member of the Group and &ldquo;Group Companies&rdquo; shall be interpreted accordingly;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Law</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the laws of the State of Washington;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Marketing Information</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means all and any information (whether or not recorded in documentary form or on computer disk or tape) relating to the marketing or sales of any past, present or future product or service of the Company or any Group Company including, without limitation, sales targets and statistics, market share and pricing statistics, marketing surveys and plans, market research reports, sales techniques, price lists, discount structures, advertising and promotional material, the names, addresses, telephone numbers, contact names and identities of customers and potential customers of and suppliers and potential suppliers to the Company or any Group Company, the nature of their business operations, their requirements for any product or service sold to or purchased by the Company or any Group Company and all confidential aspects of their business relationship with the Company or any Group Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Material Interest</B>&rdquo;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">means:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
        holding of any position as director, officer, employee, consultant, partner, principal or agent;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
        direct or indirect control or ownership (whether jointly or alone) of any shares (or any voting rights attached to them) or debentures
        save for the ownership for investment purposes only of not more than five percent (5%) of the issued shares of any company whose
        shares are listed on any national securities exchange (as defined in Section 3(a)(1) of the Securities Exchange Act of 1934, as
        amended from time to time), or any similar exchange in jurisdictions outside the United States; or</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="color: #010000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
        direct or indirect provision of any finance; other than on behalf of any Group Company for the legitimate purposes of that Group
        Company;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify">&ldquo;<B>Options</B>&rdquo;</TD>
    <TD STYLE="width: 75%; text-align: justify">means stock options to acquire shares of the Company&rsquo;s common stock;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Technical Information</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means all and any trade secrets, secret formulae, processes, inventions, designs, know-how discoveries, technical specifications and other technical information (whether or not recorded in documentary form or on computer disk or tape) relating to the creation, production or supply of any past, present or future product or service of the Company or any Group Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Termination Date</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means the date of the termination of Your Appointment; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&ldquo;<B>Your Appointment</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">means your appointment to and holding of office as a director of the Company as confirmed by this letter.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">2.</FONT></TD><TD STYLE="text-align: justify">Duties</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.1</FONT></TD><TD STYLE="text-align: justify">As a director of the Company, you will be expected to exercise the general fiduciary duties and
duties of care and loyalty as provided under applicable Law and provide such advice and services as the Board may reasonably require.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.2</FONT></TD><TD STYLE="text-align: justify">The Board as a whole is collectively responsible for the success of the Company. The Board&rsquo;s
role is to:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.2.1</FONT></TD><TD STYLE="text-align: justify">provide entrepreneurial leadership of the Company within a framework of prudent and effective controls,
which enable risk to be assessed and managed;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.2.2</FONT></TD><TD STYLE="text-align: justify">set the Group&rsquo;s strategic aims, ensure that the necessary financial and human resources are
in place for the Company to meet its objectives and review management performance; and</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.2.3</FONT></TD><TD STYLE="text-align: justify">set the Company&rsquo;s values and standards and ensure that its obligations to its shareholders
and others are understood and met.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3</FONT></TD><TD STYLE="text-align: justify">In your role as a non-executive director, you shall be required to:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.1</FONT></TD><TD STYLE="text-align: justify">constructively challenge and contribute to the development of the Group&rsquo;s strategy;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.2</FONT></TD><TD STYLE="text-align: justify">scrutinize the performance of management in meeting agreed goals and objectives and monitor the
reporting of performance;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.3</FONT></TD><TD STYLE="text-align: justify">satisfy yourself that financial information is accurate and that financial controls and systems
of risk management are appropriate, robust and defensible;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.4</FONT></TD><TD STYLE="text-align: justify">endeavor to attend all meetings of the Board and the annual and all other meetings of the shareholders
of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.5</FONT></TD><TD STYLE="text-align: justify">at all times comply with the certificate of incorporation and bylaws of the Company, each as the
same may be amended or restated from time to time;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.6</FONT></TD><TD STYLE="text-align: justify">abide by your fiduciary duties as a director of the Company;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.7</FONT></TD><TD STYLE="text-align: justify">diligently perform your duties;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.8</FONT></TD><TD STYLE="text-align: justify">immediately report your own wrongdoing or the wrongdoing or proposed wrongdoing of any other employee
or director of the Company of which you become aware to the Chairman of the Company; and</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.3.9</FONT></TD><TD STYLE="text-align: justify">comply with the terms of the Armata Pharmaceuticals, Inc. Code of Business Conduct and Ethics adopted
by the Board (a copy of which is enclosed herewith) and any other code of practice, policies and guidelines issued by the Company
from time to time relating to dealing in the Company&rsquo;s securities.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4</FONT></TD><TD STYLE="text-align: justify">In addition, your duties require that you shall:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.1</FONT></TD><TD STYLE="text-align: justify">promote the highest standards of integrity, probity and corporate governance throughout the Company,
particularly at the Board level;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.2</FONT></TD><TD STYLE="text-align: justify">use your best endeavors to ensure that the Board receives accurate, timely and clear information;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.3</FONT></TD><TD STYLE="text-align: justify">use your best endeavors to ensure effective communication with shareholders;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.4</FONT></TD><TD STYLE="text-align: justify">use your best endeavors to facilitate the effective contribution of non-executive directors and
to ensure constructive relations are maintained between the executive and non-executive directors;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.5</FONT></TD><TD STYLE="text-align: justify">ensure that the performance of the Chief Executive Officer (and of any other executive director(s)
from time to time) is evaluated at least once a year; and</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.4.6</FONT></TD><TD STYLE="text-align: justify">at the request of the Company, serve on committees of the Board as shall be agreed between you
and the Chairman of the Board.</TD></TR></TABLE>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">3.</FONT></TD><TD STYLE="text-align: justify">Time Commitment</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You shall work such hours per week over the
term of Your Appointment as are necessary for the proper performance of your duties as a non-executive director of the Company.
You will be required to attend Board meetings, the annual shareholders&rsquo; meeting, Board dinners, meetings with non-executive
directors and training meetings. Some of these meetings may involve travel. You confirm that you are able to allocate sufficient
time to the Company to discharge your responsibilities effectively and should obtain the agreement of the Chairman of the Board
prior to accepting any additional commitments that might affect the time you are able to devote to your role as a director of the
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">4.</FONT></TD><TD STYLE="text-align: justify">Fees<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black"><B><SUP>1</SUP></B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will be entitled to certain cash fees in
connection with your services as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: left">i.</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 71%; text-align: left">Annual retainer fee</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: left">$40,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">ii.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director acting as Chairman of the Board</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$60,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">iii.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director acting as Chairman of the Compensation Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$10,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">iv.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director acting as Chairman of the Nominating and Corporate Governance Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$5,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">v.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director acting as Chairman of the Audit Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$15,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">vi.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director serving as a member of the Compensation Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$5,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">vii.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director serving as a member of the Nominating and Corporate Governance Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$3,000 in cash</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">viii.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Annual retainer fee for director serving as a member of the Audit Committee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">$6,000 in cash</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The annual retainer fees are paid on a fiscal
year basis and shall be prorated for any partial year of Board service. The fees and the terms prescribing the frequency of payment
are subject to change upon the determination of the Compensation Committee of the Board. On termination of your Appointment you
will (if applicable) be paid your director&rsquo;s fee on a pro-rata basis, to the extent unpaid up to the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, you may be granted stock
options under one of the Company&rsquo;s stock option or stock award plans then in effect. If such options are granted they will
be subject to the terms and conditions set forth in such plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">You will be entitled to participate in any
equity compensation program established for non-executive directors beginning in [20__]. You acknowledge that the Company may determine
to change any equity compensation program and this Letter shall in no way be deemed to be a guarantee of future equity compensation
programs. [You will also be subject to the director&rsquo;s stock ownership guideline, which requires each director to own Company
stock equal to no less than [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ], and you will be given up to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] years from the effective date of Your Appointment
to reach this threshold; stock options do not count towards this guideline.]</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">5.</FONT></TD><TD STYLE="text-align: justify">Term of Office</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Your Appointment will commence on May 9, 2019
and shall continue unless or until your successor is elected and qualified or until your earlier resignation or removal, subject
to the limitations set forth on page 152 of the Definitive Information Statement filed by the Company on Schedule 14A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black"><SUP>2</SUP></FONT>
You agree that you will give not less than sixty (60) days&rsquo; (or such lesser period if agreed by the Board) prior notice in
writing to the Company in the event you wish to resign prior to the expiration of your term or in the event you do not wish to
stand for re-election at the Company&rsquo;s annual meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><SUP>1</SUP> Note to Company: How will the
number of shares be determined and what will be the conversion price be for the Options?&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><SUP>2</SUP> See: <U>https://www.sec.gov/Archives/edgar/data/921114/000114420419018110/tv517046-defm14a.htm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the avoidance of doubt, by your counter-signature
hereto, you acknowledge that your continuation in office is subject to applicable Law and the certificate of incorporation and
bylaws of the Company, each as the same may be amended or restated from time to time. Any term renewal is subject to the review
of the Board and re-election at the Company&rsquo;s annual meeting of shareholders. Notwithstanding any expectations, there is
no right to re-nomination by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On termination of Your Appointment for whatever
reason you will promptly return to the Company all documents, records, keys, correspondence or other items in your possession or
under your control which relate in any way to the business or affairs of, or are the property of, the Company or any Group, including
electronic records, Company and all copies thereof, regardless of the medium upon or in which such copies are stored or held. In
addition, you will cease to use the Company&rsquo;s facilities and cease to hold yourself out as being a director of the Company.</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">6.</FONT></TD><TD STYLE="text-align: justify">Expenses</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company shall reimburse you in respect
of all reasonable traveling, hotel, entertainment and other out of pocket expenses properly and necessarily incurred by you in
or about the performance of your duties under this Agreement, subject to the production (if requested) of any receipts, vouchers
and other supporting documentation that the Company shall reasonably require.</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">7.</FONT></TD><TD STYLE="text-align: justify">Confidentiality</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.1</FONT></TD><TD STYLE="text-align: justify">Both during your service on the Board and after the Termination Date, you agree and will undertake
to maintain any and all Confidential Information in strict confidence at all times and you shall not, directly or indirectly, publish,
reveal or otherwise disclose or make available any such Confidential Information to any person or entity and will not use Confidential
Information for any purpose. Notwithstanding the foregoing, these obligations shall not apply to any Confidential Information that:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.1.1</FONT></TD><TD STYLE="text-align: justify">is necessary for the proper and effective performance of your duties as a director of the Company
and then only with the prior written consent of the Company; and to a person who shall be subject to equivalent, express, written
confidentiality obligations to the Company or a Group Company;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.1.2</FONT></TD><TD STYLE="text-align: justify">to the extent that such information is or (without default on your part) becomes generally available
to the public;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.1.3</FONT></TD><TD STYLE="text-align: justify">to the extent that you shall be required to disclose the same by any applicable law or legally
binding order of any court, government, semi-governmental authority, administrative or judicial body, or a legally binding requirement
of a stock exchange or regulator; or</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.1.4</FONT></TD><TD STYLE="text-align: justify">to the extent the Company approved such release in a prior written consent.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.2</FONT></TD><TD STYLE="text-align: justify">If you are required to make a disclosure as contemplated in clause 7.1.3:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.2.1</FONT></TD><TD STYLE="text-align: justify">you must disclose only the minimum Confidential Business Information required to comply with the
applicable law, order or requirement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.2.2</FONT></TD><TD STYLE="text-align: justify">before making such disclosure, you must:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: #010000">(a)</FONT></TD><TD STYLE="text-align: justify">give the Company reasonable written notice of:</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: #010000">(i)</FONT></TD><TD STYLE="text-align: justify">the full circumstances of the requirement for disclosure
arising; and</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: #010000">(ii)</FONT></TD><TD STYLE="text-align: justify">the Confidential Business Information which you propose
to disclose; and</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: #010000">(b)</FONT></TD><TD STYLE="text-align: justify">consult with the Company as to the form of the disclosure.</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3</FONT></TD><TD STYLE="text-align: justify">By your counter-signature hereto, you acknowledge that:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3.1</FONT></TD><TD STYLE="text-align: justify">the Company and each Group Company possess a valuable body of Confidential Business Information;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3.2</FONT></TD><TD STYLE="text-align: justify">the Company has given and will continue to give you access to Confidential Business Information
in order that you may carry out your duties hereunder;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3.3</FONT></TD><TD STYLE="text-align: justify">your duties include, without limitation, a duty of care and a duty of loyalty as provided under
applicable Law;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3.4</FONT></TD><TD STYLE="text-align: justify">the disclosure of any Confidential Business Information other than as permitted in Clause 7.3 could
place the Company and any impacted Group Company at a serious competitive disadvantage and could cause immeasurable (financial
and other) damage to the Businesses; and</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">7.3.5</FONT></TD><TD STYLE="text-align: justify">the obligations of confidentiality assumed under the provisions of this clause 7 are reasonable
and necessary for the protection of the Group, the Businesses and the Confidential Business Information.</TD></TR></TABLE>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">8.</FONT></TD><TD STYLE="text-align: justify">Other Interests and Restrictions</TD>
</TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.1</FONT></TD><TD STYLE="text-align: justify">It is accepted and acknowledged that you have business interests other than those of the Company
and that you have declared any potential conflicts that are apparent at present. If you become aware of any potential conflicts
of interest after the date hereof, these should be disclosed to the Chairman of the Company and company secretary as soon as you
become aware thereof.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.2</FONT></TD><TD STYLE="text-align: justify">By your counter-signature hereto, you agree and undertake that, during the term of Your Appointment,
you shall not, without the Company&rsquo;s written permission, assume or hold any Material Interest in any person, firm or company
which:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.2.1</FONT></TD><TD STYLE="text-align: justify">impairs or might reasonably be thought by the Board to impair your ability to act at all times
in the best interests of the Company; or</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.2.2</FONT></TD><TD STYLE="text-align: justify">requires or might reasonably be thought by the Board to require you to disclose any Confidential
Business Information in order to properly discharge your duties to or to further your interest in such person, firm or company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.3</FONT></TD><TD STYLE="text-align: justify">By your counter-signature hereto, you agree and undertake that you will not, without the Company&rsquo;s
written permission, during the term of Your Appointment and for the period of 12 months after the Termination Date, in any part
of the world, whether directly or indirectly:</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.3.1</FONT></TD><TD STYLE="text-align: justify">assume or hold a Material Interest in a business that directly competes with the Company&rsquo;s
business at such time;</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.3.2</FONT></TD><TD STYLE="text-align: justify">solicit, or by any other means induce or seek to induce, any person, firm or company with whom
or which any Group Company transacts business (whether as customer, supplier, contractor, licensor, adviser or otherwise in relation
to the Business) to cease dealing with such Group Company or to restrict or vary the terms upon which it deals with such Group
Company; and</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.3.3</FONT></TD><TD STYLE="text-align: justify">solicit or entice away or employ or engage or seek to entice away from any Group Company any person
who is and was at the Termination Date or at any time during the six (6) months prior to the Termination Date a director, scientific
adviser, regulatory adviser, bioscience engineer or other scientific, program, product development, marketing, sales, licensing,
research and development and/or other senior manager, key salesperson or secretary (if any) assigned to you.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.4</FONT></TD><TD STYLE="text-align: justify">By your counter-signature hereto, you agree and undertake that you will not at any time after the
Termination Date, represent or hold yourself out or permit yourself to be represented or held out by any person, firm or company
as being in any way then currently connected with or interested in the Company or any Group Company other than (if such be the
case) as the holder of shares, options and/or warrants in the Company.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.5</FONT></TD><TD STYLE="text-align: justify">By your counter-signature hereto, you agree and confirm that neither this letter, nor your or our
actions, past, present or future constitute a contract of employment and no employer-employee relationship exists or will exist
between the Company or any member of the Group and you and to indemnify and hold harmless the Company, its directors, officers,
employees and assignees harmless from and against any and all demands and/or claims addressed against the Company by you or on
your behalf, or any third party, in connection with any alleged employment relationship between the Company and you, or in connection
with any liability, obligation, debt or responsibility deriving from such relationship, including by virtue of any agreement, arrangement,
statute, extension order, custom or the like.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.6</FONT></TD><TD STYLE="text-align: justify">Each of the provisions of clauses 8.2, 8.3 and 8.4 and (where applicable) the sub-clauses thereof
is independent and severable from the remaining provisions and enforceable accordingly. If any provision of the said clauses/sub-clauses
shall be unenforceable for any reason but would be enforceable if part of the wording thereof were deleted, it shall apply with
such deletions as may be necessary to make it enforceable.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.7</FONT></TD><TD STYLE="text-align: justify">You have given the undertakings contained in this clause 8 to the Company itself and to the Company
as trustee for the benefit of each Group Company and will, at the request and cost of the Company, promptly enter into direct undertakings
with any Group Company which correspond to the undertakings in this clause 8.</TD></TR></TABLE>

<P STYLE="color: #010000; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">8.8</FONT></TD><TD STYLE="text-align: justify">The Company agrees that each Material Interest that you assume or hold as of the date hereof is
hereby permitted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">9.</FONT></TD><TD STYLE="text-align: justify">Indemnification and Insurance</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As with all of our directors and executive
officers, you and the Company will also enter into, and be afforded indemnity protections pursuant to, the Company&rsquo;s standard
Indemnification Agreement, which we have enclosed with this Letter. The Board has obtained Director&rsquo;s and Officer&rsquo;s
(D&amp;O) insurance in an amount appropriate for the Company's business on an annual basis (or more frequently as circumstances
warrant).</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">10.</FONT></TD><TD STYLE="text-align: justify">Independent Legal Advice</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Occasions may arise when you consider that
you will need professional advice in connection with the performance of your duties as a director of the Company and you will be
able to consult the Company&rsquo;s advisors for this purpose. Exceptional circumstances may occur when it may be appropriate for
you to seek such advice from independent advisors, at the Company&rsquo;s expense. In such an event, you should, where reasonably
practical and not (in your reasonable judgment) prejudicial to the interests of the Company, consult with the Board or, if you
consider appropriate, the non-executive directors, prior to such advice being sought or expense being incurred.</P>

<P STYLE="color: #010000; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase; color: #010000">11.</FONT></TD><TD STYLE="text-align: justify">Governing Law and Jurisdiction</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Letter shall be governed by and shall
be interpreted in accordance with the laws of the State of Washington, without giving effect to its choice of law legislation.
The parties irrevocably submit to the jurisdiction of the state and federal courts of Washington State in relation to all matters
arising out of or in connect with this Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On a more personal note, I want to tell you
how pleased I am that you are joining the Armata Pharmaceuticals, Inc. Board of Directors. I know that I speak for the other directors
in saying that we look forward to your leadership and contributions as a director. I would greatly appreciate if you would confirm
your acceptance of the terms of your appointment by signing and returning this Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With kind regards,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 65%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Duly authorized for and on behalf of the
Board</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I hereby acknowledge the above terms and agree
and undertake in the above terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Date</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-weight: normal">[<I>Signature
Page to Director Agreement Letter</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>9
<FILENAME>tv521048_ex16-1.htm
<DESCRIPTION>EXHIBIT 16.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 16.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 10, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 314.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commissioners:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have read the statements made by Armata Pharmaceuticals,
Inc. (f/k/a Ampliphi Biosciences Corporation) who has merged with C3J Therapeutics, Inc. (copy attached), which we understand will
be filed with the Securities and Exchange Commission, pursuant to Item 4.01 8-K of Armata Pharmaceuticals, Inc. (f/k/a Ampliphi
Biosciences Corporation) who has merged with C3J Therapeutics, Inc. dated May 9, 2019. We agree with the statements concerning
our Firm contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ PricewaterhouseCoopers LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Los Angeles, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attachment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>Attachment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 4.01</B></TD><TD><B>Changes in Registrant&rsquo;s Certifying Accountant.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The disclosure set forth in Item 2.01 above is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dismissal of PwC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PricewaterhouseCoopers LLP (&ldquo;<I>PwC</I>&rdquo;) was previously
engaged as the independent registered public accounting firm for C3J. On January 28, 2019, the Audit Committee of C3J&rsquo;s board
of directors (the &ldquo;<I>C3J Audit Committee</I>&rdquo;) dismissed PwC as C3J&rsquo;s independent registered public accounting
firm, effective immediately (the &ldquo;<I>January Termination</I>&rdquo;), and engaged Ernst &amp; Young LLP (&ldquo;<I>EY</I>&rdquo;)
as discussed below to serve in such capacity instead. EY has served as Armata&rsquo;s independent registered public accounting
firm since 2015, and will serve as the independent registered public accounting firm for the combined company following the consummation
of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In anticipation of the Merger, however, the C3J Audit Committee
engaged PwC to audit C3J&rsquo;s consolidated financial statements for the fiscal year ended December 31, 2017 in accordance with
the standards of the Public Company Accounting Oversight Board (United States) (the &ldquo;<I>PCAOB standards audit</I>&rdquo;).
PwC had previously audited those financial statements in accordance with auditing standards generally accepted in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 18, 2019 the C3J Audit Committee determined to terminate
PwC&rsquo;s engagement with respect to the PCAOB standards audit of C3J&rsquo;s December 31, 2017 consolidated financial statements,
and PwC was notified of such determination on February 18, 2019 (such termination, the &ldquo;<I>February Termination</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PwC&rsquo;s PCAOB standards audit of C3J&rsquo;s December 31,
2017 consolidated financial statements was in process but not yet complete at the time of the February Termination. Accordingly,
PwC did not complete the PCAOB standards audit of C3J&rsquo;s 2017 consolidated financial statements, and PwC did not issue an
audit report under PCAOB standards with respect to those financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The reports of PwC on C3J&rsquo;s consolidated financial statements
for the years ended December&nbsp;31, 2017 and 2016 (which were issued under auditing standards generally accepted in the United
States but were never filed with the U.S. Securities and Exchange Commission (the &ldquo;<I>Commission</I>&rdquo;) because C3J
was not subject such reporting requirements) did not contain an adverse opinion or disclaimer of opinion, nor were they qualified
or modified as to uncertainty, audit scope, or accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s fiscal years ended December 31, 2018 and
2017 and the subsequent interim period through dates of the January Termination and the February Termination, respectively, there
were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K under the Securities Act (&ldquo;<I>Regulation S-K</I>&rdquo;))
between C3J and PwC on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures,
which disagreements, if not resolved to PwC&rsquo;s satisfaction, would have caused PwC to make reference to the subject matter
of the disagreement in their reports on C3J&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s fiscal years ended December 31, 2018 and
2017 and the subsequent interim period through dates of the January Termination and the February Termination, respectively, there
were no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K), except that PwC reported to C3J and the C3J Audit
Committee that it believed a material weakness in internal control over financial reporting existed related to the lack of segregation
of duties, particularly as it relates to the processing of journal entries (such matter as reported by PwC to C3J and the C3J Audit
Committee being hereinafter referred to as the &ldquo;<I>Matter</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata has provided PwC with a copy of the disclosures it is
making in this report and requested that PwC furnish a letter addressed to the Commission stating whether or not it agrees with
the statements made herein. A copy of the letter, dated May 10, 2019, is filed as Exhibit 16.1 to this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Engagement of EY</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described above, effective January 29, 2019, C3J retained
EY as its registered public accounting firm, and effective February 21, 2019, C3J retained EY to conduct the PCAOB standards audit
of C3J&rsquo;s December 31, 2017 consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During C3J&rsquo;s two most recent fiscal years and the subsequent
interim period preceding the engagement of EY, neither C3J nor anyone on its behalf consulted with EY with respect to: (i) the
application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that
might be rendered on C3J&rsquo;s consolidated financial statements, and no written report or oral advice of EY was provided to
C3J that was an important factor considered by C3J in reaching a decision as to the accounting, auditing, or financial reporting
issue; or (ii) any matter that was either the subject of a &ldquo;disagreement&rdquo; (as defined in Item 304(a)(1)(iv) of Regulation
S-K), or any &ldquo;reportable event&rdquo; (as defined in Item 304(a)(1)(v) of Regulation S-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>tv521048_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; color: #569BBE"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; color: #569BBE"><B>C3J Therapeutics and AmpliPhi Biosciences
Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; color: #569BBE"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>Shares of the combined company to commence trading
on the NYSE American exchange under the new symbol &ldquo;ARMP&rdquo; on May 10, 2019</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Completed $10 million concurrent financing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Ongoing collaboration with Merck to develop
proprietary synthetic phage candidates</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MARINA DEL REY, Calif., May 9, 2019 /<FONT STYLE="color: #363C2F">PRNewswire</FONT>/
--&nbsp;Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (&ldquo;Armata&rdquo;), a clinical-stage biotechnology company focused
on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the previously-announced
merger between C3J Therapeutics, Inc. (&ldquo;C3J&rdquo;) and AmpliPhi Biosciences Corporation (NYSE American: APHB)&nbsp;(&ldquo;AmpliPhi&rdquo;)
has closed. The new combined company, known as Armata Pharmaceuticals, Inc., will focus on the development and advancement of phage-based
therapeutic candidates to treat antibiotic-resistant infections. Armata will trade on the NYSE American stock exchange under the
symbol &ldquo;ARMP.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are pleased to have consummated this merger between
C3J and AmpliPhi combining each company&rsquo;s complimentary and unique strengths and, we believe, creating an undisputed leader
in the development of bacteriophage therapeutics to combat the increasingly urgent crisis of antibiotic resistance,&rdquo; stated
Todd R. Patrick, Chief Executive Officer of Armata. &ldquo;With a Phase 1b/2-ready lead asset, an extensive synthetic phage library,
and world-class, phage-specific GMP manufacturing facilities that can efficiently advance new candidates into the clinic, we bring
a unique set of capabilities that clearly set us apart. Further, we believe we have the leadership team and financial resources
in place to advance our novel pipeline of natural and synthetic phage-based candidates through meaningful and potentially value-creating
milestones. With the merger now completed, we are working diligently toward that goal.&rdquo;&nbsp; &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata&rsquo;s innovative pipeline of bacteriophage therapeutic
candidates includes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">AP-SA01 phase 1b/2 - ready <I>Staphylococcus
aureus</I> natural phage product candidate </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.45pt 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">IND filing planned for 2019</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.45pt 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Pseudomonas aeruginosa</I> phage
product candidates </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.45pt 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pneumonia and cystic fibrosis natural
phage product candidates identified; engineering started </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Planned entry into the clinic in 2020
with a phase 1b first-in-human study of synthetic phage targeting one indication</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 37.45pt 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="padding-right: 37.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proprietary synthetic phage candidates
being developed with Merck, known as MSD outside of the United States and Canada, designed to target an undisclosed infectious
disease agent</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concurrent with the closing of the merger, an investor syndicate
comprised of certain existing C3J shareholders invested $10 million into Armata, bringing the Company&rsquo;s cash balance to approximately
$16 million. The financing proceeds, together with cash on hand, will be used to advance the combined company&rsquo;s preclinical
and clinical programs and for other corporate and general purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The securities issued in the merger and sold in the concurrent
financing have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered
or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such
registration requirements.&nbsp; Armata has agreed to file a registration statement with the Securities and Exchange Commission
covering the resale of the above-mentioned securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the closing of the merger, AmpliPhi completed
a one-for-fourteen reverse stock split. As a result of the reverse stock split, every fourteen shares of AmpliPhi common stock
outstanding immediately prior to the merger were combined and reclassified into one share of AmpliPhi common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the closing of the merger and the concurrent
financing, the C3J shareholders, after taking into account the issuance of shares in the financing, now own approximately 76%,
and AmpliPhi&rsquo;s current shareholders now own approximately 24%, of Armata&rsquo;s common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LifeSci Capital acted as the exclusive financial advisor to
C3J and Thompson Hine LLP served as legal counsel.&nbsp; Ladenburg Thalmann &amp; Co. Inc. acted as exclusive financial advisor
to AmpliPhi and Cooley LLP acted as legal counsel.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information: <FONT STYLE="color: #363C2F">www.armatapharma.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Phage Therapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phage therapeutics are uniquely positioned to address the threat
of antibiotic-resistance as they can be precisely targeted to kill select bacteria, have a differentiated mechanism of action,
can penetrate and disrupt biofilms (a common bacterial defense mechanism against antibiotics), are potentially synergistic with
antibiotics and have been shown to restore antibiotic sensitivity to drug-resistant bacteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Armata Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Armata is a clinical-stage biotechnology company focused on
the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based
technology. Armata&rsquo;s lead product candidate, AP-SA01, targets <I>Staphylococcus aureus</I> including multidrug-resistant
strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage
for <I>Pseudomonas aeruginosa</I>, leveraging its proprietary phage-specific GMP manufacturing capabilities. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements &ndash; </B>This communication
contains &ldquo;forward-looking&rdquo; statements, including, without limitation, statements related to the anticipated benefits
of the transactions contemplated by the merger agreement and related transactions, the anticipated benefits of the sale of $10
million of Armata&rsquo;s common stock to certain shareholders of Armata immediately following the closing of the merger, and statements
related to the anticipated filing of the IND for AP-SA01 later in 2019 and the planned entry into the clinic for the synthetic
<I>Pseudomonas </I>phage candidate. Any statements contained in this communication that are not statements of historical fact may
be deemed to be forward-looking statements. These forward-looking statements are based upon Armata&rsquo;s current expectations.
Forward-looking statements involve risks and uncertainties. Armata&rsquo;s actual results and the timing of events could differ
materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include,
without limitation, risks related to Armata&rsquo;s ability to successfully integrate the operations of AmpliPhi and C3J and achieve
the potential benefits of the merger; Armata&rsquo;s ability to advance its preclinical and clinical programs and the uncertain
and time-consuming regulatory approval process. Additional risks and uncertainties relating to Armata and its business can be found
under the caption &ldquo;Risk Factors&rdquo; and elsewhere in Armata&rsquo;s filings and reports with the SEC, including in Armata&rsquo;s
Annual Report on Form 10-K, filed with the SEC on March 25, 2019, and Armata&rsquo;s subsequent filings with the SEC. Armata expressly
disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained
herein to reflect any change in Armata&rsquo;s expectations with regard thereto or any change in events, conditions or circumstances
on which any such statements are based.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>At the Company:</B><BR>
Steve Martin<BR>
Armata Pharmaceuticals, Inc.<BR>
<FONT STYLE="color: #363C2F">ir@armatapharma.com</FONT><BR>
(858) 800-2492</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B><BR>
Joyce Allaire<BR>
LifeSci Advisors, LLC<BR>
<FONT STYLE="color: #363C2F">jallaire@lifesciadvisors.com</FONT><BR>
212-915-2569</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; color: #569BBE"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tv521048_ex10-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex10-2img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 7 !> P$1  (1 0,1 ?_$ +$   (" @(# 0
M      D*" L !P(& 00% P$   8# 0                0%!@<( 0(#"1
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M48EV8T7FK--?6=1-ER9)F;J"A+5.EO 7BZPD;K2%1-S(AJ+A#M.#;]F7=:U
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M3.FH41263. @9)4"^I#A_,/4!#B%=U;32Z5:DB<CC+'[H;U?0>DR'#E%@O\
M;!>7N;W28V?[$=QMH7F\_8%J*$IA^Y3CX5IG+6#(A1I%*Q,LX<#W92]XD47;
M-7*XB=Q(PR[9R?J50=J#7FLIE4=0NG6""E7&&B\T6G"##=/!:.< ]^X5WSRF
MQ7QJ97L5'FS0>8\Z.V.WC$+]NH*;^(G,A-9#ZMMK$Z9B+MWE-QO&S#]LN00%
M%^FV'740XW;;+KJ6^!,HZM)*EB*M+$&/IZ[62L4ZHP4A8+1:YV%JU4K\:B=W
M)S4U-/F\1!Q+),I14</'[YTF0O+F<XB/+4>)]VE;:6V4/U]7(4Z$X\\,<O\
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M>L'EM%Q$.T#K&,JW7ACLQBCMS"(_!VNG3EZ<25=NS.PV+.Z\BSTP*4*,_5J
M G.<\_'G$&*[_4*;\W2?6HU.D@">&!Q!Y?&)V;5O/KNFQA*1,-N7BX;<)C]1
M1%*3GXN)BZ;EF);&#0[R/<11&-2LHM^H3F;NV;99;IZ0=)CSXC7=/\7Z&JHO
MK-J/.T]P+(7TE^M!U"?SY@^PCPAQ[3_D-:+K6*I:QUE38Q!2?5I"M.1D,_A!
M+O(KYSL,XFVGP=JVBW&)R/FW-\/(,Z"B9L JX@;)=3*;NF1ZZ\ KN+G:^Z,*
M,=$.B%%Z^ %1ZVB1S*0GL+LMN&\[J-HW'3NTM!2N#KK4)%8SDWP4"!GD!EC%
MA:*^6NX-M/TCJ5MNB:9'+SY17NWI]8K38IZYVB:EK-:;++/[!8[!.OG$G-3L
MU*NCO).6E9%R8[AX^?NE3J'4,.HF-RT#0.+R)M]%3TC=NHFT-4C*0A"4X )3
M@/?F?$F)8LM8'$I9)_; PC5<U'$?,SCTAU@&H!H F$-!#GK^&G$6;IM*1J"1
MZB(/U39"Y'%,X^3MMW%7_9)NDPMNEQDNY0M>%[[&7(K%LL= MD@&PJ,;O2WA
MB:=R-O-*>/XI<A@$O2Y VG44HA53?5C-.OZEL#7K.KRE^<,Z[T*T.3$N?LBX
MJ#<GBG]LAMW'U&W_ $4#"G[@ L_=;]C].?HD+_\ ,>ON=@5/D Z]/5KW/A]>
M(QAOZ3/3QA%_[R3.;ZP[E=GFVQG)&&%QUA^YYDF8U$VJ0V;*=M2I,$N[(
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M*G' " I6J1"4I) ,YG&8$@8],OXV7R[[IH'JI]]IFTT*4=1U:\ M0)2B1XJ
M)PY1^.7/$I0K9C#*&3-BF]/%^\Z1PK7G%PRIB.$J<QCW*,73V9%59*T56$FI
M%^:U1L8FB<ZI2D1ZRE$J*BBPD1/%]!W:K*>\L6K>MGJK,U5JT,NN$ELKX!9*
M1*<Q.4SX2B_UAN#&AM5*]U$%(Q_+PY3@ IR$!98I1*9,X 8F@CH)#@!@$-?P
MT'B2=RL-U%.'D@3(X1*=*OK4ZM6<HT%?V(%%<PA_=&!0H#RYE.!M1#\>*P;W
MH MIU*ASA&NK8=]9,I"''L=[H+-?OLX<\LVDBL%CPE,0NTJ4<$7.+LU)F-UN
M'8-%DJ8%.X1,V'<L(L@ 1YHD]-.7%:@TKZCHG/7+XPR__?[8'?\ =%53(]I\
MP-S>1M%O,Q!,,$[?X6'E(VK3LG$+I)1%GEWB+!^R9N6:HMY"85!4"F Q5-0,
M'H(N':JVDW1(<,H[4'_G$,/?:28N?4W9_N2N,[7I>OV"Y[AV40LE.13^(?*P
M]/QW6U(SH0D&S98[0KRS/!*8NI!,8P!S >%ON0\FHKZ9E)]*&9CS)./P$'KZ
MXHN-()](3(>^"T^;JWVNH^,/=0-*;R[FQ6FLU:@-4H-H[?29F%\OE9J]A*W:
ML"*.U2JUN1=IJ= #TIG$P\@'C3M0S357<"WMUFGH(>*C/(%#:U))\E!)'B,<
M(1T3"@1G" F+,9Y 1:)B?'MZ(8I1$ -3+"0P<M/0T:7^''HW372TK>U/U+ 4
MM>M9*PC4J0$\?#@)#PBMG>1=S-/4(I&5*7H,BE)7PXRRB;.,<9W82H"O0[HG
MU',8_74YT- *;0-1,P 0* ARY\2?;]P;;DD.U]"D@# OI& ]D>.O<NS;O4'G
M/H:M6IQ1FEER7P2K[_9!$\08SD8Z<IDO,52[J*NK&BA$Q,=!/V BFQ% KR3E
MY!U%.P;L@4=%30222,JL<BAC&3(0.MI[UWK25E#<K+M^IH!2M4I4NH>>&92=
M3;*4RU$R,IY C,G"/]C;&KF[E072^T-T54U51IITLL.'0AM0UNO_ +>15Z$@
M9B-4WO%DR: 8RD-5;HNRDO=-%&K^NR*DK$23!)L+M@Z,UCTD7;5<CM%5JY(F
MEW2"8IB%.F8!<-@WO;JAQRT7JKMB:^CIF-);=DR\A:<%(4HS"D9+2>.6$(=1
MLN[TCS-WL=#<#:*I:PA"V7.HVIM0"@J3<BE4R4*R,]/S(,0DGL7Y>F)5G3*]
M1LC/C6V9AV*=?95^Q$:3D^#I:/K@.&AVJ,>N];N)4Z;95;3L"N?0Q ,8>$S<
ME]V<FG7<ZFKMZ*A@$I<"DN+2DXJ"52FD&0F!G(<HN-V4M^]VKK3T:*:L;I']
M.M"@I"5RP$TJ2D*E.4Y&4\X))L1VCYM\=%[R/O\ MW=2DL2X\H6'\C46G8M>
MK-YW)&=;W?8U*-A*5%TJK.)AZ$4*S8JBJKOH JP)*= (I*K)TU[G;YL'<-NC
MV+LYT5E2[<!4+?DK13A(T*U$C 9K,I#AF9'V V-;+A1T(;KVRRK2D"9Q $*G
M3.,LGN)A=S^EU_;^[<.7)F[>CV?L-O<+'6]LD(16@(H"?H)_PE#B=:ZLH1;4
M)^H:F !/RB>[8^ST"-4\(TED7%^3.A<0QKD'44C@&M(LVNO/U_\ %Z^H<5\W
MA5T/[B2ZE0,Y2\LX*UZT+2H)$'DV<5G(I?MA_+E3I*E75L[_ '5[=YBN0[NK
M3K=](IO,C;0UI-Q$L%617T@D@:',991),Q2 0=3?";2K\D?]K\\T=7/ECE]N
M<,;_ .G_ '1]3[MBFV>@>3O'60F<M.,H/,&V"A230K.3D&;(LQCVZ7>HSR1$
MD%TTA<I,'\8=0=->E8G\SVVZA+%S0%2]1$=*%02^)F#-_:$9=)9-NF[3$TC+
MN7\[3<R4_("*3]\X>._D5^I*<$11+W)U#E;)2M"7 =!TZU.'1W*94FMIJDC!
M=.![9G#XB#MZ!4XVH?+I@\?EUPY8,Y^.+=;1*@1VI;$,<&O%<28JKI/7$EC*
M:B<A R:&;&(N9S(M*TJV(4HZF,J   B.G"9VXN[%AWQ;KK4)U,(J %#F%@H^
M]4X2FE:5@Q7'8KN\R)$2#89TW=T,433,EJ8BA0$O(70B ](\>E=.6/J5.AL=
M):PH @83 B#^ZEF<JVGEM3!*%3EY81,JB7J88N"MU)V9$0,51$3RST2F = %
M/XG&@:?AQ(]M-&Z@:6D'A\H_*/'_ +J;;NE)5/TCRJA"%+*DR)D=1\_""'81
MR['/Y^EP-C=V YFME1<Q,C%3':>MU7WM_>,GS=\*B#Z-6.U*H4H&2514ZC%.
M8JAR"V][V1\4%PNEC^F:-92:*AM:<PRDR4D@'2I0F#@0<,B)Q$^SBXB\4-HO
MJJP,L/J53NM%75:65 K2O&3K"I:N:%3E,1J3(N8DGL1'0E>=3+&&BB.7"*CJ
M<5>2D@]DB-32$G+NT!:H%6,1HBDB@DF5%NDEIJ<YCJ'7K#:E48=O%W%.[<*Y
MBG3)")!I#8(0D @S*I^I7$\ )"$8T]7<'&;5:!4MV6A+JDAQ2M94XM.M9,Y2
M.@$#,3\XA[*3V17"4Q?:ZYOA8>AN8E>0MT.XL/L*I(/7W3 O'TZT.#:$<.9)
M, :'442.94@= ]0<D+=-?86P+-7BD#U2"$LN%*2X,C(9G/&47:[!;/OU5<V;
MRSU_IZ8":_4I(!QF2)RR@D_B,W3[@]T&YFV;*L^W:[9^VJ9=P_E$^7H;)4U(
MVU+&S*$KKB4B+]%6Z96<S%15).IMV1# [(E[ETDJ0H+HIG+4/O%L_;VT+4QN
MS;3+=LW'3UJ4H#4QU29'TI/S2!QD",P<(]7=H_\ 8*H@Y7/!PJ2)"1\OB(5M
MM$W+-;3/,8NVV&0BXV:F(^-D?GTH89"-923EJP?&.#O0PO&21%!$.0B;B;;@
M\XY:&W'DZ7"@$X#,@3B>*!.BF5K$L/PB/N1+98 (XZ;)8C!T&(/_ )V4T 1'
M3D .]>*X[T>"6G5 "0G[H2K@M&@B?.&4=M=4M%2^TE\AN39*0G >96W98S>0
M+]9_)B\-7JQN3VD8N[[1XJN*Q6@S,')IF[1@)TD, \^KBL77G6]7@'/QAD3'
M7GXP77[P/::\R3M"P;NXK<:9S*;7\ENZK>UVZ?YJ&*\YC#0!Y)T8I!,9I"Y+
M@J^7U J9'ZIQY .F*-SHU2'>2A 85I=!A>'[;C?#&[2/('3H2[S!(7&.Y>$)
M@>Y.W2R2$?#VB5E6C_&%@>J+G20:MVEP2+'*K&-HDA*J&'X0$.)@W%2)O^T_
MJ&/574RI^8EC*7VPAQ5+;=9;NH@?N-Q:*+E(NDHB8B:A%"F3435*!TCE'D=-
M4@Z@<ARZ@(#R$!T'B$E^I/I)"P0<,P09CXCW0U=1U2E(Q73>87QO6WQ][B)?
M(M$A';O:OF*S2<UCV?9(*K1V/K#+.%I"8Q/8E2%,2,6C')U%(-142IOHXQ4R
M&,LW6*%\NS'<-.]+,S:*MQ*=QTH"5)6H K2,$J3/YCP(S!QR(@G>;6U=*58"
M9KT8P/NKW9F^01*HL'44H=)BCH<O+T$?4=!XL'1W%RG)"5'T*((D1ZAF,<_/
M(Q3/NAV>H[PRI3C,GQD9><N$2@PM;W@9,H"8/$E4C6:,('<$HB)3*:!_(0'G
MP=O-]IW]OU"-<EEIP2\=)$5AHNP]\I=QTU2@*+#:R0)C)1PSY"4YQJF1MJBC
M<H.WI 3Z"]:2(Z .A0Y>O]DWKPI.;@2S1(2B?5%.V!A/AGAC[>$&-O?Q]N!N
M"W;MJ-*5E,A+$A9/ 98QN#;]Y&LS[+5[%'4^#J5]Q5EF-2^O<+9>K)Y[&63H
M5,SB.2D1:+>W6[R9D56Q7S10Z1^@R2I%0(!2PCO?8UF[AEEVK?<1>J0DI>8=
M3U&M6,I3XF1QD<,(OSVEV<]M&F-!1IT6]Y !3I^90P"B<, "1ASCV<S>9BZ.
M<,Y"PAM;VO;<-D5<R]'N(?+%EP5 NBY#NL([2.@]@?JMVE'J0\6];+K(G!-%
M5<J"RA$E$@.81:5K[0TRKE37K=-VKKL]1K!80_+I(*3Q25+.8QD0#@#.46<L
M]E;ZB4D   >67VS@&3E=-HU46-H ].A>6A0#0 *4/X=(!RX=&Z;BD)2PV9 9
M\H>A'226CQB.-N=O)-\WCXQFXE))\Z1;Q\8S2.X>24BY7*A&QK)ND!E5WLB_
M4301(4!,=10"AS$.*L[\NH#+J$G'[_"&K<GD@J3F8M*D_%FY)X E_&6FFD3(
MBVTP&2YRHI%(MN+!='- *J"&@*$#-Z1"]T?B[9 'U  X@B>&OPG#2GZY\)P8
M+<!@S'NYC"F4\ Y6B"3F.\P46Q8_MT:8$^XI$6..68*NF:BA% ;2D8JJ5TS6
M .I!TBFH7XB!P/SC )29C.*=C=[M4RMX_-UN5MK674G2-GQC9>S#V5-%1@SO
M-*>JJN\?9/KJNI3EC;?")I+@*9M6K]-=L8050. 27LN^(;<Z%6KTY2Y^<+MN
MK-/I,IG,18/> 7S1UK>GC&L[6]P-J81F[;&L"A%Q,G-.TVY]P=+@F0)-;1#K
M*"F1WD2%CFY"SC$!%P[ @R"13$.N5!)WCM-RUU/_ &M!Z[8]B)&>CC(_APX0
M5N%)H67V0>B/APABO).,,>9FHUBQOE.G0-]H%NC5HJQU*TQJ$I#2S%< ^!RT
M=$-T+(G %$5B"1=!4I5$SD.4I@9UOJ:BW5:;A0+6S6H5J2M)(4".4ON,)VM0
MR,*Z[FOM?:;,SLA:-G.>GF*VSQ==PEB_+D=(72JQHJ]1RLX*\1#E*V,(U(X]
M)$WS666*30.\;3BQFW/Y'WFB2BFW12_6H0D#J(.AQ0&05/4DGQD)P4J:.GK$
MR?2#$1<:?;M>0FI9+JDK+9$VX'KL#8&+]Y*MKA=W"ZS-JL J&:QBE 17%4R>
MH@0YR!^ F#UX?%5_(C9K] XPFBK@XM"I#T8*(.&J>4^,O&&X=G6E53]26T:@
M?'[3@BVT?[;O$^/IB+MN[S*[S<#(1QT7*6-:A&OJ+BY5PAT&*G8GJLDZN%N9
M ?7\@JD6@H  "R:A!,08YW/_ "(W!=FE4>W&#0-%H-J<)U.2 _29 )GQ,E>$
MH-4FU;+1+#C3(U3)QQS@DWD(\56W;?3@:+Q:X@8;%=SQO"+,L$Y&I]?8,E<9
MF21Z6M;-#1B;!"7QT]4*4'</J0@:=YN9)P4#C&FRNX%^V3?4WFF6Y4AQ?[R%
MJ)Z@/ZB9YIG@?@8<U,MJG6GTC2,) </"*S_<G@C(>V3..2L!Y9^1$O6++(YK
M5A/69YA8H%RX(DDZ:/HV48J*$%!\P<)*]E8$G;4QQ1<))+D.F6];&\;3>[#3
MW>W:TTSZ-0"AI4#,A0(\% RYB1XQ)E&[3JI$/(!25#CGG$1;A8DVZ"B13@"9
M -\0&Y#H \P#UXB+<NX&B5+4K$1PK:Q+:#KEU)80=/[:'QK2V]7>NQW.Y$KR
MSG;IL^G8BYNEGZ A%WK/"2826,*,T.J)$WR%.<=NSRX$!1-+VS!NJ >[T&L&
MZ+HJX5RD(/[(,_;E#&K*G6LZ<S%G=PV83HS@0( [YSO#34?*9A1C8J.>"IV[
M[#L;)'PM?)),&D7;8AP)WTEAS(D@@@LX^D+"]+WF#P2J'A)00<)@*2KI-;=M
MQQI>MHE*QQ$92I2<4F45BLM&9JVK9EF:+?8:\84SCARVI-I2,>G?5F\T"W0S
MD'#!XT?,5D'+94IB$<Q\BS5,W=MSD6;JG3.4PR]MK<M)4,_17"185@4&1&7(
MPX*&K:<(:J,63F#]N<.$>.7[J^UTN(@L8^0&HR^48>.;MHUCN!QJU8%R$5JB
M4B**V0J*LO'0]K<$(&JLC&+-'BNFIVJZ@B<Q:]=O:>J)K-OO)!4)],G#P"3B
M/MG*.E19DNS>HB"/\N4O*&ML#^5SQW;DV3-UBG=QAEZ^=HI*_3-KMC3'=O;'
M43[AFSFKWT*[,E<HCJ4Y2)*% P<C#Q'M9MC<-"]TZJE<!X225S\9IG"([15+
M2M*TJ!\!/[HF*7,&(U$2+)Y1QPHFJ4IDE"7BL&(KUA\'0H$H)#]8CR$!Y\$S
M;*_&=.]/_0K\H+EAS@DZO(YQ!7<#YA/'!MI92"F0=U6,):<8(J*?1N,I@F5+
M@\63Y>R;P]$";*@[.;D .E6Q ]3&* :\+%KV;NB[K":*C<TXXJFD"6>*I"#E
M/;:ZIDE"?5+C@/C"I7D7^YTRYFB)GL6[*Z_,;?<?R:;F.D\N6%RT6S=.QR@*
M)*%K+2.7>0>,4W2)P_[A)>0E"_\ 36;& >)AV]VIMUMTW'<SR'*A)!2R,4X9
MZO\ -RY'C#BI+"RP0Y5J)<!P Q'V_K"E5IOB[A1\[<O7#IV]<N';Y^\<K.WS
MYVZ5,LZ=O':YU'#QZY74$ZBAS&.H<PF,(B/#\O&XV6J=+:"E+20  )  #
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M*8H^H!Q(ULW\V[(:_5/C,??"TU>043EJ\<HWQ@J\LR9BQD!B-RA]90@% Z!
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M2]8)D(0J#!")'<"!&<"!&<"!&<"!&<"!'CX=>73U?CZ:Z:_Z_7@0( ;Y&/\
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6[VFFO].NG/C,:QRX$",X$",X$"/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tv521048_ex3-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex3-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0 #X P$1  (1 0,1 ?_$ 'D   (!! ,! 0
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F7K#9*5#7V1 $D$X1N"*+S]N@+TB(B(B<HB?Y_P"_/07Z"N@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tv521048_ex3-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex3-1img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2 &, P$1  (1 0,1 ?_$ )T   (" @,! 0
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M ,F%-NZU6C:M6L@U"!6?IL+XID>JJ035:M6:MR"T>?YM%U()*)2*2J8B78!
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M4E?F:M+\@%(Y8M>9';F3.T>R59FI)NV5*<1 @H&$""(;Z8O6]*UMKXR?'O\
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M^33RK\9>#;.L6-+C!Q,5'DKR(L[^+?-:K<[2Q70C*92F<B<Y6,@NS<+*K=@
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M'L* =/K7T!3<?^&P?KT'(U_E1N.V1<-;?%MOCZV?^XO;O_.GX%[M_P!(B&@
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M/=\O\'S/^G[O7M[>F@VWH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
M: T!H#0&@- : T!H#0&@- :#RIQ@ZE8:4C6,FXAG;]@Z:-I9H4#NHU9PB=(C
MUL43I@*[8QNXGQ!\0!H%8XO<.Z5Q?Q[=*S"6>U7/(&4YJ9MF6,U6EZ=QD:^W
M"915;GGI"546<N6P1:2NS%N"QTVG42#N8=P2J,\#'C4/!R;._8-:Y=M5BFY>
MR6S)>3'ZMER#:YR;M+NV/9"<L3HHNGJGSCL6Y /W=C,I40^$ T#@XNX(X+PW
MF#+6?*"PE665LJ5&O8_1L$H^_-FF.J)5&;AO T[&T4J1)"J5QLZ=J.E6S<Q2
M+N! QNH=;;;U6VWJ[W$'AI1>(<-D<8&R6G(%^S)?)'(^6,G7A\I(VJ[65XJY
M*R4?N%55U"-(6-7*T:I>X8"(IAMMZ!$8)8/&WQONO-^+Y\9 C9^_YGJM(A:3
MCQA;I929I>.48>0FI()NGUQV11I%3CA>:.(KI@4Y1+ON(CT!8LA<9N(GC,><
MHN<M$HSBS<E^2UO-'ULELD3V.1G\M95G4XNNT.BMW#=12OUZ<M,HBYDDFX"!
M&3954VY4Q 0C!Q-P:J^<N:$%Q_M4'!7&<QZ2'Y">17*<$S8M:Z\R98'#B=Q=
MQ9IC)KWMH>K4U),%95JBH(.1?G<G(!EQ* 6 <5>.WAOA_$['"M8P93)&@LK^
MCE0T?:XMK97<CDALX%TTNLL_D$3KR5A:+#NDX5W,G^&VF;C'9<W&.S]N1'CN
MX4\K9,9[/O''%^1K&8D8BI99VL1R\^LSASD.PCUI04?F5F*'8!2I&$2E+T#;
M1&98*X:<:>-5NR+><)8GJM LF4E(0;<^@XUJT%RWKJ#QO$1[(J2)!81S1-^K
MLBF($$3;CZ!H.<Y\+.)W)F5C)W/O'S%F69N'1(VC)FZ5.-EI5DU(?O*V1D%4
M@=@W[OW!.)=NF@\BH<"^%U!5:KTWC!A2O+,AW:JQU!@4U$!^$=R',T.8!^$/
M_IH&>B*_!5]N1I!0L5#-2%["-XJ/:1Z)2[[]H)M4DB &_P"K0>OH#0&@- :
MT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0
M?)2@4-@WVW,/4PF'<PB8>IA$=MQ_]-!]#UZ?IT'!2@4H%#?8H  ;B)AV -NH
MB(B(Z#G01.>2KB?RGY$7#B_=.--QQW 2&&;Y.SK]')#61?QM>>V.H6&GH9-A
M8MNY1C)6U4>.L#A>-1>I.6X//;.9(W;H&YX@\3,?<0<5DH=/7?V2RV&6>W/*
M63K$M\_<\IY#F^Q6=N-HE#A[KEPY,0B+9$.U%HS1212*4A #0-5H#0&@- :
%T!H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tv521048_ex3-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex3-2img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ V +4 P$1  (1 0,1 ?_$ .<  0 " 00# 0
M       )"@@" P<+ 00&!0$!  $$ P$               8$!0<( 0(#"1
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M8O9O4.8Y[-T5JN'U2[@K;&E/[,V;FILH$T!"GCHEX'5A'O?ZAQ&UZ=#X)<=
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M4I0 3G$0V![S;7V;V*NEEMNV;+:W;&_6NMONU%/UUN*1TEE +BEZ &U%7I"
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M3I:U8DSSP!$A,G*,@W%!J:%VG FI;9T^)X??%>C[8W3;R&Z/W+82/V/U4O\
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M676Z73<E16_,U;26D$4S;PEJU*5KZ@5+S1,^,4V[+747-ANGHD:FT<BD2RP
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M5OK.V@RRU9NYEH+[-WH>K2N/Z]2]((73. ID0I URYZQRBR[(KB2]1.Z24D
M \YF<B>?ARB<_P"Y(U(KF5?$Q<GE/KK&-?:BOJ3ENB,F#?Y*4%2JB5&E7"#C
M2$'IK%-<>S2RGRP$$R%8IC\"AS!7TN;O3MSNZPQ6K4+?=J9QIQTY=17ZK.H\
M9O($U$^D+48OVZK9\[:EN8=9D$I$^>!_@?9$</VPVSUYM.G65M1LK:_YFRM0
M:/;U[?A.=2QJ]EL6V6KW%X69GL=+76U!$8^BW%=O+,TNV^K>)I"G)"9(WO1
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MX\B_V^NJOD:M2^3;]E#8NBY8)&/(F(M$9E"3OU8A(YW(.I0T3%8_R2>P1,'
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M22E-+J0Q1D.&G2 H\!Y'B?Y\#A'6@[C7[,/ET\B.Q&7<85.S7F-MMI?2%?\
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MHY,IHT7+-?@<DUMW^G'FX2T131] 6!Q&+H.T%)> 43/%/&AWJ!53,U4U&HB
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M3<LW[!\U55;/&;I!4ITU$S&(<H]@/,&+<#;QIW 14)E-)$CCG@>7&?LG%\2
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M%19J=02[4(02TV3.06O\N1_A%0MYAMWH+6@.\!//RCFY)PFL7W$]W7N]H]@
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M%*4.KN'S((#&B4N,YC'D!+Q_C&6R;4Q2I%-[#BF7^\;LQ@4$OM,8HB7XF 1
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M0^'0]@(?P$!XU*3ZDRU#*>4<I6M"@I$L\?**^?E8^WQP?Y.\LUO/(Y9GM?\
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MGJK3HTK5J*?4$JD-*D^J.[U<VRVI"DE92F9EEG*4_.,86FQ>4WZS?%ZFF\#
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M4*" #(@"8)!SF9&7ASC([=SQ@:Y9?TNR+K_EC*2=8<6S)M:M6 <I68M<J#7
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M]IMQ%\)>7BH:M35C0=%M=/['1GU-5D__ 'A4@=*TCR)$_P"U@(MY"T*6M*W
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M,P4S$_NB([<N=11752GYJ0<")X"?VG';5MW2;@I%4CI*HG*FJDNBH"J2R2H
M=)5)0  JB2I!]Q3%[ 0]0'GR/4I754TV)E*9XX8\HR[B7-*1-$LX_0YWA#B$
M.(1X'X#_ $#_ )N(1\C<;G5<?5BP76\6.$J%0JD4]G;-:++)M(6OU^$CD5'#
M^6F)9^HBQCV#1%,3'45.4H!^/.],Q45]1\C2MJ=JEX)0D$J63DD 8XQU?<13
M-AYS_#!Q/(<3%;WSCYOV;Q)K_BSRI^/_ '37+C7%2M)A;?B6O.JK?-?,TT6[
MW@C%I<A%!!\E*324X_;1CL2K^\(XQA;JM7")A4SIV)L6V+SN&J[6]P;:I=?5
MH=+*TS:?86!),P02))FK^SJ'J2H8B.WJJ>;I$W>W*ULI4)CA*>?OYQ 1KCMU
MO/\ <1^0JHZZ90S-=, :F(PLMD;)V&M?;3(TJ%C<<4AFQ;.H]:QHIA8;?9;G
M:99HT!U)G<),TW9SHH$!$H#L5N7MWLWZ=>W W2NCIKMN>K>Z+"ZM$PA6)2K3
MJ(.D>J0TDZ<QA$?H*VJW%="TZM3;2!JDDG'PEAAPQG'898[H<+C*BTW'=;/)
MFKM#K$!4( 9J6?V"8&%K42TA8H)2=EEW,G+ORL61 5<N%#K+' 3',)A$>:!5
M3JJRM>N%0$E]YTK(2 E"23.2$C!(QX1D)*0E 0,DQ]FIW[#==]]?A\?B'/!P
M@(),Y>&?LCAP$H(&<51/N(]AMRS[">/;1;1#*60\9YGV&GKO89Q;&EB>UN1D
MH('<#4X)2QO8\H.B5.OE4F91V85"I$18J'/_ '"];5_3AM[92++N3N+OZC8K
M;%:Z=M(;=TE2EN!0&E)$R02B0 XC+C%=TONE^FI*6?66N6$_X'P.'*?LLQX,
MHDSBS#^,,;6*^6?*5AHM&K55G\DW1\:1M=[G(:):L9:U3[TY2G7DIQ^DHX.)
MNS![P 1$0[YJY7W&GNEQJKA2,)IJ5RH7TVTB0"2HR \ /YQ*:=KITR 3-0 G
MXX1RUW_+\>N>))! &,X]8\\YCB'$(<0AQ"'$(T*= 7U'KU_T#SJI1$@,5$R$
M/.(X]RO)G@C2O+.KN"+T61M&7=L,M5;&= HU9=1@2<)#6&=9UQWDVVC(.4"Q
MM-B9=^DV)[0.Y?N3&3;D-\I8R<]V+VYW/O\ M-VOEG;2BTV>C=??=<FE,VQ/
MII,L5J$R!G(3Y1;+E=&J!UIE("W'7$IE.4@?S9&<N7WX1(RF(B80'H1#L#"'
MP[[_  YCMFI0\HI;*3I)!D<00!PEEC^'.+H1*-[E3'$.(0XA#B$.(0XA#B$5
MP=[M-)7R >8G3K&F;:!>)W2[6;6N\;"/'8Q\['XTO&=)+(L;!1%'D[$P32BW
M#U!I'13QY'?.3<.&#=5$2_(64$<[;#WK1['[*WJLM+X:WS=KFAA+B<5MT.DD
MJ G.9)(Y9'A$;K:!-;?&DO@_((3/3P.9,_&<O=$2WELW,RUY6O('1/"KJ-97
M$%A./R4SJ>Q=SKAD3(W:6J"OZQD=5XX:@4#8QPE"L'  S*8$96=0$J@*)IMP
M'+?9SMI0]HNW3_?O?;*/GFVW'*=I20A2@X)4*Y9A502=1 _33BG,Q;KU=*BX
MW+]EMJBAC %:<3Y'\HX\<N68R9^Y/URQ%J5X9,#X"P;4V%/QGCS97%$1!0S1
M,H+.#ITS(YI&;FGO7U$O89^1,H\?/%A,LNX5,(CUT 6?Z5MPW?='?>Y[GO3[
MC]VK;55*4M1]22VI)&D\)@!.6 '&&[6&J.PHHZ=(2@$XC^Z9^^,7/MGXF*F/
M%[Y64IB,CI9LB^L[I-G*,6L@U(Y;:ZS:C=R5!XDLD5=$Y^RG  , AZ#R:?56
MMQGNMLZK96I'5#&I(,OBJ4)..?&<4>T VNR5!6D'0DR]B3$MWV_^I&K-Z\5&
MF64+IKA@BV9)=U?('U=_LV(Z!/W%V=/+-Q135>6.7K[R5=K)(,44R'45,=--
M(I2B !S!/U&;CW32=XKK;Z&ZW!B@34I ;0\M* %,(<EI!E*9EECGG$ALM'1.
M6A*ELH*IG, _F^WE%B^*AHZ$9HQ\4T:QS!L1-)JQ8-6[)BT12*!2(-&C9-)N
MV0* >A"% H=^@<P+^NMY3]2XIUU7%6?OSB_H2VW@A( CJ/-JHQO">:K,K&.$
M&B#;R22BC?Y9"%!L*V?V[LQP*(&*(@NN8_KWV(^O/KYL\N.]A*%HJ5TW=NGT
M@3/_ +F5R'/' 1ABN=U;G6$ID#49#GJ.7W".R[\B?DPUP\:.(7>3\X6']0L4
MO]<WQEB* =-%,@Y2L#81 \;7HY93_L^(9',49"7= 5@Q3'LYC*&32/\ ++MC
MVQW1W.OB+)M-D.$U#JEOF?R[>96'G9:4.  Z49J(D(RQ=KI3V:F#[YU%7Y0<
M9<_(?;./K_'[Y \#^1_7J&V#P3(/D6)GJE>O-$L16[:YXSNS)LW<R=2M#1JL
MX;&631<D7:.T#G:OVBA%4C>IBD[=P-B[E[;;@<VWN1D(KTXH(/H<1P4E1P,_
M<#@8YM]RI+HR':)6J9 (Y3C(/-VP&%];L?3.5,ZY/I6)Z! MSKO[5>IYE!19
M3D(8Y6C7ZE0'4I)+>WI)HT37=+G$"IIF,(!R/62U7O<]R39=KT55<;PN0#3"
M"X<>9& 2#@59#B8KGW&:9)74+"4#/[<8B*TO^X*TGWHVZG=3\3#<H!TK"N)#
M%&1LALF55KV;92'57-8Z]3X1RZ-8(J2;1:8/H].32;.9-JFN)44S) 13+6^N
MQ&_>W^TJ?=%[91J>5)QA!*ETX_M.R& Y\CA%DH+]27"K53M$=,?FGB?X??$Z
MI#E-[!(8A@,(>H#^'Q[#X]\PHIU*2F<RA1D",1/D8OP&J9'PC+QC?4-[2&-Z
M>@"(]^@=?CV/.5JTI*I@2XG+VQPD:C*,*/(=LT.H&DNS.Q+-Q$$LV,<26Z;I
M#25=-$$)"^#%+MZ8R!%XHF1\HI8%D#_3E]RBQ"& H#R;=O-KC>N][9M<A?R]
M76-H<(X-:@7#,3D B>)P'&+==ZQJAHG70H=1*,,98G 2BFE]L=Y.M?<&67;'
M&VX.9XO'61=BLDU[,\3E;*4JC%5*YV<8^9CKI&6"YR0I-HBT/I"2(_0-(+I-
M72:BI4C$4+[5-N/JN[6W^N9V[4;+HWJFVVNBJ*<MTR2XIIEMQ :3*4R5#$JD
M58$# Q#]GWBCU5":I6E2R""HB69.?M_GC%L[('F'\7F.A.UM&^VL:"X 0P(0
M.3H6YKE#L#& 4:6I/G*H'0_E]1#\0YJ7:NTW=2\TIK:';]V<91,R73J3/1B9
ME0$I2PPQ.438W.SMG]1U!'@J>?A%8*-\JGC*RKYI,H;^Y]RM 5O#FK>,XW$&
MGZ<'BBZV&TYJNS]*03N.;916LTUX[78PK=Z[:P?ZXJW7317:'1*F9$_-FJKM
M-W7MO9FW[*VY2U;UUO;QJZP!1Z=*R@I+;#@) 2M92DE&1,QQ,0M5WM#=]54N
M+DTR. GJ)!&)..$R9X\.6%EO6OS4^,;:J5CJSB7;C&I;=)+@T8TS(ZDMB2V/
MWRHD!)G%1F1HVMI3;I8ZH%*1DJX,8W8% >:W;A[-]S-I)ZUXLU4W2-F:G0@J
M2-0X:0?;P$2FGOEJK !3NS=.0.'WQ*#(2#9DR7=N7;1H@V24<N'+I8B+5LU0
M(99=TNNM[$DFZ#<@J'.80*4@"/?0=\QRVZMY912@J6%:3ACJ."4RS,SAA[(N
MATI:+SR9MC'^4=7+Y^_+!*>1O9)Q0\62SC_A0U^E)J Q>V15,@PR5=R?-BK+
MF233]PI+M9(R0LH$#_\ 41 ?- "G>*@'U1^G'M%2]KMN*NM^9ZV^;@AIWTJ2
M@TK:IE+96N0"G-4E<9R G*,2;BO:;D_\M,BG2H>D>''^,N$I<#%MOQ7^;?QO
MS.(=%-&:UEVS+9X)B/"V#&=?>XKR!'0SC(T)0HB&>0W[G<P988H+2\<JDFX%
M7Y*IQ 0-T;OFG/<GL/W4M]??]\UM$D[?9J'JE;I?;40RI:E$X&:U $1-[5>K
M44L6QA2NJE$I2PR&9_")2-G/*EH-J!%7-UG#:/$4%9*(JHQGL90%MB;GEPLT
M5O\ 4(UQOC2MNW]L_7'0'3 J2S9 B0* 991,G9@Q3MKM]OO>#K/^G+1<*FA>
M2%!\,.BG2@F6I3Q3H !SQGQB\5ESMM$%!USUIS'&?E_.(PM3?NBO'/L9/N*A
MD]_<-3;&O//8^LN,TLVKBBV&*,\53@Y)QD*I*2L#4G[YC\M1TVEOI6[18XI%
M=+@7Y@Y3W5]-'<_;U.*RW4R+O2I;"W#2'4IL<0I*I$E. ,IXG 19Z3=EHJ'2
MVZO0D<<_M[HDP@O*WHA;)K8"'J&Q='N+/5[%C?,N;+A3_P!0LF-JI1G@+&:J
M(9-B&KRAS5@5!'V!%M7ZK\5CE3*D)P.4F*JSMWONE9HG*RV5=(FXO=*G#J"A
MU2_!I4ERP(U:=.!QRB["[VY16:=9<2E&J?NY><=:'Y+O));_ "5;M*; 79:4
MK&'*U:X2KX=HCOWN0QQAV)LC-^[=N&33W YMMI*W/*3!T@.=1RJ1L4?E-T0Y
M]/>UO:)GM?V]J+0SI<W=54*GG%I6AM744D(Z*E+E)(*M0 ]4Q.6<8PN%S:NU
MS0Z])+:%X G#B/?'8RZ>>;'QX;P9=9Z_:V9;L%GR8M5IRT,(&;QE?J:U=0=4
M;MU9D[:5L<&RC?G,FRY5 1,J4YDP$2]]<^;>\.S7<GM_8G=R[CHRFT_-R4Z7
M$* ZA)'P$R&&"E2!P&9C)]'=;=6'Y:G<!6A ) X# 1EKMIO)K%H]CL^3MFLO
MU/&%>435&'823PSZX6]XFF*A8FE4J,*[LMJE%O@!&C90B8B JG3)^;D4VQM3
M=>]+D;3M:C76UQ6D)2T%*FA7YE* T@^V4L8]*VX45$SU5KF>7'G&&'C'\U6L
M/E(L68J;B:+M6.[GBJ23>1M*R4K"M;7?<;NOE-V>282-AWL@DV8I2AC-GS$5
M57$>8R!E3=+E]N0.Y_9;>G:EJEJ[^AMR@J$@*<:)4EI[3J+"S*742)^!D910
M6J]TMT6I"" H 2QG/Q_")BDA[_$![ !]/Z_Z^8A2L+]2<6R,#%YGCI.8@J/7
M7]?^CG5QY+2TI4#ZCF.'G!4PDD9B/AK]D>B8LJ,YD#)-RJM"HM89*2-CM]QG
MHVN5R#9) 'O<2<Q*N&K%HF)A I?<?W',8"E 3" <J*!FINE>FV6UEY^N<("$
M(05%1.0 $SY\A'0OTZ&2Z\L)D,8K]X[^Z&\;-XV6M6"Y6RVNAX\8N6$30]F;
M7".&N([[-G.LC*I.44TCV>C5])S\DK"6E&I&;T@G45%H0I!4SW7?3/W8H]K,
M;B^30Y6+"BY1H)54M)$M*I?"K4"20#-,L8L#6Y[<Z^6)F4Y \/;R^V$3W1V6
M\=3V/G&6JS=JM:L9MJ[(6O\ ?-1FX^U5IU7XR/6E7TBPE8%>09R"*3!N<_\
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M/0;2359\+,"M;BO>VSZNY4%-8VOF+K4U72=?6WTCT7'.GI>:;) THDI!23J
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MD+R1+R$=/[Y<, 1NL_D?W,PQ QI(BLP>9;%8*<Q0("3=G4\C-661:\S:$*
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MNC#"M2PNZD&^<J]F"9@H2:Q$BBNK^B2]I<M7[F-7@[9' 1:.<M%%BN%S':%
M7*1TPE^_NTF_]@[H:VC64*JF[5(3T>E-3;I(F="@,0V,7.*1(Y10V^[45PIC
M4(5I*?B'(<_&)$_\8*#_ (6_XU_NZ)_PL_8W^)?[U_WS]&_8GZ'^Y/W-W]-]
M9^G?HG^\_P#4_-^7_P!#OTYCKH5G[K^R=,_NO7^7Z?'YB4]$\I<)SSPBX=1/
M1^8G^CS\.<<+[U;!IZF:<;+['E+[G.'<-WJXQ"/M Y7-G:0JS>I(G3.!R"5:
MRNFA3=E-^41].7[8&U'MV;RLVU6E'HU%<AE0XZ"J2N'!,SCA'A452::G>=6!
MJ;&$47?M(8)G>O(KL/DVW."2MX@]:+).-)%X!E7R\U?,I5%.V39%3B8WU3DO
MO(J?U,8KD0_$>?0+ZSG'J?MI::!E112?NC3!0,$EIBGU-((&$D9#PC'VRCU:
M]YU>*D$RGG+Q]YB<?[N/_P"&50O^]?C$.O\ ]D,D<U\^CC#N@\[Q_9Z[\4Q?
M-[_^G)\U?\,1\_;'>OC!\KW7K_M+4'I_'_AQFN9-^K'_ .I6RO*G_P#.-Q;-
MF_\ H=7_ '5?\*HGE^W4_P#@W:5?_1C(?_M=OG-=/J2_^MUV_P#Q3?\ Y1N)
M58O_ $<>?_,8F\[[^',/1>(Z@_?F2LL5YA=GY.F1"4_<(O?*Z2E3@EQ.5"<L
MT=E<7E>AEC$6;& DM,(HMQZ43'I3T,7XA]ANW=-0UG9>RTER<4S;G;$E#KB3
M)2&E41#BTG@4IFH>(C"MQ;6C<3A9)ZP?&GS*S*)YO,/XILW17C_N/DNWGSS:
MLC[]?OZAO+I5(-=DIA3&>,+[/L:M%8*I4*B"2,8VQ^\F >*R+,X(.7@*IB5Q
MV+Q76CLGW3M%9W&;[6;$HV*7MVZS4:7"%!;[U.VM9J'% S6\YI 3J$DE0.&4
M2V]6JJ5:E7&N5_FR9$<"DX&7(_A&U]G1?9)ILON/BM22.$%:L'T2]FASF$45
MYFG7Q2O?J":??M!8D;=#)', =B42]^A0Y=/K9LM%6;=LUX=0/F?FGJ11_,IM
M#84F:LYS!GPB@V&Z$ONL">F2I>$I?T_PB";=C-N8]D/)5>(C/V4;WEZ)KVX$
M]C6N0UTLDC(0M:H;#-*]6:U>LPI%VT37X\L F#8?HTD%% _,<YCB)^; =N=M
M6?:W;:@J=GTS5MO%390XX^R '75JI&G3J4J>:E2Y2 .<62LN=17W<TU4H]!+
MI&!/PB<9!>77QI97\0.XT%;\32=HBL*6>WCDC4_+K!RJ>5IDE R:,R%#F9DI
M$B)7S'+L4Q34,(!)17RE^A$7!21#LMW1V_WH[;OVK<ZD#<"9HK6%RUK94%!;
MB 25$$#@3(S$\(K[Y;G+17-FBP:6 H'C[982$7U?"WY/8;R<ZJ1.0I)J2!SE
MC-_'X^V#K*#(S6+)=C1@/&%MK/7N0_;=]CD1?(( ?YC%8%VXA[4DS*:!][>T
MMU[/;T_T_5J2JT5R354+D]1=8XX#%&G(A>)S&<9%L5R;N5!I2).MCU1,6X P
MHJ 40 PE_*(AV #^ CZA^7^/K\.8C>6EMI2UB:0/ZOOBZH^(1UZ^T.?\:^4'
MS]/M2=[<F/:-I=AB\99P-BNGM;A^QJN?(=:K#V+AIV=F3JI-?W;>,BHB9-TL
M)3E(@UCR*%2,8JF_.W=M/]I?IY_ZB[-ITU&_ZIFF<=<4 LAFH< 4E EZ-"!/
MTXG$F<8_N1^>W%^VOJTTXSEGD3QPE.7OC$;.?VM?E$QO9+ VQE4\8Y\I368?
MMJQ.U3)];K5BD*V61,VA7TY5KR6L_I\FYC135=H-5W:*2GO]JAB@'>0MK_5]
MVHKJ)BANCSENOR6T=<*8=4@J0F2OU$.@@*Q5,(Q(' Q:ZO:%<7]=&$J8)S)Q
M/G(X1AQL+X/-_=4&6&1S51L>0]FV"RK!85Q'CBK9,@+KD&Y7FQ%4%)!C UI!
MZV3B(EN!59![]09!B55,#]B< Y)=N_4=VYWI^X)VU77?Y2WHZSSJD*;8DTH+
MTJ=6I:4I<*="-23K)TC$X6^Z;4KJ5"2H)FHC'49SF#S,^642U$^T1V;803):
MT;NZNU>S+ W%> <0UX5CF9!$J;D"SSL\6Y>';^O7M8$(H8.@, #[N8O?^MVP
MO.5.BQ7,T%2_D*AM&A2#.8DT/2K3EXX1=CLH/J#CSS275)Q3JSERP,1M;_\
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MD6>?&.+\-9F96M?)F2'S!MD::H4-./9Y.LN[.K7>@E9-55) 6WTZ0B %( %
M.:"=RN^W<Z[5][V/<[FI>W%5C[!;Z;8"DMO*0C)(,Y#GB8GMIM- EFEKD-RJ
M"$DD'P!,_#[3B/?8?Q1:@9!\W&8<.[1XZE)?&GD9PY,Y\P'D>N6R<J=RH&Q^
M*EVR>;ZG!3;-P1DY_<D"X-/?0OFSYJ(?+ $P G0SZP=ZNY%H["T][V3<U-KV
MG5FDKJ8RZ2Z6K/Z3JFQ@K2I 1/ C$@XQXO6BDJ[XZU4%6EU!*<1F)<"#X_=%
M=?SC^'^I>*&^X90QWFFRY5HN=6EZ>P,==:[%QMMIO[*<P*2S*4FX-8D+:4'R
M-@3%-8C%@H4R1O<F/8&YM!]._>BO[M6RLI+E04U,[2K;"W&E+'4+C;BTJ *C
M(_IF?G$/W!MYBS-%U/J!.'/CXYX<,(L=?;-ZG:\;&^'O8K&>5Z<%MK6P&PEZ
MJ.9XOZN0@G,Y"U"$H+FHQJ4_ KQDRBC%![72!DG &1764Z$ ,8!U9^J[=>X;
M+W@HK_15#@J[?:VG:?6KJ!"CJ)P7,?E &&42G:+-.]:M*D@J<(23Q *9X$^,
M_P 8IX[C8,QIB#R?YPUQH4$M$XAIFW2V**]6EI.0DE6=%3OT9 !$JR\@NXE7
MBIHQ<Y/J55CN.S>[W]AWS=_:E]OET[5TVZZRI*KW5V$5;BRVV9N]!;N (D!-
M$O(F(-7T].B]&CT39#IXF>$Y8B.QBJ?AYT$\=U=S;M#J3B&7QKG.G:\9J:U.
M\.<CY!N"U>%Y1)5XJ[CHFWV.:A2OOGQJ(E5.W.8 *)0]#" _,ZY=YNXG<:KH
M=F[MKS4[<=NE)U&="$H7K>")*TI!( ,P)RG*<933:*&AIG*JC1TW>DK$$XR2
M2)^W&<=>QH#7Y7R0>2_7RB;?WS(F8_\ B!M5AJE^M-HM\K)6XS:3HEJ?-7D1
M,.W"AXM2"EFC=VT01*5JFH@4GRA3$2\^C?<9R@[4]I[M=NW]'3VQZB0T$)IV
MP%*"7$(/J(*@2E1)(,8QMKSMVN_R%2L!I:B)^1X3GB?&<?1Y=QKMOX'/)!%+
MQ<DLVR)AZQ)VS&-S*DZ:T[.F'I=P=J8[E-,PD>5RZ0 +QDVP$RBD>^!0GHHB
MDH-OL5QVG]1W:M=-((15,)IWM:DJ<IJIL%9J-(_,M20C41(@Q4%A6VKLM3>K
MY=I<YG\PX"0\\([/S0K<S&F_6L.--G\4@]9UN_1*A).NR@!^K4RYPS@\9<*;
M)*%*5)VXK\TBHD5PGVDY1$BI>O=T'RTWELZ[=O\ =%5M*\Z!4TRO3IQUMDG2
MN>7JY9CC&5:&K:N-,FN:P2L2ERE_.,PUC"4H"'\^0VO4M+*0@R*G$)]A,C%8
M@3<"3D9QU=GW)^P><KEY--A\&6W+-ZL&%L5RF/C8]Q.^GWA<>U962QI4IUZ\
M951J=O#N9->4E7"@O'*2[H/F"4%/: %#ZK?3#M/;5'VWMVXJ:F91N2N:J"I[
M3-TEAQ]*-"C/1()&J4M4Y&<A&(=T5K[=W53I)Z4QA,Y',1E3Y"OMHI;7S62>
MW.UKSF6W8SJ.*X;+=YQ)E./)'W.OUM6LQ4K8%ZG>HA,\+;C1R[A54C1]'QRW
MTX 0BRJA>CP?MM]6G^HMVTVQ]W6_3=G*E;;;[4TSFYH *)R&0F3.<YY97>NV
MTNDHA4VTS5H"EZI<9G"7M_IC@?[7:U6^7\CK;!;JX6X,+9*P3G1.]XL0LDTU
MH=MZJ7TZ3B9JZ+U.)</6R;U3Y+@$BKI"8?:8.3'ZNK3:4=NG+K3T[*+U37"F
M+52EM*7D%1(5-0 U9"6J<I1;]HU#S]T^5<6K0L*"A/\ V5?UQ@GYLM9<.:<^
M1[8#7W7ZM.*;BFB1V.'%6KCJ:F+&I&J6'&U;L<H7]6L+V2EG**DK)*G(158Y
M4BB!2]%#KD^[&[GO>\.V=MW-N-XU-X<U,J6H $I;>4T@F0$R$@>V+'N"G:I;
ML:1H'IASCF9Z3CD./*.P7\-/C3TZU?P1@_:/"F+W-5S;GG5O$I\EVYS<+=/D
ME@M=;K-WL"3"%FYE["02,C9?:N8C-NB4H)E(4 *'0_./O-W)WGO/<]QVYN*M
M746:V7FH0PV0D)2&5J;3D,RG/F8RU8Z.GIJ-I]A.E2D8^)YF)NRE]H==B/\
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M]5:IH(&EFT#(-?G*D(0IW!#G*0ONYOCVVOM9W&V!9MS.TH;J+A2NAP$_I**
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MY8G2K_A/\Q$Z'VZH]>&S2LW\*MD0?[,MWP>:[_4G/_K==I9_--_^4;B26/\
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M>;U;!Q[%VQ)R.U/_ .C>,0:O)5N%2SGUE?\ -':@;7?_ (+VR __ -A,O_\
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ME<TL.33-Q"5$A/6 R,Y<P8]JMND6V%O)27$C G,>4>_I'K+KU7*+C/9&LTF
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M;V!+O3(F3%%%+YCA+">QNP&ZMQ5RZC>3'[+M:A6'*FIJT&FTH;(7)K7ZG"2
M-200D*U&8$C([A?Z2E;#=,>I4NI] PD?L(K\ZR:D+>#/'M[\M7D6E:HCM_>H
M#(4'J/JK%C#/II#,.46:[N2MEK<1HGBX]Y%I22I'K:/(X8U^,=+%4<&=JMT"
M[+;GWBCOY5T?97LXEYS9-N0A5PN*O0RMEJ1TX^HA!3,.$ZG%"73 ]41^GM[M
ME:=N]>I(J%#TH&>H_P N42.?;'>-S*F&8W+OD,VGK$G7,N[*1YV&+HBT-C-[
M,RQS:I?][W._2T6Z3_4(![DRRJ-1:ME_EN2QK$%#E KD YC7ZJ>Z%BW(+7VX
MVF]U[+8V@'WP9]5Q* V$H(P*4!)P(.)..$>^TJ%:5/7*H20\XO#"6$Y3\<./
MG%;+[F.Y1-V\O>R!()8CI.FU#$%"D%$SE.'ZU"XVB'<DV*!3&$ZK1S,"B<H?
MF*=(0$/CS:/Z5VUTO9VB57)+;1J:A9)P :6HD+_WI3B&[D6DWIT*_*ZG_D^[
M"+PV5<N26-/M^I?)^/Y1%>:K_C+@"UZ:B'*;T&4N\P;$U@SUHX9F6*+N$>NE
M#&]H]I+("!O:)3=:"V"TF[_4.U9KBV%"HW2>H@B0Z1JM<U3_ "KQPXB,AZS3
M[:;?:(ZB:? >P?PBH9]J1L;1,)>1"SXNN\BE"'V0PN\QC09-XL1!LM?:M.QU
MVC(!8ZB@( YL47&OT6O8"*SPB2)!]ZA0-NI]8>VKE?.V2;[2S7^T5:JNI2!,
M,,.IZ9+8QDALZ/3F 29RB%[,J5-W!3&I*2^E2CSU B023A+.8C*G[OS->+KQ
MF?4S$-3NL%8LC8@KV4Y#*%8AWA'[RBI7=S2U*FSL9T ,A&3,PTA%URL5# Z3
M;E(J=,I%4A/$OH?VS?V*"Y[@J6"U9*U]D4[KP(<?6TE>M30,OT4ZY*P/J*1,
M2(BKWZ_3N.-@3-0E!2>0GP/CA/[HEU^TO6%IXP;"99PR*G)[9Y9;M4OFA]2"
MB5;Q^D9!5/W=E<*_).J0H (B@'O'\OKS"OUBN,_]2*9DMOR596$K4E.I,RM]
M.'+$C$S XYQ(=GM(IK.AQU0U+6 !/_9BDONM?X._>7C8;(46Y0+6Y7?6PR+2
M0.L0&IXV*S0V8*20N#&^45FJA&&< <1]I4A$1'H.^;Z;'I%L=EK)2K!#QVXM
MIT$2((IG$) '#TJQSQC'M20]?5%$I!XB?F5?SCM7MM)IHWU-V;EP73=,4-=,
MQRB:R!P6;N&),961V5PW61%0BR*J  )#E$2F >P$>PY\?MJBJ3NJTJ=2>N+M
M3I(TD8IJD:,_]G/GX1F"N6VFW+""-725/_=/V$=4EX>(#$]M\DNE];SFPI4K
MBB5RK'IV^/R&:-+2G9&L!,/H1"?_ %E1*,,U4L;5F!$W _*75$J1@.!Q(;Z^
M=]J]ZC[/7=VT+>1=W6E!);)"TJ"T:I:05 :)Y$'QC#NWZ=MZ_I0Z 6M9)!RP
M/\X[=6:L%0HE:?V:<FH&IT^M03B4E9^7=,X6M0%<AVGU+A^ZD5SM8R-AX]DG
MW[S&(BFD4.A  #GQK:9K*FY-T8;<=N[[82= ]:E:L<<9J).4ISX\(S6EQA$U
M*(#60 RP^V?LC:QGDFA9>I-9R5B^X0-_Q]=(9I8*C<ZM(-Y>N62%>"H#64AY
M1H=1J]9KBF8"G(80]!Y4N4-RME<[;[DDM/-&1;7_ (R2#CKR]F CN2A0FC(Q
M]NO\"AV  /8#WZ?PZ /4/7G1YM+B4I5EK!\R,1]XCH"4N)7^43G'4T_<"V2/
MM/E[W7>1BQ'*,9>*C6'"J(E.G^HUG&5)AY5 IB&.!E&;]JHDH'Q*H02B " A
MSZ\_3E:ZFB[&62LJDD5AH:IQ*1Q+CS^G#D0J8QC#^X5)7?G O_W<K&(_V?ZX
MO1[8;)8&V3\%FTUEP%ENAY9A8G2";B9=>FV!C*/(&7C: T8/HJQ1!%"S%=D&
M[IJJ4R+U!!7LH^G7KSYV[(LEZV[WULK%WI7J90W V4%:%2*2I9F< )8X&>(E
M&1*JH9K=N.HI5)*TM)'X3_"7**?/VM!@_P";ICKK\<&YU H"'QZK#+T_F/0<
MWI^KYA^C[/U:6%-K9;>I5IQF2M;J_NP.'WQCW9"#^\CF-6K_ '52C@'[BNS1
MUL\OVY#F(<(/$89]CBJ.%FRA54AEJ]B*ELI1N!R"8!59/_<@H4/4BJ1BCT8!
M )-],5(Y2]H;"BYMK#1+KJ].!"5..J!$YX' CPBFW0MG_4"DF>"\Y^7\H[)[
MQP2#!YH!I,NR>-GK=;5; Z:;AFNDZ046;XUKS=TD55 YTS*-G"!TU"@/9#D,
M4W0E$.?+;?A4-_WL+"DJ5=:I<B#,A;JB"#Y>^,KVY;+5O8!.)1&;I/@/]/\
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MK[,Y6F+3AW"C^IW_ ",RJY;6:"5D6D)'@9%PF9--)*VV=MX5J;6BUI7N&EK
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M<V- AVN/<=25EJDY,ML?,,PXHAP?GAY.9Q^6(5)8&7RG#D5#*KD==&2)6O\
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M60TN_EI]]]^PO??Q[]H=]]=<U\;4E: I D@@2'APSB[2TX<HU\[PAWQ"*/\
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M.A4<N5SIHH)I_-* F.8 #\>?8?N=_P#2&_N%MQ;O[(4)0@8EWI:% \DA)4?
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M^7SA,9+3^KMT!?\ ]W3^$4%OML?FG\PVI(D055 D9F)584@ P((%PA>@.JH
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MSY1220*W:E,9V":8&ZR.YW4[,;WVC47"MNU&[; V%/-/J6<-0,ET[@4K63\
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M2053.H@\A$4545-W:+#:3J3( RQ /.4ID3./'RB]-XI_&C.>)?#D_6H&60R
M\ML7'7C8*]SAW$3'NKC%1C]X_)CJI,%9N0?0=%AF?Z0S*8(Y286=B\4.I\LB
M1=">[G=17>7<K=X=2JGHD+4W1MDSZ;2C(DX":ED:^( P$\S-K1:_VBG2U/\
M6*05&<Q,XGB?Z\L(@T\\/FPSJRQ^RTYJL%_AK,YDP-CNZY04B8V;9OFT9EYK
M.RTQBV6E+ :*GHZ5KU(6A?KD&;, 7=O7";A0B/L;GSW].O8VV7&O&^KVZ'K9
M25BDL:I!*N@!J<]/Q#J RG++$1']TWIUE'R#)DHB9XDSQ /V_"*8*E5?OX*<
MNM@GXV-5!&,D(QG9)"0"TWT\P_\ I ?59F5F[4E6+=)!==R^7408D(@9,BYU
M^D1WM9NE$IT6^WM!VF(!FV-*$S3JG(82$Y#V",>.I6I/4=GU<)@_;W<?"-RE
MT"=RG8J3C?%5.NM\RS=9D\#"4VM,@L$A:9-VX2+$,JO#1;,97ZWY0G^H!85$
M0*'S?>0A3 'C>;A3V"CJ+M>ZBF:LC*$*#KA"$R)DI),\5822(J6*5%:A#5*E
M?S/YSC+/"6'+\(OC^(KQ8V7QXX_#/\14,-[6[GN7J4!LUB^OY-J$W<=;,"RC
M5S^ZL2XACF+M:,F<_P!L(ND:37DGL:T<MV2\6S5,90JBWSP[V=Y:+N=<#MZG
M<JK?LBF*S1N%M:45=2):77B1(4R3J2G2%'5ZE2$].4+!9V[52EQ(G6+SF0<)
MY#['\8S5M.P^G&O6J-]RY!Y*O[+2C5+(E5R6VQQ?H69E;-;\SD70N>&=:,06
MZ^2"ESP]*XHO<(C S=(<QGZO ,VY155:M7*ZBF.+/MW=VZMUL60TC0WQ<D=$
MN-J2E(:&#M2^EKT.I4V2H.$Z2G#25"+B\^*8+J=0^01AIEZBO B1X 3E+[XY
M<\'6K>6&57S-Y)MN(55EN)Y"Y]'(4W%/FZB"F+,%("0V*L91;-?_ 'F(;+0Q
M&[U9N;I0$$V2:I050-RI[W7^R"X4W;79KC;FS[ STD+1BE^I.-0\H_G.LJ ,
MA^:6!$>5D86ZI5RJ@0^^,/!.8EYYX\ (EVSYF]CA2CR<DQ3@[)D>1K]N7Q1C
M"3LT75I?+-QK, [G24BM/)94B"TF\0;>H% ZA"=F ANNN8=M%MJ[W<$T],DF
MC2Z ^Z 2EE!($U 8X<\N<7YWTI4I12'#,IY1$S/7&:W'SII77YG$])H=_8T$
MF:]W:;%9/@1R1AJD3D>NWHN,[M,0[4KFPP$];DD'9&9EDG)A9F]I$B&4/S*]
M%3M;'L^XUTE2]5-U3@8MRRP5-N!!Q=:!(Q*9XCGX11I"JD(2UT]8 UD#&?'R
MB7W$&$L-X6AWL1AS&./<70\Y)J3LK%8YJ<)4XV3E7! *I+/DH-DT2D'BZ0%Z
M64$Y_;Z /7KS#EWJZZZO-UESJ*MYU" D)==60,,1I)P(R(\(J.DALZ4@#'.6
M)\XYM#X!_0'/!&"!+*0CDQYYVA'%69LFL<-8LR-E>5C)R<C,<4FU7E]!5F*?
M3EDG&]6A7DTI#P,-&MW;^3EI,K,44$DDSG,H<.@$ 'G>UTM7>;U1VJB+214O
M=,EQ00 2=(,S( 3S)PE'98"65.<0)QU\^JWCE\X.^UDV$V*K4N?2O'N]UZE<
MD93R9>K [HN1KI557DK,5>E1D77F+G+R>+F(/T6R#4GZ0Q?D115/]0BFF ;_
M .].Y/8S9EJL^U:TJO\ >;$P$4U.PF=&VZ0 Z5A0"''"L$K))QF98QCQBU7F
MXU#SR%!LN$C5D9:IS'M'(C#PC'C>/[9_>W4G#-CV))8L>;$U^I(.YO)D+C-Y
M;I/(\% M')2N;@DQL=>8N+BR1:J?/>E9^YXS1*8_RU2$,8LN[>?59L;<EU;V
MLTW46:M4$I2IQ>FF!E@)I,D@9#(9 1273:UR:I#4!?4<!R!C[+13[<ORE9QQ
MZYM#ZS5K33%.7(F&_6VE_FK$TR=<Z6"@RK!&6Q]3&QYEO7W*Q4E_TJ;D(P7"
MH(J+-S?+3$OEW$^I7M1:KNBBJ*=S<E53J/K:'HZ@PU$NX+4G(* ,I1UMVV;E
M5,@(5TPKBKXI2X<>/++*..?(;]MSN7HCC1QFBK6"M[/XJ@B&<WE_BVMS4-=J
M*BN^*T;2;['KU66D9^ -\Y+ZAY'K+G:>X162!,OS1NO;OZJ]D[[NJ+#5ERPW
M9!]!J%'Y<C/$I &6&,O".ESVC5T8#J-+QR/'A(<CXSQGQ,65?M^/!M'Z;56$
MW VEK#5UMQ>X%-Q2*=(H-G:&N=/G&X^U .RJIFRM8(Y0 DG!3",4W/\ 1(F
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MDRR,9DSQ\3Q_E+")ZO#EGN#\UGB_RWXU-ELBWBJY!PM!4FD2MIQE,H5BYV[
MC1=F?&LNY<NFDG'2H0\A71@9MLHW%!\U0;"L'N<&,.N???:=;V)[N4?<;;%.
MS5T-6^FI;0X-3(JT'6\DI)$DJ*M21/ SD<(F%FJS>K7\H\J3P&,L,!AE.*]W
MD8^WWW!TFS12ZUB*NVK9W#^8;G&TK#^0Z37C_NAI=9,_S8RE9*KT<HNWJ4XH
M9(RC>4!0L.Y22.<%4#IG2)LSVS^IG:6_=OUM9?U-VJNIF7'*^D=3@XP9!WY5
M1_Q#,I"4B9Q/#&(G=MO5MN6E^G!6GJ"1&<SD?YC'S,6J-??M\7.1M6;15/(S
MM)L?E_/&>2XBD\M2=2RX_P#T&JP.&VKHF.<3Q'Z^UL$996-8.\(H^D%VO;MX
MV(* E3)\Q;3>\]]:2S;W8OW::U4-+8K=U12)=9"BKJ&:G'4ZDG6K'2"H222"
M. E+-A?K*$IKW2.H1JX\,A/[#A$,>^'VEV;\6PTWD'1O*A]A85A]2\5PODIG
M#U/+'Z>D@=95.KVIJJVI-T?A\LP$;.4(==7\I4Q54$"CGSMG]9%MK'&;-ORF
M5;GG*B8J&E$-%9(.EUOU2:S41,@:1,Q9[AM#Y5CJV]96Z.'AGP.<Y1A-XS?
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M %*1(@)II_/#=._Z=WND.X5LI4T]EI[DBJ+<IJ*DN:IR$IZC.:?OC)C%*O\
M:OE%9]/3A%"C4?P@^2=[Y '6LA8N]ZW6G$+@DQ?-G81S,1-5J^,9<LE!DO6-
MKI#.(W]W.KY$"X;14>S<D<**J*)/ 0(BY%/Z%[Y[]]I*SMNC<A<37T+S:2U0
MK^)=2/7^L@_]VA1!3/ 8R),IXZH=N5Z;N$MZD-ZO4>('@?'ASCL-/^7;A+_@
M'_Y=OZAD'_!3_"K_  J_<7[L<_XF>SZW]=_>'[H]OO\ W)^ZO^T.O;]-[_\
M9?+^3^3GS@_UW>?]6?ZX^58^?^9ZW2T#I]/+1IG\&G"4YR\8R/\ M Z/R/45
M\K\4Y^J>><I2GPTRB1#D>BLC;!(@?@/P$/41_'G 2D9 1P0"YU/S1I!ND4
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M/$>,:"M$">WHIORF]_8G.(B?U_,;U_,(]_CZ=^OQX"0#A,)E*7#W1PGTDE(
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M.X@W+9JT)#N)FI7F5MLFH04UU5GBE9CS+?.!,&B!0#K!ZK3:EK0[17"D0T5
MR<Z@7J&8">F0F0D0 HX"?&*Y3E4,V]9 S$@/;+^44:M[/%5Y0]O/(/FC/% T
MPR-/8]M-C2?T5EE>>J]9A74;7ZU&5F-9IH7>Y,Y16/>FA4I'VJH(F^6<B;E(
M!((<WU[=]W>UVTNV]!MRXW=E%R:#G7#32W-?445+D D!)(6$S2,"#GG$.NMG
MNM=7FI2T WA+(Y"4\?'G'(^L_P!KAN;M);GU^VTV0P[C.,&<6:79OCVQQN<,
ME)2C0"J.ZZ9E4U8K&E/=L4S>P&A7ZJ;(A@*1L!0 .4VY?JQV;MNW?M>RK?5U
M54VB2'G@66M"<!/_ +QR?-6/ 81PUM"KJ'.M<B DG$##PEAY9SB9'%.)- _#
MC<Y#'V.J9;,+V:CW.$J^P>QN>*BA:;+G_#V1J.HW0F<0[&1JKNEX6<5AW,&G
M#5T[& <S0P+MFW^>NC[CZ];BW+OSN\TU7WNI8JZ:J:4:>DI7-#;#S*R0E^G,
MBM2T8)7-7Q!<P#$EI**CM?Z=(G21F2)S'@</.7'F8R@G4*3K%C+"F?=P$\/X
MRH^L-5NF.;AMW0;;4BT3<C6&S46=@:?CZ-H==D"9!M&1[W)'A9DT2JW7;1$_
M'.'\6^73=#R%V=FOW1=JC;NS4U-<_<'6]%*M"BNWU+9!4H%8(;0G$*5@E2%
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MI1Z_T;?\W:8#[NO=V(B ]&$P>@^GH8PC_7SQ53LK,U)G^'L&4<>6$;WRB?\
M@ASUT^G3,^_&.VI4I3,HW.=HZPXA#B$.(0XA 0[ 0'X#Z#Q"/C7>.Z"_N$5D
M)]2ZL[OT##/J[!W=S QB]NA8"4<I/).%B+&HV-,1D7(NT"*+H(+$36.0HG 1
M .<LE5-0KME.I3=N<<"UMI)2A2P9A2D@@*5/B9F'B<Q'UI$$DR@4A *4![
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MBO2DS#8P"? RS\O'/"+$*MMI%91.V<S]6@6$,^C:Q\I>7B(MI$2;YLW_ $2
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M7X>PLF\LS<1<J@TF6#>1;(2D8X*FNPD$47!2K(J% Z2@"4WJ'-.'K>JV5#M
M\I+CC2U(44K+C:BE1!*%*)U).8/$1>PI#Q%0$@$XQ]'\/DE[$0*<@!WZCZ (
M!V(^HCSH  ))  Y# >Z.Y))F<S'M<YCB'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<
M0AQ"'$(<0C28H'*)3!V4P" A_(><$!0DH I/ P!D9C./BZAC7'N/F\NUH='J
M=*;6&>E;5/MZG7XJNHSEGG'2CZ9L4PG$-6A).<E7JIE7#M<#KK*&$3F$1Y[U
M=34U[C;M<ZX\MI(2C6HJTI&  !)  X#A'"4I2HJ2 %'/ 1]D"1 ZZ+UT/N
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M.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA&@X=]?P[]>>#^O
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MU9554CA RCD11Z$P@(;2_5-MKM@JZVQ%XNK]I=I;5IHJ5JC74-J;224DNI4
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M<%I[8TM<$-,,*=JZA>IVKQTD):R90H@J &/JQB+[L1=5-TZZ]Q!$S@F0/Q#
MR \.>6<72=Y@ /#?LH(>G6@=P]0].O\ U*&^']G-'.WR1_UOM6$I[B9GY_-
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=AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tv521048_ex3-2img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex3-2img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ R@#+ P$1  (1 0,1 ?_$ +(   $%  ,! 0
M       &!P@)"@,$!0(! 0 " P # 0              !00&!P(#" $0   &
M 00! P,# P(%! ,!  $" P0%!@< $1(((1,4"3$B%4$C%E$R%V$D<3,E&!F!
MD4)2H7)#)A$  0,"!0(#!@,%!P(%!0   1$" P0% "$Q$@9!46$B$W&!D3(4
M!Z%"(_"QP5(5T>'Q8C,D%G*2@D-3-"7"XF-D%__:  P# 0 "$0,1 #\ W\:,
M&#1@P:,&#1@P:,&#1@P:,&#1@P:/#K@QPN'+=HB=PZ71;()!R47<*D113+N
M;G44,4A W']1UQ<]C!N>0&]R4QR:USSM8"7'H,\1LR!W)ZO8P%TE=,WX_BW;
M-%==6.3GFTA)G*V/Z2Q4&,<+I=91-3P)0#<-)*_D_'[84K:N!CT5-P<4_P#"
MOPPUH^/WNO<!2TTI:2BEI:%_\0&(^3/RO=((9ZNR4RH[?BW!(3N8FI6209&%
M4I3@1-PC'\5#E WW 'T'5<G^Z'#('[#5;CW:TD?'+#YOV^Y2YH)IP%T!<%_!
M<-_,_,ITUC)A".:2-_FX\[9)RZGXVF.@C&(+'],B2Q'KAJ_44 P#OZ:)@#^N
MH;_NSP]KBT2R.:-"&9'V9],2HOMKRF0+Z30>Q.8_#'JQWS"]*)!ZW:'M=RCB
M+J"0[V0HTTDR;%X&,15=1(BQP24X[ )2F\CYVU]B^[/#93M]=X=_T...#_MM
MRM@W"%I'@X8>*I_)+TIMZ)%6>=ZK$&4.HF1O9ROZZN84QV$0))M$2\#!Y =_
M(:;T_P!PN'U(&VMC"C1P(3P*C(X65?"N348)EI7D#L0?XK^&)95+(M"OC%M)
M4RY5JSL7A>39Q"3+"0*L''G]A6ZYU/!/.P@ [:M<%91U+0ZFECD:0"-KFG(Z
M:'%=?35,0)EC>T H5:1F/:,+/4G'1@T8,&C!@T8,&C!@T8,&C!@T8,&C!@T8
M,&C!@T8,&C!@T8,&C!@T8,&C!B+W83N/U^ZQLQ/E.\-6<VJU.[84^&($Q;9%
M(H[ 9&(;' 6J1S>"JNCMT3#X PCXU7;[RJR\>BWW"9OJ$H&-(+U1<PJCVG#R
MT\=NUZD#**)Q8?S$$-U3(G4^ 7Q3%)^8?FLRA<9%Y6.MV+4()-WQ;14_8FZU
MGN*RIS<059UJ.37C4P5$-@*<%A 1#[@$!UCET^\=;43.IK%2$NTW%2Y#H<AT
MURQIU%]LJ*B@;67JH&B[?E&1"ZE3[%&&<1ZM_*5V^<%L.09*VP41(II(HCD*
MV*TR(3CS'(X5!.H1P&?D2,=,H@4['<=MN6VDT?&?N/RB055342_3R(?.3&UJ
M]/3*%P3-0/##;_D7 N.-]&CC9)(%)VM5Q(RR>% \ NN>)%4CX*)%RW9N,H9Z
M10>G5]>09TBK>H0!,D4PHIR,X\$RIP<B<QE 0)S#;Q]=/Z3[)R$^I<:Y9"5(
MC9M'\%/CVPKK?NW"NVW41V[465^XZZ#(HWL!U7"VG_C-^.S&#8D3DKL&]:61
MFH6-?).\AP$=.+2:PE,"):M'>O((O%2G "I%1,<=PV#SJ8[[=?;VV.].XUK!
M,'(6ND8"7'0;5)7PU.%YYKS.XM]6DHCZ#@K7"-Y&T9%'(B#OTQ('&'QT_&SD
MV,=K8^BANX5MP2&FW;.[V/WK*3%N)A0EV9EVAVKQ8A14X*)%\[B ?75BMWV]
MX!71>I1L$NPHY)"H/^9H(+5&B@*,QA%7\OYI0R;*J1\(>% 0(0.K3F#XD'7Q
MQ\R_Q#]$73]Y4H]2V0=OD(IS*L8]')CMW,,XPSGVYI5K7WRJQEXY!V()^H=(
MR7/[1'?QKA/]K.%35!@C,D=:!NVMF\P!R79JG1<=D'W!Y7% *E6NI@X-+RTH
M7:H7*BX9JT_!UA _M4X+.%Z@9!=O[=NC,M*Y)I/G2(>NX721,5DMS]$!$Q$O
M!"^? :3UGV;L)>&054D<SM XA2FI&:E.NOCAC2?=&\^9]5!'.P:Z@ H@5 4_
M!<17M?PZ]M<7.S36$<JU^RJ-5S.F!XF=FL?6%$VYQ3%,%5EXY0X% H&_W! $
M1\!MJL5?VGY5:OU+)5"1'$HPB$]$4]TZ@G/#V+[C<=N,?T]YI'>D1X$*--/[
M.V$>Q[N?)+T\G48;-L+:;)#,GB;9=CE"OF>1LLBFF( E WZ-0XK F A]R2QP
M'QN CJ)#R[[B\7>(+LU[HAU>PD$#5'$=<^J]L2AQ7AG):=+3M94)HUPW#)5<
M 2J>S+KBSOKK\P_7[++IA7<H,)'"EH>>DBD\F5R2U'>.C\2<$[&U235BQ.J;
M8 =H)IE#R94-M:58/NM9+H8X+@#353R!G\@)[N/R@=2<O=BA7O[?W2V-,](?
MJ*4 E6@J@^(/NS\,6SQ<M%3D>TEH6282\6_1(X9248[;OF+M!4H&36;.VRBJ
M"Z9RCN!BF$!#6H0S15$8E@<U\1T<TAP/L(4'%%EBEIWF*=KF2#4.!!^!0X]#
M79CKP:,&#1@P:,&#1@P:,&#1@P:,&#1@P:,&#1@P:,&$3D'(]'Q55I.Z9"LT
M35*U$-U'#R3EW:35+9,@G]%N0Y@4=.E #8B28&.8?H&H==<*.VP&IKI&Q0#J
MXI[O;B324=373MIJ1CI)W: ?MIC.GV;^6[+.8YU?$W4BMS,#&S:Z\/'6MJQ<
MO\BV83B=J92O1:"2I(!NKZ@"FH8#KCL!@,7?6 \E^ZE;<Z@V3C<;VSN>@< 7
M.=T0)D%4=M,\;':?MS26VF%SY!(PL;FX*C6#Q7X8ZG7WXC<E9.*.4NX-^F,>
ML7XM9!S"GE4)&^2Q%3>HX&S6"956:UPRYS>2&!PL!O E#ZZ^63[75UQ<;QS.
MI='U#'%"TJGF4H.VONQV7?[@VNA']+XS3-D#521NFFK4"GX8OEP?U6P!U\B&
MC#%6.:[#.4FQ$E;,LR;25IDBB4!,L]L3E)1\H"V_(2)F30 1^TA0UL]FXK8+
M*S_X^G8'%/,0'$IH03IKT3&47*_W>ZE*V>1S OE4AH7HG]JX];LM8KM4<#Y0
MLF.FCMY<8:KN7L0E'MP>2*14UFX23V.:&(H5U(QL29=P@D(""BR12_KJ1R2>
M>EL=1-2M>Z9L:@,^;4+M\0%Q'M,3)[C##(6ACGIYM,]%\"<5;4//_32?R'AZ
M8QQW NT'=ZW=8I>?A,MW6ZR$1>&TRQ<P]AK;R/LCLS.)F'A'8^W%,J:#=P4H
M<  1UFM-?.(U%QHZBCN<S*EM1N>R5S_.K0"TJ.ATU"KGB]U]GY3%25%)-;X/
M1V*'1AJ@=' @Y^S7/3#D=K.O\;BOK7DS(QV4#9;DEV/K&?WEC91"?Y9ZS/D&
M#_&Q!WQTU'"J4='+D2 G+VW$!$  !TTY1:H[189[CZ<51/\ 7B?<1\K'/"!<
MRC0>AQ%X]<I+G>64,TDL-/\ 2.C#6E 7!O;12G9<6.U^AU"HVJ\9:8^G"N;[
M7ZRM<@+[=K$JFJ+23,UGG8%*0H/DHV1,DLL(^442;_VAJ_4M/1TWJ7.(-C$[
M&O>0$!1H0_\ ;EBF5%74U4<5#(2\0ES6+F4<[3XK\4Z8ITK&>:?(]L\.]E"9
M+1-,Y5R+<,&63'3M=5F[@L72GJ,L0OFL0\;H?M.[!'>Z</ -P7*\3$F^LHBO
MD,O)Z.^>JDL\[X7QE1L@((B<[_J=GVQI-3:ZB"PU%F?!Z<$=-',),B'2CS.1
M.I"M">_+%D/8S"E)M<NYS9E%;\_4\0XJO*L'1W"[QC$EG7;87\A9I!VQ<MW"
MKHL;'%:(%#8$P5.;??ZW[D-MI#*Z_7)[S1T=-(0QB@JA).1"E/E&BHN6*59:
M^K$8LU$Q@J*FIC\Y0E 4 4Z9G/P7PQ%[JICG.$%C_J3DR.OF4IM._P S,2^8
MZG9;0ZLU<BJ%:8&Q3590:-9D72T0WK3E"/;-SMU"G,"P%-X^E7XY1W6CH[56
MTCZR6*JD<^<2%=D;E<T.'1 @!S\,.[]+99JVYPRMC8^)H;$6:ND:@>AZ@D'M
MDN'F<Y]MEKSEF["$AAF%S3CK&$;6Y2<F($&3I]&KV-J9XC3I*JV)-=A8K(V9
ME]P)&JQ#"F8 X 8=M/9+S-67JKM$M&RKMU,!O<T!Q:7-W-86G(N<- .QPK%M
MAIK?37&&I?2UU0"C7*U0J%P<W,,UUQ$F_P#QR]0NY-.?9,ZY/#8GLJ\I*,'A
MH^*<HP25DBEE&TK!66G/P(K"OVCPHIK U$H(COLF;Z#4:_[><5YI1"X68NI9
M5+7($0C5KFKD0=<R,66#F/(^,3-MUUVSTZ MT(+#U:>H(TT\<5MN&_??XLK"
MFX*=_)XN6>) H")W=FQ+-I"Y'[%A.@=Q5Y5<A0W/N@J',.0B'@:&!SW[:U3P
M?4JK2#Y#F6)V/8I[\7'=Q/G, :0R*L=EV<PGJ>Z)X@^.+P.G?R/X<[5)M:RZ
M.3'66!(4%:--O4A2F%0((J*5234! LN &(;DAQ*X3V\E'ZZV+B7W!M/)6"GD
M<R&YZ%A.I1?+_9C+^1\-N-@D<\++0_S@9 *@7%BNM Q3\&C!@T8,&C!@T8,&
MC!@T8,&C!@T8,&C!B,O:+M=BOJA0G5QR#*HJRJZ*Q:K2V3E$+';'Z8; WCVQ
MN1D621O*[I0OHHE\;F.8A#5WD?)K;QJC-37._4(\K!J[,#W :DGMEGAU8[%7
M7ZL;24C2A.;C\K4"YGNG3&:Q5+M[\LN75UVR2D3CZ%D!317<JOF>-L<1#@ 5
M*1SPYEFK.=N&XI$ SA8=A$2$'</.SSRC[EWD1DN-"%1S/)&QG8[M3XYD],;8
MQ_'_ +?6\"1C9;F6G+(DDCJBJGMTQ?SU0ZB8)ZLPEAK.+SUZ\9JB8UJO<+38
M7+->R?DY!FLI$-7A6I73JH0#M1 1101)R%(!,/J#YUN_%>-67C\+J:W[)KC&
M-KWE%!.:$H2 H\3C'KUR"YWJ;U:USV4;RH:"=J+VT.7NQ!G*>2824D^R=?[^
MO73NQ8Q+6YFD8:I%PF:M0+'CFPN&;9*T4<A 9R-QMT8LLN)S.MW"1D!V3(0>
M1:5<KJK;A!SPN+J<B2.FA)VNB+MK9&$!7N&I;J "2,6BFHGM922<1C'HS_IR
M2R;<Y-2TAQ&T>(\JE [%L^#)6J1U$H-0BLC)7@7--;V&FNY-TT"R2V/@410A
M7KE--4RTH,2T<-VCEWL)C*\15V.?SIMDGIQ1PPLG];?$'L<06DQN7:$.9VC(
M]>X&*1=J>J;63/FB#'LE<U^U"T/!SS"A#T(*'IAX9EN^=Q$HUC'2;&3<QSYO
M'/E42N$F3Y9JJFT=JMS?:NFW<&*<Q!\& -OUTVJ \P/;&GJ%A 70E,AA9&6M
ME:YX)8' E.W7%73]K8LOX-D<<Y%Z02#?*UXA9BM/YYO6,?15+":]PO'?SIS9
MTI)&<KJ1'7_4DR@W%V/CTN0B.V=R-J+I;)+=46KT[E("P2-8P, Z2!XT0KY5
M51HA&+H'4]MN,5=37#?1,+7F,N>7$IG&6H5T 7((FJ9R=S5@6\9&ZK$Z\UZQ
MU]C,R5+J=)F[7.DEW"+9"";18.IB-2CSMW;I^+R+*=,JIB 8##R$!T_NUEK:
M[C)L=',T5'IL89' GY4S\=,)J*YT<%]==YF/##(Y[6-(_,3EGT0],>Q=,-95
MOW7MQB"<RM&,+=,1K6#L%Z@JB9NV>0B0(E=L&T(YF5E$!D6Z/HK*^YYBF<^P
M (Z*JRWFKX\+2^L#:PAH=*&=&IY0,OF3,JN9QR@N=JI[T;F*4N@ =MC+_P Q
M7S$YZ*H&:$82G8/K39<N]?V.-H"1QY7LDQ0TES&W@]2<(L(U[2I./D62L&@U
M>JRL(!@CBID JZOI)G, ?4-OE]X_+<K*VBI3%'7LV;7[?Y".NH7'*RWJ*WW%
M]15M?+2O8YNW=_-X+TZ8\/MI5NQ]\ZM2>,*I3ZS<,A7NNM:Y?'\%9 KT5&-U
M7#3\\XKC.Q "\D+U@14B*:[I#8QON'8?$7EM/>ZCCGT-'&9ZJ0!LFU HT) 4
M*IS0?#';Q^:U07KZVID,--&XN8""XJN0.U=._7#NV3*M3Z\]<F=^ND?(U>'H
M]$C&H5UXU3-*DD(R'3:,*]Z,,:39INW;IJ5$AR',@7D!A.!?.FDUUIK!QYE;
M6@QQ0PL:6D$%0U$0 ]1\,+HZ.6\79\5+YC)*YRJ@0N4DJ1T\5[8KDZWXCRC6
MR8ISU:LFSM7IF9YZU]B>Q7IRD4RJK)P(GD<9U@\R*R<PFBY1E$DG"/J&34*0
M4M@, %&A\8M-Q6FN[I$I:JIEJJIQ>W)^D,2;E(3L"![QBXWVZT=4^6UQ0!T\
M$+(H/(509O*H@ &BHO?%L&+<>U'&U6&'I2:WXB6FIVX*N%U?76?R=ODW$](O
MSJF*01!RX>B) $ XDV+^FM-M=#3T%+Z--FQSW/)1%+SN)_'%"K:RHK9A+4$E
M[6AH'8-" #]NN%C.0<+98B0@K%%Q\U"2C59E)Q<JT0>Q[UFL42K(.FKDBB*R
M)R_4# (:DU%/35D#H*IC9(' @AP4?MXC'5#--3R"6!SF2@J""AQGQ[D_$HYK
MIW^;.GKUZ@XAU5+"ZQBU=KJ2;9RW6]P+W&\H@J14BK783 P.;U#<=D3F-LD;
M#N8?; QEU[XQO]=A#O28X DKF020" ,R"5R0+C7.+_<"+9_2N1M#H'A/4(73
M11KKUT[IA1="?E8=.G\+@CM:Z68V,CW^/064I4I&)SOTE!01A\B(+'(>.?\
MJ 5(KX0 AE/M6V-]XR>$_<F1]2+%R=S6U8R$FUP /1KU'70.1.Y QU\OX$R*
M,W>P^>!P#C&U,@=2,^G;4]!C0 0Y%2$43.51-0I3IJ$,!R'(< ,4Y#%$2F*8
MH[@(>!#6W@AP#FD%I&1QD9!!0ZX^M?<?,&C!@T8,&C!@T8,&C!@$=@$?Z>=&
M#7+$8NV'::A=3<6R.0;@J1]*K%694VI)."HR5LG@2%1)@U$2G%%JB7]QRN)1
M(BD&X^1 !KO)N1T?&[<ZLJ"#,AV,ZN/NS0=3AYQZQU%_N+**%1&3YG#\HZZ]
M>PQF\PSAK/WRJ=@)G).2I.1BL=1KXJ%EM)&_I1E=ADSF78X_I+0ZA6ZL@=L<
M 4.7D! $551$QAY>=[7:KW]T[T^MN;GLM<;]=&IF@ ZYY 9_#&TW"X6;[>6H
MT-!MEKY&>7+,.4*7'IEU3P&+VT<I8?ZR7W$?4;'%'/3:O9GCV D;T\;NZ_58
MB9-">]8QB%G>,5&UIR18E#D.F4QQ*)Q^X_+BGK;6W:T\;K:?C%$STHWA'2.\
MK04_F1"\]!\,9.::LOU/47ZNF$E3$A;&/,XYY^5<HV]3B-<E;FW1OL9,+X_F
M[=D[!UM6:R_:)H[;O[E,X=M;XK5C%Y&F;FFCOO,H' [V..)C(MTA4 B1 *(H
MC5Q<3Y*X4#WSVFH<#4N*O$![N<,@5.0/0IAQ%!+RNQF6J$$-RI\HAN#/4:-0
MUI^;HJ?VX>WNS#5V08X2[1XQ;1EYR3CBV5\U8BH%FE8W.5*!=%/93E+:(MDW
M23@LE'NC.F:JG%))8@F$X!OIKS*&GF;1WZV1QU%TAF'IM!!]2-P21J?F\N@.
MAPKX[/-$RIL=:\P4M0T;GD$&-["H([;CD4.F>%_1,47N]9'Q3F*9KJ/76E8A
MC+8RIV*(T[%S8IUC<T6GYXN0',:M^#B88JK--=LP;^HJFX**BI@$ #3"BMDM
MPN-+>9H30T]*R41PER.=ZFW<7@(  6E!GD?'$6HK(*.EGML+A53U(9O?^5KF
M[DV?S',9]3XX]7,G?;!.)4)1M&.;)EVR1)#^[K^(Z_)W8&2Y">IZ,S/Q#9S7
MX4WI@)A]=P!B@ B)?&N^Y<ULEO>Z+>Z:9C27>DTO:U.CG-!#3U37'VU</O%S
M VM9$TN 'JN#''Q#7(7 =2,@<07OWR1Y8F\2'RK14:)C&-=KP)HN L-/R'?;
M@O$3DFW8J/W+YE&PU'CW+%HN*Q4_<N.:@%)YWU1KASZY5-LCNM'+#1VZ8@-+
MHI))$<2W<F@*@C:1T70XM5!PFD_J)MSVRU$[&N)1[&1@L"D$J7.")\IZXZN0
MLQI)9$P7!RO;W/EDJMVLUK8Y*+&T!]CDC>&CZVI)0H0C6*HQ9@JP2A *H9LL
MNH9+R8 #R/16W<-NUMCJ+M7/;/*]C@V(Q!VUNX( -.BYGKCE;;?4.MM>Z.VT
MN]D8+"2'D>;:[,N)/<9C'EPTWUO?]EKM7Y?+'9:3QJWQ/4Y6.%S=>P*+XMT=
MV.8:RSI9K&$8/&B!X=)LF4WHD34$!VW'?7*&JL,O*IH)JRN-.RG:\-)DU>@!
M/E5=4[(%Q\E@O,=BCJ&TE$V8U!CR:Q4:W<F;NZ>U<>)BR[8E2K>?)17/G:*$
MEZOD/(*.+BL+#E.80:0,1$(KUQ%\E8*_8FQ3'<<@63D! 0*.XE(.PZCVVZVQ
MD->V:LKO4CFE;$CGHC&J-Y#<B3D5]V)5QAJG5%+Z=/0"/T8G2AS& JXYH%5V
M790N.5CW!RI1L 4?*<)V:F+I=)>,I@6.@9.P7+24$C)3SZ/C)16/NE<BZ\HD
MSCA6.J0I!<F7X[$$1$ UV?\ *:JWV*"\0W1\F]C"62PES6EY#0T.:T.< 2BG
M,@;EQ%_XZVY7B:A^A8UNYY:Z.1K<F@N/E5/ET"=AB227R/Q=:L$30<WXV>V1
MA:4W+>/MN+:M<[#"S96R*2CM->AV>N,;.4Q450.JFF1T0A-Q$1#SI[_S\4QA
MI^0TZP5)<UGIL>\DL"N+F.;\O484GAD\L+ZZTS,2,JX/D:PM"=#NS[%,/+7L
M1=/NRS>!E<=6%RY@:A:F-GDL>U.WS<'72S<8NDX;QESQ6_5(WC46KM(IO:BQ
M:$*JGX#<-.(;;Q+D<<;[=(#'&]K]L;R$(*HYAS'CEX862U?(K.XR5C'-?(S:
M'.:JM(3)PR/Q7OB?NKUD0G3%5Q6AE%UD;M?V4L'72M6:Q8_P%AB.AW^<K'57
M2T/9KW:;$V,]A\<Q<\W4(ZB(PD8(.'BS<?4.41)N'T'-+E]5RWD<O'G.?%9:
M,-,NQVUTA(R;N&@_L.+O0_1<?LT=UF8V:ZU(=Z0<%:UH*;B/V)RSPI'4)4.K
M&=.N..,0+S$?%YFEKA7K1CA]99VQ1@PT%6'4[_.XQM.R<@K!R49)MD4ESH"1
M!TBJ<HI\R\@9$T7'+O;[30F4-JG/;L+RY0UA.Y'*>BJO3$&,2WBV5E;5,:'P
MAK@\ -S+D+5ZY')O]V&,^0?XWZ5V%BK'E'$;-G"9YA6?O9"*C!22C<@@DB*X
M1\S'HJ)E:6!XBD/MG7V&5-L!]]P,"7G7 *#D3);A;@&W:,>8-(&\:EI31Q'7
MKAQQ'F=799HZ6O)=;'Y>8$H-,C_+^[V8BC\:_P AD[2+!']4.RKE^Q!I)'K-
M$MMG6<EF:],IN#(A1;@J_ %S) X-Z3)PIQ%+8J9]RB0VJQ]NN;2T,O\ QB_N
M+0T[8G/U9F (W$ZM14=H$3KBS\\XC%5KR"QAI8YH=(QJ)\JEP3\R].NOMT5@
M(" " [@/D!#Z"']0_P!-;T""%&8.,7Q^Z^X,&C!@T8,&C!@T8,)6[W6L8YJ5
M@O%REVL%6*Q%NY>9E'AP(BU9,TC*J& /)E5C@7BFF4!.H<0*4!$0#4:LJX*"
ME?65)2&-I<?<%0>)Z#OCOIJ::LJ&4M.%FD<&CVDIUR \3D,9/9U[EKY8>X'L
M(DKR(Q_%N%4F1CG.I'8[QHS>>@I*N$S)E06L4Z?<3%#8YUC@F B4@Z\M2277
M[G<M<( 11L=L(.3&1 JN6[S'&_1,H. <?WNV_P!4+55/G<<D"HOPTQ<ME?*N
M..K-0H_5W"TDZQK5V"[&HY*SC%5UW8(3!*4PQ,>/E+*]11-'%N]PD$RD(=VK
MQ9 MZZI>)2%UL5QN%-8XHN-6@R4\+0/6J&,#VQ'(-:<_G<47)&M*JH3&:4=#
M57Z6>]7+]6I3='"2CI0OFV_Y6-\WBGQE7(X.=9GP;*8HSI:(+)3%^S9&K63*
MW'EB9UP+=NFZ@;NBW35D(^,MD:[X*I.6*QT5Q+S " <2!99;,+K976^\2LJ
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MB?-.$;$ECR$ID7D.,P5CO)U3@#3,)(S(Q4:\R;<5'S-:R)BNT4!2-:KH-P5
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MI^Y)<*ZFF81X_<X23$"B8Y2<UW..(T7)[:WE5KWLF,>]X 1Q8 I09C>"!X$
ME<,N'\B=8ZV3C%X.ZC<_8"""T.)[N3RGV ]$P\/Q5]ZEL[5(N#\H2AE<K4>+
M(>!EWRNSF\51B5-N957FDB)YV!$2I.0W,95/90=O.\[[8<Y=?J3^DW(>G<(
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M6 )$ !U4E0J^S+#[2-#K<K%?C9.F4QZQCDQ)$,Y*N14@Q12.!]R%CU&*B3,
M*( )4BAR'?\ 33@VZ"2+TI8XMBN\H8W;F<DZ^WQZX7-K:EAW-DE<Y %+W J
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M)L%,RBO\K+O65)DF=$YCR_:%8$#3X'4$G$R\3S5O'Z::WTE([T5#F"-3U4@
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MU9P!&+$RQP,BBB*I1*)MPS*HOEIY!<*N>X-?)04['Q1L##(UY<"CR IR1<D
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MF-;<-V<@^GH<=U'"*3^49QTFT?2<#!(N&#]%>;DHU)4$04("8\1*)@WW"O\
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MGCQ:8<@Q92UNAD6Z,5)U(7BR:;A<A14;BH!A$0U I7<KLCQ3\@=%665[MKI
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MT.F-!M"3CINCXYF@!1P*=3K[^.<&.^1.4'L"S*8ZB;ARJX.*J)_)7!U3@/\
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M[E_#'5>8IGW^BJ)F_J3LC+NBE2H\.WAICCSE<^PV!NLF%:>ZSO*VO.G8;)M
MI;K("T;!&4K3.T>U6GPH[*,C6S'V\0U5#TUURK&. B8-N10#C>ZWD-CXU30N
MJW3WRKG: [:T(TYEK &H@!52#V7';;:>TUMZJ:L4;6VRDC)=&KB"5V[B5*9J
M@5/#$LL73%AJ6?[#U_5OLWDRKQF'8:[23ZUN&4C9ZM9GD\:%&->2[!LQ,JPL
MT?S=H(+)BJ@9$XE.)#E +/;:J>*^RV-T[JB$4C'%0U8GDD$$M /GU <IR'OK
M];"R2ULN38!"XU#@UP5'M(4  DCR(BC7JN*'?CU<'Q_\H%PK!R)-R24[FZL
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M,8_,.!MOX12T\7&HZI\C(X)92][R1M:Z(Y!Q_*>P*'/&0<P<Z>\1L9&]\P4
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M$P <P[^1*([:^[' ],O[OPQU^JS=M7S9=^NGO\<?@[#N'@0'D @!R%W 3&Y
M41.&PB'@=<07M\S';7C0D*A]B?#'8D2)."Z$Z@:GV>/?%J_5OM%VIS3>NO\
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M-E<KX94A2KQRCQOZL-60 HF*0D"P<<%  =C.3JF_76@?;WC$?'K(R21FVXU
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M@ <XY.> 4W.(4;W:H-!U7%:7QF=6+5VAS/,=M,YIR,[5X6T.;%&/Y='@WO\
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MIX@9%=(Q=RF+X$0V$;M:ZNW5U**BU[#3DD':-J$9$$=QBMW&"MI:HP5Y/K@
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M=+I6WBL=6USR^=W?H.@P[^F>%V#1@P:,&#1@P:,&#1@P:,&#1@P:,&(,=O\
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:-&#!HP8-&#!HP8-&#!HP8-&#!HP8-&#'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tv521048_ex3-2img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex3-2img03.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2 &, P$1  (1 0,1 ?_$ )T   (" @,! 0
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M ,F%-NZU6C:M6L@U"!6?IL+XID>JJ035:M6:MR"T>?YM%U()*)2*2J8B78!
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M4E?F:M+\@%(Y8M>9';F3.T>R59FI)NV5*<1 @H&$""(;Z8O6]*UMKXR?'O\
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M^33RK\9>#;.L6-+C!Q,5'DKR(L[^+?-:K<[2Q70C*92F<B<Y6,@NS<+*K=@
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M'L* =/K7T!3<?^&P?KT'(U_E1N.V1<-;?%MOCZV?^XO;O_.GX%[M_P!(B&@
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M/=\O\'S/^G[O7M[>F@VWH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M_IH&>B*_!5]N1I!0L5#-2%["-XJ/:1Z)2[[]H)M4DB &_P"K0>OH#0&@- :
MT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0
M?)2@4-@WVW,/4PF'<PB8>IA$=MQ_]-!]#UZ?IT'!2@4H%#?8H  ;B)AV -NH
MB(B(Z#G01.>2KB?RGY$7#B_=.--QQW 2&&;Y.SK]')#61?QM>>V.H6&GH9-A
M8MNY1C)6U4>.L#A>-1>I.6X//;.9(W;H&YX@\3,?<0<5DH=/7?V2RV&6>W/*
M63K$M\_<\IY#F^Q6=N-HE#A[KEPY,0B+9$.U%HS1212*4A #0-5H#0&@- :
%T!H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tv521048_ex4-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex4-1img01.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_X0$V17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    <    <@$R  (    4    CH=I  0    !    I    -  +<;    G
M$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3,R!7:6YD;W=S #(P,3DZ,#4Z
M,#@@,3$Z,3,Z,#0      Z !  ,    !  $  * "  0    !   #-* #  0
M   !   $)0         & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $
M     $@    !    2     '_[08:4&AO=&]S:&]P(#,N,  X0DE-! 0
M  << @   G:\ #A"24T$)0      $$46KEE:;LY=+@[S%&D:X1<X0DE-!"\
M     $I:  $ 2    $@              - "  !  @             8 P
M9 (    !P ,  + $   !  \G 0 N &H < !G    = !R #A"24T#[0
M$ $L     0 ! 2P    !  $X0DE-!"8       X             /X   #A"
M24T$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M       ! #A"24T$"@       0  .$))32<0       *  $          CA"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #30    8
M        !"4   ,T    # !E '@ -  M #$ 7P!0 &$ 9P!E %\ ,0    $
M                         0             #-   !"4
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P  !"4     4F=H=&QO
M;F<   ,T    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   0E     %)G:'1L;VYG   #-     -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     $_
M\        #A"24T$%       !     $X0DE-!"$      %4    ! 0    \
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M65H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M     /;6  $     TRU(4" @
M                           18W!R=    5     S9&5S8P   80   !L
M=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@   BP
M   48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E9
M TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C
M:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,
M=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O
M;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M   2<U)'0B!)14,V,3DV-BTR+C$
M                                 %A96B        #S40 !     1;,
M6%E:(                     !865H@        ;Z(  #CU   #D%A96B
M      !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO
M+W=W=RYI96,N8V@
M                9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT
M(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                 &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@
M5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                  !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<
MG@    %865H@      !,"58 4    %<?YVUE87,          0
M              */     G-I9R      0U)4(&-U<G8        $      4
M"@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W
M 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4
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M(#Y@/J ^X#\A/V$_HC_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/
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MM@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]522224I))))2DDD
MDE*22224I))))37ZC_R?E?\ $V?]2Y$Q_P"8K_J-_(IN:US2UP!:X00>""D
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M/K;]7""1G,(;](P[2=-?:C[<_P!R7V*XX?O#[773K';];?JZ6EPSF;6F"8=
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M_K*7_17C7M]D?^DC.1TVN\.=TF@V@[@X/M!#N=V[>[<E5=TST;KV=(IW4M:
MX/L$^I['-(-G\IR#4W%KM&+D%M=C2!7>UQ+(+6W:UOWWN;N?[;?9L5C]EY3[
M'^G47%CFMTVC:YIEVX/._P#S4"8CJ?/BEM_C*'$=@#Y1BB;E=):/;TB@$@MW
M;[=6_NEF_P#.C]Y&M?B55&P=&Q_0C;8X&P@:[F^K%FVIE;=K['6_U$:[I-]5
M(M;CNONU+&-( :1]!U@.WU-SOS&/3U= RZ*R]EI;DO@,%8+VM;+W.-OVEKMS
MO?[J?H)IG#?B/^-)<(3_ '?^;%J'*Z;Z9!Z3C;70=NZSL/;/O_-]Z@,_IA!'
M[(QM#NB;")T;P'_]!67X.5<2+.G64F=HLI(X EUKJ7G_  C_ /!L>ANZ-EL(
MK;BNOJ>!OL,L>T$?1;JYOL_\^?\ !IPE#J3_ (__ *$M(GT _P 7_P!!0'J7
M3!L'[(QH!,2ZP@3]+_")#-Z?9[:^BXKH :27/  G<&N+K/S_ -]2?T/*;[?L
MUV1 (!TK8"6[FNY-C_?[+?YM'9T?/RZA7D568M6PBND'=7781N]3;L>][GO_
M )RW?^C_ #$3+'N"?\:7Y<2A')=5_P V/_>H;<WIH>6OZ/C.EH_/LX:/9[M[
MOS%(9N"\NM_8^--9]1Y+K Z26M8YLO\ WG(E'0\H/./=02TD%N4PF&[R]S]S
M;9LM:WV_N*)Z)U(;AZ.Z(V.D'6?ZR'%C_>_YQ_[Y/#D_=_YH_P"]1?M'IK7!
MXZ1C!P<3NW6 S.O+U/[=B8]@MJZ1C,V C<U[PYH/M>YVVWVM:Q_]M%=T;*IH
MW_9SDW&7-9N$-(+=GJ_1];=^XUZ!9TJSIK1:^]U5[[ *GU$C:/>[^<N:_P"G
MO_F]]=/_  B7%C.@)/3YI:_\Y%9!J17^#%$,_IM9&SI&.)!!]]O#AL<)]3^P
MI-S.E[7;>DXX:X;2 ZW5I/@+/WA]%5<A]3+3]KQW8SG2X/K.A:&AQ?MLACK+
M'O;[*WU[$_J8C YK&^ONDW6.#F[ ?:-K #[FN;LW?0?;^B4G"*_2_P :7_?+
M>(^'^+'_ +UMLR>F.#FCI.,&.B0'VD0-6\6>[:IU/Q+W&FGHM#X(?8 ZT@1^
M\0_;4[TW?HO5_1JMZF!2[TV>IEV.T8(V-)(W5^W]);9O>W8]714,DC'R;/L)
MM9->,P ACY$.NL:'VOWN/Y[][/\ !UIDM/WOK*7_ $5PL]OLC_TF%EW2ZR&.
MZ10\"2 'V &1J[=O>G9;TRQEP/2*'"BN6C?8.;&-V>Y__"H#!BU6-HR7-]Q#
MZLAA=M L#KBYS+=V18SVL_P?Z-/E4&JUS' [FM_- @:MVN]W\G]Q+3:Y=[XI
M(L]A]D63LKI#VC=TBEP@-!+[3 UVMV;O^_HEHQ7,^T?L:BQ@UL<'6N(( V;M
MMGZ/:WWV6VJ&0W&QFUV7C?:\%U5(=L$;7[+'NL]KFO=7_-[_ 'IZ\5E%+LEV
M5Z5[MK:V5[C'J;;W.N]=MC6^VUF[9^B_?0TT()^V:=>M?9%;[5TPN];]E4;R
M[>UX?;,_2W;A8HMZATUKI;TG&#FDNW;K._YWT_Y2;*OJJ?LS,8U!T-9DU$ /
MT=9;?L]U7;^:J>JS[,:H^T?:&.;NM+@YCJV?G#<-[?;_ (1R< "-1+_&E_WR
M"2.W^*/^];'[2Z8P>WH^,(EIAUD@'VOX>D,[!(+*NBXI.V'^ZP "1]/W_0<_
MV;E2<[ :6LW69$D - ].-WL&[Z3W.K?[;&LK5NNLWLIQ\O=AUV M9CM.YH>Y
MI:R]['ML>YV]S/YQWZ'^NC(1 Z_XTORXD R/;_%C_!,_-Z:P^F[H^-#X)&]\
M$ ^S5MCOH)F9G3W@QT;%]OZ1TN>- ?3T]_\ *5=K,?&?Z&3#FV0]ES-S7-+W
MFL[F7?I+/;3O?7Z:>W'-;B(WM+-U;H,$.VN98WZ/M<UR%1VU^V7_ 'R;EX?9
M%,[J'3 T-/1\;VS +K( =SHYZ>W+PFAL=&Q7-VQMWOD#Z6OZ3V,9]-Z%8,;&
MJ#[_ -)?8TO9426Z!KGU/M<X>YCW5[6U[TS<.NECLDY!KN>]OHFO<TM+_P!.
MYWJVLLV^VVO^:_1?\*E4?'[9ZJN7A]D63^H]-<)_8^,X$ :NLG:T>S\_]PJ?
MV_ICR7'I&,3H=VZR9'YWT]RJ95E8NW9F.ZHO(C(88+@!ZEMSFN_1;_\ @F>G
M[TPMQ*P36/M#G#=87AS QD:_0W?0=^?O]B=PBMI?XTO^^1Q&^G^+'^#>?G]/
MR;GWV]*QWOL.]UA?822/&'IZ[<>W(VT=&H?D!V\D.M,.!^E8YMA]+<[?ML_F
M]ZJMMP*2UFZS(<\@ ?S;07;FMW[M]CMEGZ-[&L5VMGKBNC*_R>R]A'V=@!(=
M&UMMKW!]WO=8W^=]/T_ZZ8=-K \Y?]%<"3V^R/YL76]+HM _9-!.I$66 ZZ?
M3#WI\>WI+C:&=(I 958XP^T:#EG\X@!N-1:*<DAS+"'UWUET#<YU;G.9?^FM
M_F][V,K4LJD5O(<"Z6%P+1H0X-<RSW_O-VI::"Y:_P!:2K.]#[(KMRNE!A!Z
M10-P <0^W2"UWT=_N]W\I%(Q/0+ZNC4OK!WV-:ZTG0>SV-L_.]_O?^C96HV5
MXM55;\GW&TCTJP0PN!EOJ.L>"W9O;L^FH48];:G9UV1Z5KFA]==6[<#8!9[_
M %6VUL]M=G\SZG\M*QO<O\:>JM=M/LBIN1THUC_)6/LDD0^TB3[7.'Z3_BU$
M9?3(%;NDX^UH<6MWVP)]SM/4]J65<RD@9>-+7 -9F5$,%KG'W6;1NQV[6!WL
M;L5=[\:J'4SD![=SFO:YCF,_..YN]N[8?4?_ **M$ ?UO\:7_?()/A_BQ2OS
MNF0&GI&.[:-H&^W03,?SG[RD<[I[Y:WH^-8[;MW%UAAK?HN]UF[TV[?S52?9
MTU@#@^RUAAWI@;(;(;#GO_PC&/9_-U?05NH3753EAV'CN=#J6&0_4M]>RNQE
MCW.:UG\V_P#1UHD #]+_ !I?]\@$GM]D4UF=TYKVFSH^+NL(.CWF2-(W-L=]
M!*O.P'O+F='Q@^3:276#Z(-CW2Y_N57T:<%XIR0+FOF'M+FO:YCFXW^&^G^]
MZ;*_^N*=F,*W[6N]6IS"^M\&'-CVO;NVH5'I?@>*7\4W+P\=(I!U#IC)<WH^
M,TB8.ZP?2'N_/]RD<G":QI9T3%<"T^P/?NB-W^D_DN=ZG[B%Z>/16VW*E[[M
M*ZB=DC4>H^PC:VKU6>FHUXM0J.;;;Z;G!CZFU;VEKK-MD^H]ES:]K*G_ ,PD
M1'Q[;R_BJY>'V12?M+ID$-Z1C$/B8=8) UGZ?]529G]-(/\ DC% )W$;K(W#
M^VJN6^+ [,I=+MH;E!T.>9.^VWZ5&[8QWL4678C(?3^LV/ =ML#FAC1[G%^S
M=N]KVO=L?^AK1X17Z7^-+\^)'$?#_%BW6YO3BUH'2,;;J6C=8=2-I_/_ #OW
M5(7X=EC<>GHV/8^"&#]*X $\N8U[GMK_ .$_P:JMMZ=1L<Y]EP>![&CTPT..
MUP+G^[]'N;]"OZ"N5$.;4S+:>GTV2U]+ '/< #^F?Z@?=LT_FW^E6FR &OJ^
MV7Y+@2>WV199-^ TU,NZ30[TV[*V!]A#023Z>YMCVMVN<Y1IMZ7?;L=TBB&U
MOCWVZ-8QUC6@[_Y* ZK'PW^CDN;?6\^RZMS@0]CFXW_:CW/_ #]]55?[BGE4
M-8YG^$8YI=6Y@C<TM.Q_Z2$M- "==C<E6=Z&G2HJ^U]*?+W](I<Z "=]L@-V
MM#?I.WHOZJ\'(JZ/38X.%CR'6N? GW"MMCGN<YWT/S$-U6*S&9=E$['%H96#
ML<[5K'GU'!S6;=Z;'QZW,=G77#']A?555N+Y=NJ9R+J=K?1?[ZMZ1JMY=MY?
MQ4+\-KVBM7D]-(%@Z3C;IF=]IDGGW>I^\HMS.EL,?LG'$M+='V_1(^B?TBED
MW>D&NR<?U:W-TRZR&^H]Q:QK"VO=CMV_];W_ ,XJKWXS'!^.3DNLW;:[&N!
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MU-[=^W=ZCW^Q7*!UH'Q)X/\ T9J:C2Z/8#C_ /14N+=U#-JL-#GX6 V"[(:
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MTC[& _0]7>WU'_V/S$W?6K'<G@_]&7;:77A7%_Z*DQ,C.SFVLQ"_#P@T^IE
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M%V<_ZQ](MZ?CW&J;/3++6$-$L)^E:S5SZG5_OHW5NK9&9T?"%@VTY=;;K2X
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M $Z[&_I*D3*?<+&N<UM@M,M<(<-OTAM_=^B[Z7IH>6X65X5[FQB.>66-U
M8'UVV6^G[6;G[=_^"_FT3*JL-[6NL#!688! &T>UGIMT_,*>.E_UOS6GK7@P
MRK+&9F& X_::7S8UCI(9.YAM+ '?H]MGYVRK\]6<.Z[!ZTVS&$V7@"VM@/N%
MA_P1?ZN^O=^GJV/5?)KLLS<)H&[)ML'J; )+)VU>JQD.]WZ3W?\ ;BL8./;G
M]9#:9#J0'76MENC#_@][:=C=_P"BJ;6]--<.M5PFTB[TWX@AM?D]2^L6<(.S
M%;Z%3RT$LVEM18UTM:Q]KGV.?L6EET](Z$15G5V.]6IYKL#7;++!M]*AFWV>
MJLW(JR.F?6/-<'>W,9ZU#-T;]Q;:XMT>VQ]3F6-=^>M'(R.C]:/K=1#Y92]K
M&ASMC'$@5VU_F>LFS_0W]OA'R;[+H_I;<=GYME=3Z(!4[*JI>X9%9L.+:W@L
M;[*GL)^GI[%GX/5<MWU4=26G<VPXE]I@;:P/596_>'>[:[T?=^8KW4^M--3L
M6NQ]56.PU?:K''_"-]MCWN]V_P#<5+"Z3DL^JI?O(M+SEW4$CW5N'I,<]K_S
MMC?5]S+$8WP#W/WX\-JE7$>#]TW35NIV]%KKK:[TW%ECPV6'ES;+(>[9Z=>[
MT6O>STT&RP6/=96-]3B=A: V&M]HW,]OT6M^@BW6[NBUVU;Q56YC'[0Z0==[
M/4M;4UK+-K;=KOT:$]K6O<VLAM0DUAA!!:[WB7_G;Y^FU31ZWW+#+IY!GC.#
MLW&<TN]6@O%KVG:UC0)#WN9LL_1;[/TG\U^8K_27VX?7]N/7[LF&7T@ $[A^
MDV>IOW,K=^D9^D]-4,5I.?BM8"ZVTN=8U@W![8VM#Z6^[]*VM_\ P7_!J_TF
MNS-Z]NJL+/LX:^ZZ2"=@]VSU6U>VUWM_T?\ P:9DKU=N$KH78[\00X?K]6ZM
MU&_TB&-?Z=5K6C<UC3Z7V>IQ]K?9[WL:M3-;TGHWZADU6NN-7ZL\-=^E>71Z
M-.TN]VUZRL9MO2>K]0J%I(N=ZE-37$%];B;?6J_,?M;[/8M7*LZ/U@'.S/4&
M0ZD^@T.=^B<UT^K1^X_:U,R?,-_;H5P^3)#8[>Y9OB0=:Z)]GQK7T5E]=M1>
MW'<R2-IFMCF.<7^HU#9U?+N^JE$[CZN['R+C$$5:;?HNW665>WW)^M];^TXM
MM=3C7376:V7/>X.EWT-SG--CK-J3>BY5/U6H!!WTAV1?1(B+I/T-?TE=7_!6
M)#Y(^YOQBK\D'YI<&W";II9;#5@8M3"6T[VV6%LM,.&UUCVV%S6U?SM5/J,_
MP"+E6VD,M:QEE=NE1;JW:?H-:V/T?_0]-!RG%_3\:YC3Z#+&LL#=VFT2YCK+
M15^C?[[*_4W_ ,^C9E3I8P6-;4P TAH&W;]*O9MV[O;_ -N)_:ZW*SO78(\Y
M]N[&K:2<EE@<QC'2_P!,F6[]HW_3;_-[_P _WHXR+<+K->9C0ZVT$NV@G>UQ
MC]'8?6]1MS=EOZ/_  B#G-M<[&#?Z398 QS(W^F#M9OV;+'L]1WT_P"0K#<:
MW.ZRS$H&VRJ18\ MVM:[<[8US:F,;5^CI_16H&JUJJE:=;TWN-,.H6Y'4/K/
M=2&NV8-6RLN:":WD;WNY].NU[W_3_P"#6A=B])Z$*7=28\UW,=NN:UVR=N^N
MEVSV^JY^]9_4J+NG_66S)#B&9U6ZH.?!>^ Q[-P#ZWVL?7_X(K]F9TGK7H_M
M1KRVBM[36'.V QL9:1]#UFOW_P"OZ-,EM#?V^$7P_,OCO/;CXC7%LRRNC,MH
MJSJ:7L^TUC=C6 1#6SLL:]WNW?X-9O1^J9C/JYEXXK++:+?0<X@#TJK1O],^
MH'._1O:^M:&7UBNJBO"HL>*L:L3DV./#FQNL>\?F_P"#6?T;I.2[ZN9-K;2;
M[[/M 82/TE=?L:]V\AWZ5Q?8S<E'Y/7^]'AM1KB]&_#+BIJBG9T1[<=KMM@#
MWANYI):[79[MNRAOI>[T_29ZR$YS;"33[ZFC:R-H(#!'NC:S_A/;_.HHL+^A
MO=1N#:MK7[0XD%SOS7N;4RMMWZ/\_P!+]!]!"(8'32=E3_>P @DAPETN^C]+
MV.V_];4\>M]RPRZ>07I<#E8P:'.OIM#G!I@-9#;?>YL6>SW?\'3^>KV+;=A=
M>KOQV[KK0UME<1O#SM=Z;G^KO99[+_8]4J6G[5BAD^O?:)V:[F -J;OJ!WNW
M>[^O_A%=Q:;<WKK*:7&JVH--MNHV[#O=L]1E/M9[:-M;DV=:WMPFUT.E;\06
M)R.I?6/J&VH^EB_HJGP :PPBOTZW_0K?=OL?[5IY5?2>AL91FUVEUE5CZ+]I
MAUAVEM#-I=^E=N_SUEO9;TSZQ9KFVGT\P>I0P'6T/(L?Z<?HWV4N8]JU+[NC
M]:8R_J#;#8RNRNFG<Z \0UMK!_IF[5%/]'?V^$?+O?"R1_2V]RS\VVZ+J/0A
M5CC(IK<UE]3R<6Q@)!#?4#+6O.YSO4_]%JMT[K&;_P U@T;FV->[$LM,0U@'
MJ,:_<U_OV.]%G_DT;J/7&V8OH4O+:,>IS3D6/<'>YOIM=8YX<_=O+MBAT[HN
M6WZK@C=ZSGNRW5$B'-(]-FYCC]/TF^K[F6(CY![G[XX;5^D?;_=-TT+V.JZ1
M6S'EK;',M>&[F'\YN[W..VFO<RO>]OI>HCY-I+665!MM!AM6V" (V?0:W]&[
M^Q_+0+W66='8_'!%=+V,?M#MVN[A]C:OT5NUC]KOT6]'R:P:V,J<UF/ =4&[
M=NT^\:M^F[?^=N3^U]RQ^78(NHNL&/74?Y\O#J6-,OVGZ8]FY^W=L_1,<K%]
MUV-U*CJ%)'VETND20X#3VV.]9KO5;^BMV>_U&*OU(6'&J+B3<7AM#A LV#Z?
MT-EEC/4]/Z*L78UN5U6KI]31]H9+'. +0T?G0TLKK;Z3/<_T[?YQZ&E"ZKU7
MY)ULU_5KS9=9R,G-^LM.(:W>GBT^IM<T.++'M]9UKOS&V;O3JWJ\[#Z;T:K&
MR>IA[JKR19>UKBUH+7>R[8?S[%0ZUC78/UCHS2\^EDU>EN<^"ZQC?0-;K!O9
MO^A8W>KPS>F]69CT=4:\LQB=]0<[8X!I&ZYK8;O8_P!R9+Y<=7P</JX?F7CY
MIW7'?IXOE7=TFC+QL?J-%5E+;VBOT+!^;]+<_>?=4]JSN@=4S<?IG4Z&TFNW
M%?\ HV@ >BRXEMGT]VUM>W>Q7W]5IP\>C QG6.JQVBSUK''1NK2'N?\ 1J:J
M'U?Z5DW=,ZC:V\FW*?-+MT>LRD[G'](6.V7/=M:D/DEQ_+<>"_[W_>J-<8X=
MZ/%7DU:*=O2KS0TDW!V\-W-W;2UVVO8X>IZ; ZY^UB!O:X-%(+V5M:R/:'!P
M:'/W.;^C=[S8[>SZ:/18YW2<@4AP-(=ZFT/,2X0]IV5-KW-<^E_IO0(;#75$
MM98T/D%I<70&OWGZ&[>QS=JGCO+S83L/)0.^RFIH<^]MK'L8S2&G]YS?TGYC
M'[*_H?X17C=9B=:HS<<;LAVO>+ 3M;LL?ZN[[15LW[/>J( #Z7-+FWV7-:Q[
M#+BUO[[/98_:][6^Q7W469G6:<.J:[VZ.<9;Z8W;H8U[*6L]"O:W]$]-E5Z_
M+4K3&_K<:9YCK^H_6K(H;4?2PZ]C26B:G "U[VN_FV6V/<[WK1MHZ3T.ND]0
M98:[P^P9!:2UCRS<VKVN/Z7<U9N=6_IWUHNR6W15F5[J_=_.O@565R/T?JL>
MW<M%V1TKK+*?VFVPC'WTLH+G;7.V[&O+?],HI[0W]OA%\/S6RQWGMQV:XOE8
M7]%:[$IS*:W5,R&$/Q[62[W-EPL;8[W;GJIT+JV?7]7<BMK7,NQK3CAT "ME
MGO ?N:]S/1=O]/V[%8R.M,9B58E+G&C&9+KK7N#M&[3ZCK [V[_H(/0NC9CO
MJ[<YKG&[)L.0P3I8ROVLW[BW=Z_O<S<E_D_7^]'AOM?_ 'JOT_1^Z>*FBYCJ
MNC/^SC6XAS@W<QQV._,U_FZOT?J/V>GZEZO8EFZ[#?5MLQQ96QCA!B##R]C0
MWW[O=]#WJB[U+>C6?9P1Z!;O@.D;G?3:7-IVM?N;ZC?YO]75[%8#=A"HM90Y
M];V@;8DN_2A[V?3?ZGM3Y;&^\OR61W'D/S>YS'Y5>+;9B5"_(:TFJISM@<[]
MPV:[%SN/]8OK#D^I6S Q:LJH$V8MN0]ES8_.])V/^D9_+K?Z:Z6VVNFI]USA
M756TN>]Q@!HU<YQ7.9_7OJ?U+&<<JTV>D ZEPKM9<=QV-=@N#&76;G._[3J@
MWFU]5^I=<ZCA8^3U''IKINI%C;Z["7.<?WJ-C?2]O_"/6ZL;ZN=1Z19C,Z9T
M\VUG"K:T8^2Q]=HK^BRPMO:QSV_\(ME)2DDDDE*22224I))))2DDDDE*2222
M4I))))3_ /_3]522224I))))2DDDDE*22224I))))2DDDDE*22224I8'URV#
MI;76_P TRUKK".=H#BZ/Y2WU@?7.IUW2!6QVUSKF >[9S/YT.;]']]/Q?SD?
M-9D^27D\-87M;?9.Z[/]C9AEK:G0YPW,^E9O]&G_ $?I_P!M:#LH#[-900_'
M%44,!]K&CV/;'MVV[V_I$*VRO)]/&SB:,BAKJ18ZN&@M=NHWV6.KJ]M/Z+^8
M_P +ZJ S(R^F6'$RJ@YA+G.I>)$L'OMH>T>WW>I^D]E+_35^KZ>H=.\?ZK2N
MO+OX^+==Z?4;VV6BP95?L9E5 .<)#AZ5M3OYUGYON0VX/4FT9#6==H%-;V"X
MN+Q8TGZ+& 3_ &VUO_,3AN1D8YHPVNQ,:V'79=[VM-K';F^E6UKM[J6N_E?S
MB@WI.*X$LO<6$2YAVGF?4]2UFZFA[]WZOO?].M-NM+KPKC_]%75?2_&^%OTX
ME/3KZK0\Y^:& ,R7-#:P';G?H );8^QON]7?ZJL47W.RP]KQ4& EUA_-'YV]
MW[FU4<:G.Q6.91.;B7.;&.U[6V,+G66^M6S<ZMS]*][F?H_20+^JNR/U3#$5
M.#FD-:3;<6GW-W?U19^C:_\ STSA,B=>+^MX?W?T5W$(@:5_5_\ 0FO8ZFWU
MZ<8-K:+79&&YX!VAWNM: ?:RO8WU?W_YS]Q=?]7,AF0RU[=P<T[+ _Z6]OM?
M/];Z2YRDU]*=M>!=F0_U-E8M%<B*F.>S8_>U]E>2_P#0?H]_IK>^JE=]=-_K
MN+K'NWN#OI-+@USV.;])OO3<]&!K8?*>_P"\NP:3\=;\',^M9O=U=V,[J->/
M4^EMU=1NMK<Q];;*ZG6>BQU=5#;;7YGJ.?\ I_0])=A?N]-L;R=S)-4 \B2=
MW^#_ -)_(7)?6''Q;.O6'*JZDVDUU[G8%3K:[@YMM%E5_P"B?Z+V4V.J_0V?
MS5O^D769(;Z39:"-[(!?Z?YS=ON_>;_H_P#"*H-VY#YAYMD*%&[?=.^-^F^(
MB&_S.W_!_P!;\]3"'C1OO@ ?I-2'[Y.UFKF_X'_BTE#:7E^UEE;O2&WU)W-_
MFHW?2'[_ .9_I/Y"F4+,V^B) <-[-"_T_P YOYX_ZC_"?012CT4?E'F?^Y05
M;M]T[XWZ;XVQM;_,[?\ !_U_SU'(W;6[=\[V_P W$Q/YV[_!_P"D_D)Z(]3(
M@ >_4A^Z3M;])O\ @?\ BU'+C8V0'?I&0"_9KN'YWYW_ !?^$2ZI_3'^#^20
MKG/K58:GXSPW>X$P/OW+HRN:^MV6_&=C ,98RTEKZW@D$ .(VEGNK_KI^$7D
M JV'*?1+HXKWLZA8PWM>ZZB!5D5@&QG[K7-=_.5^[;L<H-Z?U*MF557UNEM=
M;6^LUY<VQ@G1C&-WM:_V^F]E3_\ @T];[\BDC!K?BUY$.MS;GM:#670_'I_/
M>WW?IOS_ &(=?2L8@!N07;0#8/:X.<-+76N9O916YNYE+KG?SJN76ET.U<?_
M **U-]:OQO@;M>#1A/HO?:>IY8!=1D%H%0W$'U*S[O6M?^_=^XK==V1;F,+7
M;'@SNF"V?SMQ_,VK/Q:,S#8_[).7BV0'8GJ-;9+G!C;*@'/JLM:ROV[/S%#(
MZJYQ.'A#:';JWF";;'#7T-[?8QN[]%[;&;TWA,C^]X_^@_HKN( ;</A_Z$U\
ME]%]V530UNRZS[1CEP!'J@;;#76[VMKOVV/VJRZW[0<< @V[ACV.M(GU&L]7
MUN/YI];?I?RTL85=,L8^\>KD3O=4VL6%E>W>QMD&JUEENZN[W5V>EZ5G[Z ?
M5K%KLLBR[(8'0\.#FD_I':;?T'\SOWIVA\AL?WEFO7<[CLO;E-=D.ZB(+&L#
M<-EH&YKB-N_>WW;=K;+ZU?P7M'2<=F.?908MK)U%OTO5MCZ3K9^FJM=WIX[<
M#J&ZQ@>"+S5N'IO;&\6O=4S;Z_ZQ_A/96]#%F9TE\-<VRJZ-D@OJN:[WLV^F
MW_1['?HF?HO7_G4"+%=0?3_6B$@UKT._]4NEENIS:JZ,RHOJ:0ZNUFMK'S].
MOZ3O:P;W_P"#52SI?4:+LEN/UJEK6U.?;7;+',:?>8JKWUMM;_P?[Z(W+R<F
MES^EL=0RYCB[,>\-#"PM<^FC7>]__HI51TFELAN26%I(>\!KA,^S?Z?J.HQO
M3^G;?_VVA'2Q=?U:X_\ T5,M=:OQOA_]&7'3ZZZJ[<N]W4X)LJ@ 4R(9O>]Q
MWV[/YO9:IV9U^394X$EY</2L!@AW%>URA1C7X>]^$1EXKVEM^'ZC ]PAK&[-
MKGL>]ECWOJV?X5!MZ@:IQL.HT6%WIFRULVASO\"R/T=3F[D\#B/[WCM7G%:=
M!^[^/XL<NRNW-RJ06.JRB Y\^PY%?%E5?\W[\C]';_QB'RVJLDNNJ+:;7$0-
M0;*G5PUWZ'TD:G&HPV579H(M<6O9C!FY[:_IO-C6.HNK=8UCZ6>IZG\UZBF1
MEWV7Y>2\-=DUN<S<2R9=M86ULK_1^UM'Z2SV(V.FPZ_UOE11Z[]O!KNN:VQW
M4*CN;L]/#;9[7M!!J>[U&>[VU>I;5_+?[U:JL]/ Q65>ZNDN8ZJ=1<-;'W-'
MTK'M/TU$N;Z5?3^H[FFAY].ST]\5V-&UWJ;J*GM;D#U_\)O96@EV9TNV"&V4
MWEH <-]5H(WUN9Z8;[MGI?I*?]+_ #B6^G7]'^M$*VUZ=?ZLFY;;5U!U=>2U
MSC1#JK:R/4JDC;MYW,_D?046=/ZE79D5T]:JK_1%UM=TUO8TG]QF^NNW^36_
M\]*FVZYCW]-J?0;OIYECVL8QK2WU:*'?2<YS?YS_ (-09TBB=M>5+P#NX>"Y
MIVM<_9ZGI8WM]UM_^E3;K2Z':N/_ -%75>M7XWPMNK HQF8^5D9!ZI?)LQ[-
MH%+7>UN]SW;G6V-=^C9ZZN&_)NR*]OML)D&=0?WFG\W:L[%HR<+U+<%QR,=[
M2+,)UC6N?/IT^W8Y]=EC/TGH_G[TV1U1S''$Q :+)-=MCQ-H>X1]G:]OZ.OW
MN;^=_;3#$R.GJ\>W^#^BN!$1^[X=_P#"1YEF/D9^934&NKRBUP>0"TY%?Z/U
M:V'V?IG>HW_A/T:D+?7IQZR6NN8ZK'>ZP@ NL&ZFZO\ X#9_J]/C5U8#J[\I
MA?D/<UXQM@L>RH>YWJ-W56L?<UCJ6-_2_P UZB$YUHM?=EP]V2P[6/#@6R?3
M]M<-]-KV!FRW\S\Q/H'0; :'O)9XG<[^3*_(8_)9F@!].,P"BNT _I6ES0]K
M_I-I?<W?_P!;_P"#5OISA^R!70[W,>79+"=2^P^JV^S]_P!FW^HJ]-SL?&^Q
MYK3D56.9:UXKWC8X'U6LN<ZIGO?:W;[_ /!J$Y72G^K58+*+P/2MV[JK6N,A
MKF5-V[GM9:_TZV;ZO]*@1?I['T]I)!K4_P"%WC;?R;*\O'&-F4FW'=J-L^H'
M_FOI/N>UR _I6?5F/;B=9J836]YIR!Z9:P\N-=>ZOU/\*I,S<C)8YW3:C4^T
M/K=DEX970\ ES:BX[_4]K?3_ )"JGI51+G?:'"R27V- <?=N>QS6,W7,J]^^
M^R[8A'2P3P_U:X_^:DZUI?C\O_.69T^L8S+LS)=U-CB'L8P17+03^FL?^E=Z
M6[W5.])$NZA;D;0XD@$;7 P6[3[&U[?H^Y1HQKL6PWX%C<BJ",C%-C/TC8<\
MM;M<ZM[-UK=GM]1"MZ@W$FG'I=CVAP:YV0-UE>_\QNS]$U^W_"NV?V$\>H_O
M=OT:_P %;L/W?Q_YRLVVM^?=6]S7-R&"C,LGV>JP[Q:UOT'VL?Z/J/\ ^,0!
M/I5T/)=?06L?H W;8X^GZ+=I]E3O48]$KPVX]0OSY999'I4%N]YU(MML8'4W
M-;N;;3]*SU/48K!=?E9-F=8X5U7LL%0?N9[!_-1777ZFYM/^%_TB-@;;#K_6
M'[J-3ON>G]5J^JP7#.80YF,W9C,M@?I6DMW-L;[O2W^O=_UM'Q;-G3:F4DD5
MV'UJG&7&YWZ1EE_[_P"C_FTP?Z>,WI_4 YS ]ME;@PV2'MVWQ:PT5NWW/9_V
MW96A/&7TJWU&.;;1= %NW=5<PNFOVU#Z?MML_1_I*?WTJO3K^C_6BK4:_;_5
M+<MOJS6-HRZW6,9[V;#[ZCSOJ=[OHPDWI_4F95C<?K-5+WUO>ZK(!J<UIY?L
M9OJ99[][5&G(OM:^SIN.^J^P.9]J<]K:J2T>YM-EAW>HZ/;_ ,"]#'2J=Q8,
MN;O=O+8?)DFO]&S?;Z#-WZ:VU-VL7PCM7'^'Z*[>M+\;X6S1TW'JQZ<K+RCU
M4N=NJAOZ)K@-H]>P[GO])WL]*WV*[9DY5]C)'Z0D$!O,]MO]I9^+CY.&^R_I
M[Q8P-<;<5UC&BP!OT&/8XL?M?;^B_P +O4K^JF@FBAAQKI O=:-UM>X?S3',
MW5L]O^%=_P!!-(,I?O?A7^"D$ ?N_P OWD?4;<>SJ616-MC<A@JOL,;3=6?T
M=[&_1W[RRI]B;U9PJZK2'W8Y8U^Z TML?LI]%G[E/NW_ +GI_GI4T#$V9&8T
M_:+2#5C%C;'@3^ELL8Y]5K=VRW&9^DN_G*[$K;;+,HYF1K7D!XJJ>UP+6F:Z
MW-IC_1VL;O\ \'L3J&PU &_>06]R>OX!658RS(J>X!^/A!S75O <U]K71NJ=
M[7>F^YS*_P#S!6>EV^ITZ\5NB]]IMRFS)?ZAEEG\JJO^;5?'O?BXSJ<EIR,>
M\-M9##8 -WZ:MECC3_@=M&[?]-0<+^FN.3C6@XU@(JO#0:W _H_1LJK!9OW^
MI^A_3?S"!%CA['T]I)!K7_&[ATLBYM^*<;*I%^._Z30?=N_--1^DVS=]#8J[
MNEYM>94,'K%=9L87UX^2/3.V-OZ1M?L=N;^][W^FIT9UV00[!QRVYQ--MF\5
MU4.+3[PZSW[OSJ?W+%3'2PXEUV2YV0??;8T![CN&[]%6TNR'N];^<LVU_P"$
M0CI8OA\*X_\ FI)NB!Q>/R?BM5TX.Q1;F9CNITO<(94(87-E^RZZS]*W;_.^
MGLK4[L]]U09M_1,]K6C0,#3]&N$U&'?C6B_I^0RUS=+Z76,#+6^]]C!#MCJK
M=K/8]F]"NZBW$D58SJ+A#W?:6[C5/9FSV^[_ $EC4X>H_O=OT?\ FK3H/W>_
MZ7XKY][?MWZ9PL+ZACY[R[2'>_<[_29%%>Q5R#71]FL)?=2=P@ ,]-[MFVMH
M'YEN[>ILP2RHY&<XL>\D4M<W>]]D[7WN9NKN])CG;O4]5_J^LK6^[*S&YA=Z
M6+#JJ _<S]&QGZ-OI!CK;-OZ7W[OYQ.T&@V'7^L/W45>_7_HEJ.+!:S(!#JL
M*0RNP"'7M.X;'QN]%]WT_P#BT;&NGISPUQWF[U<IF[W/-GOQWO)_G*?W/_)I
M,L=CXIP\X.?386W5EK383!<W(VVU^A].MS*O<_\ 1H5E>3TNS[30YMF,X0VX
M-!K>PG9LL8SV;]_J?HOTMK/22T.G^+VE2MM?\;PMN79%>94,3+J-U1]PK:8<
MPC\^DS]).WIW4&9K1B]7KJ?8USF59(],[=O\XX5[ZOY;+'[/H*%&3;<YUF#B
M.9E&:Q;N#::'P?TC76G=ZG^AW(;>EUN<39EDWO)=8ZN+"Z??MKK:7W/]S]UC
M_P"0F[$B^'PKC_YJ[>C7%X_+^+8HZ70W$;DY^:>JL#P16QIV L#C^GN/Z78S
M^<]/V5*[=E9%I8' !^@VCR/# /;_ )JH8F)D8F0+\"YIL8/TU+GL;79M;98^
MH/8[;Z+GNK_1V;$]_5CBPRNDXN2 U]OK>]U+3V9M#F^]G^&>FD&4M^+_ )M?
MX*01$?N_C_SE=5OH_:3FO+;?4I^SYKR?:7"+&N=^];C_ */](I],L+3CXUQW
M6XUK7Z[6M-9L%7ITL;_A*K?IJO7C^@/M683ZUFF/4]HL>YT['9+JWN8_TF..
M[^>L];UU9HOLNZSC9U@V8[[@VBA[2PAK2US-M7YVS<]COY:) X:&H W_ *P_
M=4";L]3M_5>VZMT]O4^F9. YYK&36ZO>-8GO'YRKXO3<C(9B6=992[+Z?:7X
M[\?<&?0]'?ML]S=S7._1HW7+,ZKH^99T\$Y;:7FF!)W1^:W\Y_[JY_I^*'XW
M[2^K?5,C.RL<@Y&/E6N>RXQNLQ[:[1^JWN_P;J_YMZH-UUL3 ZG=UL]4ZB*:
M6T5/Q\6JDN<XM>]KW6Y%CVL_T3-E3%LKF.F];JZI]:JQ2ZRL5]/?]HQ+ YCJ
M[?5K]MM3O;ZFW_"+ITE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]3U
M5))))2DDDDE*22224I))))2DDDDE*22224I))))2ES_UT)_95<?Z9OY'+H%E
M_6#I?[3PFX_J>EML#R8W3 <V/I,_>3\9 G$G8%9D!,) ;D/ VNQLF'6?H\H:
M>H&R'D.8[]+R]C]E7I;F)JLL9H;6S&#LIKW/!K]@VV?I+'N;?8[T]CWO_2K=
M_P"8^H)S22#(_1COS)]3=_FJ5GU,MMD/SR62)9Z8AW[P?^D]W[W]=7/=Q?O>
M6DO2U?:R_N_D\Q<W%=>YUMUF9:2?<!Z8+3%C/<_>_P#1O]WL:I>GAO\ TS0*
M0T_I*?<0\@[F^F_?N9_G_H5T7_,?W!SLTZ<@UC4SN_TJD/J0((^UN \?3'_I
M5'W\7[Q1[.3]T//^E@WN]0!^);KL<WWM!<&M;&[;:W97_-[7J\;_ $"^ZRL9
M_M%5>5N#@[<=LY-3=EC?;8[]%9_UJQ:C?J:YNHRS/,>F!K\/54JOJC?2[?7G
M.;NT>UK(ENNX;?5V.<YOZ/>_?[$V67&?TOH;_-<,60?H_93@U/QG/;DY#198
M[^;I#(J #?1!_2?I6_1WUUL?L74_5BPVUW6&"7N)+AW/>54=]3G6.-CLL[]-
M?3;K_P""+3Z'TL=+=9CBSU=\/DC;KHS]Y_[JCS3A*&ALLF&$XSU&CSOUR-3.
MHO=9U*NBU]5;<?'?E6T;6D6LLM=5CAS/9=Z5[-_](_2TKL\@M;2S<YC1NK$O
M:7-^DW\W]YWYC_S%P>3U/)JR;L_&ZCF6#(WV7%F)C$-Q<9_H-S/TQ]]#7V^E
M3_A[O37>W%XK:6%\[F:U@$Q(W2'_ )G^D54;MJ'S#S; 0\8M-E\%I(L@[6[2
M#M9I9_I'_P M$"A07%]P<7Z/]H> !$-_FMOTJ_ZZ7=0VEY?M5F%K:07%K1O8
M)>W>WZ3?S1^=^X[\Q$*'F.L;2#7OW;FZL )B==TM?[/W_:GJL=;7O<PUF2-I
M\C$]OI(]%$'@!\2BH+39> 6DAX!#6[2#M;I8?\(_^6H9CPRMI.W^<;])NX<S
MW+&L=I[;/S$)I/VWFV-[N>/H]QN_F/W/8B9KMM0.YS9>![>_\EYW5[6?VT>H
M7\-3AX@%G7:RZL6,F#(UYT.U<[];@7'':RIUUA=[&-+1J \S^D(8W^O_ (-;
M^(=V.TESG<ZOYY/\I_\ 9]ZR^N]'/5WLH]8TA@#G0 X.$[75V-+F>Q.QD1R
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MLCZ'S14+(^A\T@IJ?G?!.-23_KHF[DI<-'G_ !3T,AKK]R1/8<I$P-.> D!
M04J/$RG@>":?#4I>[R24HQ&HE#J$9+_Z@_*IC<3.D#A1K/ZT_P#J#\J1V2V
M@YG\TT2 2]L2"23X5PU_Z3^PC!#R8](3$%[ 98;!JX?F-_\ /G^#31NNA\P\
MV6!_1AJ#JZ2T1KN/TI#/?^_[$.JM[LMSV^D6LL=OVZD2-/ZM_N]ZM,:U@VM
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MH>Y'9%2G:Z#YE,/8/$=_%+Z \1V'=.-=3]W@DI7TM> E]#^K^1,[0^WGP[)
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MGKE(>WQ2X]S>L0GRRW]J5$O <TU!H)(=#G.W>BW>W>U_^&]BU-#Y+.R;\O\
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MTK&%CQ8[:3N;9ZP@N<6-^T_X?8SV/M_/6#UO%KHR\G/=94UN]KWL;U#(IL=
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M#[TQ/N/WIXB6]CQY*#3+0_P_@DAD.-O@=OW+$ZI9Z?HN!>'FVT#86@1Z]/\
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MU&ESFO)=OV. =4YS=J2FM4T#ZW9(G_O.I_\ /^0M>&^*QZO_ !6Y/_INI_\
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MWU.0Z!(D;?I?U5F=8'Z]T/\ \/G7_P!!\E)3;SF.<<9TO%++-U_I%P=#6O\
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M@%[BPN?SRZE[_H?RUFN</^;>/6W%J'J-JJIQB;,>K>]S:Z:QN:,FMNX_0?\
M32^KN'CX@L#6DWWAEKG^IO:YI+V,]%C7/;12W:_\[>__  B*G8C;R23\4T1R
M22?-.YNTDR9_UX301[G'7X)*5 ;QJXI.,>T:DI01)<=4X 8">YY24Q(&C?F4
MAJ[R!(^\)'Z)/=V@^:<""/C_  20IOYOP63ELN<<<M_FA9D"R:79 GU!Z3C7
M66[=NVSW[EK#\WYK,SZ>H6X3FX&SU/5MG<XM,%[OYN"*]W_&I*;5KFNP YK@
MYI8TAS1 (TU:W\U4&?SC?ZP_*K]K&UX(K:"UK&-:&NB0! AVSV;OZJH,^FWX
MC\J12],G3)TU2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/__7]522
M224I))))2DDDDE*22224I))))2DDDDE*22224I!R/H?-&0<CZ'S24UDW<)TN
MX^*<I1_BD?XI'@_$)'AWWI(41I\"D1N$C1P[I^'?%,?89_-[^22EYD21!\DV
MX$>!'X)S^\..Z<\R/FDE8.W"(,A/+BW:[23\92_E#E)SFN: -3WCL4E* V-)
MY!,2>4^A!+>>-PX3:[0'=SI"<@-9(TD\=D%*9[9<=8'TDF /()^B.R0,M.[3
M71J6D&/I>/@DI8M#G0-!WC\BD\:[ 3IRF;+=09C@'Q2!<!)'Q*2EXTY.O;R3
M0)@?$_!*3S'^Y)H=!>=)24N[D#N=853J?3,?J3:&7/MJ./9ZM-E#S4]K@UU<
M[V_R+')W76-SZZB89:PDB!)=^;J@_:\@8GK;MSQ;L$ 00##ITVHTR##(U5>J
MO^=_Z*A_YN50?\H=2T/_ '+>G_YMUG<!U#J7_L6]7'93@<I@(FENYI$'73Z6
MK_\ J5//R+*'4["&->\"PP#[8XU0I Q2) T]6W^+QH<#H>/@9=F57=D9%UU;
M:G69-KK3L8XO:UF_Z/NL6@&^?Q5!V3?.5+I]%OZ. )!(W#L5.O,>^S'J,#U6
M;W\3/W[O_ TN$I]J57I_*/&W2/,0.$MOFJ5U][>F^NP_I8!W0/&/SO:K37[Z
MV.:9! ,\3(2I:8$"_$Q^L69![#1+:4P'R4;[C56YXU#>WCK'FDM LT.K*>W9
M(:IO4_3BHM!EI=/P(;_%57Y64W&MM#6DAT5[03(#MCMP+F_]76E2Z,">VM;_
M -9N3''WI]T\A4VY-YR65;!L=5O)@\Q,?ZUH7V_)&(V[TQZALV%NTQ'^?_W_
M /ZWZGZ)+A*X89>&M=?WO_172#1S^"8S_L5/[9=Z^0PLEM+-S(!!)CB?=_Y[
M_P"W$:K+98:A&UMK26[C!D$>P?O?YR5%!QR'3I?X<252T_.0,9^0\V%^W8'%
MM>V9]I<UVY%26R%&ES^'DF3B>R<1VY00\A2:Z\_'9TS.S,V]U?V>IS*Z&T>C
M2X/>S[7=0VNSTM_O]#UKEUQ 'FN1Z7]CS,ZC)>:<"^ZDY>._#?Z>T.<VN[&R
MJ;39C76/:ZG=;Z-;WKK9['A)2MQ7._66NO*S<;%;;5B9 K=>W)MN?22QCV.=
M17Z#ZW6^]K+G[W?H5T>WP65U;)Z73=75EX;NH9!87LJJQ_M#VL!VEYEOZ-F]
M)2OJ]F8.3TND8;J@VII:^JJSU0PASV[O4/Z1S;7-=:RRWWV+!ZH!9U#,R&68
MUU3]S3G.R0PX\?9K*F>BS=;^IV4/NK]#^>?;[_SUU/3J\/[.+\7$&'ZPE]3J
MA39I(_35M"Y+JE%V-U"]U-=.'2VXMIK9@UV>H_;39B_IG56.W9OZQ6RRO^9M
MK24]MM,_WIXG0D3V3?2^(4245,MH'=* X1.J;Z0\TW"2G"^L'0K^H9(O]-N5
M356PLQW6NJ!<RQS[ZX;^C_6J+-GK/_FGT+3Z7B6XO3<3&L ;934&.:T[@(&C
M=^F_;^^JG6;NIUWL_9@NMR',UH])KL8B3[[LBQU#J7_\3?ZG_==6>GY.?87L
MS\88V12&R:WFRI^X;IHL<VI_L^A8US$%-F-!YF4QT!/F5.?:P\A+:#('QCXH
MJ8NU'C"1U:'#7N"DW]T\A(:.(X!UT24K0PZ)53JM8=T^X![:QM!+G$ANP%I>
MQVW<[](S]&K4.:[;H0=0A96.,FAV.\[&N((<WD%KA8-NX.;])B(W"[&1&<"=
M ) _86GT]M;[WOKJ9BQ6T&E@>TG7]':ZNVJC\W?7N6DV""./[PJ].,^N\W67
MOM<YNSW!H@3O_P &QGYR.UHW@@2?/ND3JNRR$I6.P\?QD\OBXV[KK'#U\>MM
MSBT6XU6ZYP,_HWLQ6NHQF_Z?U_7?_P $I?6W'H==399ALN?8T8PR6Y7V6YHO
M=Z/I-&RS?COW_I=_Z/\ D)JK>GOZACXN[&==1D$MR@\FTDV^N^L4>GN9E7.8
MRBZSU=GI_P#;2G]9L7(R.H44C#JM;97M;E68[,AS!OWY+OTN[^8QF[Z:-GZQ
M=<@QMR]EEO1,6K)=8[)#Z(?4^LN]86,]%WK^E]G?M?MWO]#9_P &FZ+BNQ,K
M*HM-^^MK6TFY['DT-?>RIVVNG']/>]EEFQWJ^ST_TBECBY_U:H!PJ[KG4MG"
M;MI9S^:&[F4;?YSTV?X11^K[',&4;=S;S9[Z7L>US6M+FTO]7*=;?=ZC/^&]
M/_1I*=AP<'%Q@_P49)U+?A_>I.<'$$Z"! /=-.XP..Y14H$DS&@X3 ;CN=P.
M G)G3CQ3$S[6_,]H24H>YT]@G\/B2E&UNG)2X,=@$D+#\WYH6/\ S3O^-L_\
M^/11^;\$+'_FCYVV?]6])2V9_1G_ .O=9K/IM^(_*M+,_HS_ /7NLUGTV_$?
ME2*7IDZ9.FJ4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI__]#U5)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2D'(^A\T9!R/H?-)362[CXI)'
MCX:IRE'\[[T_?XA+\[XA-V!\.4D+C41W"<&?XA,=#/8Z%(CY%)2@T Q]R:(,
M28[)SNC4?,);I$$'S22MM#3/([HCAHTCF% %TP1'Q[IW-(B3+8X\$E+EP<T-
M DCD);2T GW?P3N AL:0-$Q<7  :'N?'^J@I1(+ !K)^Y+;L9H=)DRD6@-$:
M'DE,22&[A [>!\TE+@^W<X028"=L&3.C?RI..C6CDZRD6M#!HDIS^J=7;TX@
MV8M]U6GZ2KTR"X_1I8RRZNVR[_@ZZU>;;ZM=;RQU6]H<:WP'-D3L> 7>_P#>
M6/U##]?J9?0:ZLG%H:YUUUMS98\O]M#<>VIM7\W^FR5I].>V_#Q[PTM]6MCX
M<2X@$ P;'>Y_]=)2)SW.ZFUC"!-9!)G0PY[80+MM73#Z3FD&T$$:^[31_MJ_
M/_D*Y981U%E>\AIK)V3W&FY5,:AV3B;:WM:/6+CIS&KOWMK_ .R].'3Z-J!
M$2= ."_^>W@3Z=Y,.V.(;QP&M?X*B,E]E6&][]]I>-Y(B==CHV#:K-N18,O(
MJMTH93+ !W(]TD?R2@UW6-Q\5P>*]UA81'T@#_+_ *J01"-"R!K1'_A<F18&
M-R[-S2\L(?M^DV YS=(K_,_EHV"7O;6TENE+'0(Y)>/^^H 8;+LQC'M;8=HW
M.'E^> ?[*+OOQKL.@?S9:6VF)U ]OYK?SDO#^6RI"XF/Z5"6O88^)KV9#SAY
M3'O&YENU@C0 '<UGL'\E:E8W5L,C5H/X+,KR+6X][Z0'?IAM!#C(=[G>WW+3
MF&@=X$E"2W/II5>H_P#1@S(,0./% RQ^K72--COR(K1.B'F/>W&L%<EVV!'.
MNFG* W8H?-'S#3KLL8, 5$.]0%MA$NENCCMWNW?23B\>G?6?:W%N:7/)F07^
MJX_R5$LL#\&JR@%U9DN;)VF8T+?^FD8LJZ@UA!#C]'0<SN]W\M._E^+9H'7Q
MN_\ JN_^*V6MJLR7WMAQ]-NQPGAP?_U2I/Q[&]/I8WWNLL#P  #JW=MX_P"I
M;_;_ ,,C5MG-Q1] &C5I<9X^CMW>_;_*359+J\5EMHVLHMV0T.DM -3/ZVYY
M_J):H'%$CAU^6@?\.,8L7 ?:L[_BCIIX#_7Z;_\ K?\ A!U3_D^?$S_G=_:Q
MO^>QG_%5JY9L+,MQ W:R>#&QAYU4/L@;?B,9!;2'/!?S$MG:?[:5_P OHD9!
M5'33_HXE^G^IZV4'.<X>I[00=-3Q*OZ?G<JCTYCVVY3HAK[#M.FL%P/'_F?_
M !G^#5U [L&;YSY#_HJ/X)O@G$\\)_;VY08WFV.^HK[ 68F*; ^ YN(?IAVW
MZ7H?3;8NC.A\2N9JZ_<QGK5WX0NMLE_2V,L&27.,.K=^DW_:OWG_ &3TETTP
M8[(*5N*Y_K73>LYF37D8M8K=4+*P^K,?CN-9<UU>_P!/%NW[]NYS-WZ)=!M)
MU'"P>OYN7CYE%+,C)Q<9]3G.MP\8Y+S8'-#6633DLKKV)*='!%N)TRO[<XML
MHK+KGNL-T!NY[G.R',J?;[/^#7,]1ZC@')S,5N5B/KS[*[C?;ZWK5$LJ]'TF
M5TN99Z3?TN*[[13Z>]=-BQD='&XV99LJ>'?:6>A99(<W;=7LI]#?]#^:7&59
M^+A&_P"S7.LI98"[;U8!V[94'UUTM9ZF1Z?\VS^<]9)3WY:9\$BV>XGND?=Q
MR.5'5%2^T#\Y.0#J#KW31.H^83<&0@IYKKN!T7'R2ZR[!Q'V--CVY%+[7O))
MW6^R^GZ7[NQ;/22X],PW&OT9I:?3#2P-_JUO][&_R7K,ZEAY>/GNN;^TLG#N
MK]K,3(U9<7.W[F66T[*O3]/T=GZ.O_"+5Z6S*IP<:K,<YV0VH"YSG;W%W\NS
M\]_[[DE-@&&CP!2?[2#\BG\6N'<Z_%.!O9')'*2EB [G1PX*@Z1R(([]D\QH
M?D5/D1W"*F$M>S0ZC4)!S#R8G1(0UWQX0LN^G"ILRKCMIJ:7/($F!X-'TMR2
MDFXSQ)'*:"'0=!VC\DJE5U9UF375D8>1A.OD4&X,VO+1O=7NIMN]*W8UUGIV
MJ_N#BW;K,)*>:9:\]1:QV8RRVO*;4T"ZS<9?9=D6>AM]_J5,9A>DS?CX_IW?
MID#ZTX'[2ZU2RO)IKL%-30R]ELCU,C8WT+L<M]+[4_\ 5;_=_-*STU];;*LI
MEUF@92*G,K_F[,FZC9ZOT_YYCWO_ )"']8<=F3U^IAP<O+<S#98+,*XTN:6W
M.+!9NNHK<UC_ -(S_"[TE-]F1]GZ!C6XCJJ6N%58LJK=Z-;2[TGVUX[_ -)Z
M=3?S+$7HV;DYU3K<FYCG" **V.9MV[F^H\V>YSK]OJ;/H5?]- R*78_1<&G'
MK.(^J[%]''R'DF1<PMHOOI]?<ZUWL>_](B=&;G/8V_)?5;6:*ZJGTV/L#MCK
M2^UWK5U;7.W[4E.J_6 / 25':!H!![!.X;0()XXY3#<-3$_D14J&M'$GS[E.
M! U^:8;CKH/!/'<ZI*6&NI^28_1)\>$Y,^U(ZD#L-4E*_.^ 0,;^:_ZY9_U;
MT8\./CHA8_T'>3[?_/CDD+9G]&?_ *]UG,_G&_$?E6CF?T9_^O=9K/IM^(_*
MD4O3)TR=-4I))))2DDDDE*22224I))))2DDDDE*22224I))))3__T?54DDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*0LCZ'S14+(^A\TE-5+G1)(<IR
M%_W2D.2/%-V([A.3H'#LDI0X@\A+Z/P\4CXCE.->$E*!!X2([CE+:/\ <EM\
MRDE6A"1?,#D@)MH!F)'<*3@"&QX:%)2SFD1.K8^B.RD[:6B>(3%XT;^<!PDY
MIT=WCCL@I8S#=VK8T\?FI/<('?31,YP@>,<=TBS6>'0-0DI=S ([&-2JK,K*
M?U&[%=C.;C4UL?5EDC98YWTZFM_?J7.LZC@8/UTZG9UG+^S7>G57@"YVRDXQ
M:UUOI3^C=9]H;[T3ZKY&)9]8.L#I%[\GI5GIV[B2^H9;W/.2,>Q_\C8ZQ)3<
MZK4#U&VW.?B-PZ::75?;&BS8[=8VY];?4J=4USGX['_Z3V+;J<\TL)+7%[0=
M[=&G3Z3-7^QW]98?7<MW3LE^4VHO98RKU;'TOL8UU;GNI?792YNZUKW_ -&_
M/]BU^GL97@XU; \,94P-%C=KX#1_.5_X-_\ (24B(9^TV;W$OV%S!&FW5KQ]
M/^W]! II];":U[VESKW/:\ D&)V[?3(9]$?25I[@SJ+##C-1XG;/N]KOS6^U
M!JR*78]>78P5-9888P!PW.!KT]/V_GIW]C9!D(CANZC1\?UG#$?WF37$YN4-
MXCTB7?2!:6P/IH<LMQL-UUAESO;J7C?NW?3:YO\ 5]Z/<^SU[Z'/VM-<MX!)
MB=K7>S]W]]5V68UN/@64OW4FPN:_7][CE_NW_H]SWI?R_!(&@.H^74?[.7@R
MV>M=G!S@:W;6#2=OYI:[TBUWTOY2(YAJS<2H/;+&EKFD'4$'W-CV_F).NKN=
MEAS!6*2-[VPXN#3ODAGYWL1?7>_(QWUD^E<TNU G02.1N;RE_+\$$RVJAPG3
M]'^:'_<L,5SW!P]0N+<C;],N]H[?R?[:N[9/(64Z'8.4&.+G>H&OF0=P(;]+
M>_Z7TO\ T6M.LGTFZ%KBT2#R-.$"LS1Z^/#^$4D$"!\U6SVG[';I^;V^(\)1
MQJ@Y\?8[F@;I;J/'7Y(#<,>/YX_W@TW9AQ_LU]CHK])WK6/UAH][W;M'^W;_
M .E%E_MB[(P[7X_3+78I>"^_?6Q[@7;V[<=WN?[7>Q$ZW1?D=-KQJ&$WV4%E
M=8@$F?H^[_R6S_C$%O5.I-Q,EG[,R)+FB0YFD?!V]W_65* *N@=>].GAQ0,!
M,1C.7'7#.?M<,8STE7'CXOF_YCJ=/RZ\Q]&3C OQZJ]I<\0YK@'L<U[?]*US
M=CU .:[IKVM(<3=N;6_4=G;1_)5;H%>57E7ONK.,,FQ]PI<1,.8W:YQK_1?2
M#W?OJMU&FJ[(P;<G+&.QH<PL=NVEH])IV[!6_P#2;F>IOO\ ]%9Z?I(4.*O[
M5OM1]\P!](X91,?UI]/'DX?1\\OZT7<-;#U#(+P6EU$:#0@#W0]0JR+PS#ML
M]SKB:W;]#!(=/Z,;=WL1"+6W95\AU;6E@&I,AK7#_HN0*B&,P6RZIPL=H? N
MU;!]VU_YJ;_+\&L*(%ZZ ?\ C4F[B6-<ZVD27U/=NT,>XE[8)_DJS,:'54\,
M?K>69:6N>(($&=?:[^JK<0FG=@R "6G8'ZRCJHB=1JHN.UI=!.T$P!)T_="E
M'>83R#Y'Q26/*V?6]N1CBRK%?M%3;,I['.#V"QVVC'JMKK/ZTYK=^QWIL_P2
MZD'0. B==1!^Y5KZL:BE]OV=KPP^ML8UDE_^D;O].OU?^$<]'K>7,#BTMW"2
MQW(_DNB4%+R97+_67/Z0,NE^8_'S<9C;*CA/R&4EMS7-W7;;GUUVNK_FG^[?
M0NI+>_ 7,]=MOQ.IA]%^9<^VML8M(Q6ULWVLQZWE^:S_  MS]G^$L_X3TTE.
MMT(_Y(Q2VUMP+26V,L-K=NYVQC<AWNO])GZ+U?S]BQ,C/ZAA=3S:\8XUF,+?
M6>ZRFUQJTQZ[J_5HV,=Z7JUW6;=_H5O_ $KUM=(O95T.O(L-K&U,L?=ZY:ZU
MI:Y[KO5-0%>]CFO]M:R,_$ILQV]<LKRZ:+_TF;AUVL ]&S9OOL9M<]V^NC'^
MTX^/?7_Z42GI]I!YA.0#K/Q3'74?-1!(U14R  [I%HY!T3'Q'"8'77CN@IQ^
ML]5S<7*&#C-:PWUL->0]CGL:2]_VFY^TLK]/"QJO5>Q[_P!(^VI7NGWW9.!B
MY-S=MES&N>(+1)'.Q_O9N^EL>L?.Z7UMV?9EX[+#ZH+2T=0?2P!K[/2].MN-
M9].MV_;_ (/Z"V>FTNHZ;1CEGI/JK#2S>;8</I-]=X:Z[_C-J2FSR?B-/DHD
MEKI&@/*D2'">#R"$G"6[AP>4E+N <)'S"& 0?:4[26G34>'@DX@'P^**EGAQ
M[C74*CUT56=%RADO=72:]MCZ@"]NK?<P/]KG;OWE?D%O/"S?K!92SH>;9:TV
MU-KFRMI+21(^B^N7-?\ U4E-$8UC>HXCLSJ65F^EEOIKJ?72UGJBFU^]SJ:Z
M[-C:GO\ [:WXC:X?1_._O7.=//1K<^KT']2?>+76U_:F9 J]38ZMUK_7J95N
M]+V^]RZ, %HW:D'4=@DIY;I/[,==2;:NEC-]9\NWL;D;O5L]/;577_/[?Y:/
M]8Q5]OQ*K*/M%U["VC_*#L)SB'?S;*&.;ZKO^$35C*KZJW)SJ'EOK%E%MN.!
M74'NV5MQ_1RK=EEOT?M5E'J?\7_-JA]=QD4YE.:VO(&,:&LMR:S5Z337;]JK
M]3UZK[&.]1K'[ZTE.SE46U_5['HZD?6MJ%/KW>H\!CP]L7NR:]EWZM]-]W\A
M#^K@KJ%M5#"RG97;76ZRVPL;8;'54O;D/L].]U6S(?Z?I_SR,VW(R?JY1<QM
MF==;2QP;5<*GO)/TFY5'V=C6?O\ I?F(?U<#&NR6.ONNR06FYMEOJLK)F*J/
MT^4YG_">K9ZKTE.T3P7:&-/)1D./D/Q4GF8 \-2FVM\ BI4@<I3/'WE+:!V"
M124K0:_>4W )[E+Z7P_*D=3'8<I(5$;0@XWT'G_A+!_TWHW))\-$'%_F7>=E
MG_5O24MF?T9_^O=9K/IM^(_*M+,_HS_]>ZS6?3;\1^5(I>F3IDZ:I22222E)
M)))*4DDDDI22222E))))*4DDDDI22222G__2]522224I))))2DDDDE*22224
MI))))2DDDDE*22224I!R/H?-&0<CZ'S24UD@DD$Y2_#OBD-"1\PD1(^&J1U$
MCGLDA0T,?<G([\'Q2T<$P)'/WI*5+NX^Y/N\BG222M)[#[TG-( ,^WN G3N(
MVCQU$(*40-C8^4)G.(#0=3XICNV@C1NLCNI:%@CC5)2SFB 3S'*3RZ0.=!)\
M$SBX !NH[^2EI CP24\E];;NLTFZ[(Q^D6=(J(]!^?N=9PTN;L_TGJ?F5*Q]
M2,_K>?199G]/HZ?T]K1]C%+#5N)/O<VE[OYK;^?L7.?6VOIUOUGOR,C.ZBR_
M'<ST658GKU5^QKOU=[[-G\O^;^FM[ZE9]N5E9;3U'.ZALK:=F=1Z#6R3[JG!
MSM[W)*3]?WU=4IN8'ES6!M! R7-#W;Y])N-C9..VYS&_3_G]BW\)KGXU+K)+
MRQI=NW3,:[O4:RS_ #V,6-UJQS\YE#+[Z[V>FZFMEM==?J/];])^DQ\BS;71
M7D/OM^A_(6QT^_U>GX]XWN]:MC@ZP@N,@'<]S(8YW]5)2*Z3U1K@"&LI<-Q'
MM,ZZ._._JH74I_9 <TM;=8UI8= T/+?:[_.5EKLEV=LB*-D\&-VOY\;51NR0
M[I]EN:]U;*GNWEC?S "6[A[?S?\ R"<-QX4VL=F6,T#P\&WJ.O%^BX5F):<A
MW[7&0W $$^I^GN-C0"QK[J!9931:[^;LK_XO]$M;IK7_ +-Z74\&IXL.UCA!
MVM<X-#F_0:[8K;;Z'9][6/)MMQA8UH:2=GMU;M_KINGY3S@X/V>2Q[G,>2T_
MFO+.VYM?T?WT^4B1M_*FSFSSGCC<.'A,37RPUQ9-A^]^]_G$C\O&=@W7/>P-
MLLLI88V[G-<^MM?N'T]S$/$./?E4L9<'68C6^T@Z;VE^T.V;7^Q[/S_8L>VO
MK-;;,/[+ZE6+ENRV/;8P$L+[+3MW?G?I5;Z/3:.I?:,AGH>ML-51>U[MK:Q7
M[G5_O(<( .J)<O"&/(1,'24H<,H3W^7TCU?S3>V$XF374Q^\VZ  S^\U_N_-
MT6G6/8T$^Z!,C68674W(./>:BYMEF1N:/H'][_"%BU&^UH!^E"9)J9^UC<_W
MOEBS@ 1/Q0,MOZM9J( D_ '<42)*'E:8UH! ]CI)T'" W8H?-'S"&^K&SB&O
M&^BZH^X2T_2;]%XVN8Y<O;TW!RVV8W2*K;;#866YK[K1CUDNV-#/?^LV?U=Z
MV\C$JR\;!Q[ZW"A\LL:)T!@;?4^DS<L')9]7,(9-5?K7&FP"FBBVT@">+'M=
MZ-;7O_E[U+#P)\@ZG)7&Q"64ROTP@.+'I/V^+)PY,?%_T'<Z7TH=+O9CBRRY
MXK)LM?)ESA[MKOI-K]OL9_Z-6-FMZ2<G%#R[[5ZA(-0UW2STM^S^W_X+ZGZP
MMSH#6T5NKNH^R/R +*Z3:Z]Q: ?<^VPN_P Q5,^IN9;C8&%16_)96VVV^XGT
MV>H-S&;6;M]EOH;_ /K:0/J-_:K%ED.8F9RD=/5DB80%<,[G+AXX<''+]";H
MNC[7G"=?2U$<:<_O?Y__ %O_  BE7DML?AOL L=:UP:=.9;M>-2W\W\Q9AR.
MI8F5:.J5U&O*!I9D8Y.QMI;OKKLKLW.9ZC6_35VD?T SJ"9G=^]^=Q_X+_YF
MFD?R^C!/%0%U($>F438_FI=?\%N8+*=][F'](7D63/ <[9$JYNCA4.G;!?E[
M0)-GN@1KK]+_ ,S_ $G_ %O8K^V>/Q33NU,P]9U)VW_NK:'R*0:92T'F4C[@
M6G@Z::?<FL;QS!9]JJ%^.;^B>KZ>+BORJ36S)#S->COUFMFS]!CWO_5[?T==
M?\UZ79&>W"Y-N3OI9]6O7PS2US<49(=826UD?HVU&G[+]O\ ;_W._G_TO_!K
MJX,SPDI:2#HN<^M.17BY5-^3CT7XMM+Z"+;VXSP]SF/_ $=A_26-]N[V_P Q
M9LN72^T_%8/6[LK&ZC1?TQINZAZ+JW4>D;6^B7M=ZQ/K8OHN;:/])^F_T:2F
M]TNJJSI-#&TMKILKCT18+V[73/ZRW^D>KNWNM_/WJO\ \WK'5-Q+NH7V=/;
M&(\5@N8V-F/;DM9]HLI]O[WJ6?X2Q'Z0:*NC4NK>Y];&O>X^F:W3N>^YOV9O
MNKV6>HST/["YCJAKR,_(]1[[&.?ZN,'8V6379:VBNNYSJZ/3_4:66?9?3?\
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M$@ELC377S4F@;3W(C4I" PD\(*6D;0.")T2< X-/ \1W2V[VZZ 'YI]0P3J
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M]']9DGP0QN[T^^[)OQ+;J'TV"HM+7.:[2-WK?H_I,L6<YO4,.VSJ.&P9C+K
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M6[8U;OW;_P"2M&W7J=8;P&.:7:\GW_N[/^DJ8HIMZ6ZK[0:-UKHL: 2'$?\
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M()^,I.\?*/F@I8B!\2G(ET^'/R2\/Y*9O!GOHDI9LD._!1&C3YIR=H'C*3Q
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MU(^*9KYT=]ZE!&O(24\KUCI]7[0;12;036Z]UMF:<5AWV/\ T;(JO]9];O\
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M PR:_L^X,>?^BO4_VGB9>%B9M>99B4Y5?JU ,:2YICZ;7U9&US5Y=UWZX/\
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M],P;^JY1]K646VAA/_&SN?\ ]:KL7H_2VEO3,1IJ-!;16/1,DLAC?T1W^_\
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M$.<US;;VON]1^[_A5S_40^WJ&66_:79M=NS"KQZ6V8SAMK=MRW^D^KU-Q?\
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M]8LQ<;=L])MQ<?;[PVU=9T+HN5TZVQ]_5LKJC+FM#&Y)!:V/=OKV_OK!ZO\
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MF01(V4O]U3?Y#EF==?B5]2BYF767X]9KRL6I]X%E=KK:=]3*+V-MQW>^O?\
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MZZMBW*V/934RR ]K0'02X2/!]GZ1_P#7>DI"3;^T'.#SZ+606RV X[MKMO\
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MB]^*7M#.H 'NZ=F7_+V_0O;^BM5OJ%+'48].34ZVOT]MN.V=SM?H[6[/SO\
MU'Z:J]-S!G]*S7/H#6E[ ^LR0Z1[BYKSL<S]SU+/?7_.*45P[=73AP' +AQ1
M&2Y3'#&7KGP8^"7]7U?ZML]$-S\[-<+C9CX][V-:XEQ#"QGI[--O^8J%N,;+
MLS(QL_T+7"O[1CNK%C=H#W4O=9=^9_..6CTWIV/T_);5B5N9796;7 EQASF_
M1]QW[?;]'9_X(LIU[Z<S*LR,3(LINJIJJ?54YS9K9=7MWL<[W[[*_P ](:DU
MV"[&>++D.,Z<&/A!C"Y\,XW&6.7'#_6)L/&LPK:!^TS;AOKKJIBEA;:QPBNG
M>W<]N[_2K7HMO#,%Y/JV6ES+'?2]I(<7:;=NW:N=Q7Y'V7!QOLN4R['?1ZOJ
M4EM8%8]SWVN]OM_EKH /2;A5.::GBPN(^+O_ $8E,=UO-Q-CB(E(F7Z,(\48
MQGZ_U<8_,W<1\ONH(@U/)+I&N\E_ ]W=69C0?BJ6&?UK+(@@O![S.H[JY$\*
M([N;E $M.P/U,=5:'XI$%HD]M8')^"6@\RD"?%!8\>W,Q?LS;J</";16*NH9
M5>I!?;8YF#C,<TM:W,K8U[O?7;5Z_P#-4KL=9CE<C;;DGJ6/C]2I9TC#LN?:
M[TJ6;3<W;]GL_:;A;3ZN1+_H5XV0NN,]DE+>WX%86+U3,S3UI@R,;%=AVNQ\
M5MFIK+&S]JS YS=U=SG;Z_\ @EN05PGUKWGJVRWI/2^J9CSMQ: ;7Y;ZP?8_
M(977Z=;&_OWV>BDIZ;ZO7'*^K6+;C55X3[J#Z;:6_HF..YHLIK_T3G_IF+,;
MU[K>)?;C9XQGFJP-LR&-R#4P%M>WU[Z<=]-+G;]_Z5_L_P (M_IIS#@T?;::
M\;*V#U:*3NK8?]'6[]UK53R.C"ZZ\4YMM6-E/W9N+6*R'OVM99^E<QUU'JL8
MSU6L=_VVDITLAMCJ+:Z7>G:YCFLL_=<00QW]ERYSHO0\S$ZK5D6TO'L+KLA^
M2ZX:U,ILQ_3M>_?;]J9]HKNV?S-G]A;W4'9/V.XXME6/<&DMNN:7L; DN>QK
MF?16/TCJO4,W,QZ[;GOI#"YSFX-]%=OL]KOM62]S-G^$KV5U^HDIWR1QV2'B
M>.R?VGMH$M_B- DIP>N!YS&OR6Y=N"RL;6X-AK<R_<X[\GT[:'[7U^EZ&]WH
ML_2;UJ=/KRVX&-7F$G)]-OKN<03('Y[F>QS_ /2;%E5.^PU9F'E]+OS7Y-UM
MCGUUMMKR&V/<ZGU;'NV5^E3LHV9.STO3]GL6CTC'OQNFXV/D'==34VM^I=J!
M]'>[Z>SZ"2F[('&I_!1/Y4O$I $GP Y**EP0WXGLF&YSN(GQ2)' T"D/:W7E
M)3&7E_;\4P+I.GCPG:1,SP$F]X\$E,=S=IUCA*):"X? )H#@2> =$C(: TZD
M\'A)2SB1 ;[M.$Y@P>21JE(@#OWGNF?KMVZ$#5R*E/\ :1'! T_N3NDF> 0.
M$N('YT:I/AL$> T04NYH!GQ"CHG))@@=N2F]WDBI4#NF@CC[D_N\DMWCH4E*
M!^]-P8['A(B=1R.$OI#P_O20K@QXZISPFF6SW"<\)*:^9_1W_#^*S6?SC?B/
MRK2S/Z._X#\JS6?SC?ZP_*D4O3)TR=-4I))))2DDDDE*22224I))))2DDDDE
M*22224I))))3_]#U5))))2DDDDE*22224I))))2DDDDE*22224ARPTXU@=4,
MAI:9I.V'?R3ZOZ/_ #UDXU%?VW%NHP*\!NYTVM?4/4:6/_0L9C.=ZON_2>[Z
M'IK1ZK6;>GW5@-=N ]KCM:1(W,<\_1W_ $5E=+8RC.LNMQJ*FO>XU/%S'"EA
M:W=554/H>I:'OL]/]]/C\I;> ?J<A!U]0X;_ *M?+[D/WO\ -S>@0LCZ'S1$
M+(^A\TQJ-9())<:IRE=B?'A.1H&IOW0G')/@DA1/8<IP(X3#B?%+GR'@DI?<
M$MWD?N2  &B1/8<I)6W F)CQ4W$!K8\- HZ 1SX)%D09@Q\D%+EO#N'$)%TP
MWO'/9,7$@ Z-CZ2DZ T3H(24LY@AOC'*<NU CW #0*)W0-VC2-#W^:DYHAL:
M$!)3R77/JAU#)R>IY-?5VX6#U,UNRZ'5!S8K:UC-]SWM_=_D(_U5S++NH9>,
M_KK>MFAC#[*1776=Q;I>SV6[_P!QBI_63ZM]7S.KGJ):WK6"-I'2+;7TAD
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M?94QO\_L6AUCU_V9D?9]WJ[/:&&''42&.EONVJGT?*N9=9BG"RZL=]A=CON
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M-/SDT[L.2^(WX'Z$:+"4^G8ZIC/R3<I+'CVG&R\QI+NIX&+59HPG.=;<0?\
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ME/(=+Q7/ZM5GX(-[FL?:PYS0VZZBXBOUJ<ZIU^YE+F?HZ,BBFS])_+77@:K
MP?JSB#T,K#ZKFNJK9Z=#F6U.9Z6X/-+2*/YO=6NAD'0:>2"EMT<?>N&LZ?\
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M+W!A#3JX\ )*7L<UHGQX']ZK$$.(/YPD?#Q1!(=N=[G>';^JFN8(W RZ9?\
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M2R?MOM_2ZG=8/3_1_2_<7.W]19B=7ZA2WJE'3]V2'.Q[L4W.<2RK](R]MO\
MA?\ P-=+T^@XV!30;_M18W6^&MWDG=O#*8J8W7\Q8'4SDC*S+C]K=?6_]3RJ
M+PS%I8&UG9EM]9M-?IOWOROM&/9ZM?\ -I*=WJ.;BX.';?DVMI8&N +GBN70
MXMKKL>6M]5\?HUS71V]-RC3C6C S*^JU.>?1>^S)8&M%GZ?(NLNNM_T?J_JW
MIW?F+INI9&/1C&S)QW9-33)8RL6$0"?4+'?FL_?5/ ZETJ[(H;1@6XS\IKGT
M7/QQ4UP#=[OTGYNZO\Q)3IIT_M2]GB45/(];MP.J9SBW(KO9C,;.(_(..0^J
M^VO)J+2^EF_)K:]E=CW?HO0K_P '=ZBZ#H]1JZ3B5.+265-$M=O'&D6C^=_X
MS\]!S;.AX^<T78@OS,AHW%E(L=ME_I>LZ/;ZEGJ,J_/M>KV)?C78M5V*T"BQ
M@=4(VPT]O3]NS;^X@ID_B?,#[TBT;R"8!$J3G$P/G^"&9VD]P8^Y%3BO<*OK
MEC&8.5TZQKA')IN98TG^S:M6V)EVHUGX?F_])<S]=,VSI74ND]6QZ_5N R<2
MJO3W675M^S,?Q^C];Z:Z-K;_ $J69!;Z[6M;<6Z-W0/5V_R=Z2DE&D!_)X/Q
M5@F! Y[E"<&ANT?1_-/_ 'TIF/+='\<!W\$5).ZQL#ZJXG2NMW=4P+7T593"
MW)P6_P T7DA[+6?Z/9[_ &?RUM?1]W<\?WIOB@I#FF\8EYQV[KA6XUM',QYJ
MGT8./VJW=98RQ[/3NM;Z;G@5L;_,[:]FQW\C](K?46-=T[)8XD!U3I(,$"/$
M[FK.^K%0;C7 ![7&P MLK%+@ T;=V,S=Z7M_E_I&)*=GAOQ45)W.G'9124I)
M),2 )*2G%R,WJ/4L[(P>F7-P\7!(KS<XM%EAM+=_V;"8_P#1;JFN_376?S;_
M /!J)^KSW5.!ZKU'>X0'&]ID_P JMU7IN_J;5?PL)F(VYK/=Z]]N1!$'=:[U
M#N_J?05KCW'\W\J*GE,?HWUHZ#D$]+RJNI88:2[!R!Z/F_[,ZO=558__ *W5
M_P &NCP,FW)PZ;[L=^):X2_'MC>W7\[9+49X@!Q^D#N/P3@\GL-/DDA?@/CM
MJ%B_69U3&8CW5"YP+PUKQ4:X/IL<7_;/T7MW,_E[/5_P7J+9X#0>9@K*ZXW[
M1MQV[[143ZU#'6MW"QOZ(N=B-=9^99['?HTE.CA/;9AT6, #7U,<T    M!$
M-9[/\U''(0L9NW'J;!;#&C:9)$ :$O\ ?_GHHY"26Z.$Z8<)TU2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE/_U_54DDDE*22224I))))2DDDDE*22
M224I))))2#-#'8MK7VNQVEL>LPPYL_G-<L3I@Q^G9UMGK8]M5[6M=<TEE@+-
M_NL;9ZOJ^KN][O6_ZVMO-##BVA[;'MVF6TSZA_XK86NWJITX=9:&?;'5>D28
M:[6_;_@VV65[<=UO^D].M/B?26SAE6'("?3+24;X>+]+T^F4O2Z(((D<%#R/
MH?-%0LCZ'S3&LU5SW7/JYD]4ZBR]CZAC75LHR18'>HVMEOVFQF+M]GZY[:LC
MU/W%T!X*Y?ZX]4.#?CTT6YK,FUGM^SN<W'8V2/7RG5TY%KG?\'5[TY3K=!Z;
M?T_!NKN;57;??;?Z./(JK]0RVFJ0WVL_JJSU"ZFG%-ES&V4ES&/:^-NU[V5N
M<_=[=K-^]4_JQ8;.DUN=G6]2>'O]3)OK=4XNTW5LJM:Q_I,_,6AD5&VA]0K%
MI( #"XUS)W?SC YS$D-?IN7C9;\C[.U@;^C<Y["""YS?HNV?G5M:UBO#W-CN
MU4.F5OH=D5N'I[7,(QQ8^T5[F_Z6YK?Y[Z7IM]E:T' 2'?*4E,>-1JT\@IB
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MFMMPR]^\ESK'V6"ZO>]\M]__ (&MOIV*W"P<?$)#S0P,W-:*VF/W*F>VMO\
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M3Z3V[O5]7V>FM.&^*S^NL:_ AU1MJ;;6Z_:"Y[:VNW/MI:PM?ZK/WZ_TM?\
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MX^Y,4E+Z'E>?]1ZAT+"S.K58?2Z^K9U>0^_,MS!4QM3K"ROTZO4'VJ^EC_\
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M*6X#1VG@D=QU;I\>Z<!I'CXRBI;:3Y#]U(NC3@_@E+AH-?/P3@M@^'=)2T-
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MK/\ -_VI>K9P*K"/':A:DA<1IW\>R<0!/CR4,6.'^!L_S4V]TSZ5@C@;45)
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M6\-?B:G4 V=C]%)GUVRGDEN).P%SP;2(;.R?H?RES]=>/2X4Y3@0^'5WUO)
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M/]H&@/J>I2W;3>^N/U?>SZ=B*XLZ;<UECK#E6?I*\6J&O,![O5LL=_-L_/\
M>H-S^H''R'-Z#2:;'L=<'!YL<[\U[=NW^WZ3/\)_+3:!UJ^QO@_]&7;=:\*X
M_P#T5/BW9F4QS\><+%I<W]9%;76/+2^KT:W[65M=M->]M?\ @D&_I;\<G*PR
M32T$RUQ]6G<?<7,]WYKG_I6L?_UM7*\NGJ%]-08<#,+ :\5[@6%HW,_01#6/
M8W<STG-]96*:;FY8K#!9O!#JX^DWZ)#A^[M3.(@G3A_J^'][])=P@C>_ZW]C
MG4MKZH[<[]#FP\6[;&U;R!NJL<QHLL]SZZ\5_P"F_P"$6]]4[<BQMQR&EEC'
M!CB=7.+0UKK'3]+WKE'MII%]V.6V--KL?$:\@;@V&V.#C[7U["VK?_QG^D77
M_5O&9CBYK2XN>=]F\0[>[5XT_=^@AGH0/;]'P[IPV9COU>8MHIZ?G9CL85U,
M:&NOJ;U=] KAUQ:-E;-SMS3ZGI?X'^;7?9C2_ R&-:'E]+P&&2'$L=[?;[G;
MER7674].^L5[V8W2[CF55V%N82U[#7O]2_V8]S:VV;OIV/\ ?Z:ZGJ>7B8N!
M;9F6555.::YN=LK+G@M;6^S\W>J;;<3ZG,S6/#,EV9[<<-]+*PZL9C2"QOLR
M*6[[7?R'O6UU@U%N/5Z=EN78\_9?2?Z3VN#7.L?ZTC8ST_I_3W_Z-<U]2\;!
M;U>V[%_9U#AC%CL? R7Y#G OK=ZUGK!OILKV[/[:Z+KUE8IIILKJ+;[-OK9$
MBJHAKGML<YFUWJ.^A5^DJ_XQ&/S!FY<7ECOUV\O\'_%_3:CJ<JE]5G5*[[,8
M/KG]9%C6O+VMI=;2VK%=8UMNS_2?U%O%<UZ6/B7T6F[$SCZC&MI:;#9N<X,]
M2AMF3ELWU;O4_FUTI3I]&3F_T"-M>DH1_P 2<IL5$J2B4QJL2N9^MV)9E/QM
MKV5MK)+WO<0&@APX;[K/ZBZ8KG/K4PV68S6NVDDP3\"I,.F2-:+,W\W)P:F7
MX]!?A6.RZL>&6X5[&N#6;@Y^13IO:SV?IOW/T:'7U7&@%F,6[@-Y]K0''W6-
MM:S8R^MONLJ;:W^=1G5LP+&>NZQMU\&G'K@66?NNW._FZ]S=V]R@WJ.?8S*L
MKZ'4^NUK?7<\/<]XGZ;',V-<_P!WJ/?4S_A%<H'6K\;X/_1FIMI='M7&EQ;\
MO,;9]C'V/%J@NS/3:ZP%KP\5U;6LKKM<RWVM9_@U"_I5C7'+PG;@TNL>)(MK
M>=/6V-]K_?\ I-^Q_IJQ5FT9[Z,=U3NF91!;1C%P-3MI V5CV^E:S]RUOJ>]
M6ZZLBO+:T#>YQ(+(DN Y;M/TF;4SB,2?T?#P_O+N&QW\?_07-QS3U2UC+SZ6
M3/INL:]M;GU[=C'OTMM=95LKI^G7ZOJH!%UOJC+ KNQV $OW$N(_1N_X[;ZV
MS8HWLQ\>[+MQW-=739Z%#7. !L(FQK;#[75TM=8W>K+J10[')#19N&18VUHG
M>YGI>C_Q5;'>W^I_.)^@VV(T';])9OH=QN5,I]:AO4,_=767@-H-H:/38WZ(
MJM98W;Z_ZM^9_./0PS-ZLX;&AE-,; XEE5+6_HV?0+O\&:VNV66^KZ/\VHVX
MK6WGIP@,<P.Q'VD!SG1O]/:/>YNU]E-?[ZO83&GI&._&$LO.ZVPCFSZ)JMCZ
M+JMO\V@36O4GT_U8E(%FN@W_ *Q8C#R<:ES>G/.1736X.PWUA[7N>0U]U'Y[
M'^[_ +957]KX[A(QB_>27U@M:))]C'^GL]?%V?3KM_D+1R64X===^9::Z7.#
M:ZZ]+'O)CTZOHN]S/8_\Q5+.IYUUN2ZCH=;@:G,NLME[GL'M=MLJV5NM=_P7
M[B$==:XO&^#_ -&3+32Z\/G18^3=EE[,)@Q<9C2Z[--;"]FC;!MAK6,L>]CF
MTMW>IZJ#;T]UOZSAVNOL#O4=788N+F@_I6M %=N[;]%%;GU6TUTY-#NER?3J
M$@TDF'['-=[ZM_\ .[[?I_Z13LPLC&LK:6N#]P].L-)<3RS:T)U\)_=_YWVR
M6D6/WOY=FO5DTYK:J<TDVM<UC<D/VO=7]!WJ/#;[K'5;[+F;_3_G/34R<NA]
MV)DUA[\9CFLW!SH .Y@;8Q_Z7V>C^C>A9=55.;DV-#&5XI!?5^:,BS5M55D^
MG[+_ -);_P 6AD[6U6P6VV[;K6$Z: UUL8[<-U3JO>G4#5;'I_6^9;KUW[^#
M:+&&JO/ZB''UGGTZ]^R:ZVC:WTMMU;&NR'>A^9Z?J*N1F]4MF6UTT%I!<=E5
M30-E89Z9=[MGI>RKZ?I?03&IKK'8%8VM#!9AOM]SG:&US?3K]WNIWUT^WZ=:
MLTU[\'%?4-M=Y+S=&IO.EC+C^;8S\UB5UKUZ=HQ35^77QDRJHOIK>WI]SLGT
M='X=K&O:\.+?4OH!&]NW_"?G^FH5]5H/NKQ8>1[XVL <X[FLL],,];%]W\U=
M_H_IHSZJ\!S+,E[VNN(;54P#U+=6[0V=NUG\O^;3-ZCU%[\FRKHE=FZHMNLN
ME[WL!_>KV5V6_P#%L_P:;5ZUQ#O?!_Z,NVTNO"N)EBY&1F>I7@-^S4-:39FN
MK:YS(-=WL;6UK*[7?I/2_P )O39'2K'N.5B$W/W&RUCC%N]HG[0UC?99[V_]
M;_T:-5GT93*,6_'=TJZ2S'J+OT+W#:[:YIVNJM<[](SUU;-.31DU@:V[H  D
MG^2UOYVY-XC$[</AW_PDT"-?5X_N_P""YN.^OJ#V4Y+C7>QS6#(WMK>^KZ!]
M1SFV6O?0Q[KFN_0_SWIH;FW&RRC, K=C5G:Y[G'< =X]_P#A&5L]/]$GS*L?
M'SLRZHM:S%<UHK)  OLFST:WGV?H7>IOW_S?Z/\ <4O1-%.-8X-;:]U60YMD
M0#7+:::_^!<Q.L#4;'8?NGYEOGN/Q7II=?C#+S7.QJ:W,J:T6!@VMGUGLJL9
M8QVQ]3?^W$)PRNIN]*FH5T4@>E5NV55-;HUSK*SMW,8^VOU6/_2_Z%/?CM9D
MMPP0VK(;NHLL(:/5<7/%;6_2]%MKO3_ZYL5SIS&CI LQVG=8\MR;"((<P^FV
MBS]S:W8_^6D30XNI/I[1M(%FOM_K+,PLC&J<SIUOK.J%EC\8UBRNYY:6N?0#
M[_4]S?3_ .#54=5H&[]6<;"2'U-(:=)8QK;&!EEE3MGIW5VK0R:Z\7'&3EW&
MG':8!;.\N_,;2-'N<[^2J[^J9EF:]V'T2NQS:WL-UY-A<P?2:;*HJ]3;^B_?
M_P &FC6['%XWP?\ .2=*UX?"N+\$%.3=E/./T^EE#(/KY3JV$5MAS"YL-V,8
MUU7M]_J(5W3_ +4XVT7/R;20Y[;SMLLV_GLV_HWN<UW\S_Y\4Z\^LXS:<K&?
MTNL$,8YIFK<YI_G:W_IF^JWZ=K_51+<"[&VDR&DC: )+I^@:MOTO=^ZG_*?W
M>WZ7_.6D6/WOP_YK59FMR*FTY\NNKCTKRX,>-3ZM5K]MMVW>ZV[^;K]/TE8+
M;\7)?@W,%E5#+#27AS_T9_FHMK=O]U/N]'_2?RT+-JK;U"Y]@:QM#!?EU1[?
M4?[/2:9V,NL?Z/J5N_X1 &XU5WOEM]VU[@2-NVMQV>D_=[J[7>HYR- [: ].
MTCV19&^XZ^ ; K-N,WJ'42YC'/;76 _T_:QN[(VT[;ZV[+V,_P"W++$*PY?5
M+/38UM6/3!;7NVU4L#MM?NK);OVNM9[/??L_FU'TVNN;@L #,AN_&?=_I7$N
MVAC3N]+=Z]/T?\(K&-7OZ=794"!;8?6M(]PN;^C97?\ Z/\ 1?0:E=:];]/]
M4%6^G3]+^LSIQ[J6V,Z?>ZZ^O<\XKF-?5<7#WNI98-WJLW;F_P# J#>JT[B]
MN)%IG<&PS:9+:QO8&6.HLAK;JK?^W$6W'KP6-R,RQU3;/:S:/?;_ ":A_*E.
MWJ/4'95CZ.BLM>VM['6Y$V.<P?2;NKV566>S8S\]-J[-<0[WP?BG;2^'P^96
M-D9&9991@5MK;M=ZN4ZMKA6"WZ;6,9L9N?7^B=_.>HGR.DNR''(HL=E7$@WM
ML.VRS:/YYC60Q_M_P7_GQ2HZEC6X].+DXQZ20[94-WZ)SB-T7,=ML9ZOT_5N
M_1JZ_'R:;F:Q;(  YG^3_;323&6@X>W7B_PEU C?B_E^ZYE5S<S91F.(R*R!
M3D;VUO+=WZ6M[[&V6.^E;DL_1U?0KK2MJM9E'"R-&8X?Z5KW.)<UI-M36W?\
M74U^W\_>GZC3C5=2R+!MK;CM;;?48#1=9_-TM_-W[PRQ]3E'TB,*NVP!EN26
M/>'P6AM3]]/HO]VYEWNW_OIUC0C0'I^[(K:W!UKKW#+'HLRL9UN0YV/CXX;6
MR+/3:1N_36,KL;8UVVG;D;?WU!QR.I.^RXM.W&K!]*@.#6 #])ZUEM9V;MWJ
M?IMU7\__ #:EE5,KOK8Z&X^:'.=8\M:UEKW3MJ^E^C;<UC_;]#^HK/2ZO3Z?
M>ZL?IVV&G*=$%GIGV5']VNSZ?N_G$":'%X^GM&T@6>'_ !O%>C NQO;@WAUS
M2;KJM@LJO<&GV-#_ ';V_P"!_P!)8J;>J-8Z+,9S;V^RUC"&.  VGTK&AM[7
M>M_.5N]3_"K2NI93BG)R;ACX]?TWCD'\STA])UF_Z&U /5<NS,J.!T9MKF-+
M:\C).\ENW=^D?7[&N:T_GO\ 4]Z UO3B\;X/^<DZ :\/A\WX-2G,MR;A1T_&
MKK>X?IK75L+*F^YEC_H[6TTM<SWV/4+^G-R]QJRG9%VC'_:"&&R/]'M]OM_T
M5CU.KJ+6XWI96$_I=+7#])7.S<Z6[[:K/TWN_FM^ZQ3NP'TU[R8J?[FN D/:
M[\ZN/:Y/'I/[O;]*_P#"6G4?O=_T?P:S<TVUG'SVE]E9)I>YP98Q\[WT/>6V
M6^F][6,V-I_1>BK)9=B9@PW#U<;W68Y?N?-;V?HW>LUS;&;_ --^CV?SB#G4
M,.=%S16YM(R<]D'AOL]P_P %DY#-GL?^^J\NMI^T6 LOO.QL$%FQCM^ZIS3^
M=;OWHZ';8]/ZQ[(VWZ=?!L,K=D8QR\TNKHK+*:VM<:HDN=D;:8O^A4&6_1_2
M(=MF3U-_V:BL5XS1+: X-8QH/J>I:^L[-^_U?TWZ.Q_JIG!AM90T!M6;+F66
MD;6WN,#8R=SJ67#W_3_G4;%J_P G/<UGN];T\JPM.YAK]E#'M/\ -U?N[DM!
MK_B]HVK?3_&_K4DHQK:7.9@Y3K,D3::2UKZ;W0[]&QMHW>K_ *+=]-0;U2EK
MCOQ"W(:2U[:HK+8_1S7:P,N9[V;+&._TB+;C,PZAEY=IIJ$M%@$N>?W*9]V]
M29U'J#LYIQNCMNLK:YC;<DEY+-O\VXU[:OH^RMCO43?FLUQ#O?!_SEVU:\/A
M\RV+EWY=XQ\&A@L>#ZMSJVNKK+FOK?9L8W^9:]M?Z2URED=(?E@65VNR<DAK
M+O6/INM:.]>W:W<QG^"<Y-1U3'=BMQ\W#=TEFX;;&D^F7.W#]/4Z+MCV^SU/
M?4KUV+?26EY!>8AP\_W"/:FDF,M/3_SK_P )- C][\*_P7,;D&]IQ<R3=7KC
MVN<VMX=.]^.ZRUCG^F]S=O\ ,L]+T%9HIMIZQC8%A+L=EP-%[W.<7-<1LV6_
MF^IM?8[\S>A]4Q\?]IO=9MJ+*OM&;6[0 F*V-/[EN1^C_1?UU/IU9><?*N ;
M;DVAFNUS16+6W>I2]OY]EGT]J)(X;&EC;^M+]U0!XJ/0[_U7T,)TR=4&ZI))
M))2DDDDE*22224I))))2DDDDE*22224I))))3__7]522224I))))2DDDDE*2
M2224I))))2DDDDE-+K#FLZ;>7L;8W;!;9]#4ANZW_@Z_YRQ4V]/Q,+J&"^FN
MDFW<TP"'[MCG'(J][_9M'IO_ .,_G%I9MK:<6VQ[VUM:TESW-W@#_BP6[]W[
MJP\-XQLNNFK%;@WY,MJ<<5K=[6CU'^ZO*=M:S]QZ?'8_5M\OQ'%( D#UV->&
M=P_]1_.]&N?^ND_LI@ W3<W3QT<M\3&O*P/KI(Z2PB ?6;!/P<CA_G(>;1R_
MS<O)Y' >3GFVF7.?066EIV,<\'T]F]NQUGK;&,][Z_YS]&KWU?R1B9F5C-:;
M\1^]SY:26^F/4WO]3U'M]HV/_FU0P&.9FFNF633ZEK#JP/GU6.W,#_YC=59^
MF_F5?^K^.[.S\O(JL->,P/9<\D.)%@],5O>]V[OZGT%;R54KVH?V-3'=QK>R
MT^AX]_7#?DV-+;,FXM?> 9+7\,W.^C53]#V-6O?^PZ+G=-N];[8'55;&L?OL
M:0-]E8U<YC=OTUE= R\GHS;:,AY<<2X[Z 1+&MTU8?<VJYWN]O\ W]:U]?1\
MC)_:]N3>W,#JK&/#CNJKC])57M _1NWN_-3<E\9N^#]#@[_HK\=< JN+]+B_
M%R_K#TN_IM%CV^\U.994X-,L<X_SC'[MU>W\]6^K]8OR^DX@(V,RV-NM<1M!
M=HWTV.;Z;MOK>_\ G?\ K:!]8^KVY^-?Z7Z,O+*F$. +R/I5,T:^QS_W$;JW
M2\G"Z/@FP[J<2MM-H<1M8\P]S@YKF[?TA]/_ $B(VQ\?S\7[$']/@^6OVM/+
MVUW8-%QG%H#B=TN;$[]US+/4V>M[+/I^I^G73_5T73=ZWTW&>Q&O!#F_2W+F
M,S;D9&$]X)Q<C=/,'AC77O?L;ZM/Z*IUN[U?T*Z;ZNFR;A8-KFF T#: !P&M
M"CS?S8O^7J7X?YP_RZ.3U:K!ZEC6?6,_;:L*NPTY-=+JXNQZ]^)9FAM@<]M7
MI6WU?HW>M92NDZQ5U6[IKZNC/IJS';179D N8UOYS@W:_P#2;?YO>U4W_5/I
MCWO!LR6XEMAMLP&W.&,YQ.]^ZC_1V6>^RK?Z:VPJK9<#ZK]$ZITRZU^?7B/?
M<W]+F5OMLR;7R/YZR]K6MIV_X.KV,6IUC[5Z53:?4]!SR,HT-:^T,VG;Z;'A
MW^$V^IL9ZBO!9W6[ T8S+['4X-ENW+M82R&[7>DRRUONIILMVLL>C'Y@R\N+
MRQT!WW'%T_1C^_\ YO\ KM*NEM-U3NF-S3<7L:X75%M19N'K&U^177M_1[OY
MI^];Y7-9^)TH/Q:^E7,%MMK!9CTV.>;JRYOJ-M:VS;Z/I[[+;WKI2G3Z'\]V
M7FZ(QR!EKQ?SD>'+I^]_5_<8J)4E$IC58E9F?D.IS\>L5FUF0#78  8$.?ZF
MH/T=JTRLS/QKKNH8UE=AJ;C@V6O$?0AS',]W[^]&-7KXHE=:/(=+;?UO,S,I
MS"QS[=C+FM)+:W;FMH8?HM94UC=VQ:V2WHO3G'IV3Z@RV,K96 Q\V[G;'_9_
MW]K5E='MR.C9&;BVO+O0NW"EI!=M&X^LQCO\%<US/>M;+;TCJ-O[6OR+F96R
MM^/M<Z:0';[#3M#?:YO\E7,GS]?;_1X&K"N'IQWZN)H?6#HS\'&O>P>K6&BZ
MINQQ<UVX,:_=N]1EK&/1LSK61D_5[%<X$',KG)L(@.-1]&QK7^S^<<W<_P#2
MJ'UAZV[,QK_0<:V-8*FW;P"XEP=MW0U_J65M^@GRNCY6+]6L/U"0W%9.162
MUCKCZNZ=S-OI[O3>E^C#W/FXOV(.\^#Y>']K3S *Z\+'<XG$#R^PZD$$-]2R
MVNSU/:[;9]-S/T7T$3+LL%K765AWJ']&1!$<M],MG\Q#S7-O9A6$$XEK]M@$
MND-#&[+GV!C?T.ZS8][_ -'4B95=WKM87-K%1@-&@@>T;/WOI.^EZB>.E^*T
M]:\&.39;7F83P=N34\!X:1N#)W5&Q[ YS?\ ">W_ #U8PLFW ZSNIEQN %M+
M9<?>=OZ/>Z[=^D_2U.96JV56]^9A.#?UB]\6%C8EA.Q@L#"YS=^ZS^1=_A%8
MPZKLWK;68QBV@-=;8PSM%9_P37&OTV?X"K:Q--<.NW";^U(OBTWXA2')NOZE
M]8\QC1+<)GHT.VSLVEM3]NK&UV6N>]W[ZTLC'Z-T4^CU%SP;*7.:=KMCW AU
M=5?YGK?G>U9US<GIOUBSQN.S*;]HI87"7[BVTV-:?INJVV-?L6EEV=(Z\1;G
M6V,]*IXKK#CLKL.WTKV1[?50E^CO[?"/DWV71_2VX[/S;(^I]%:*7Y-=;[:<
MBLV_9K&N'\VSVL>P[7M?_HU3PNK7V?54LV%UV\XEMY .UC1ZC-[G?G>F[TO<
M^M:'4^N36[%IN>W[/66'*M<!J]OLNL?M;M<V?8L[!Z7EM^J;KBXRZPY5]1VG
M=61Z3+'[RW]UUW]1*-\ ]S]Z/#:)5Q'@_=-TUK:RWHC*JR]U=CF/?M+I).[<
MX56NM:]E>YM6[V5?\(@V.:YY=6 ZJ2*RP  -;+&[F_F[&M^@U%NOW=&K?4]W
MIM+*["V7NY<ZRKW#TW5O<UMVQ]FQ">P5O=77#:VD[(ATM<=PW.]WTF_G*:/7
MS+%+IY!GC.C/Q;*RYM])>RU[/:&")9ZES1_@V6/_ #O2_P"$5[I-K\3KI94P
MO&3#+Z()(WCW;?5=;_-/]W_HQ4<9A&;C!H=OR"\W-:-S7L(V['!FZQOJ[+?T
M7\TK_2VW9O7P[&L]^/M??<"'$!@_2;-^W:RQWZ-GZ/TTS)52[<)_/1="[C6_
M$$&,ZSJW6,^X5D"EWIT7-:265M/I>C5^8W=]-:F77T;I .%F.L^T-I/HOVN_
M2$NV^E0?\(_:[\U9>%]HZ1U;J-!M.QS_ %*ZFD;G-<?5&14P^UWL]K]JULT]
M)ZT/VAD6VLN%1^RL#C^B>'3ZM.T-_<4>3YAO[="N'R9(?*=O<LWQ-3K?1/LV
M-;96TVT65>HRI['%TM_F]X);8VW:DWK>5?\ 5>AQ)]2\.HON($15[3[_ &_I
M+*_^%K4^M]<^T8UK:'EK*:BQN4YX:27:,<][FM=O<ALZ3F4?52B=P]+=D9%)
MB +=0\^YGZ2NOW>Y$?)'W/FXQ2#\TN#;AUIIY8<SI^-2UQ--EHLL<"XS(]SW
M5V>I^B9[ZZ]^S^81<NUPV/\ 2:ZI\"C;MV;.*O3V_1]OT?W$'+>;>GXUC 74
M;VUV;9>2&C<ZIY>&M=7_ #ME/J/_ ,.C9=5H+*V.;757_-@:-+1JUP=/Z3_I
M[T\=+[R6=Z[!'G/M:<8C3)KL!8&QO],F6;RT/LK9ZC?H_P#"*PW*MP.LLRJ8
M<^R3;6"7;FN=#MFY]K7^K^COW55*OFMLW8UC6QE.L#6/8(=L!AOJ;/?]-VWU
M=GO]/](K#:+,WK%6'C -MJ$$M)BMK#/Z.LFK8VEOIU?H_P#"(&JUVJ5I%WIO
M<:8]2ONZC]9K,8-)KP:HJ+F2660'OLV L8VUSG_^!J^_#Z3T;T?VH]S1D5O<
M7[7;# %C:R[Z'K.?N_U_2*AGUY&!]9[[]SO3SJO48TN:#8^-CF[?YNRZNQC_
M &-_?6C?D])Z\VEO47O;72QVZEKCLW;=E=YV#;ZC7;TR6T*OV^$7P?,O&\[K
MCXC7%\K#*Z/7=CUYM%;S3E5B<:QIX8V=MC'[?^MJCT;J^0/JYD5"H^O19]G:
M\B?3KL&]C7EX+OT4/J9N_P ]:.5UEE5-6#5<]_V>L%V3:1!#FCWV%[?;Z?YG
MTUF]&Z7G6?5S,R!87V7V^NYIAWJUU>SU/>6N][W/>D/D]?[T>&^W_HJC\WH_
M=EQ4U0PLZ)8VDO<VV'/VETDAWT6L<ZYMC:=K/S?3_3_SB$[8XQ2-U3/8S: "
M P0[<WVM;[O>]%%Y=T1SJ'G:P;'%LO<"YWN:V YNR]OI>S?Z?Z%"<QM;BVD[
M*7>YO!)#Q)F/9[OH>W^;4\;UON6$]/(+TN RL1S9]>FT?0TVL(;:WU+0'/;M
M]_\ Z,5[%OMPNNLNJ:;;+=HMI]QW;SL=L]1]VYKG;+V/K8J5+2W)QG,W-ONM
MVN+?<',AM7OVS9[_ */^CN_PBNXM=N;UVJG%=MOJ#2]X(/IAAW.V-=Z>QM;=
MF/[&)LZUOY>$KH=*WX@QL?9U/ZQYK&5'9ACTZ'ANM086UO#!/ILLN<][UIWT
M](Z,QE'4'6"UU5EM5Q:Z'/,.;4P_G7.W_1_?6:1D=,^L?4(M/I9/Z6ID@FP/
M(L]2MGT+'T[;6/V+4RW](ZXRO(S;+6FNJQE- <8;8-H;>S8&_I?:HI_H[^WP
MCY?F^5DC^EM[EGYMMVMU'H3:\;[12PNQ[ZG.]"QCB[1OJ-]0.++-V\.VH?3^
MMYA^J[2-WKASL1UL#VM:/4;O>[_">D[TO<^M6.H]<%N,,>FPO914X'*>Z"26
M^F'V/L V?I%6Z=TC-'U5W^YUC['9=E>A#F$>FUS]SF>[8WUO<B/D'N?O"K4?
MF/!^Z;II7!]?1V,H)++WL>\M+B2?=IML-OZ.K=6W=_-[T?*L K8YC&OQM&T;
M=NW:)8/H?0=N_-V_30+['V](8ZB2RMS*WENY[M=SMGN;[Z+-K+-CW>GO1\FF
M&,JH+:Z  ZJ( +8WZO#O>[_KB?VON6/O78(NI.>,:L.&V]KPZ@"#9L/\Y]#U
M+*Z]^SZ*LW9-V+U2K/K=^G=+W,DNW#\Z)>]CO5K]K]E5GZ1BK=1;8<:JX_SX
M>&TV,;#]H^G]#W_2V?IF,]B/?3;D]3HZ?2!]I;+0&DPT'W2VLFK;Z;?TUKF?
MI/4>AT%[5*_)/4UOZ:9]:RKL[ZQ487IDU8U7J[7LF+'M-_J.K'ILWM]E7Z17
M?L/3>E,QKNJO>&9,[[0UVP M)+;G#V;W.]BI=8IRL+ZRU99L<:\NG82YS6E]
MC&^@ZIW^#=9NV6;%>=E]-ZS3C8W4G/951K90'$,> T_I+=C?\'8F'Y<=?)P^
MKA^9>/FG=<=^GBV8NZ33F8]&?BML;1D-%7HV-<)&KI>U\;JG*AT#JU]/2^HU
M-H(MQ'Q0W;/I,N);M=Z@<[938SVK2=U:K$QL?IU-MEXH:'^M81]'C:_<-K:J
MV_G[EF=!Z;G9'3.J9#+C9=DO]A!#O692=UGTRW<VQSMC$A\DN/Y;CP7_ 'E'
MYQP[T>*O)K4M+>DY+JBYWK!PLVEPF'-VUM]]S;-K0^VS8Q EFUC:@7,K:&P
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MCQZ.0R-]0D;6O;/NJ_DJ-?3^ML=>RCJ.,1Z1<YMGZ-]=9/T_2<QWI/\ Y/\
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M&_Z7TTT@R.GJ[?HU_@I! '[OX_\ .5U6ZD=1=7:0[UZ11FF=K-X(LK?].O\
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MGJ+F9)=Z9 I< 3/^$VO_ $E;7;OT?\VF$7MQ?9+_ *2X:=OMC^2X?C9%HNR
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MZ?\ ]Q:?^VV_^15E,EQ'N54.P:_[-Z?VQ:?^VV_^12_9O3P(&+2!_P 6WO\
MV593)<1[E5#L&I^R.E<_8Z)\?39_Y%+]D=*U_4Z->?T;-?\ HJXDEQ2[E5#L
M&G^R.E"8PZ-=3^C9K_T4ATCI0$##HCP]-G_D5<22XI=RKA'8-/\ 9'2H ^QT
M0W4#TV:?]%+]D=*Y.'1/_%L_\BKB27$>Y5PCL&F>D=*)G['1/CZ;/_(I_P!D
M=*F?L=$]SZ;?_(JVDEQ2[E7".P:G[(Z5J?L=$GG]&S7_ **E^S>G3/V6F1W]
M-O\ Y%64R7$>Y50[!K_LWI\S]EIU_P"#;_Y%+]F]/_[BTZ\_HV_^15E)+B/<
MJH=@UOV;T_\ [BT_]MM_\BE^S>G1'V6F.?YMO/\ FJRDEQ'N54.P:W[-Z?,_
M9J9_XMO_ )%+]F]/_P"XM/\ VVW_ ,BK*27$>Y50[!K?LWI\S]EIGQ]-O_D4
MOV;T^9^S4R?^#;_Y%64DN(]RJAV#4=TKI;G;G8E!=,R:VDS_ )J7[)Z5,_8Z
M)\?3;_Y%6TDN(]RKA'8-3]D=*F?L=$C3^;;_ .13?LCI0_[1T:\_HV?^15Q)
M+BEW*N$=@T_V1TJ"/L=$'G]&S7_HI?LCI1T.'0?^ML_\BK:=+BEW*N$=@T_V
M1TK_ +AT>/\ -L_\BE^R.E&/U.C3C]&S_P BK:=+BEW*N$=@U/V3TK_N'1IH
M/T;/_(IQTOIH :,2D =O3;'_ %*M)DN(]RKA'8-?]F]/F?LM,C7^;;_Y%+]F
M]/\ ^XM/_;;?_(JRDEQ'N54.P:W[-Z=S]EIG_BV_^12_9O3]?U6G70_HV_\
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M22]R?[Q5[./]P?9V]+2/2L<UU5[[HI)+3ZKY,G=^D=N_2?VU+]F4;[G[[9R
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M[-_TOYY&H]T\&"OFUUZZ;^G]'Y?;_P">W&9U-M5MM(=:RF9+!.X@;R*OW_\
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M&;0"_$QPRIC^P:?HG_KEF]=9UWK3:OJ=3;6_]+FTUU,,Z^YH]?\ Z(>J6/\
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M,L<_W>+YE_K;3B=$Z37T;IK7,^W6^K8W<7$ANUL>X[O>_P!/_,0?JP+OJ_\
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M4I))))2DDDDE*22224I))))2DDDDE*22224I))))32S&O&7AV>JYC-[VNK!
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MW8A.=G]7*CQU1_N\?Z/J<IF1DM8RMGJ/HJRQ^DI=O8X&RL5T,M<[U'5-:_\
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M8N]<,(?NW$;G;2Z7/#C7N]/VO>YWT4]/3\2FMU;6;F/ :YKR7RUNC6?I2_\
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MBL$0)2K)*ZE9XXQXOEX-?TFS2>F-QF>DYOH/L&TDG6W=[9<_WNM]1OYRK_Y
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BRJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tv521048_ex4-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv521048_ex4-1img02.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_X0$V17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    <    <@$R  (    4    CH=I  0    !    I    -  +<;    G
M$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3,R!7:6YD;W=S #(P,3DZ,#4Z
M,#@@,3$Z,3,Z,#<      Z !  ,    !  $  * "  0    !   #-* #  0
M   !   $)0         & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $
M     $@    !    2     '_[08:4&AO=&]S:&]P(#,N,  X0DE-! 0
M  << @   G:\ #A"24T$)0      $$46KEE:;LY=+@[S%&D:X1<X0DE-!"\
M     $H"  $ 2    $@              - "  !  @             8 P
M9 (    !P ,  + $   !  \G 0 N &H < !G    = !R #A"24T#[0
M$ $L     0 ! 2P    !  $X0DE-!"8       X             /X   #A"
M24T$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M       ! #A"24T$"@       0  .$))32<0       *  $          CA"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #30    8
M        !"4   ,T    # !E '@ -  M #$ 7P!0 &$ 9P!E %\ ,@    $
M                         0             #-   !"4
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P  !"4     4F=H=&QO
M;F<   ,T    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   0E     %)G:'1L;VYG   #-     -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     $_
M\        #A"24T$%       !     $X0DE-!"$      %4    ! 0    \
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M65H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M     /;6  $     TRU(4" @
M                           18W!R=    5     S9&5S8P   80   !L
M=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@   BP
M   48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E9
M TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C
M:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,
M=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O
M;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M   2<U)'0B!)14,V,3DV-BTR+C$
M                                 %A96B        #S40 !     1;,
M6%E:(                     !865H@        ;Z(  #CU   #D%A96B
M      !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO
M+W=W=RYI96,N8V@
M                9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT
M(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                 &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@
M5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                  !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<
MG@    %865H@      !,"58 4    %<?YVUE87,          0
M              */     G-I9R      0U)4(&-U<G8        $      4
M"@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W
M 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4
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M(#Y@/J ^X#\A/V$_HC_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/
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MM@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]522224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_T/54DDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]'U5))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_2]522224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_T_54DDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]3U5))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_5]522224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_UO54DDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]?U5)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_0]522
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_T?54
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]+U
M5))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_3
M]522224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_
MU/54DDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\
M_]7U5))))2DDDDE*22224I))))2DDDDE,7!Q:0T[7$&'1,'QA5*\7J8#/4S0
M\M=+R*FC<WV^SZ3MOYWN5U).$B-J^HC+_I+90$B"3+3]V4H?]%I?9>H[8^V^
M[=.[TF_1_<_\R2.+U(AT9T2Z6_HFZ#7V*ZDC[DNT?\2'_>K?9CWG_P"&9/\
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M7J4?T[7=,^DSC]Q.<7J,/ S8+G L/I-]HU]G\I7$DO<EVC_B0_[U7LQ[S_\
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M9D_[YI?9>H[2/MNI=(=Z3=&Z^Q._%ZB2_;F[=SI9^B:=HU]G\I7$DO</:/\
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MFF,;J'LG-G:#O_1-]QDQ_53-Q>HC9NSMVTR[]$T;A^[_ "5=22]P]H_XL/\
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M!GVHCT]W\SZ'M^A_/)*=M)<MB?6C,O\ 3V&NVUWK.OQA3:PUUU>K^G^TV/\
M2M8VRNJM^WZ?JJ5?UGSG8'3G&JO[;D7UUYC ';&5E]-;[*O=O_2-R\7T=_\
MI4E/3I+!I^L]3^M9."YU1IJ;:*=KIM-F.&.RFV5[O:W]([T?_"]RE7G];_9X
MZJ_[.ZBW'?D?9P'-=7^C=?0/6WN^T_F5W?HZ/])6DIW$E@?MK,9TM^:7MML%
M=3Q6<>VEH-CF-=^DN>?4^G^8KN5G98S[\.@UL]+%;D->]I?J7VL<PM:^KV[:
MDE.DDN?_ &[FXV#@YN4*[6Y=%F38VMI86M9CG,]-F^RW<[<W;O5NC)ZICUC,
MZC9CG$-+KKA6US'4EK19M:YSK/M+-N_<[] DIU4ESG3_ *SVY?3W7$4G*KR<
M:FQE;M[!7E/IV>YKC^E95>ZM_P#P]*O=:S\W$LI%'Z+'>'&[)]"S)VN;L].M
MU&.YCV,L_2?I_P"0DIU4E7Z?D.RL*C(<ZMSK6-<YU+M]9)'N])YC<Q8K_K)E
MU9C!;4PX3+,IN58)W5UT758M5_.W8WUMV5_P?Z7_  :2GHDE@XW5NI=1R#BX
MKJ<=U?K/LO<PV#:S(NP\=E=8LJ^FW&>^ZSU/^+6QBNR'8];LIK&WQ^D;62YF
M[OL<X-=M24F22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224__]?U5))))2DDDDE*22224I))))2DDDDE*222
M24I4^IU]/=54_J-C*Z:K6V-]1P8PO;/IA^_VO]WOV?OJXJO4\7[7T_(QPUKW
M6U/:P.XW%KFLY^*2FM1@]&=D_M/&L8=I]8NK>#5(K?B^KM;^C_F?9_UI(_5[
MIA;8S:\5VMO;L#B&M&4:WY'I?Z/])5ZK/]'9]!5,_H_4#D/OZ>X4DAC UKRQ
MNP5Y#+ ZH?H_YVVG\U6>F8O4Z<S*.2XNQ[-:W.>7.W;GGV-_FVUMK+/\%2__
M ([^<24JGI/1790]-S;;<8U[J=X>&FJM^+3ZE6OT*K'_ $T=O1\&NWU6M+/U
M@90:##1;Z?V7<UG\NMWT/](LQG3.J,Z<,.FFJC)QZ'5,S0\%[R7,+S6YK6OJ
M^TM9ZESG_P"&_P"W$F=(ZDZL/O=98ZIU3J:3<X !N0;[6NVO<QS_ $&U>FZQ
M]W[GJI*;K.F]&<RO&8YCK6VC+:X/!M+_ %#D>MO'O<U[R[_K?Z-7:\2FK)OR
MVR+,@,%A)TBO=L@?F_36 SHO6:WV6ATFUU3KPVPM=8VNNBJVH/\ \'O].YJ>
M_I?7;[6-!].@,+'--SGRQU5U;JK'2W<]M]E7O]'_  ?\\DIV;>EXEU694X.+
M.HZY$'GV,Q_9^Y^CJ8H?L3I_HBKT]6W?:?5_PGJ^I]I]3U?I?SG_ ('^C5+I
M.#U>G/-N4YPH+3#/4W- (K%-.TN=[Z-MGO:RO_C+/40F=/\ K#6_+M;<76RZ
MR@.>?3L(M]6FMS)=Z=?V?]6LVMJ_Z[_.)*;MG1^E#%JI<[97@N>6V;X<SU [
MU6/L_<MKO]S')V?5[IK'%S6N#G#':3N/&*YMF/\ ]*JOU?\ 2^FLSJ?1>LWX
M[\8/.36]H:TFTL]X;C3?:/\ "LW59'Z+_5A<3I763NKS+GN8ZQIM+;7-#P!?
MO?7M=ZE;7N?C^S]#]#^:24Z+.A].93CU-KC[+8+:WS[R_P!V\V6?2L];U;/6
MW?SGJ(3?JYT\!K"ZY]-3'UT4.L)KJ;8TU.]%O\FI[JJM^_T:_P":6=7TSZQ?
M9'5V6N.6:V!^1ZYVN ]#U,=E0V[;/9D-^T?H_I[_ %/TOZ.Q@X/6J<['LM>Y
M](:1:++"0UOZ78QC6._G/=3_ #OVG_C_ &)*;+>@XE>+9C9&3D7XUE8I-=]L
MM:);L=60&.9:W:WTW[E8Q>E8^.ZZPOMONR&MKLNN=N?L;NV5M^BUC6^H]WM:
ML[+Z9U2_,RFR3B7[2"ZPR-KZ'@4M86M9M;7=_@O4_P"'?O0!TSZQ-RJ]MA%-
M-SC6XVN<307Y!]*S<[W/]&S'^G7;]#^>_1I*=C]CX)JQ:7,+Z\*LU5-<9!8Z
MO[,YMG^D_1*L?JST][6LN?=?76STJJ[;"YK&;FO=6R?WVL]%[[-]GH?HE0_8
M_7&6-;7D6^F*6M#A<=P=Z;VWM<^[U=S[,EWJLL]&S^O5Z2NU8O5?V-Z%G](%
MD[6V.#G4BP/-7K%]KJ[+*?9[;4E)<OHW2\J][2XTWOKKW"EX8[;5:,BBW8W_
M $=[?99M0V=*P;; VO/O?EXV]KK6W@VM;9MWTVP-OI[JVO9ZE?L>FZ/TW,QL
MO+R,K3[174ROWFQS0QV2YM;G.^EZ55U+-ZKU=-ZC7A4XK<:MEF+6*W9+;(LN
M;OK=<VJQC6OI^ULK>^Y[_P#"_P#;J2G5P^GLPB*Z'%N,RMM;*.0'!SWONW'W
M.LM]3WJ-/2,*F]U[6ESG^L'!QW-(R'LOR 6G]Y];5FLZ1U.US3D6V-K#H%;;
MW^VH_:?T3G,+?4?[\3])_P %_.)K.D=5M8'67V>MLVG;>]HD8];&Z,+6_P!/
M:ZU)3:H^K73L:BJG#==B^@VQE=E5A#]EKG7/J<YV[>QMC]U6[^:_P:M4XV%T
MNAH;9Z&-2P5@6/\ 8-2[U'.L_P +8Y_Z2Q[_ -(LRGIO6'.+;['AKG-^T/%S
MOTGZ7U'.J:V/L[/L_P"BV,]/_P!&(C^G]2?TC"IOF[+QGM=8]M@%@+0]C;*K
M+&OJML;O^CD,V6?\8DIV6O:X M(<" 009D'@IW.:T2XAHD"3IJ3M;_TESK>E
M=4K+#Z0<STZQ;73;Z,[#E;:AZ7IL8YGKX]K_ $O3KL?79_42/2>N6TV4W6G[
M0[TS]L]7<V6OQ[&^GB/;Z>^CTK??[-__ %[]&E/1J MJ+GL#VE]<>HT$2V=6
M[Q^;N6;?C]0LZ?B,<PNLJ(^U4LN<TO :^OVY/ML_G?3O]R!A=(SJ^F=3HR"'
MY.;N(>'DASCCTX^YSH&W]-78DIVFN:Z=I#H,&-8([)W.:QI>\AK6B7..@ '<
MKG+>C]9 >_$>:#?ZKKJ_5<>;,>RJMNNUMGHLRJ_59L_G/YQ7']/SK>BLQK#Z
MN0RQMIKL=(>UEOKC&LLBWVNJ;Z7^$_ZXDIU:;J;ZQ918VVL\/80YIC^4U36%
MDX75+7&VBAN-ZA>177;L+;2*FU9F2:O9?M;4]OI?I/9_I/S!,P.K,S QKK2^
M&6NO=<\UM<ZZYUWZ)QV6[\9M=7H_X+_@TE/1*+GL8)>X-'B3'DL+'Z;UC:SU
M'/:*RUY8<AYWVLKM#K7/;[O0NR74/]#^1_,JMB])Z\VWU;CN)T9-I)KW#&-W
MTWV[VOLQ[?S_ /")*>H27.CI76;&FM]CV-VD6$7OFRT,R!]H86[74U/M?C.]
M'_@_YOV+2.-FY/2+</(=Z62^CT3>"#+G5AK[M!_I7/24VZLK&N#C3<RT,.UQ
M8X.@_NNVGZ2(US7-#FD.:X2"-005SUO2\^_(IR6XK,9N,VJOT&6 !^U[7.?+
M UNS'8/T&_\ TEG\V@.Z+UZJEM&/<[T&-K_1BUV[>*?2>YCW.9M8S(VO]/?Z
M?_!?F)*>I4=S=VR1NB=LZQXPLT8.>W#S@VYWVS(+O2L+R0 &[*M@^A1_UJO^
M6L_*Z7U>P-./6:@YKF.:Z]S[&-FQU?Z4.J<[WNK]OK?H_P#A4E/2)+F&],^L
M7IO;;8Y[G5UE[Q;[G6-]/>VN#4ST?YW>W]6N_P"[2F[IOUA?:Y]ESFEU+1^A
MM( (I]-](]7U/=]I_2^KZ7_H0DIZ10]6OU/2WM]7;NV2-VV=N_;]+;N66,7J
MAZ/739_/ML!LK98YKGU!Y=Z7KN?8YECJMO\ AO\ @O52Z/T[-QLK(R<HR^ZF
MFL'>7F:W9!VN<X?F5VTM]3_")*=;<W<&2-Q!(;W@<G_I)UR[>C===6\N>YMU
M3'C%L-SM_J...[=:YKO3<W]#9^:RI_\ W&K1J^F=<MR[79%CJ\:YS2]C+GCZ
M-SK)K<'[VM=C;&>ST/\ 1^FDIZ))<NWI?UB;A.8ZU[\@.:?YT[7/#;0^WZ8M
M])]CZG;&78_T/YGV;+=/JN+U.\4G'/N%;FD,M-89<=GI9#O]-55ML_1N_P"V
MTE.DVVI^[8]KMCMCX(,._<=^Z[5.US7M#F$.:=01J"LBOI>35TRR@-W6G-=E
M-:'D2PY7VMOZ3]_T/^FJ+NB]:IJ95CVN%(;2;:A:Z2]OVD7>D=]?IM]^&[:V
MRNO]$DIZ2VZJFLVW/;76WZ3WD-:/BYR=CV6,#ZW!['"6N:9!![@A9N5AYCJ>
MG6$?:K<)S7W5.<!ZA]-U+K-Q;L]6NQ_JL_FU4'3^KB[=2QN,'2ZMM5I%=37"
MWU*#2!LLNLN>RWUMG_GKWI3OI+FQT_K NLIQGVL-5;6,R+;GN;K0X/8&V;_4
M>[+>RSU__5:D_IO6'->]F^MK0?L^.<A[BW<:&V^H]KV>J[TV93ZM]O\ A/\
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M8%?3^MTTFXN^TY?=CKG!C@*!56T?1]/]:WOL?6RNRQ#9TWK_ -HJ>+[&M#
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M02T^JU[7O]WTC].M_J(-_P!6GVWL>,K;6RQE@9L,S7:S(^F'C=O])M?Z3?\
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MUV(M?U>][+;74BUFT,]&K8&[7T6$ME[G;K&8VQ__ )@DIO6-Z56!N;7+B6M
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M "%7_;__  :1ORQ,8T^'O;X5_P#D[?\ MG_A$4Y% 8'FQFPDM#MP@D3N;/\
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M1N/Z/J[V_P#<M5G=(ZLU]MV*74WML'HO-I+2QV5=D6NL9+M[/LM_\W:U=$2
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MFQF874[?LIHEFRIK=HM+15:"PNM?M_I3?3#J_P#U:HGI6;7TF[&I);:_+NO
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M_P BEZ&1_P!R'?YK/_(I*<ROHN8W.KRW7!SJ\@V$[G$^B6Y#30)_EW4NV_\
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MDI.D@>AD?]R'?YK/_(I>AD?]R'?YK/\ R*2DZ2!Z&1_W(=_FL_\ (I>AD?\
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M_,7ZJ_\ <+_P6[_TLMY))3@_\Q?JM_W"_P#!;O\ TLE_S%^JW_<+_P %N_\
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M56*.H]4^W48CO<S(<\LLLKV6"JDAUEMM7LV>NVQM-7Z.M)3K?:V?N6_]MO\
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MT=?_ &X[_P!))B_+ DUU #_A'?\ I))2=) ]3+F/3JGF/4=_Z23[LS_1U_\
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MK_[<=_Z12W9G^CK_ .W'?^D4E)DD'=F?Z.O_ +<=_P"D4Q?EB)KJUX_2._\
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MAI],_F57X[%NI)*>??\ MJW)RSCF[TVV/89<QK2P&C;7B-=]"[9]H_2V;/\
MC/YOTX/I^M(C[.YPKEQ:VUU9>&E[\>NNQWN]U6/;7F_G_I,?TET:22GGCB_6
M"S+O8^ZUE#[(WL+0/2]6O9Z3][G5V-Q?4]7;CU?V_P!$KG4Z^J'*J.)ZAK#6
MAI8YK6M?O'JOR6O]UE?V?Z&WU/\ /]-:%N5C4$"ZUE1.H#W!L_YQ4/VCT_\
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M_<9_^<S_ ,FDI.D@>O?_ -QG_P"<S_R:7KW_ /<9_P#G,_\ )I*3I('KW_\
M<9_^<S_R:7KW_P#<9_\ G,_\FDI.D@>O?_W&?_G,_P#)I>O?_P!QG_YS/_)I
M*3I('KW_ /<9_P#G,_\ )I>O?_W&?_G,_P#)I*3I('KW_P#<9_\ G,_\FEZ]
M_P#W&?\ YS/_ ":2DZ2!Z]__ '&?_G,_\FEZ]_\ W&?_ )S/_)I*3I(!OO\
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M2DZ2!Z]__<9_^<S_ ,FEZ]\?T=W^<S_R:2DZ2!Z]_P#W&?\ YS/_ ":0NO)
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M\/\ [8K_ /(+%ZEA](Q,US1TS!&,T!NX8U3SO<US]C]NUU5OT/2997Z5E?\
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MOHE]-;K6[ZV;W[<CZ'_@EB#9;T-]C?2Z1A5U[PQ\X];R00Q['U^VKZ3+6?\
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M7UL]-KF%P%CG.@@;?4?M:T'\Q)2;_FY]7O\ RKP_^V*__()?\W/J]_Y5X?\
MVQ7_ .00!]9L,["VNS:]Y9N($2TAC_SOS=[/>[]'L6CAYE693ZU4@26EKM'
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M *'_ *42^TO_ .X]O_0_]*)*3I('VE__ ''M_P"A_P"E$OM#_P#06_\ 0_\
M2B2DZ2!]I?\ ]Q[?^A_Z43C(>2!Z%@GN=L#_ *:2G+/_ (LA_P"FT_\ G]JV
MEBG_ ,60_P#3:?\ S^U;22E))))*4DDDDI22222E))))*4DDDDI22222E)))
M)*4DDDDI22222E))))*4DDDDI22222E))))*4DDDDI22222E))))*<'Z]_\
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M3)(/VNK]VS_MJS_R"7VNK]VS_MJS_P @DI,D@_:ZOW;/^VK/_()?:ZOW;/\
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M)3B_LWZS_P#EU7_[!M_]+I?LWZS_ /EU7_[!M_\ 2ZVDDE.+^S?K/_Y=5_\
ML&W_ -+I?LWZS_\ EU7_ .P;?_2ZVDDE.+^S?K/_ .75?_L&W_TNE^S?K/\
M^75?_L&W_P!+K:224XO[-^L__EU7_P"P;?\ TNE^S?K/_P"75?\ [!M_]+K:
M224\YU'ZN]=ZGA6X.7UACL>\ 6!N(UI@$/T=Z_\ )71 0(3I)*4DDDDI2222
M2E))))*4DDDDI22222E))))*4DDDDI__UO54DDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE/\ _]?U5))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))3_ /_0]522224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224_P#_T?54DDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE/\ _]+U5))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))3_ /_3]522224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224_P#_U/54DDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]7U5))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DD
MDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_6]522224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_U_54DDDE*22224I)
M)))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE
M*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))
M))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE/\ _]#U5))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))
M)2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2
M2224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))3_ /_1]522224I))))
M2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2
MDDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224_P#_TO54DDDE*222
M24I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2D
MDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*2222
M4I))))2DDDDE*22224I))))2DVYLQ(GP3K-S.EMONNM8Q@?96Q@?P[<'%SW;
MP-W\VB*ZKX1B34I</CNZ2;<V8D2>%F8N)U.K-#[;M^,-P#2XN.W7TVG=])_Y
MWJ(3NE9#G%^]IVEI]/2';;K<@M-FSU*G>G:S;Z;D:'=?[4+HY8]-1_6=@.:Z
M=I!VF#!X*=9F!A9&-ZXAE>]FVN""=P+S.\5UN]/W_P"%]6W^6@#$ZI5;[\F:
MB6@-=8X%W\VYU;7GW-=[;O<W_P!5KA'=7LP,B!DCI57^D[*=8M.-UA]-0<^-
M&O<7N.Z8I_1N:6_FNKM=O3G!ZN'EK<@[#6!],S,,W_2W?X46/W_];2X1W"?8
MC='+!V4EE9'3\O(JQP]P]1E;J[8>X"7&IV[^7_-(-_3>J6AU?JDUECV:VO$@
MBST]W\K>:O>EPCNB.*!J\H&]_1VTEFY&+U%^4U]-^S'.W>PDR)TMVZ?F^FS9
M_P 9<H8^/U)F#>W(O!L?&RS<8&@]1^_\S>A7BCVH\(/N1UKT]?5_WKJI+#=1
MU07EK;C:RQQ],-L((:1::K7N]SMC/T3/^%>CLQ.H/>&V7S6XS86V.!>V7%KJ
MVM_F-K-C-M;D>'Q"XX(C7W([6ZB=8]G3K#7@5/?M=2QM5@]5P)(=1;[/WW[*
M+/Y:)AXO5*\MC[[M]+601),^UK>_YWJ!S_42H=T'%#A)&06+T/Z7#MP_WG42
M62<3JLB+-=9=ZKHW[@6W>GM_F_3W?J_T%+$P\VO)JMR7[PPV $V.)AX9$M^@
M_P!U;TN$=U'%$ GW(Z Z!U$RQ?V?U5@8VFSTZV$>SU7'4.!<_AOL>S_!?^E%
M*S!ZNXOB[\YQ:=YW0XM.V=OT=K?S/12X1W"?8A_G8NRF#FN$M((\0L^_&ZA9
MZ(:\-AC6V%KW !TM]9T1^FWU[F,WIOL655B8E%#MOHU['@/+??#-MFZ'>JUF
MVS]&[Z:%#NM&.-#UBR723+%'3>JV8]M>3<7%U;@P"QP]\5ZN<W\QVVS^HITX
M/59'JVZ;FEWZ1Q(:=GK-8\^YO#__ %&CPCN%WLPU_6QT=A)9UF-U'T<1K+)?
M21ZTN,.C;]*!O?[55/3NIU5-JHNB(('J.$. ]VW_ (/^1]#_ (-+A'=$<4#_
M )2(U=M)8UF%U@N::LD[2WW'>?I'U-^W<'-]VZO9[/T:TL-E[,9C,@@VB=Q!
M)[^WW/\ =]% BNMK9XXQ (G&7@-TZ222#&I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))3_ /_3]522224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I
M))))2DDDDE*61?B9MF<]S+V^F3)I%KVDM'H^R&[O3_K,_P!)_P (M=9=G1VO
MS+,D/:PO>+&D#W!TX^X[I_=QG?\ ;J=$LV"0C(DRX?3U'&C.-U&K(8_U!M'N
M+G6OV.]U(90_</;[?48Q_P#A4W[,ZD:0#D?I!!,/> 3^B#Y,?G-KM1<7I5M6
M+90^_>7OK<'>'IECG._KV;%4'1\VFRH!_P!H&]A+B0 S:ZIS[?I-_2VLK=O_
M )Q.OQ'V-B,XDD#+ &)T)A\X_P )LX>'DUY-.1D7MMAA8'EY.XN;6 QE<"O_
M  5CO4^G8JUO1\JZ69-S7.DNK:;;/I%MC?ZS6N<6(M71[7-+F937APT=!=)#
M75;IW;O;/[_^8HLZ(YS-]60P'WL#V@Z#<[]'+2S\YSMZ5^/X)&2()(S &A'Y
M#Z?F/^"V,;I_4&Y?J7WE](>7[ YVO\YL[-^CNJ]GT/8HYV#U+)M>]CV50TLK
M+7O:2/>YKG[6^W:[T_\ 2(E/2W,N9:ZP2Q^YC&@PT3;OKKU^@YMK/\Q#?T=]
MF59<^UIKM)+F0=08VM=K^:A>N_X,8R#CXO<CI'?@_P"Y7.)GLN#V7AUIW.-3
MK' .$N:.SMOIMM;]%BA7TWJ/K VWS5[18&V/DANSC_,?^<I8^+7A98LON:]S
MZS6-#O?.QWN,GVUMI<ACI&3;CM%EVQY#FDG5S!+!4YA:[9ZS<>OT[$K\?P7"
M0&\X@$ <7!Y_+_<;6)0\X#VYSMQNEL6&/;_,TM<#^?8T-=9_PMBD:,H=.&-6
MRLVU-K8PV:L):&?I(VGZ#OH*+<"Q^+93DV->;'UO, [=M8J&V'./T_1_Z:J-
MZ2ZMSGC*8"S]&QT?1?\ HCCM=[OS'L_F_P"6EIWZK!PR))R >KB X9&'A7_0
M38W2756,W-8*@2YXW%SC-?H&G=M9NK=_/?\ HM%Q.GNQG4V ,W58XH>1(F"P
MMC3Z#&M>HXO2WX^;Z_KEU89MV'GZ+&>[^3N9ZJ SH]TN R6D;C&AW-)+'^HQ
MV[=ZNUOY_P"^E=]4F8D3>840/T9?UO3_ (+9&(U_4V9N]KFD%U8#C)!8VO<&
M_1<@?8^HVNL<VQS6A[VTA[W-(;.ZJXAN[U/3>ZWV/_G*O21,3I3L>_U3:TQ4
M:@X AVHI:WO]&OT?T:6!T[T[&6NM;8VO< UL[=X#*76>YSOTFZNSU/ZZ5^/1
M7&!9&02X8B,;CVXO2K&Q,TWUONN#ZJO;[7N.XM]0;WCV^[W>^O\ D*%O3,RV
MRW?;^C=8;*_>_<T[;F-VENWT]OJ5?14'=&:X75UVU@[R=H'T0YUM^TZ_2=ZU
M7_;27[*]:HEF2U[W-#7/$PZ/1+/SG;OYJS]_^=2^OX+N*-DC(!?I_F_E'S<2
MJL+-LR'DY(<QKHL#+'F'"2SV_P G=7N;N3XO3^JU75/MR-[6'WM+W$1 #]-K
M-SG._><F/0K06&O(#""YSRT;?<X[W/;S[G?0>GMZ(XN8ZJ_T]I' C0-J:-O\
MIKZ['M_X]&QW'V).2!T]V-2%?S>U?]\RR,/..1<ZO,%=4.(:7&6;FEU;S_U_
M_P !0V].ZB^@QD[G2 V+'$ !S_6KWAO]3W;?^#4Z.F5OHS<?U:[#D,#'%HG4
M>HWU;?=[GO?]+^HAW]%.S:S(;4;7< 0'.)O?Y^YK;F[/^)2OI?X*$P/3[@%&
M.^/< <5MG(Q<S[/3-X#JJB++'/<P!\,_6#L'Z79M?[+%!G3^H B+_3:2=S=[
MGP UI86/?_W8;O?_ ,%9Z:GG=+MR7M+;MH%1J=N!).X.:7<_G;D&WI#F/]5M
M[:JJMY&A&QKO6=$S]%OJM_S$ =-_P61G'A ]R()O3@MBWI?5/0#79/O;J/>Z
M.:=WNVM^FUE_TOH>JC8G3\VO*INR+/5])I!<7N)U8UFP5[17[7-=^F^F]!/0
MK9L#,@"M\;6]N6N@_P EFWV;O45C+Z;?D''BYH=0T F.2'5N<YNOMW;-J1/B
M-?!,L@/I]V-2XK/!P\/%%!]CS,?TV"PUUN>&.#7N+0PSZMF]^WT[+7>DRIBV
M5D?L-X-<6-+6.8^' Z%OH.?8SW?SEKJ'_P#;JUT)';5BSR$N$B0D=;H<*DDD
MDU@4DDDDI22222E)(65<ZC'LN94^]S&DBFN-[OY+-Y8W_I+G.F]=^L-=-G[0
MZ+F66ONL>S8:2UM;G335)N9_-L24]0DLWIO5<O-N=7=TW)P6M;N%E_I[29C8
M/1MM=N6DDI22222E))))*4DDDDI22222E))))*4DDDDI_]3U5))))2DDDDE*
M22224I))))2DDDDE*22224I))))2DDD-U]37['.AWS^/*2DB2%]JHV[MVAT&
MAU_JZ>Y+[31L]3>-@,$^:2DJ2&S(I>[:UTN/;4'\4QR: 2"Z"WZ6AT_!)25)
M1:]KYVF=I@_$)C=6UCGET-:8<? I*9I(3LFAKBTNU'/.GQ3?:J-?=]$P=#R?
MDDI,DA#(I<'$.T;J[R3',QQR_CR/]R2DR2@VUCYVG@ GMH5 96.7!H>)<8;R
M)_JI*3)(3<FESMK729COSX2BI*4DDDDI22222E))))*4DDDDI22222E))))*
M4DDDDI22222E))))*4DDFD!)2Z2%5D56DBLSM[]C_5_>14E*22224I96=TEF
M1:^P7BMY?O=IPW8RIOYS7>QS-];O^$6JLJW!ILS+;LBVMC6O;9MTDM I_GW.
M/T'.J]C4Z.^],V"1C(D2X-.W'?\ 5I%^R+1=:6WL:US/2WELEV\V.L]3WM_3
M^ZO](D.B1;ZHR@?TFX;A.NYSO=+]C[?=L^@G9TW%-@>,ECHW5@.8(.KG/>=S
MOTF0S?\ SZ@SI.-6/2^U@/K>UVYPX,>FT>]Y9ZC_ $W?^DDZ_'\&S[AU_6G;
M_-+LZ"QKSLR&AAEK6!NG_%%H?[J_]+6B6=-JOP/L;+ZVBA[R\AHV@V![FM#=
MWL]/U_WT"KI6&XL<S-]C'0-OM&C@W;6_?_.>I0__ $BM5=,I;BVXS;F?38]^
MUH &P5MAS-WY_H[MZ1/C^")Y#8O,28D'7'P\/Z-_XLE9O3GW/-M5K38*#6&$
M3NEMC1KN]C7.L^DU!LZ)ZKP1E!A@RQ@AK=7RVIN_V5?I/TK$;"PL?%M9>W*8
M]M53:W1 !T#&.<[<[9]%5:^F8#[W5U9@W[',<P<EP:^BP_2VN_.]1FU('QV\
M$1F18&4@0&DO;_YLFR>CUV.]3U*VG8YC?39#6[O4_F_<=O\ .*1PZJ<)['W5
M-;+7E^V&N%9:YSK_ '_I?4C]*J@Z;3M<+,IE;<JUY:VL#W%WJTU^E#O;_2/>
MU$?T&F-C\@26N:X%LSOW[8;8]_LW/_\ ,TO\+\$F0T$LQH'3]7^[_P"A+W=)
MK#7OLR&,8T2\AI;H!7^C=%G\RSTMU5:)]@IQ,&QEMM466-M+WU@-)8UCG;ZV
MN&[=Z&Y!=T.BUUSADA^[?+2W>&^IZAES-_TV>K^A<K>2S#S\1E;LAA8_<6NT
MU!8^N-KC^8VU"]M?P1+)\H]PRC?J]'#PUZHM1O1!8!8,@%KZP!N:0XM/I;=W
MN:__  7YR-C=)->15D?:0\LB8:-1M]/:WW;&;MOYC5+-PJ\JZFIMC:V"MS'0
M1+M!Z36L_P""=^F0Q@T4Y,'*8QTMNMJ#0T 5NW-V#=^@9^E_.^FE9K?\%>[*
M4:.7<'T\'%Z?EWBQR^F5V.=0;ZVOM<]X]DO.[?\ SAW>[TG7LV)V=,8X&RO)
M8[TWAWJ%LEKV/=?L:[>-M;M_Z50OP<')R[OUEK'S#H #IL%5@9ZQ/Z3VU>QG
MYGJ(XQ\*BD8MMU8]6YMH:&AK#+F14VN7-]\L1O0:_@HSEPQ R2XC1,?;[]?E
M]2"SI#6AKK<I@(>UY);^<YU>W;[]S=^S8W^NICHK:V[!>QK6CC;&P>R+*_?^
MCN_1?SB@[IF%56US\IA8QS0PEH)+VFD;'>[])_,?S?YB)E8E5N5>^J^LW.=6
MQ]+P")FFP;Y=[OT=7T&;-Z5^/X)]R6@&4UKK[?I_1_[Y-7TVNO&MQQ:!ZH87
M$ #Z+6,?81N_PNSW*G;TG&?<VBG)%;R"[TVM,1+W"SV'Z5;+JJZG_P A)_3<
M*K)V/S VPAOZ-W$D>T.;OV>@[T7_ *'_ *:E?TJH-MOKM8+1H^QH:T5 ;/5<
M-N[;MKK?^C_X1('QW\%1E1_GI>O7^;KU?+'YOT6?[#I$[;6,<\N]-P8 =KO7
M.SZ7NW?:/TG_ !:D.D^E>V_U:]]1-C6EL!O\[MKJ]_Z&C]-[T]E&%EOQLFN]
MM5=08:V.$&&/98(W%COS6L2MP\?)M=D,NK<#=W8'^]@%;Z;';OYIOI?0_P!(
MA9ZG\%ON3/S9"+!$KAL?W%\[ JR,BNU^0*7$L8ZL?G.UEO(_G,=]U2:CIU;6
MYS?M.\7A];Y_,+B]WZ3W>YS?54,;I&/2T7C(%E=3FV[B 1->[>XOW'\T_F?0
M2.-AY6[(&0QC;SO;+ TD%U5A]3<6NL_FV>F[_![TO"]/)7%IPC(3"-#BX/'B
MX5/Z-0;VGU6"H.,5!@T:\VN]-I:?:UWJJ>/T=S,FK*.2;7-UL='TW?I-SA#O
M:U_J?0_D(%'2,5M3B,MKJV'T['0 -S!Z7N+G^W;_ "5H8K:.GXS*;+FD;]K2
M8&KG0VL:N=])VWW)$GH;^BLF20!$<AF3Z.'@X=/TFXDDDF--22222E))))*4
MDDDDI!FYE&#B79F2[930POL=SHT3H%5PNK/NQ+LS-Q;.FT5#<'9+F FN-WJN
M;6Y_I?U+%9ZA@T=0PK\+(GTLAAK?M,&#W:?WFK&H^KV3E&MG4^K/ZGA8[A&-
MLK8USF?0^UOI]U_I_P"C_P ])2?IGUE9U'J7V)F)=34^@Y-&1=#196'-JWLI
MGU6-=O\ 9ZNQ;2S:\2C(ZT.K49#+!5CNQ'5LAT$V-MDO:[V[=FS8M))2DDDD
ME*22224I))))2DDDDE*22224I))))3__U?54DDDE*22224I))))2DDDDE*22
M224I))))2DDDDE*5:W&>^PN:X-!Y(F8B-I_-<K*&ZYK7[2".->VNB2D%>+<P
M-(<W<SCZ1!TVF=SDSL.YS7,=8"'G>XQ!W1'^:CFYFW<-1.W3Q"GO$M'[W"2D
M%>(67BT.EH'!DGC;](HGHR^PNU;8 (^$_P!Z=MS7 N$P-93?:*Y DZG;QWB4
ME+T5>C2VODM&I\3XJ#L>:GUDCWOW?*=T*7KC]UPUV]N?O3.R6-G=(A)2#["\
M.<6O&I]IU#FC320?=Q^<BOQB\.!/TGA_W;=/^BI_:*]Y9.HY\.-R89%9YD'L
M#R4E(?L5@WAKQMMT=,D@3NY4QC7>GZ1>W8&[6P-?[2)Z[>P)UCMS]ZEZC=A?
MV$SXZ)*8^C[['$Z6 -CX _WH)PWO=7ZK@6U M  @F1&[^LC?:*Y@R#KI'AJF
M&0PF #/<:?WI*0TX=E;FG>#!EQ$@GR<)VJXAUVMLF)T@Z^!X4GO#(T)), !)
M3))";>QQ$3!,!T:3^ZDZ^MA<"=6Q/SX24E20FWAS]FUP=WD*3K&L+0?SC 24
MS20O7:8@.,ZMTY'DF&2PB0#!,#3_ %\$E)DD-EH>8 .@!D\:IK,BNN=QB)G3
MP&Y)25)#=:&F"#Q,]H"8Y# 2!+B!)C6 DI*DA>NWVP"=X!$#L5)]C61NTW&!
M\2DIFD@G)8!NAQ;)$@=PI&UH:YQD!O.FJ2DB2%Z[-Q DP0"1P)X14E+$@"3H
M JXR+K;"VEH%;?\ ".F#IV;[43)9992YE<;G:>[B"H"VVLM%S6AI]N\'2>VG
MYJ2F5=XU9:0RP<@Z C]YLJ$F\.WN#:@8<SOI_I'?FHSZJ[-'M#HXD2J[\([@
M:W -'#7 F/\ I?1_D.24N+:V6FP#?60&[F:ANW\W:U6&O8\2QP</$&50^Q$V
ML87[GM;N>XGL3^:W_P R34W!N0+'M%;0PM<X: D=_HM]1)3I)*+7-<T.:9!X
M*DDI2QLVK&]>QN][G66@[6,#CO#66.;ZGM?M].MGT7,^FME95K>F-R[3DV,=
MM?ZHK<)A[FLI?H0[=_@OH_Z1.CNS<N:D3KM^B.(WT:=>)A-K&.VVPMV2^PUM
M]H8ZW:_<_P#F]MC+-^U2^QXV1N99;;79:=Q+V!LBUUFRQH!^COMV?^?JU9K'
M1O3%[BUPN:&#U(D->77<^W9[<OW_ ,A(,P#LG+-I(9[K2)%=3O5V#:VOZ3J_
MI/\ TEB=?FV3EE9/K&N_#]OZ*.[I_3_6-1RVLM=NK],[9BUUC]NT_P"$_3_H
MWIW.Z50VZK[2)RF.K<1!(!>Z7R/W79B)E_LYKJ[7%[SF/'IAL:ESL?\ >V^W
M]#2H,P.D8;@[URTL<!!(_P &:G[/:S=^C<RM*^]K1*XCBEDU_1$1ZI1W_1_>
M8WX/2W@D93*B0;@00!M<Y]F[VEFYGZ;VJ+>G=/'3WY+;7.Q]I<U[6C<&CU=V
MW][=ZKU8;T_I]A8RN]QV$65M:YI]]36L;=]'\QCJ_P#@U)CNF.PSA_:-]5DU
MF2)EWN=^;^=ZK?Y"5^)5[DJ C+(?4#+T_H_I?HM.JK!=<;77&NRMX?:'L:T
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M%GU!S,FO#Q\;#NNR)%89C @P-SOTGI;/:W^4MOK.%9G])R\*IP;9DTOJ:YW
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M.:&U.+MM7JO=M<0]KJ]SV_IMS_\ MG_!)4=)ZDZD^EFM>TO>-VYYB2QK_?\
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F5)+Y5224_522^54DE/U4DOE5))3]5)+Y5224_522^54DE/\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #I 9 # 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYGLT2".)$'10!7E/C;3?L&OR2*N(KD>8#[]#7K KE_'>F_;=#-P@S);'>/\
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M-%-^[;L%=>_S=]3D+;2[/4_%FM"\A$H0Q[<L1CY?:K.H^%[6WM)+C2P]I=Q
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M8[5U)Z5SGA;_ (^-9_Z_6HGK)1"B^6,YK=$&K:%%I5F^HZ.)(+BW^?8C,PD
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M/YUO>6F/N+^59*,I7?<Z)SIPY8V=UY_,R/"M[]M\/6S%LO&/*;_@/%5O%?\
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MT##%(1TI12'J* '4A%+2=Z $HQBEH[F@0>M)CFEH[4##%&!110 F!1C-+10
M8%&***07#%(12T>E, P**!UI: $- I.U** %IN*=2'I0 4A -+1ZT & *2@]
K:6@ QBEI.XI:0"8YS11VI/2@ X]*,"B@]:=@#%&!Z4ZD/:D M%%%,#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
